WorldWideScience

Sample records for therapies product development

  1. Cell therapy medicinal product regulatory framework in Europe and its application for MSC based therapy development

    Directory of Open Access Journals (Sweden)

    Janis eAncans

    2012-08-01

    Full Text Available Advanced therapy medicinal products (ATMPs, including cell therapy products, form a new class of medicines in the European Union. Since ATMPs are at the forefront of scientific innovation in medicine, specific regulatory framework has been developed for these medicines and implemented from 2009. The Committee for Advanced Therapies (CAT has been established at European Medicines Agency (EMA for centralized classification, certification and evaluation procedures, and other ATMP related tasks. Guidance documents, initiatives and interaction platforms are available to make the new framework more accessible for small and medium-sized enterprises, academia, hospitals and foundations. Good understanding of centralised and national components of the regulatory system is required to plan product development. It is in the best interests of cell therapy developers to utilise provided resources starting with the preclinical stage. Whilst there have not been mesenchymal stem cell (MSC based medicine authorisations in the EU, three MSC products have received marketing approval in other regions since 2011. Information provided on regulatory requirements, procedures and initiatives is aimed to facilitate MSC based medicinal product development and authorisation in the EU.

  2. [The certification of advanced therapy medicinal products. A quality label for product development in small and medium-sized enterprises].

    Science.gov (United States)

    Berger, A; Schüle, S; Flory, E

    2011-07-01

    Advanced therapy medicinal products (ATMPs) are gene therapy, cell therapy, and tissue engineered products. To gain access to the market within the European Union, ATMPs must be authorized by the European Commission (EC). Especially for small and medium-sized enterprises (SMEs), the European centralized procedure of marketing authorization that is conducted by the European Medicines Agency (EMA) constitutes a major challenge, because SMEs often have little experience with regulatory procedures and many have limited financial possibilities. To tackle these challenges, a certification procedure exclusively for SMEs and their ATMP development was introduced by the EC. Independently from a marketing authorization application, development and/or production processes can be certified. An issued certificate demonstrates that the respective process meets the current regulatory and scientific requirements of the EMA, representing a valuable milestone for putative investors and licensees. This article highlights the background, the detailed procedure, the minimum requirements, as well as the costs of certification, while giving further noteworthy guidance for interested parties.

  3. Development of the First World Health Organization Lentiviral Vector Standard: Toward the Production Control and Standardization of Lentivirus-Based Gene Therapy Products

    Science.gov (United States)

    Zhao, Yuan; Stepto, Hannah; Schneider, Christian K

    2017-01-01

    Gene therapy is a rapidly evolving field. So far, there have been >2,400 gene therapy products in clinical trials and four products on the market. A prerequisite for producing gene therapy products is ensuring their quality and safety. This requires appropriately controlled and standardized production and testing procedures that result in consistent safety and efficacy. Assuring the quality and safety of lentivirus-based gene therapy products in particular presents a great challenge because they are cell-based multigene products that include viral and therapeutic proteins as well as modified cells. In addition to the continuous refinement of a product, changes in production sites and manufacturing processes have become more and more common, posing challenges to developers regarding reproducibility and comparability of results. This paper discusses the concept of developing a first World Health Organization International Standard, suitable for the standardization of assays and enabling comparison of cross-trial and cross-manufacturing results for this important vector platform. The standard will be expected to optimize the development of gene therapy medicinal products, which is especially important, given the usually orphan nature of the diseases to be treated, naturally hampering reproducibility and comparability of results. PMID:28747142

  4. Advanced Therapy Medicinal Products for Rare Diseases: State of Play of Incentives Supporting Development in Europe

    Directory of Open Access Journals (Sweden)

    Andreas M. Farkas

    2017-05-01

    Full Text Available In 2008, the European Union introduced the Advanced Medicines Regulation aiming to improve regulation of advanced therapy medicinal products (ATMPs. We applied the ATMPs classification definitions in this Regulation to understand the link of this emerging group of medicinal products and the use of the Orphan Regulation. A total of 185 products that can be classified as ATMPs based on this Regulation have been submitted for orphan designation. Prior to its introduction in 2008, 4.5% of the products submitted for orphan designation met these criteria. This percentage went up to 15% after 2008. We analyzed several parameters associated with active ATMP ODDs focusing on sponsor type and EU-Member State origin, therapeutic area targeted, and ATMP classification [i.e., somatic cell therapy medicinal product, tissue-engineered product (TEP, or gene therapy medicinal product (GTMP] and the use of regulatory services linked to incentives such as the use of protocol assistance (PA and other Committees [Committee for Advanced Therapies (CAT and the Pediatric Committee]. The aim here was to gain insight on the use of different services. The UK submits the largest number of ATMPs for ODD representing ~30% of the total to date. Few submissions have been received from central and Eastern European Member States as well as some of the larger Member States such as Germany (3.6%. ATMPs ODDs were primarily GTMPs (48.7% and SCTMPs (43.3%. TEPs only represented 8% of all submissions for this medicinal class. This is different from non-ODDs ATMPs where GTMPs make only 20% of ATMPs. A total of 11.7% of ATMP ODDs had received formal CAT classification. A total of 29.8% of all orphan drug (OD ATMPs requested PA. A total of 71.8% did not have an agreed pediatric investigation plan (PIP. Four products (Glybera one PA; Zalmoxis two; Holoclar one; Strimvelis three have received a marketing authorization (MAA and a 10-year market exclusivity. Strimvelis also completed their

  5. Product Development

    Science.gov (United States)

    McKim, Brian

    Product development is a vital piece of any industry, especially the food industry. It drives innovation, advances technology, and encourages growth. With the increasing concern for the safety of the food supply, product development has become an important step in the overall business process to provide consumers with food they feel safe eating. As a result, the product development profession has become an increasingly important and rewarding line of work.

  6. Developing a dashboard for benchmarking the productivity of a medication therapy management program.

    Science.gov (United States)

    Umbreit, Audrey; Holm, Emily; Gander, Kelsey; Davis, Kelsie; Dittrich, Kristina; Jandl, Vanda; Odell, Laura; Sweeten, Perry

    To describe a method for internal benchmarking of medication therapy management (MTM) pharmacist activities. Multisite MTM pharmacist practices within an integrated health care system. MTM pharmacists are located within primary care clinics and provide medication management through collaborative practice. MTM pharmacist activity is grouped into 3 categories: direct patient care, nonvisit patient care, and professional activities. MTM pharmacist activities were tracked with the use of the computer-based application Pharmacist Ambulatory Resource Management System (PhARMS) over a 12-month period to measure growth during a time of expansion. A total of 81% of MTM pharmacist time was recorded. A total of 1655.1 hours (41%) was nonvisit patient care, 1185.2 hours (29%) was direct patient care, and 1190.4 hours (30%) was professional activities. The number of patient visits per month increased during the study period. There were 1496 direct patient care encounters documented. Of those, 1051 (70.2%) were face-to-face visits, 257 (17.2%) were by telephone, and 188 (12.6%) were chart reviews. Nonvisit patient care and professional activities also increased during the period. PhARMS reported MTM pharmacist activities and captured nonvisit patient care work not tracked elsewhere. Internal benchmarking data proved to be useful for justifying increases in MTM pharmacist personnel resources. Reviewing data helped to identify best practices from high-performing sites. Limitations include potential for self-reporting bias and lack of patient outcomes data. Implementing PhARMS facilitated internal benchmarking of patient care and nonpatient care activities in a regional MTM program. Copyright © 2017 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

  7. Innovation in Product Development

    DEFF Research Database (Denmark)

    McAloone, Tim C.; Restrepo-Giraldo, John Dairo

    2005-01-01

    The course on Innovation in Product Development attempts to identify and understand the nature of innovation and product development and their important factors. The course takes both a theoretical and a practical approach and employs a mix of lectures, project work and group discussion. Format...... insight. Course content The following aspects of innovation in product development are considered: - Humans and products - Needs and products - Product life - Teams creating products - Products creating business - Product development models - Organising product development - Product development tools...

  8. Development of local radiation therapy

    Energy Technology Data Exchange (ETDEWEB)

    Lee, Seung Hoon; Lim, Sang Moo; Choi, Chang Woon; Chai, Jong Su; Kim, Eun Hee; Kim, Mi Sook; Yoo, Seong Yul; Cho, Chul Koo; Lee, Yong Sik; Lee, Hyun Moo

    1999-04-01

    The major limitations of radiation therapy for cancer are the low effectiveness of low LET and inevitable normal tissue damage. Boron Neutron Capture Therapy (BNCT) is a form of potent radiation therapy using Boron-10 having a high propensityof capturing theraml neutrons from nuclear reactor and reacting with a prompt nuclear reaction. Photodynamic therapy is a similiar treatment of modality to BNCT using tumor-seeking photosenistizer and LASER beam. If Boron-10 and photosensitizers are introduced selectively into tumor cells, it is theoretically possible to destroy the tumor and to spare the surrounding normal tissue. Therefore, BNCT and PDT will be new potent treatment modalities in the next century. In this project, we performed PDT in the patients with bladder cancers, oropharyngeal cancer, and skin cancers. Also we developed I-BPA, new porphyrin compounds, methods for estimation of radiobiological effect of neutron beam, and superficial animal brain tumor model. Furthermore, we prepared preclinical procedures for clinical application of BNCT, such as the macro- and microscopic dosimetry, obtaining thermal neutron flux from device used for fast neutron production in KCCH have been performed.

  9. Brief therapy: focused solution development.

    Science.gov (United States)

    De Shazer, S; Berg, I K; Lipchik, E; Nunnally, E; Molnar, A; Gingerich, W; Weiner-Davis, M

    1986-06-01

    This article describes the form of brief therapy developed at the Brief Family Therapy Center. We have chosen a title similar to Weakland, Fisch, Watzlawick, and Bodin's classic paper, "Brief Therapy: Focused Problem Resolution" (20) to emphasize our view that there is a conceptual relationship and a developmental connection between the points of view expressed in the two papers.

  10. Global product development

    DEFF Research Database (Denmark)

    Hansen, Zaza Nadja Lee; Ahmed-Kristensen, Saeema

    2011-01-01

    Globalisation has enabled companies to globalise their product development process. Today, everything from manufacturing to R&D can be globally distributed. This has led to a more complex and disintegrated product development process. This paper investigates the impacts companies have experienced...... as a result of this, and how they have been addressed. Data was collected through case studies of five Danish multinational corporations. The findings showed that the companies experienced several challenges when they globalised their product development process. They consequently implemented various...... operational solutions to counteract the negative impacts with varying degrees of success. This paper presents a unique look into global product development through an investigation of its impact on the organisation, the product development process, and the product. Furthermore, it shows the solutions...

  11. Profile and scientific output analysis of physical therapy researchers with research productivity fellowship from the Brazilian National Council for Scientific and Technological Development.

    Science.gov (United States)

    Sturmer, Giovani; Viero, Carolina C M; Silveira, Matheus N; Lukrafka, Janice L; Plentz, Rodrigo D M

    2013-01-01

    To describe the profile and the scientific output of physical therapists researchers holding a research productivity fellowship (PQ) from the Brazilian National Council of Scientific and Technological Development (Conselho Nacional de Desenvolvimento Científico e Tecnológico-CNPq). This is a cross-sectional study, which has evaluated the Lattes Curriculum of all PQ physiotherapy researchers registered at CNPq holding a research productivity fellowship in the period of 2010. The variables analyzed were: gender, geographic and institutional distribution, duration since doctorate defense, research productivity fellowship level, scientific output until 2010 and the H index in Scopus(®) and ISI databases. A total of 55 PQ from the CNPq were identified in the area of knowledge of Physical Therapy and Occupational Therapy, being 81.8% from the Southeast region of Brazil. They were predominantly female (61.8%), with research productivity fellowship level PQ2 (74.5%), and with average time since doctorate defense of 10.1 (±4.1) years. A total of 2.381 articles were published, with average of 42.5 (±18.9) articles/researcher. The average of articles published after doctorate defense was 39.40 (±18.9) articles/researchers with a mean output of 4.2 (±2.0) articles/year. We found 304 articles indexed in the Scopus(®) database with 2.463 citations, and 222 articles indexed in the Web of Science with 1.805 citations. The articles were published in 481 journals, being 244 (50.7%) of them listed on JCR-web. The researchers presented a median 5 of the H index in the Scopus(®) database, and a median 3 in ISI. The scientific output of the researchers with research productivity fellowship in the field of physical therapy stands out in their indicators, since the figures are very promising for a relatively young area and as it can be observed by the amount of published articles and citations obtained by the national and international research community.

  12. Virtual product development

    OpenAIRE

    Buisan Ferrer, Josep

    2002-01-01

    Evaluating the functionality, security, quality, etc. of a product can be long and difficult process. Prototypes and real tests are determinant tools, however their exhaustive use during the product development process can increase the price of the process and delay the availability of the product on the market. The alternative is to combine 3D design tools with other advanced simulation tools.

  13. Global product development

    DEFF Research Database (Denmark)

    Taylor, Thomas Paul; Ahmed-Kristensen, Saeema

    2016-01-01

    Selecting key performance indicators in conventional product development is a challenging task for project management and is compound by global product development. Informed from the findings of two in depth case studies conducted with large Danish manufacturing companies, in this paper we develo...

  14. DESIGN VERSUS PRODUCT DEVELOPMENT?

    Directory of Open Access Journals (Sweden)

    Edu Grieco Mazzini Junior

    2015-03-01

    Full Text Available Design or product development? The questioning in relation to the employment of such terminology dates back to possible misconceptions regarding interpretation and approach them. Therefore, it can be stated that there are differences between these two terms? In this context, we highlight two views concerning the origin of the design. The first character creative and based on pre-industrial revolution, based on projective and methodologies directed towards the practice of designing products. And second, where design is understood as an industrial process: the development of new products includes, besides a creative procedure are developed, and symbolic formal solutions for products, but also a technical procedure based on the definition of the requirements concerning the product engineering. Is this the most widely accepted interpretation? theoretical studies were conducted from interpretations of the concept of the design proposed by the International Council of Societies of Industrial Design – ICSDI (2012, and for the characterization of the process of product development, we sought to develop an analogy between these two terminologies and can be proved that the use of one of terminology will not cause deviations of interpretation, since both deal with the life cycle of the product. The main results obtained until now the definition of design proposed by the ICSID where it is characterized as a creative activity focused on the complete life cycle of products is the more approaches of the concept of product development.

  15. Transdisciplinary product development

    Directory of Open Access Journals (Sweden)

    Tomaž Savšek

    2015-12-01

    Full Text Available Research Question (RQ: How can transdisciplinary approach increase the product development process in future industry? Purpose: The aim of the research is to develop a model of an effective product development in the automotive industry based on the transdisciplinary approach. Method: We used a qualitative research approach in order to develop a theoretical framework of transdisciplinarity. The framework comprises the concurrent engineering and experts from different disciplines. The framework was represented by a mathematical model which based on stochastic dynamic programming. Results: We developed a theoretical frameworkand a practical case of transdisciplinary product development in the automotive industry. We presented a mathematical model and information environment which supports such a model. Organization: The findings of the research will provide higher productivity, lower operating costs, change in personnel structure, higher added value, lower sales costs, lower administration costs, reduction in growth of expenses, and lower costs of work equipment. Society: The research impact on higher customer’s satisfaction, increased flexibility of operations, better quality of information, improved control of sources, less waste materials and less pollution, improved planning process, more favourable consideration of employees , improved portfolio management, and better corporate presentation of company. Originality: Transdisciplinary framework combines methods of concurrent engineering and interdisciplinary approach in a process of product development. The development of such a framework is a complete novelty and represents an original approach to product development, which will be particularly suitable for the smart factories of the future. Transdisciplinary framework was transformed in to a mathematical model based on stochastic dynamic programming. Model is supported by the existing information warehouse and represents a potential for

  16. Development of Production Systems

    DEFF Research Database (Denmark)

    Christiansen, Thomas Bøhm

    1997-01-01

    This paper presents the initial considerations related to a Ph.D. study initiated at IPV, DTU in February 1997, concerning the research subject "Development of Production Systems". The content and aim of this paper is to 1) to introduce the study by......This paper presents the initial considerations related to a Ph.D. study initiated at IPV, DTU in February 1997, concerning the research subject "Development of Production Systems". The content and aim of this paper is to 1) to introduce the study by...

  17. Micro Products - Product Development and Design

    DEFF Research Database (Denmark)

    Hansen, Hans Nørgaard

    2003-01-01

    of the electronics industry to create still smaller chips with still larger capacity. Therefore the manufacturing technologies connected with micro/nano products in silicon are relatively highly developed compared to the technologies used for manufacturing micro products in metals, polymers and ceramics. For all...... technologies, however, it is a continuously increasing challenge to create the operational basis for an industrial production of micro products. As the products through product development processes are made applicable to a large number of customers, the pressure in regard to developing production technologies...... that make it possible to produce the products at a reasonable price and in large numbers is growing....

  18. 76 FR 9028 - Guidance for Industry: Potency Tests for Cellular and Gene Therapy Products; Availability

    Science.gov (United States)

    2011-02-16

    ... Industry: Potency Tests for Cellular and Gene Therapy Products'' dated January 2011. The guidance document provides manufacturers of cellular and gene therapy (CGT) products with recommendations for developing... document entitled ``Guidance for Industry: Potency Tests for Cellular and Gene Therapy Products'' dated...

  19. Product development leadership

    DEFF Research Database (Denmark)

    Lindgren, Peter

    2006-01-01

    Peter Lindgren introducerer i sin artikel begrebet ”Product Development Leadership”, som sætter fokus på produktudviklingens strategiske og markedsmæssige rolle. Begrebet omfatter bl.a. virksomhedens evne til at generere eller indfange ideer og udvikle disse via eksisterende eller nye måder...

  20. Terpenoids: natural products for cancer therapy.

    Science.gov (United States)

    Huang, Min; Lu, Jin-Jian; Huang, Ming-Qing; Bao, Jiao-Lin; Chen, Xiu-Ping; Wang, Yi-Tao

    2012-12-01

    Terpenoids constitute the largest class of natural products and are a rich reservoir of candidate compounds for drug discovery. Recent efforts into the research and development of anti-cancer drugs derived from natural products have led to the identification of a variety of terpenoids that inhibit cancer cell proliferation and metastasis via various mechanisms. Despite the increasing number of research reports, there lacks a comprehensive review of anti-cancer activity of terpenoids. The present article provides an overview of the recent progress in the anti-cancer studies on terpenoids. Over a dozen naturally originated terpenoid compounds, in particular those derived from traditional Chinese medicine, were classified into five categories according to the structures, namely monoterpenoids, sesquiterpenoids, diterpenoids, triterpenoids and tetraterpenoids. The anti-cancer activities and relevant mechanistic insights of these compounds are discussed in this review. The anti-cancer activity of terpenoids appears promising and will potentially open more opportunities for cancer therapy. However, current studies are restricted to descriptive findings and lack mechanistic insights and systematic structure-activity relationship (SAR) studies. Future efforts into the systematic identification of the targets of terpenoids are believed to increase chances of gaining breakthrough insights in the field.

  1. Regulatory Oversight of Cell and Gene Therapy Products in Canada.

    Science.gov (United States)

    Ridgway, Anthony; Agbanyo, Francisca; Wang, Jian; Rosu-Myles, Michael

    2015-01-01

    Health Canada regulates gene therapy products and many cell therapy products as biological drugs under the Canadian Food and Drugs Act and its attendant regulations. Cellular products that meet certain criteria, including minimal manipulation and homologous use, may be subjected to a standards-based approach under the Safety of Human Cells, Tissues and Organs for Transplantation Regulations. The manufacture and clinical testing of cell and gene therapy products (CGTPs) presents many challenges beyond those for protein biologics. Cells cannot be subjected to pathogen removal or inactivation procedures and must frequently be administered shortly after final formulation. Viral vector design and manufacturing control are critically important to overall product quality and linked to safety and efficacy in patients through concerns such as replication competence, vector integration, and vector shedding. In addition, for many CGTPs, the value of nonclinical studies is largely limited to providing proof of concept, and the first meaningful data relating to appropriate dosing, safety parameters, and validity of surrogate or true determinants of efficacy must come from carefully designed clinical trials in patients. Addressing these numerous challenges requires application of various risk mitigation strategies and meeting regulatory expectations specifically adapted to the product types. Regulatory cooperation and harmonisation at an international level are essential for progress in the development and commercialisation of these products. However, particularly in the area of cell therapy, new regulatory paradigms may be needed to harness the benefits of clinical progress in situations where the resources and motivation to pursue a typical drug product approval pathway may be lacking.

  2. Leadership for product development

    DEFF Research Database (Denmark)

    Martensen, Anne; Dahlgaard, Jens Jørn

    1998-01-01

    by nonrecurring processes. Therefore, the general model requires an amplification and adjustment specific to this area. It will be discussed how the model can be suplemented with references to criterion parts and areas to address, especially relevant for a self-assessment of leadership in innovation. What should...... the criterion "leadership" comprise when the focus is on R and D? Eight new criterion parts will be discussed. It is believed, that the recommended approach will improve leadership for product development. Udgivelsesdato: JUL...

  3. Malignant mesothelioma: development to therapy.

    Science.gov (United States)

    Thompson, Joyce K; Westbom, Catherine M; Shukla, Arti

    2014-01-01

    Malignant mesothelioma (MM) is an aggressive cancer of the mesothelium caused by asbestos. Asbestos use has been reduced but not completely stopped. In addition, natural or man-made disasters will continue to dislodge asbestos from old buildings into the atmosphere and as long as respirable asbestos is available, MM will continue to be a threat. Due to the long latency period of MM development, it would still take decades to eradicate this disease if asbestos was completely removed from our lives today. Therefore, there is a need for researchers and clinicians to work together to understand this deadly disease and find a solution for early diagnosis and treatment. This article focuses on developmental mechanisms as well as current therapies available for MM. © 2013 Wiley Periodicals, Inc.

  4. Developing Collaborative Product Development Capabilities

    DEFF Research Database (Denmark)

    Mahnke, Volker; Tran, Yen

    2012-01-01

    innovation strategies’. Our analyses suggest that developing such collaboration capabilities benefits from the search for complementary practices, the combination of learning styles, and the development of weak and strong ties. Results also underscore the crucial importance of co-evolution of multi......-level, simultaneous learning processes and highlight the role of human agency in capability development with partners. Building on our analyses, we advance propositions for future research and managerial practices on developing dynamic collaboration capabilities....

  5. A Framework For Product Development

    DEFF Research Database (Denmark)

    McAloone, Timothy Charles; Robotham, Antony John

    1999-01-01

    the fifteen years since it was introduced and attempts to make pointers in the direction of a new framework for product development, which should guide industry in the future.The key research challenges that this paper identifies include: developing a framework that identifies and supports a multi......-aspect approach to product development; understanding the strategic conditions that affect product development; developing a coherent approach to product quality based on product-life thinking; addressing environmental needs in a proactive manner through innovation techniques; and understanding both...... organisational and technical knowledge-management for improved product development....

  6. Consumer oriented new product development

    DEFF Research Database (Denmark)

    van Trijp, Hans C.M.; Grunert, Klaus G

    2014-01-01

    New product development is a necessary activity for a company’s competitiveness, profitability and growth. However, new product development is a risky activity as a large percentage of new product introductions fail to achieve their commercial targets. The present chapter reviews the existing evi...... evidence on new product success and failure factors. From that it introduces the perspective of consumer-oriented new product development as a way to balance new technological opportunity against identified consumer needs and desires....

  7. Handbook on tourism product development

    OpenAIRE

    2015-01-01

    Tourism products are the basis for a destination's tourism sector operation: unless the tourism product meets the needs and expectations of tourists, the destination cannot realise its full potential. However, only few destinations focus their attention on the development and delivery of the various attractions and activities that make up the tourism product. The UNWTO/ETC Handbook on Tourism Product Development outlines the essential elements in the process of tourism product development pla...

  8. Market-based product development

    DEFF Research Database (Denmark)

    Bisp, Søren; Harmsen, Hanne

    1997-01-01

    A large body of research results on successful product development exists. The results are full of normative advice on how to conduct prod-uct development. At the same time studies have shown that product development practice has only to a very li extent been influenced by these research results...

  9. THERAPY DEVELOPMENTS IN SOUTHERN AFRICA

    African Journals Online (AJOL)

    By means of this review the authors wish to stimulate a discussion in southern Africa of the relevance of antiviral therapy strategic treatment interruptions. To achieve this aim we will review the current literature of treatment- related immune reconstitution and HIV-specific immune control of HIV replication, and will propose ...

  10. Developing Green Line Products

    DEFF Research Database (Denmark)

    Muñoz-Marin, Ana Maria; Lassen, Astrid Heidemann; Poulsen, Søren Bolvig

    2011-01-01

    This publication is based on the Master thesis “User-driven ecoinnovation process: Towards the implementation of the Green product line at JELD-WEN” written by Ana Maria Muñoz-Marin as her Graduation Project for the MSc. Global Innovation Management degree. The company-based experiment was carried...

  11. Platform-based production development

    DEFF Research Database (Denmark)

    Bossen, Jacob; Brunoe, Thomas Ditlev; Nielsen, Kjeld

    2015-01-01

    Platforms as a means for applying modular thinking in product development is relatively well studied, but platforms in the production system has until now not been given much attention. With the emerging concept of platform-based co-development the importance of production platforms is though ind...... indisputable. This paper presents state-of-the-art literature on platform research related to production platforms and investigates gaps in the literature. The paper concludes on findings by proposing future research directions....

  12. Simulation Aided Product Software Development

    OpenAIRE

    Hyvönen, Jani

    2010-01-01

    This work is a study of simulation environments as tools for product software development from architecture definition phase to testing the actual end product software code. The purpose of the work was to find a feasible way to utilize simulation environments for improving product time to market. The work was initiated to renew the existing simulation methods to correspond the demands of the present-day process of developing products. Work effort mainly consisted of studying the e...

  13. Gestalt Therapy: Development, Theory, and Techniques.

    Science.gov (United States)

    Witchel, Robert

    This paper presents a full review of the literature in the area of Gestalt Therapy and could be helpful in familiarizing people with this discipline. The roots contributing to the development of Gestalt therapy as presently practiced are explored briefly. Gestalt theory is presented in a developmental way, initially exploring the relationship…

  14. Barriers towards integrated product development

    DEFF Research Database (Denmark)

    Sommer, Anita Friis; Dukovska-Popovska, Iskra; Steger-Jensen, Kenn

    2014-01-01

    The basis for product development in many large industrial companies is a traditional project management method positing non-overlapping phases, independent activities, and a dedicated project team. Research findings indicate that integrated product development methods increase performance compared...... requirements for implementation of integrated product development remains under-researched. This study takes on a holistic project management perspective and identifies challenges and requirements through an in-depth case study. It is found that implementation requires both awareness and skills of integrated...... product development in senior management, and a set of cross-organizational project governance structures....

  15. Developing products on Internet time.

    Science.gov (United States)

    Iansiti, M; MacCormack, A

    1997-01-01

    The rise of the World Wide Web has provided one of the most challenging environments for product development in recent history. The market needs that a product is meant to satisfy and the technologies required to satisfy them can change radically--even as the product is under development. In response to such factors, companies have had to modify the traditional product-development process, in which design implementation begins only once a product's concept has been determined in its entirety. In place of that traditional approach, they have pioneered a flexible product-development process that allows designers to continue to define and shape products even after implementation has begun. This innovation enables Internet companies to incorporate rapidly evolving customer requirements and changing technologies into their designs until the last possible moment before a product is introduced to the market. Flexible product development has been most fully realized in the Internet environment because of the turbulence found there, but the foundations for it exist in a wide range of industries where the need for responsiveness is paramount. When technology, product features, and competitive conditions are predictable or evolve slowly, a traditional development process works well. But when new competitors and technologies appear overnight, when standards and regulations are in flux, and when a company's entire customer base can easily switch to other suppliers, businesses don't need a development process that resists change--they need one that embraces it.

  16. Mapping {sup 15}O Production Rate for Proton Therapy Verification

    Energy Technology Data Exchange (ETDEWEB)

    Grogg, Kira; Alpert, Nathaniel M.; Zhu, Xuping [Center for Advanced Radiological Sciences, Nuclear Medicine and Molecular Imaging, Radiology Department, Massachusetts General Hospital, Boston, Massachusetts (United States); Min, Chul Hee [Department of Radiological Science, College of Health Science, Yonsei University, Wonju, Kangwon (Korea, Republic of); Testa, Mauro; Winey, Brian [Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (United States); Normandin, Marc D. [Center for Advanced Radiological Sciences, Nuclear Medicine and Molecular Imaging, Radiology Department, Massachusetts General Hospital, Boston, Massachusetts (United States); Shih, Helen A.; Paganetti, Harald; Bortfeld, Thomas [Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (United States); El Fakhri, Georges, E-mail: elfakhri@pet.mgh.harvard.edu [Center for Advanced Radiological Sciences, Nuclear Medicine and Molecular Imaging, Radiology Department, Massachusetts General Hospital, Boston, Massachusetts (United States)

    2015-06-01

    Purpose: This work was a proof-of-principle study for the evaluation of oxygen-15 ({sup 15}O) production as an imaging target through the use of positron emission tomography (PET), to improve verification of proton treatment plans and to study the effects of perfusion. Methods and Materials: Dynamic PET measurements of irradiation-produced isotopes were made for a phantom and rabbit thigh muscles. The rabbit muscle was irradiated and imaged under both live and dead conditions. A differential equation was fitted to phantom and in vivo data, yielding estimates of {sup 15}O production and clearance rates, which were compared to live versus dead rates for the rabbit and to Monte Carlo predictions. Results: PET clearance rates agreed with decay constants of the dominant radionuclide species in 3 different phantom materials. In 2 oxygen-rich materials, the ratio of {sup 15}O production rates agreed with the expected ratio. In the dead rabbit thighs, the dynamic PET concentration histories were accurately described using {sup 15}O decay constant, whereas the live thigh activity decayed faster. Most importantly, the {sup 15}O production rates agreed within 2% (P>.5) between conditions. Conclusions: We developed a new method for quantitative measurement of {sup 15}O production and clearance rates in the period immediately following proton therapy. Measurements in the phantom and rabbits were well described in terms of {sup 15}O production and clearance rates, plus a correction for other isotopes. These proof-of-principle results support the feasibility of detailed verification of proton therapy treatment delivery. In addition, {sup 15}O clearance rates may be useful in monitoring permeability changes due to therapy.

  17. Customer-driven Product Development

    DEFF Research Database (Denmark)

    Sommer, Anita Friis

    2011-01-01

    look for new ways to gain competitive advantage. In competitive markets there is a tendency of shorter product life cycles, and thus a competitive factor is to keep at pace with the market or even driving the market by developing new products. This research study seeks to investigate Customer......-driven Product Development (CDPD) from a demand chain management perspective. CDPD is the counterpart to typical research and development processes, which has no direct customer involvement. The proposition is that letting customers initiate and participate in the product development process...... an insight into a new area of new product development and demand chain management, including the customer in the case study, which is rare in related research....

  18. Development of iPS (induced pluripotent stem cells) using natural product from extract of fish oocyte to provide stem cell for regenerative therapy

    Science.gov (United States)

    Meilany, Sofy; Firdausiyah, Qonitha S.; Naroeni, Aroem

    2017-02-01

    In this study, we developed a method to induce pluripotency of adult cells (fibroblast) into stem cells using a natural product, extract of fish oocyte, by comparing the extract concentration, 1 mg/ml and 2 mg/ml. The analyses were done by measuring the Nanog gene expression in cells using qPCR and detecting fibroblast marker anti H2-KK. The results revealed existence of a colony of stem cells in the cell that was induced with 2mg/ml concentration of oocytes. Nanoggene expression was analyzed by qPCR and the results showed expression of Nanog gene compared to the control. Analysis of result of fibroblast using Tali Cytometer and anti H2KK antibody showed loss of expression of Anti H2KK meaning there was transformation from fibroblast type cell to pluripotent cell type.

  19. ENVISION, developing SPECT imaging for particle therapy

    CERN Multimedia

    2013-01-01

    Particle therapy is an advanced technique of cancer radiation therapy, using protons or other ions to target the cancerous mass. ENVISION aims at developing medical imaging tools to improve the dose delivery to the patient, to ensure a safer and more effective treatment. The animation illustrates the use of Single Photon Emission Computed Tomography (SPECT) for monitoring the dose during treatment. Produced by: CERN KT/Life Sciences and ENVISION Project Management: Manuela Cirilli 3D animation: Jeroen Huijben, Nymus3d

  20. Integrating Product and Technology Development

    DEFF Research Database (Denmark)

    Meijer, Ellen Brilhuis; Pigosso, Daniela Cristina Antelmi; McAloone, Tim C.

    2016-01-01

    Although dual innovation projects, defined in this article as the concurrent development of products and technologies, often occur in industry, these are only scarcely supported methodologically. Limited research has been done about dual innovation projects and their inherent challenges (e.......g. managing dependencies) and opportunities (e.g. streamlining development). This paper presents five existing reference models for technology development (TD), which were identified via a systematic literature review, where their possible integration with product development (PD) reference models...... was investigated. Based on the specific characteristics desired for dual innovation projects, such as integrated product development and coverage of multiple development stages, a set of selection criteria was employed to select suitable PD and TD reference models. The integration and adaptation of the selected...

  1. Product/Service-System Development

    DEFF Research Database (Denmark)

    Tan, Adrian; McAloone, Timothy Charles; Gall, Catherine

    2007-01-01

    in the design and development aspects of PSS. The objective of this paper is to explore how a global manufacturing company is developing an offering to their customers that is focused on the utility of their products throughout their life time. The paper describes the process of how a company is shifting from...... of their products. This process of re-defining the value of what the company is actually offering to its customers is seen as a key element in PSS development. PSS development is expected to expand conventional product development in new directions, such as new activities, roles and responsibilities, knowledge...... and competencies, and value network relationships. The implications of this are discussed in relation to the company’s development approach....

  2. Occupational therapy, professional development and ethics

    DEFF Research Database (Denmark)

    Dige, Morten

    2009-01-01

    The article's aim is to reflect on and contribute to developing occupational therapy as a profession. I propose an ethical interpretation of health and helping professions in general and occupational therapy in particular. According to this ethical interpretation, the essential function and mission...... of classical health and helping professions are defined by certain ethical values: the basic elements of a good human life. I argue that the central concepts of occupational therapy, activity and participation, can plausibly be understood in this light. However, this seems to imply a rather substantial...... conception of well-being which I try to spell out. In addition, I specify the basic principles of biomedical ethics in the context of occupational therapy according to an ethical interpretation. In conclusion, I point at four advantages of the ethical interpretation: It adds precision and content to ethical...

  3. Innovating the Product Development Organisation

    DEFF Research Database (Denmark)

    Andreasen, Mogens Myrup; Hein, Lars

    1997-01-01

    The organisational innovation of the product development function is a doubtful affair since we can hardly describe why a specific organisation works. In this article two comprehensive innovation campaigns in Danish industry are described with reference to the nature, content and results of innov...... of innovative processes and as the crux an attempt to explain principal elements in the changes of attitudes and behaviour in companies.......The organisational innovation of the product development function is a doubtful affair since we can hardly describe why a specific organisation works. In this article two comprehensive innovation campaigns in Danish industry are described with reference to the nature, content and results...

  4. Sonodynamic therapy, a treatment developing from photodynamic therapy.

    Science.gov (United States)

    Rengeng, Liu; Qianyu, Zhang; Yuehong, Lang; Zhongzhong, Peng; Libo, Li

    2017-09-01

    Sonodynamic therapy (SDT) as a new non-invasive treatment developed from photodynamic (PDT), it can kill tumor cells specifically and selectively. Moreover, recently studies showed SDT has potential to treat solid tumor, leukemia and atherosclerosis, remove proliferative scars and kill pathogenic microorganism. As SDT has an extensive application prospect, SDT has attracted more and more research recently. This thesis aims to be an informative introduction on SDT. With the assistance of related literature from 2012 to 2016, we introduce the progress of SDT research in six aspects: the therapeutic mechanism of SDT, development of the sound sensitizer, exploration of the size and frequency of ultrasonic energy, application of SDT, comparison between SDT and PDT, and current situation and future of SDT. Copyright © 2017 Elsevier B.V. All rights reserved.

  5. Development of pharmaceuticals with radioactive rhenium for cancer therapy. Production of {sup 186}Re and {sup 188}Re, synthesis of labeled compounds and their biodistributions

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1998-03-01

    Production of the radioactive rhenium isotopes {sup 186}Re and {sup 188}Re, and synthesis of their labeled compounds have been studied together with the biodistributions of the compounds. This work was carried out by the Working Group on Radioactive Rhenium, consisting of researchers of JAERI and some universities, in the Subcommittee for Production and Radiolabeling under the Consultative Committee of Research on Radioisotopes. For {sup 186}Re, production methods by the {sup 185}Re(n,{gamma}){sup 186}Re reaction in a reactor and by the {sup 186}W(p,n){sup 186}Re reaction with an accelerator, which can produce nocarrier-added {sup 186}Re, have been established. For {sup 188}Re, a production method by the double neutron capture reaction of {sup 186}W, which produces a {sup 188}W/{sup 188}Re generator, has been established. For labeling of bisphosphonate, DMSA, DTPA, DADS, aminomethylenephosphonate and some monoclonal antibodies with the radioactive rhenium isotopes, the optimum conditions, including pH, the amounts of reagents and so on, have been determined for each compound. The biodistributions of each of the labeled compounds in mice have been also obtained. (author)

  6. Green development within Product families

    DEFF Research Database (Denmark)

    Lenau, Torben Anker; Willum, Ole; Frees, Niels

    2000-01-01

    , based on environmental and economical importance as well as the existence of several producers. Using this method, five families have been selected, namely mobile phones, vacuum cleaners, industrial valves with electronic controls, lighting and ventilation. Collaboration with 5 industrial companies has...... occur, and uncover where the improvement potentials are in the product. The environmental knowledge obtained in this context will be valid for a number of years, and both the producer and other interested parties can use this information for setting priorities in their future planning. However, it can...... be very time consuming to perform an environmental Life Cycle Assessment (LCA), and it would be an advantage if a number of similar products - product families - could be handled in one and the same LCA as a whole. The project has presently developed a method for selecting and forming product families...

  7. Internationalization of New Product Development

    DEFF Research Database (Denmark)

    Brem, Alexander; Freitag, F.

    2014-01-01

    A rich body of literature has emerged from research on Western new product development (NPD). However, the impact of country- and culture-specific influences on these processes has not been examined in detail yet. Hence, this study identifies the differences in NPD practices between the Indian an...

  8. Advanced uncooled sensor product development

    Science.gov (United States)

    Kennedy, A.; Masini, P.; Lamb, M.; Hamers, J.; Kocian, T.; Gordon, E.; Parrish, W.; Williams, R.; LeBeau, T.

    2015-06-01

    The partnership between RVS, Seek Thermal and Freescale Semiconductor continues on the path to bring the latest technology and innovation to both military and commercial customers. The partnership has matured the 17μm pixel for volume production on the Thermal Weapon Sight (TWS) program in efforts to bring advanced production capability to produce a low cost, high performance product. The partnership has developed the 12μm pixel and has demonstrated performance across a family of detector sizes ranging from formats as small as 206 x 156 to full high definition formats. Detector pixel sensitivities have been achieved using the RVS double level advanced pixel structure. Transition of the packaging of microbolometers from a traditional die level package to a wafer level package (WLP) in a high volume commercial environment is complete. Innovations in wafer fabrication techniques have been incorporated into this product line to assist in the high yield required for volume production. The WLP seal yield is currently > 95%. Simulated package vacuum lives >> 20 years have been demonstrated through accelerated life testing where the package has been shown to have no degradation after 2,500 hours at 150°C. Additionally the rugged assembly has shown no degradation after mechanical shock and vibration and thermal shock testing. The transition to production effort was successfully completed in 2014 and the WLP design has been integrated into multiple new production products including the TWS and the innovative Seek Thermal commercial product that interfaces directly to an iPhone or android device.

  9. Regulatory structures for gene therapy medicinal products in the European Union.

    Science.gov (United States)

    Klug, Bettina; Celis, Patrick; Carr, Melanie; Reinhardt, Jens

    2012-01-01

    Taking into account the complexity and technical specificity of advanced therapy medicinal products: (gene and cell therapy medicinal products and tissue engineered products), a dedicated European regulatory framework was needed. Regulation (EC) No. 1394/2007, the "ATMP Regulation" provides tailored regulatory principles for the evaluation and authorization of these innovative medicines. The majority of gene or cell therapy product development is carried out by academia, hospitals, and small- and medium-sized enterprises (SMEs). Thus, acknowledging the particular needs of these types of sponsors, the legislation also provides incentives for product development tailored to them. The European Medicines Agency (EMA) and, in particular, its Committee for Advanced Therapies (CAT) provide a variety of opportunities for early interaction with developers of ATMPs to enable them to have early regulatory and scientific input. An important tool to promote innovation and the development of new medicinal products by micro-, small-, and medium-sized enterprises is the EMA's SME initiative launched in December 2005 to offer financial and administrative assistance to smaller companies. The European legislation also foresees the involvement of stakeholders, such as patient organizations, in the development of new medicines. Considering that gene therapy medicinal products are developed in many cases for treatment of rare diseases often of monogenic origin, the involvement of patient organizations, which focus on rare diseases and genetic and congenital disorders, is fruitful. Two such organizations are represented in the CAT. Research networks play another important role in the development of gene therapy medicinal products. The European Commission is funding such networks through the EU Sixth Framework Program. Copyright © 2012 Elsevier Inc. All rights reserved.

  10. Development of radiolabelled compound using reactor producted RI - Evaluation of Ho-166 endovascular therapy to prevent restenosis after PTCA or stenting for occlusive coronary artery disease

    Energy Technology Data Exchange (ETDEWEB)

    Park, Chan Hee; Choi, Byung Il; Kim, Han Soo [Ajou University, Suwon (Korea)

    2000-04-01

    Occlusive coronary artery disease is managed successfully by percutaneous transfemoral coronary angioplasty (PTCA) or stenting with 95% success rate. However, restenosis after PTCA is not uncommon and the reported incidence of reocclusion is about 30 {approx} 40%. Therefore, the objective of the research was to develop endovascular brachytherapy using liquid form of Ho-166 in order to inhibit neointimal hyperplasia responsible for restenosis following PTCA or stenting. Our research was carried out in 3 stages: First stage - The effectiveness of radiation was confirmed by using animal model. Following over-sized balloon injury to rat carotid artery and porcine coronary artery, various external radiation doses were delivered. Second stage - For radiation dose distribution within the coronary artery and its surrounding tissues, Gafchromic film was used. In vitro dose distribution of Ho-166 utilizing water phantom and Gafchromic film was measured. Third stage - None uniform dose distribution from Ho-166 within the balloon caused by small air bubbles was eliminated by negative suction method. More accurate dose distribution was also possible using newly developed micrometer by our physicist. Limited number of human trial was performed without adverse effect. 40 refs. (Author)

  11. Virtual Product Development on Venturi Pump

    National Research Council Canada - National Science Library

    Sava Ianici; Draghita Ianici; Milan Banić; Aleksandar Miltenović

    2011-01-01

    .... To overcome noted challenges it is necessary to use process of virtual product development. In that way it is possible, even in early phases of product development, to assess the operational product behaviour...

  12. Integrated product development: Competencies meet and products arise

    DEFF Research Database (Denmark)

    Jensen, Birger Boutrup; Stacey, Julia

    2000-01-01

    One of the most common problems in product development is to strike the right balance between being market oriented and exploiting and protecting a company's product and process competencies. Until now research has only to a small extent been engaged in the development of tools that can help food...... companies integrate different competenceareas in their product development process. In collaboration with the Danish Technical University and the Danish Institute for Fisheries Research, MAPP is carrying out a project on integrated product development. The project focuses on the development and integration...... a need for increased co-operation and understanding among the various departments. This is where integrated product development comes into the picture. The idea behind integrated product development is that successful product development requires a balance between the market and the company's product...

  13. Development of Biomedical Microrobot for Intravascular Therapy

    Directory of Open Access Journals (Sweden)

    Sukho Park

    2010-03-01

    Full Text Available Recently, coronary artery disease such as angina pectoris and myocardial infarction has become the major causes of death. As a method of medical treatment for the disease, the pharmacological approaches and the surgical operations are executed. Especially, percutaneous coronary intervention (PCI using catheters are the mostly preferred treatment for coronary artery diseases. The PCI technologies are advanced and the various useful devices are developed and utilized. However, some clinical operations such as the treatment of chronic total occlusion (CTO remain a limitation of PCI and a major challenge. As robot-assisted coronary interventions, this paper proposes the microrobot for the therapy of CTO. The microrobot consists of the functions of position recognition, locomotion and treatment in the blood vessels. The functions of the microrobot can be validated through in-vitro & in-vivo experiments. The innovative technologies and surgical concept using the microrobot are currently being developed.

  14. Development of Biomedical Microrobot for Intravascular Therapy

    Directory of Open Access Journals (Sweden)

    Sukho Park

    2010-02-01

    Full Text Available Recently, coronary artery disease such as angina pectoris and myocardial infarction has become the major causes of death. As a method of medical treatment for the disease, the pharmacological approaches and the surgical operations are executed. Especially, percutaneous coronary intervention (PCI using catheters are the mostly preferred treatment for coronary artery diseases. The PCI technologies are advanced and the various useful devices are developed and utilized. However, some clinical operations such as the treatment of chronic total occlusion (CTO remain a limitation of PCI and a major challenge. As robot-assisted coronary interventions, this paper proposes the microrobot for the therapy of CTO. The microrobot consists of the functions of position recognition, locomotion and treatment in the blood vessels. The functions of the microrobot can be validated through in-vitro & in-vivo experiments. The innovative technologies and surgical concept using the microrobot are currently being developed.

  15. Development of cancer therapy facility of HANARO

    Energy Technology Data Exchange (ETDEWEB)

    Jun, Byung Jin; Hwang, S. Y.; Kim, M. J. and others

    2000-04-01

    Facilities of the research and clinical treatments of neutron capture therapy using HANARO are developed, and they are ready to install. They are BNCT irradiation facility and prompt gamma neutron activatiion analysis facility. Since every horizontal neutron facility of HANARO is long and narrow tangential beam tube, it is analysed that sufficient epithermal neutrons for the BNCT cannot be obtained but sufficient thermal neutrons can be obtained by a filter composed of silicon and bismuth single crystals. Since the thermal neutron penetaration increases significantly when the crystals are cooled, a filter cooled by liquid nitrogen is developed. So as to avoid interference with the reactor operation, a water shutter is developed. The irradiation room is designed for the temporary surgical operation as well. Handling tools to remove activated beam port plug and to install water shutter and filter are developed. The basic structure of the irradiation room is already installed and most of other parts are ready to install. Since no free beam port is available for the prompt gamma neutron activation analysis, a method obtaining almost pure thermal neutrons by the vertical diffraction of extra beam for the polarized neutron spectrometer is developed. This method is confirmed by analysis and experiments to give high enough neutron beam. Equipment and devices are provided to install this facility.

  16. Clinical Development of Cell Therapies: Setting the Stage for Academic Success.

    Science.gov (United States)

    Abou-El-Enein, M; Volk, H-D; Reinke, P

    2017-01-01

    Cellular therapies have potential to treat a wide range of diseases with autologous immunotherapies showing unprecedented therapeutic promise in clinical trials. Such therapies are mainly developed by academic researchers applying small-scale production, targeting rare and unmet medical needs. Here, we highlight the clinical translation of immunotherapy product in an academic setting, which may serve as a success model for early academic development of cell-based therapeutics. © 2016 American Society for Clinical Pharmacology and Therapeutics.

  17. New developments in atrial antiarrhythmic drug therapy

    Science.gov (United States)

    Burashnikov, Alexander; Antzelevitch, Charles

    2010-01-01

    Atrial fibrillation (AF) is a growing clinical problem associated with increased morbidity and mortality. Currently available antiarrhythmic drugs (AADs), although highly effective in acute cardioversion of paroxysmal AF, are generally only moderately successful in long-term maintenance of sinus rhythm. The use of AADs is often associated with an increased risk of ventricular proarrhythmia, extracardiac toxicity, and exacerbation of concomitant diseases such as heart failure. AF is commonly associated with intracardiac and extracardiac disease, which can modulate the efficacy and safety of AAD therapy. In light of the multifactorial intracardiac and extracardiac causes of AF generation, current development of anti-AF agents is focused on modulation of ion channel activity as well as on upstream therapies that reduce structural substrates. The available data indicate that multiple ion channel blockers exhibiting potent inhibition of peak INa with relatively rapid unbinding kinetics, as well as inhibition of late INa and IKr, may be preferable for the management of AF when considering both safety and efficacy. PMID:20179721

  18. New Product Marketing Blurs the Line Between Nicotine Replacement Therapy and Smokeless Tobacco Products.

    Science.gov (United States)

    Kostygina, Ganna; England, Lucinda; Ling, Pamela

    2016-07-01

    Tobacco companies have begun to acquire pharmaceutical subsidiaries and recently started to market nicotine replacement therapies, such as Zonnic nicotine gum, in convenience stores. Conversely, tobacco companies are producing tobacco products such as tobacco chewing gum and lozenges that resemble pharmaceutical nicotine replacement products, including a nicotine pouch product that resembles snus pouches. This convergence of nicotine and tobacco product marketing has implications for regulation and tobacco cessation.

  19. Understanding users in product development

    DEFF Research Database (Denmark)

    Geert Jensen, Birgitte

    2012-01-01

    refuse to buy the product next time they go shopping [1]. The issues are worsening due to the expansion of the elderly population in the upcoming decades all over the world. In Denmark the amount of people in the age more than 65 years old will rise to index 170 in 2050 compared to 2010 [2]. It is also...... noticeable that 680,000 people in Denmark have difficulties and feel pain using their hands, which account for 17 per cent of the adult population [3]. Therefore, the chance of excluding a part of an enterprise´s target group is very likely, making easy‐to‐open packaging more relevant than ever.The project......, the guideline contain a step by step process to develop easy‐to‐open packaging. The guideline is constructed in a way that allows the enterprise to pick and choose in respect to the enterprise´s needs and competences. The main focus in the development of the guidelines has been to produce a tool that function...

  20. Gene therapy of cancer and development of therapeutic target gene

    Energy Technology Data Exchange (ETDEWEB)

    Kim, Chang Min; Kwon, Hee Chung

    1998-04-01

    We applied HSV-tk/GCV strategy to orthotopic rat hepatoma model and showed anticancer effects of hepatoma. The increased expression of Lac Z gene after adenovirus-mediated gene delivery throughout hepatic artery was thought that is increased the possibility of gene therapy for curing hepatoma. With the construction of kGLP-laboratory, it is possible to produce a good quantity and quality of adenovirus in lage-scale production and purification of adenovirus vector. Also, the analysis of hepatoma related genes by PCR-LOH could be used for the diagnosis of patients and the development of therapeutic gene.

  1. Green product development : What does the country product space imply?

    NARCIS (Netherlands)

    Fraccascia, Luca; Giannoccaro, Ilaria; Albino, Vito

    This paper contributes to green product development by identifying the green products with the highest potential for growth in a country. To address our aim, we use the concept of product proximity and product space and, borrowing from the results of recent studies on complexity economics, we

  2. Virtual Product Development on Venturi Pump

    OpenAIRE

    Sava Ianici; Draghita Ianici; Milan Banić; Aleksandar Miltenović

    2011-01-01

    Market globalization and increased customer demands are leading providers of low product series to the high cost of development and construction. To overcome noted challenges it is necessary to use process of virtual product development. In that way it is possible, even in early phases of product development, to assess the operational product behaviour. Even the specific customer demands are determined before the actual product design phase. The paper presents an up to date ...

  3. Extending product modeling methods for integrated product development

    DEFF Research Database (Denmark)

    Bonev, Martin; Wörösch, Michael; Hauksdóttir, Dagný

    2013-01-01

    . Updated design requirements have then to be made explicit and mapped against the existing product architecture. In this paper, existing methods are adapted and extended through linking updated requirements to suitable product models. By combining several established modeling techniques, such as the DSM......Despite great efforts within the modeling domain, the majority of methods often address the uncommon design situation of an original product development. However, studies illustrate that development tasks are predominantly related to redesigning, improving, and extending already existing products...

  4. New hepatitis C therapies in clinical development

    Directory of Open Access Journals (Sweden)

    Vermehren Johannes

    2011-07-01

    Full Text Available Abstract With the current standard of care for the treatment of chronic hepatitis C, a combination of pegylated interferon alfa and ribavirin, sustained virologic response rates can be achieved in approximately 50% of patients only. Improved understanding of the viral life cycle has led to the identification of numerous potential targets for novel, direct-acting antiviral compounds. Inhibitors of the NS3/4A protease are currently the most advanced in clinical development. Recently completed phase 3 studies of the two protease inhibitors telaprevir and boceprevir, each given in combination with standard of care, yielded sustained virologic response rates in the range of 66-75% in treatment-naive patients and 59-66% in treatment-experienced patients with HCV genotype 1 infection. Studies of second-generation protease inhibitors, with the potential advantage of improved potency, drug metabolism and pharmacokinetics profile, are already underway. Inhibitors of the HCV NS5A protein and NS5B polymerase are potentially active across different HCV genotypes and have shown promising antiviral efficacy in early clinical studies. Other emerging mechanisms include silymarin components and inhibitors of cell proteins required for HCV replication. While improved formulations of current HCV therapies are also being developed, future hopes lie on the combination of direct-acting antivirals with the eventual possibility of interferon-free treatment regimens.

  5. Evolving Product Information in Aligning Product Development Decisions across Disciplines

    NARCIS (Netherlands)

    Oude Luttikhuis, Ellen; de Lange, Jos; Lutters, Diederick; ten Klooster, Roland

    2015-01-01

    Today's product development is fragmented across various disciplines all with their own fields of expertise. Maintaining overview in consequences and implications of decisions is difficult, since many stakeholders are involved. To optimise the product development, many methods are developed based on

  6. Orff Music Therapy: History, Principles and Further Development

    Directory of Open Access Journals (Sweden)

    Melanie Voigt

    2013-12-01

    Full Text Available Orff Music Therapy, a developmental approach to music therapy, was developed by Gertrud Orff within the framework of social paediatrics in Munich, Germany. A short historical background of Orff Music Therapy is discussed. The history of the clinical setting in which it was developed is described as is Gertrud Orff’s professional background. The role of Orff-Schulwerk in Orff Music Therapy and the development of theoretical foundations are discussed. Current principles and practice of Orff Music Therapy, illustrated by a case example show how the profile of Orff Music Therapy has developed. On the basis of the case example, theory is related to practice. Finally, changes influencing Orff Music Therapy today, training and research are considered.

  7. Virtual Product Development on Venturi Pump

    Directory of Open Access Journals (Sweden)

    Sava Ianici

    2011-10-01

    Full Text Available Market globalization and increased customer demands are leading providers of low product series to the high cost of development and construction. To overcome noted challenges it is necessary to use process of virtual product development. In that way it is possible, even in early phases of product development, to assess the operational product behaviour. Even the specific customer demands are determined before the actual product design phase. The paper presents an up to date concept of virtual product development with application on assessment of operational behaviour of Venturi pumps.

  8. MEASURING PRODUCTIVITY OF SOFTWARE DEVELOPMENT TEAMS

    Directory of Open Access Journals (Sweden)

    Goparaju Purna Sudhakar

    2012-02-01

    Full Text Available This paper gives an exhaustive literature review of the techniques and models available tomeasure the productivity of software development teams. Definition of productivity, measuringindividual programmer’s productivity, and measuring software development team productivity arediscussed. Based on the literature review it was found that software productivity measurement canbe done using SLOC (Source Lines of Code, function points, use case points, object points, andfeature points. Secondary research findings indicate that the team size, response time, taskcomplexity, team climate and team cohesion have an impact on software development teamproductivity. List of factors affecting the software development team productivity are studied andreviewed.

  9. The physics of Cerenkov light production during proton therapy.

    Science.gov (United States)

    Helo, Y; Kacperek, A; Rosenberg, I; Royle, G; Gibson, A P

    2014-12-07

    There is increasing interest in using Cerenkov emissions for quality assurance and in vivo dosimetry in photon and electron therapy. Here, we investigate the production of Cerenkov light during proton therapy and its potential applications in proton therapy. A primary proton beam does not have sufficient energy to generate Cerenkov emissions directly, but we have demonstrated two mechanisms by which such emissions may occur indirectly: (1) a fast component from fast electrons liberated by prompt gamma (99.13%) and neutron (0.87%) emission; and (2) a slow component from the decay of radioactive positron emitters. The fast component is linear with dose and doserate but carries little spatial information; the slow component is non-linear but may be localised. The properties of the two types of emission are explored using Monte Carlo modelling in GEANT4 with some experimental verification. We propose that Cerenkov emissions could contribute to the visual sensation reported by some patients undergoing proton therapy of the eye and we discuss the feasibility of some potential applications of Cerenkov imaging in proton therapy.

  10. The physics of Cerenkov light production during proton therapy

    Science.gov (United States)

    Helo, Y.; Kacperek, A.; Rosenberg, I.; Royle, G.; Gibson, A. P.

    2014-12-01

    There is increasing interest in using Cerenkov emissions for quality assurance and in vivo dosimetry in photon and electron therapy. Here, we investigate the production of Cerenkov light during proton therapy and its potential applications in proton therapy. A primary proton beam does not have sufficient energy to generate Cerenkov emissions directly, but we have demonstrated two mechanisms by which such emissions may occur indirectly: (1) a fast component from fast electrons liberated by prompt gamma (99.13%) and neutron (0.87%) emission; and (2) a slow component from the decay of radioactive positron emitters. The fast component is linear with dose and doserate but carries little spatial information; the slow component is non-linear but may be localised. The properties of the two types of emission are explored using Monte Carlo modelling in GEANT4 with some experimental verification. We propose that Cerenkov emissions could contribute to the visual sensation reported by some patients undergoing proton therapy of the eye and we discuss the feasibility of some potential applications of Cerenkov imaging in proton therapy.

  11. Toyota production system quality improvement initiative improves perioperative antibiotic therapy.

    Science.gov (United States)

    Burkitt, Kelly H; Mor, Maria K; Jain, Rajiv; Kruszewski, Matthew S; McCray, Ellesha E; Moreland, Michael E; Muder, Robert R; Obrosky, David Scott; Sevick, Mary Ann; Wilson, Mark A; Fine, Michael J

    2009-09-01

    To assess the role of a Toyota production system (TPS) quality improvement (QI) intervention on appropriateness of perioperative antibiotic therapy and in length of hospital stay (LOS) among surgical patients. Pre-post quasi-experimental study using local and national retrospective cohorts. We used TPS methods to implement a multifaceted intervention to reduce nosocomial methicillin-resistant Staphylococcus aureus infections on a Veterans Affairs surgical unit, which led to a QI intervention targeting appropriate perioperative antibiotic prophylaxis. Appropriate perioperative antibiotic therapy was defined as selection of the recommended antibiotic agents for a duration not exceeding 24 hours from the time of the operation. The local computerized medical record system was used to identify patients undergoing the 25 most common surgical procedures and to examine changes in appropriate antibiotic therapy and LOS over time. Overall, 2550 surgical admissions were identified from the local computerized medical records. The proportion of surgical admissions receiving appropriate perioperative antibiotics was significantly higher (P <.01) in 2004 after initiation of the TPS intervention (44.0%) compared with the previous 4 years (range, 23.4%-29.8%) primarily because of improvements in compliance with antibiotic therapy duration rather than appropriate antibiotic selection. There was no statistically significant decrease in LOS over time. The use of TPS methods resulted in a QI intervention that was associated with an increase in appropriate perioperative antibiotic therapy among surgical patients, without affecting LOS.

  12. The development of environmental productivity

    DEFF Research Database (Denmark)

    Henningsen, Geraldine; Henningsen, Arne; Schröder, Sascha T.

    that there is no overall high achiever group, but that the ranking, although time consistent, varies between the different productivity measures. However, we identify steam turbines and combustion engines for combined heat and power production as potential high performers, while combustion engines that only produce...... the environmental productivity of individual generator units based on a panel data set for the period 1998 to 2011 that includes virtually all fuel-fired generator units in Denmark. We further decompose total productivity into technical efficiency, best practice ratio, and scale efficiency and use a global...... Malmquist index to calculate the yearly changes. By applying time series clustering, we can identify high, middle, and low performance groups of generator units in a dynamic setting. Our results indicate that the sectoral productivity only slightly increased over the fourteen years. Furthermore, we find...

  13. Product development of pumpkin tablet

    Directory of Open Access Journals (Sweden)

    Kamgoed, T.

    2007-05-01

    Full Text Available The development of pumpkin tablet was studied and the drying conditions of pumpkin using a double drum dryer were optimized. The study factors were drying agents (maltodextrin D.E.13-16 andtapioca flour at different levels (3 and 5%, drying temperatures (130 and 140oC and drum dryer speeds (4 and 5 rpm. The results showed that the optimal conditions were using 3% maltodextrin D.E.13-16, dryingtemperature of 130oC and drum dryer speed of 4 rpm. The moisture, fat, bulk density, reducing sugars and granulometric retention of the obtained pumpkin powder were 3.39%, 1.42%, 1.004 g/ml, 12.63% and 0.67%, respectively and L*, a* and b* values were 73.85, -0.60 and 35.23, respectively. A study of suitable amount of icing sugar using different contents for tablet production (0, 10, 20, 30 and 40% was performedand showed that using 20% icing sugar was the most acceptable. The obtained pumpkin tablet was subjected to chemical, physical and microbiological analysis. The ash, moisture, protein, fat, fiber and carbohydratecontents were 1.87, 3.60, 3.34, 1.00, 2.26 and 87.99%, respectively. The reducing sugars and β-carotene contents were 5.44±0.61% and 3.79±0.57 mg/100g, respectively. The Aw, hardness and solubility were 0.56,3.25 kgf and 25.00 %, respectively. The L*, a* and b* values were 79.85, 0.28 and 23.64, respectively. The total microbial count and the yeast and mould count were <10 CFU/g. The shelf life of the pumpkin tabletwas at least 4 months at room temperature (35±2oC.

  14. CIRP Design 2012 Sustainable Product Development

    CERN Document Server

    2013-01-01

    During its life cycle, a product produces waste that is over 20 times its weight. As such it is critical to develop products that are sustainable. Currently product development processes lack high quality methods and tools that are empirically validated to support development of sustainable products. This book is a compilation of over forty cutting edge international research papers from the 22nd CIRP International Design Conference, written by eminent researchers from 15 countries, on engineering design process, methods and tools, broadly for supporting sustainable product development.   A variety of new insights into the product development process, as well as a host of methods and tools that are at the cutting edge of design research are discussed and explained covering a range of diverse topics. The areas covered include: ·Sustainable design and manufacturing, ·Design synthesis and creativity, ·Global product development and product life cycle management, ·Design for X (safety, reliability, manufactu...

  15. Towards a New Framework for Product Development

    DEFF Research Database (Denmark)

    Robotham, Antony John; McAloone, Timothy Charles

    2000-01-01

    Danish companies that Integrated Product Development no longer provides a sufficient way of describing industry’s product development activity. More specifically, five of these companies have supported a programme of research activities at the Technical University of Denmark, which seeks to develop a new......In the mid-1980s, Andreasen and Hein first described their model of Integrated Product Development. Many Danish companies quickly embraced the principles of integrated product development and adapted the model to their specific business and product context. However, there is concern amongst many...... framework for product development. This paper will describe the research approach being taken, present some initial findings, and outline a vision of a new working approach to product development....

  16. Product Configuration Systems - Implications for Product Innovation and Development

    DEFF Research Database (Denmark)

    Edwards, Kasper; Pedersen, Jørgen Lindgaard

    2004-01-01

    configurations. However, costs are but one parameter on which firms compete and firms must continually innovate new and develop existing products. This paper presents original empirical insights on implementation and use of product configuration systems in a number of Danish industrial firms. The paper discusses...... the organisational changes associated with PCS and how this affects product innovation and development. The paper begins by introducing product configuration systems, which are then placed in context to the firm as a process technology which coordinate different processes: product development, order acquisition......Product Configuration Systems (PCS) is a step in the direction of mass customization in the sense that PCS allows a firm to significantly lower the unit cost of configuration. Thus PCS is a valuable technology for lowering operating costs while retaining a high number of possible product...

  17. Linking quality goals and product development competences

    DEFF Research Database (Denmark)

    Olsen, Johanne Rønnow; Harmsen, Hanne; Friis, Alan

    2008-01-01

    Quality is a main determinant of consumer food choice. Product development is accordingly a key activity for companies, because it generates the products on the quality of which consumer choices are based. In this respect, product development managers have a focal role, as their personal quality......, including reversed laddering sessions with 18 product development managers. Discrepancies between managerial and consumer quality goals are uncovered. Furthermore, the results point to two general dilemmas faced by product development managers in relation to quality; an external stakeholder dilemma...... orientation influence the way product development is performed. The aim of this paper is to investigate managerial quality goals and how these may be linked to product development competences, which has not previously been studied. The study draws on an empirical, qualitative study in the Danish food industry...

  18. Product Platform Development in Industrial Networks

    DEFF Research Database (Denmark)

    Karlsson, Christer; Skold, Martin

    2011-01-01

    The article examines the strategic issues involved in the deployment of product platform development in an industrial network. The move entails identifying the types and characteristics of generically different product platform strategies and clarifying strategic motives and differences. Number...

  19. SU-E-P-07: Evaluation of Productivity Systems for Radiation Therapy

    Energy Technology Data Exchange (ETDEWEB)

    Ramsey, C; Usynin, A [Thompson Cancer Survival Center, Knoxville, TN (United States)

    2014-06-01

    Purpose: Health systems throughout the United States are under increased financial pressure to reduce operating cost. As a result, productivity models developed by third-party consultants are being used to optimize staff to treatment volumes. The purpose of this study was to critically evaluate productivity systems for radiation oncology. Methods: Staffing efficiency was evaluated using multiple productivity models. The first model evaluated staffing levels using equal weighting of procedure codes and hours worked. A second productivity model was developed using hours worked by job class and relative value units for each procedure code. A third model was developed using the measured procedure times extracted from the electronic medical record, which tracks the wait and treatment times for each patient for each treatment fraction. A MatLab program was developed to query and analyze the daily treatment data. A model was then created to determine any theoretical gains in treatment productivity. Results: Productivity was evaluated for six radiation therapy departments operating nine linear accelerators delivering over 40,000 treatment fractions per year. Third party productivity models that do not take into consideration the unique nature of radiation therapy can be counterproductive. For example, other outpatient departments can compress their daily schedule to decrease the worked hours. This approach was tested using the treatment schedule evaluation tool developed as part of this study. It was determined that the maximum possible savings for treatment schedule compression was $32,000 per year per linac. All annual cost savings would be lost if only two patients per year choose to be treated elsewhere because of limited or restricted appointment times. Conclusion: The use of productivity models in radiation therapy can easily result in a loss of treatment revenue that is greater than any potential cost savings in reduced hours worked by staff.

  20. Encountering Challenges with the EU Regulation on Advance Therapy Medical Products.

    Science.gov (United States)

    Mansnérus, Juli

    2015-12-01

    This article aims at analysing how well the Advanced Therapy Medical Product Regulation (EC) No. 1394/2007 (ATMP Regulation) meets the needs of small and medium-sized enterprises (SMES), academia and public tissue establishments developing advanced therapy medical products (ATMPS). Benefits and shortcomings of the ATMP Regulation are identified, and possible amendments are proposed to accelerate the translation of research into advanced therapies and to facilitate the commercialisation of ATMPS whilst ensuring safety. It was set up as a lex specialis to ensure the free movement of ATMPS within the EU in order to facilitate their access to the internal market and to foster the competitiveness of European pharmaceutical companies, while guaranteeing the highest level protection of public health. Since the adoption of the ATMP Regulation in late 2008, only 5 ATMPS have been granted marketing authorisations thus far. Hence, there is a need to analyse whether the ATMP Regulation meets its objectives.

  1. Managing Virtual Product Development team: A Review

    OpenAIRE

    Amir Mohammad Colabi; Behrouz Zarei

    2014-01-01

    Although there are many potential benefits associated with the use of virtual product development teams, exploiting these benefits requires an appropriate management. Managing virtual product development team is a critical issue as many of these teams fail to accomplish their goals. Review of previous literature shows that body of knowledge in managing virtual product development teams is fragmented and inconsistent. The main objective of this paper is to categorize the previous research on t...

  2. Developing product families based on architectures

    DEFF Research Database (Denmark)

    Harlou, Ulf

    2006-01-01

    The subject of this PhD thesis is development of product families based on architectures. Companies are introducing more and more product variants to fulfil the market demands. These new variants add complexity to many of the processes and systems in the companies. Reuse of standard designs (i.......e. design entities) and re-use of the way new products are developed can simplify the processes and systems. Case studies show that reuse can lead to reduction of cost and time-to-market of new products. One of the means for managing reuse of standard designs within product families are architectures....... This research studies the phenomenon of product families that are developed based upon architectures. It is stated that an archi¬tecture describes the building principle of a product family and how the product family should evolve over time. This implies that an architecture should prescribe how standard...

  3. DEVELOPMENT OF AN INTEGRATED PRODUCTION INVENTORY ...

    African Journals Online (AJOL)

    This paper presents the development of an integrated production inventory model for multistage serial system. The model seeks to determine simultaneously the optimal production and procurement policies through minimization of time averaged variable cost of production. The cycle concept of instantaneous multistage ...

  4. Development and design of micro products

    DEFF Research Database (Denmark)

    Hansen, Hans Nørgaard

    2004-01-01

    Innovation within the field of micro and nano technology is characterized by cross-disciplinary skills The IT-sector driven development of materials/technologies related to semiconductors and silicon The more traditional materials polymers, metals, ceramics: well suited for mass production but no...... but not widespread in micro products today New possibilities with expensive materials in micro products....

  5. Concurrent Engineering in seafood product development

    DEFF Research Database (Denmark)

    Jonsdottir, Stella; Vesterager, Johan; Børresen, Torger

    1998-01-01

    Concurrent Engineering (CE) can provide an improved approach to product development for extending the lines of seafood products. Information technology support tools based on product models can provide an integrated and simultaneous approach for specifying new recipes. The seafood industry can...... techniques. it is anticipated that other food industries also can benefit from the more simultaneous approach...

  6. Development of Production Control in Small Batch Production

    Directory of Open Access Journals (Sweden)

    Németh Péter

    2016-01-01

    Full Text Available Our aim with this paper is to develop a new performance measurement and control system for small batch production in the automotive industry. For this reason, we present our previous research results for warehouse performance measurement and adopt its methodology to production control. The proposed method is based on artificial intelligence (neural networks.

  7. Portfolio management for product development

    DEFF Research Database (Denmark)

    Larsson, Flemming

    A company seek to improve the understanding of the organization’s approach to portfolio management and the inherited activities and work patterns. In addition, the company wants to obtain a better picture of challenges within the area as well as concrete suggestions for improvement. The objectives...... of this empirical study are: - Capture and describe the current portfolio management process, - Identify challenges within the proces, - Develop suggestions for improvement....

  8. ADDRESSING THE RISKS OF GLOBAL PRODUCT DEVELOPMENT

    DEFF Research Database (Denmark)

    Hansen, Zaza Nadja Lee; Ahmed-Kristensen, Saeema

    2011-01-01

    Offshoring various stages in the product development process – from engineering tasks like R&D and design to manufacturing activities - can impact the development process, the product and the organisation. Some of these impacts are positive while some are negative. The negative impacts are relate...

  9. Market Dynamics and Productivity in Developing Countries ...

    International Development Research Centre (IDRC) Digital Library (Canada)

    25 nov. 2009 ... Market Dynamics and Productivity in Developing Countries : Economic Reforms in the Middle East and North Africa. Book cover Market Dynamics and Productivity in Developing Countries: Economic Reforms in the Middle East. Directeur(s) : Khalid Sekkat. Maison(s) d'édition : Springer, CDRI. 25 novembre ...

  10. Market Dynamics and Productivity in Developing Countries ...

    International Development Research Centre (IDRC) Digital Library (Canada)

    2009-11-25

    Market Dynamics and Productivity in Developing Countries : Economic Reforms in the Middle East and North Africa. Book cover Market Dynamics and Productivity in Developing Countries: Economic Reforms in the Middle East. Editor(s):. Khalid Sekkat. Publisher(s):. Springer, CDRI. November 25, 2009. ISBN:.

  11. Addressing Pressing Needs in the Development of Advanced Therapies

    Directory of Open Access Journals (Sweden)

    David Morrow

    2017-09-01

    Full Text Available The commercial development of advanced therapy medicinal products (ATMPs represents great opportunity for therapeutic innovation but is beset by many challenges for its developers. Although the ATMP field continues to progress at a rapid pace, evidenced by the increasing number of clinical trials conducted over the past few years, several factors continue to complicate the introduction of ATMPs as a curative treatment for multiple disease types, by blocking their translational pathway from research to the patient. While several recent publications (Trounson and McDonald, 2015; Abou-El-Enein et al., 2016a,b as well as an Innovative Medicines Initiative consultation (IMI, 2016 this year have highlighted the major gaps in ATMP development, with manufacturing, regulatory, and reimbursement issues at the forefront, there remains to be formulated a coherent strategy to address these by bringing the relevant stakeholders to a single forum, whose task it would be to design and execute a delta plan to alleviate the most pressing bottlenecks. This article focuses on two of the most urgent areas in need of attention in ATMP development, namely manufacturing and reimbursement, and promotes the concept of innovation-dedicated research infrastructures to support a multi-sector approach for ensuring the successful development, entry, and ensuing survival of ATMPs in the healthcare market.

  12. Managing Virtual Product Development team: A Review

    Directory of Open Access Journals (Sweden)

    Amir Mohammad Colabi

    2014-05-01

    Full Text Available Although there are many potential benefits associated with the use of virtual product development teams, exploiting these benefits requires an appropriate management. Managing virtual product development team is a critical issue as many of these teams fail to accomplish their goals. Review of previous literature shows that body of knowledge in managing virtual product development teams is fragmented and inconsistent. The main objective of this paper is to categorize the previous research on the subject of virtual product development team management in order to integrate the research into a thematic model and to enable recommendations for future research. So, this study reviews and summarizes empirical research in the field, also conceptual and qualitative papers, experiences, reports and explorative case studies. Results show that there are three fields of research in this area, including: Virtual production and Virtual team in Product Development, Managing virtual team in R&D[1] and product development, Managing global virtual product development teams. In order to organize previous studies in this area, a thematic map is proposed which shows the structure and sequence of research. Finally, a comprehensive discussion on the future directions in this field is proposed.

  13. Photodynamic therapy: A new light for the developing world ...

    African Journals Online (AJOL)

    African Journal of Biotechnology ... In one article, photodynamic therapy (PDT) was commended as the most suitable method for cancer therapy in the Developing World. PDT is cost effective ... No engineer, computerized dosimetry computations, or additional costs for isotope re-treatment are required, as in radiotherapy.

  14. Developing fermentative terpenoid production for commercial usage.

    Science.gov (United States)

    Leavell, Michael D; McPhee, Derek J; Paddon, Chris J

    2016-02-01

    Terpenoids comprise a large (>55000) family of compounds, very few of which have been used commercially due to low and economically unpractical production in their native hosts (generally plants and microorganisms). Two examples of natural terpenoid production are described (rubber and astaxanthin), but the advent of metabolic engineering has allowed the development of fermentative production processes using heterologous microorganisms. The two biochemical pathways responsible for terpenoid production are described, along with manipulations that enable production of terpenoids at economically viable levels. Finally, this article reviews some terpenoids that are currently in commercial production or development, ranging from semisynthetic production of the antimalarial drug artemisinin, through fragrance molecules, to commodity chemicals such as isoprene and β-farnesene. Copyright © 2015 Elsevier Ltd. All rights reserved.

  15. Developing occupational therapy students' practice habits via qualitative inquiry education.

    Science.gov (United States)

    Marterella, Abbey L; Aldrich, Rebecca M

    2015-04-01

    Accreditation standards and practice competencies underscore the importance of research for occupational therapy practice, but they do not guide how occupational therapy education addresses research. Despite the prominence of qualitative research in the health professions, there exists a need to articulate how and why qualitative inquiry is taught in occupational therapy education. We discuss how qualitative inquiry education can develop habits of reflection and reflexivity, criticality, and active engagement in preparation for occupational therapy practice. We hold that our students' professional abilities to practice in a well-reasoned, ethical, and responsive manner are enhanced by experiences with qualitative inquiry and suggest that there is potential in linking qualitative inquiry experiences to professional habit formation in occupational therapy education. In addition to teaching research for its own sake, we suggest that educators can adopt a broader view of how qualitative inquiry functions within occupational therapy education.

  16. New product development: A batik multifunctional chair

    Science.gov (United States)

    Indrawati, Sri; Sukmaningsih, Nias

    2017-11-01

    The biggest challenge facing by Batik industry in ASEAN Economic Community (AEC) era is the greater number of fashion competitors both domestically and internationally. Based on that condition, the development of new product variants by considering product performance and price is needed. This research was conducted to develop batik products with a new target market. Products that being developed is batik multifunctional chair using integrated value engineering and analytic hierarchy process methods. This research has been done in several stages, ie. Information stage, creative stage, value analysis and product prototyping. The results of this research shows that the batik multifunctional chair product criteria are aesthetic (29%), multifunctional (34%) and ergonomic (37%). There are three new product design alternatives that successfully being developed. Based on value analysis, the product design alternatives that have the highest value is alternative design 2, the value is 2,37. The production cost for this design is Rp. 500.000,-. Alternative design 2 specification are using Mahoni wood, Batik parang rusak pattern with natural coloring process, can be used as table and fit with customer's body anthropometry. Then a batik multifunctional chair prototype is developed based on the best alternative design.

  17. Product development projects dynamics and emergent complexity

    CERN Document Server

    Schlick, Christopher

    2016-01-01

    This book primarily explores two topics: the representation of simultaneous, cooperative work processes in product development projects with the help of statistical models, and the assessment of their emergent complexity using a metric from theoretical physics (Effective Measure Complexity, EMC). It is intended to promote more effective management of development projects by shifting the focus from the structural complexity of the product being developed to the dynamic complexity of the development processes involved. The book is divided into four main parts, the first of which provides an introduction to vector autoregression models, periodic vector autoregression models and linear dynamical systems for modeling cooperative work in product development projects. The second part presents theoretical approaches for assessing complexity in the product development environment, while the third highlights and explains closed-form solutions for the complexity metric EMC for vector autoregression models and linear dyn...

  18. Improvement of Product Innovations Development Models

    Directory of Open Access Journals (Sweden)

    Rolandas Strazdas

    2011-03-01

    Full Text Available Many authors distinguish product innovation as a key factor leading to long-term competitiveness of companies. This article analyses widely used product innovation development models and also models having distinguished features. The models are examined in the light of success factors for product innovation development discovered during the empirical studies. Based on the analysis the strengths and weaknesses of the models are identified which provide direction for further improvement. As a result of the study it is becoming clear that the analysed models are not properly consider the success factors such as corporate culture, top management involvement and product development strategy. In particular, attention is drawn to the fact that all models are designed for rather big companies having experience in product innovation development. Article in Lithuanian

  19. New product development processes for ICT-for-development projects

    CSIR Research Space (South Africa)

    McAlister, BN

    2012-08-01

    Full Text Available The potential applicability of established new product development processes to information and communications technology (ICT)-for-development projects is investigated. The demand for ICT solutions to serve numerous societal information needs...

  20. Effective Virtual Teams for New Product Development

    OpenAIRE

    Ale Ebrahim, Nader; Ahmed, Shamsuddin; Abdul Rashid, Salwa Hanim; Zahari TAHA

    2012-01-01

    Ale Ebrahim, N., Ahmed, S., Abdul Rashid, S. H., & Taha, Z. (2012). Effective Virtual Teams for New Product Development. [Full Length Research Paper]. Scientific Research and Essay, 7(21), 1971-1985.; International audience; At present, the existing literature shows that the factors which influence the effectiveness of virtual teams for new product development are still ambiguous. To address this problem, a research design was developed, which includes detailed literature review, preliminary ...

  1. Integrating ergonomics into the product development process

    DEFF Research Database (Denmark)

    Broberg, Ole

    1997-01-01

    A cross-sectional case study was performed in a large company producing electro-mechanical products for industrial application. The purpose was to elucidate conditions and strategies for integrating ergonomics into the product development process thereby preventing ergonomic problems at the time...... of manufacture of new products. In reality the product development process is not a rational problem solving process and does not proceed in a sequential manner as decribed in engineering models. Instead it is a complex organizational process involving uncertainties, iterative elements and negotiation between...... strategies to the integration of ergonomics....

  2. The effects of behavioral speech therapy on speech sound production with adults who have cochlear implants.

    Science.gov (United States)

    Pomaville, Frances M; Kladopoulos, Chris N

    2013-04-01

    In this study, the authors examined the treatment efficacy of a behavioral speech therapy protocol for adult cochlear implant recipients. The authors used a multiple-baseline, across-behaviors and -participants design to examine the effectiveness of a therapy program based on behavioral principles and methods to improve the production of target speech sounds in 3 adults with cochlear implants. The authors included probe items in a baseline protocol to assess generalization of target speech sounds to untrained exemplars. Pretest and posttest scores from the Arizona Articulation Proficiency Scale, Third Revision (Arizona-3; Fudala, 2000) and measurement of speech errors during spontaneous speech were compared, providing additional measures of target behavior generalization. The results of this study provided preliminary evidence supporting the overall effectiveness and efficiency of a behavioral speech therapy program in increasing percent correct speech sound production in adult cochlear implant recipients. The generalization of newly trained speech skills to untrained words and to spontaneous speech was demonstrated. These preliminary findings support the application of behavioral speech therapy techniques for training speech sound production in adults with cochlear implants. Implications for future research and the development of aural rehabilitation programs for adult cochlear implant recipients are discussed.

  3. Knowledge sharing in international product development teams

    DEFF Research Database (Denmark)

    Sonne, Anne-Mette; Harmsen, Hanne

    development process is by using teams. Teams are considered one of the best tools for exchanging especially tacit knowledge, since this kind of knowledge is transferred best through personal interaction and face-to-face meetings (Madhavan & Grover, 1998; Nonaka, 1994). In accordance with this, more and more...... multinational firms rely on international product development teams (McDonough et al., 2001) as a means to make the most effective use of the company's resources scattered around the world. While a substantial amount of research exists on groups in general, research into new product development teams is more...... limited and especially empirical research on global new product development teams is sparse (McDonough, et al., 2001). Findings from research on teams cannot automatically be generalized and applied to multinational product development teams, since these differ on a range of parameters from domestic teams...

  4. [Osmolality of products and formulas for nutritional therapy].

    Science.gov (United States)

    De Abreu, Jorge; López, Emeris; Dini, Elizabeth

    2009-12-01

    The objective was to determine the osmolality of products and formulas for nutritional therapy available in Venezuela. The samples were grouped as follows: infant formulas, premature infant, follow up, 1 to 4 years, soy based, lactose free, anti-reflux, hypoallergenic, complete beverages, polymeric formulas, semi-elemental, caloric and protein modules. A vapor pressure digital osmometer was used, analyzing five samples of each product from different lots, prepared by weigth or with scoop. When the variation coefficient of the osmolality measurements was higher than 10%, five additional samples were analyzed. Averages, standard deviation, and the variation coefficient of the osmolality measures (95% reliability) were calculated. The osmolality (mmol/kg) of infant and premature infant formulas were between 258 and 309; follow up formulas ranged between 256-390; 1 to 4 years: 343-399; soy based: 155-252; lactose free: 163-248; anti-reflux: 230-292; hypoallergenic: 220-335; complete beverages: 205-454; polymeric formulas: 247-588; semi-elemental: 238-289; caloric module: 89-99 and protein module: 30-60. We found that almost all the formulas prepared with scoop had higher osmolality and variability than the same products prepared by weight. Some follow up, polymeric, 1 to 4 years formulas and complete beverages had high osmolalities and therefore should not be administered to infants, and must be administered with caution to children and adolescents when the gastrointestinal tract is compromised.

  5. Decision making in global product development

    DEFF Research Database (Denmark)

    Søndergaard, Erik Stefan; Ahmed-Kristensen, Saeema

    2014-01-01

    Many engineering companies experience new challenges when globalising product development. Global product development (GPD) is a relatively nascent research area, and previous research reveals the need for decision support frameworks. This research investigates how decisions are made when companies...... outsource or offshore product development tasks, and how these decisions can be improved. A brief literature review on existing research on GPD and decision making is given, followed by two case studies, where implications of decisions are investigated. The findings point towards further studies required...... for creating a decision support framework for managers to make better decisions in the future....

  6. Developing a Decision Model of Sustainable Product Design and Development from Product Servicizing in Taiwan

    Science.gov (United States)

    Huang, Yu-Chen; Tu, Jui-Che; Hung, So-Jeng

    2016-01-01

    In response to the global trend of low carbon and the concept of sustainable development, enterprises need to develop R&D for the manufacturing of energy-saving and sustainable products and low carbon products. Therefore, the purpose of this study was to construct a decision model for sustainable product design and development from product…

  7. Service-oriented product development strategies

    DEFF Research Database (Denmark)

    Tan, Adrian Ronald

    to shift their business strategies from selling products (e.g. photocopying machines) to the provision of services (e.g. document services). Instead of the product itself, the activity and knowledge associated with the use of the product is perceived to be of more value to customers. In the research...... community, service-oriented approaches that embrace this change of business focus from individual products to total integrated customer solutions are termed Product/Service-Systems (PSS). The research in this thesis addresses the systematic design and development of PSS solutions in manufacturing firms...... – service-oriented business strategies that coordinate PSS development. Based on an extensive review of the relevant literature and five empirical case studies the following insights were made: - PSS solutions may be conceptualised by considering the product life phase systems, customer activities...

  8. The expanding role of the clinical haematologist in the new world of advanced therapy medicinal products.

    Science.gov (United States)

    Lowdell, Mark W; Thomas, Amy

    2017-01-01

    Advanced therapy medicinal products (ATMPs) represent the current pinnacle of 'patient-specific medicines' and will change the nature of medicine in the near future. They fall into three categories; somatic cell-therapy products, gene therapy products and cells or tissues for regenerative medicine, which are termed 'tissue engineered' products. The term also incorporates 'combination products' where a human cell or tissue is combined with a medical device. Plainly, many of these new medicines share similarities with conventional haematological stem cell transplant products and donor lymphocyte infusions as well as solid organ grafts and yet ATMPs are regulated as medicines and their development has remained predominantly in academic settings and within specialist centres. However, with the advent of commercialisation of dendritic cell vaccines, chimeric antigen receptor (CAR)-T cells and genetically modified autologous haematopoietic stem cells to cure single gene-defects in β-thalassaemia and haemophilia, the widespread availability of these therapies needs to be accommodated. Uniquely to ATMPs, the patient or an allogeneic donor is regularly part of the manufacturing process. All of the examples given above require procurement of blood, bone marrow or an apheresate from a patient as a starting material for manufacture. This can only occur in a clinical facility licensed for the procurement of human cells for therapeutic use and this is likely to fall to haematology departments, either as stem cell transplant programmes or as blood transfusion departments, to provide under a contract with the company that will manufacture and supply the final medicine. The resource implications associated with this can impact on all haematology departments, not just stem cell transplant units, and should not be under-estimated. © 2016 John Wiley & Sons Ltd.

  9. Development of novel radiosensitizers for cancer therapy

    CERN Document Server

    Akamatsu, K

    2002-01-01

    The novel radiosensitizers for cancer therapy, which have some atoms with large X-ray absorption cross sections, were synthesized. The chemical and radiation (X-rays, W target, 100kVp) toxicities and the radiosensitivities to LS-180 human colon adenocarcinoma cells were also evaluated. 2,3,4,5,6-pentabromobenzylalcohol (PBBA) derivatives were not radiosensitive even around the maximum concentration. On the other hand, the hydrophilic sodium 2,4,6-triiodobenzoate (STIB) indicated meaningful radiosensitivity to the cells. Moreover, the membrane-specific radiosensitizers, cetyl fluorescein isthiocyanate (cetyl FITC), cetyl eosin isothiocyanate (cetyl br-FITC), cetyl erythrosin isothiocyanate (cetyl I-FITC), which aim for the membrane damage by X-ray photoabsorption on the target atoms, were localized in the plasma membrane. As the results of the colony formation assay, it was found that both cetyl FITC are similarly radiosensitive. In this report, we demonstrate the synthetic methods of the radiosensitizers, the...

  10. [Developments in pyoderma gangrenosum therapy in 2015].

    Science.gov (United States)

    Modiano, P

    2015-01-01

    Diagnosis of pyoderma gangrenosum in 2014 continues to be made on clinical grounds, with the main form comprising an ulcer having poorly delineated purplish edges. The diagnostic criteria have been recently modified so as to rule out differential diagnoses (10% of retrospective series of pyoderma patients). The condition is commonly associated with other diseases (75%) such as emerging endocrine diseases (36.7%), and classical gastrointestinal, rheumatological and haematological diseases. The new concepts of PAPA and PASH syndromes, belonging to the category of auto-inflammatory diseases, provide new therapeutic perspectives. Corticosteroids continue to be the first-line therapy, along with immunosuppressant drugs in the event of steroid dependence. Second-line treatments consisting biotherapies show promise and interleukin-1 inhibitors have exhibited potential against pyoderma syndrome. Copyright © 2015 Elsevier Masson SAS. All rights reserved.

  11. Preclinical Development of New Therapy for Glycogen Storage Diseases

    Science.gov (United States)

    Sun, Baodong; Brooks, Elizabeth D.; Koeberl, Dwight D.

    2015-01-01

    Glycogen storage disease (GSD) consists of more than 10 discrete conditions for which the biochemical and genetic bases have been determined, and new therapies have been under development for several of these conditions. Gene therapy research has generated proof-of-concept for GSD types I (von Gierke disease) and II (Pompe disease). Key features of these gene therapy strategies include the choice of vector and regulatory cassette, and recently adeno-associated virus (AAV) vectors containing tissue-specific promoters have achieved a high degree of efficacy. Efficacy of gene therapy for Pompe disease depend upon the induction of immune tolerance to the therapeutic enzyme. Efficacy of von Gierke disease is transient, waning gradually over the months following vector administration. Small molecule therapies have been evaluated with the goal of improving standard of care therapy or ameliorating the cellular abnormalities associated with specific GSDs. The receptor-mediated uptake of the therapeutic enzyme in Pompe disease was enhanced by administration of β2 agonists. Rapamycin reduced the liver fibrosis observed in GSD III. Further development of gene therapy could provide curative therapy for patients with GSD, if efficacy from preclinical research is observed in future clinical trials and these treatments become clinically available. PMID:26122079

  12. Evolutionary product development in working class housing

    NARCIS (Netherlands)

    Eger, Arthur O.; Lee, L.; van Lombaerde, P.

    2009-01-01

    The well‐known economical product life cycle describes the typical pattern of a product’s turnover over time. Although it has become a central concept in product development and marketing, it has severe practical limitations. Probably one of the most important limitations is that it is a purely

  13. Business Cooperation and Regional Productive Development in ...

    International Development Research Centre (IDRC) Digital Library (Canada)

    The project will produce a database with productive specialization maps, a working paper discussing main sectoral and regional productive development specializations, a collaborative business-networks map broken down by sector and region, an academic journal article, and several policy briefs. This project entails ...

  14. Dynamics Analysis of Wind Energy Production Development

    Science.gov (United States)

    Berg, V. I.; Zakirzakov, A. G.; Gordievskaya, E. F.

    2017-01-01

    The paper presents the analysis of the introduction experience and dynamics development of the world wind energy production. Calculated the amount of wind energy sources investments and the production capacity growth dynamics of the wind turbines. The studies have shown that the introduction dynamics of new wind energy sources is higher than any other energy source.

  15. The New New NEW! Product Development Game

    Science.gov (United States)

    Evers, Marc; van den Ende, Willem

    In this experiential workshop, we will explore the agile product development space (managing, planning, prioritizing, learning and scheduling) through simulating the different approaches, reflecting on our experiences, and summarizing what this means for our daily work.

  16. Test Marketing in New Product Development

    Science.gov (United States)

    Klompmaker, Jay E.; And Others

    1976-01-01

    Discusses the role of test marketing in new product development, based on interviews with marketing executives. Attempts to clarify when a test market should be done, what its aims should be, and how it should be used. (JG)

  17. Quantitative assessment of barriers to the clinical development and adoption of cellular therapies: A pilot study

    Directory of Open Access Journals (Sweden)

    Benjamin M Davies

    2014-09-01

    Full Text Available There has been a large increase in basic science activity in cell therapy and a growing portfolio of cell therapy trials. However, the number of industry products available for widespread clinical use does not match this magnitude of activity. We hypothesize that the paucity of engagement with the clinical community is a key contributor to the lack of commercially successful cell therapy products. To investigate this, we launched a pilot study to survey clinicians from five specialities and to determine what they believe to be the most significant barriers to cellular therapy clinical development and adoption. Our study shows that the main concerns among this group are cost-effectiveness, efficacy, reimbursement, and regulation. Addressing these concerns can best be achieved by ensuring that future clinical trials are conducted to adequately answer the questions of both regulators and the broader clinical community.

  18. Transferring World Class Production to Developing Countries

    DEFF Research Database (Denmark)

    Bruun, Peter; Mefford, Robert Neil

    1998-01-01

    Strategic reasons for firms to transfer world-class production methods and technology to developing countries are discussed and the importance of the management aspects of technology transfer are emphasized. A five stage model of the technology transfer process which bases the choice of the produ......Strategic reasons for firms to transfer world-class production methods and technology to developing countries are discussed and the importance of the management aspects of technology transfer are emphasized. A five stage model of the technology transfer process which bases the choice...... of the production process on the strategic objectives for the plant is developed. This is followed by the selection of the type of production system and the operational methods which will support it. The final stage of the model concerns the human resource policies neede to implement the operational decisions...

  19. Impact of product development efforts on product introduction and product customization abilities

    DEFF Research Database (Denmark)

    Chaudhuri, Atanu; Dawar, Saloni

    2014-01-01

    This paper investigates the impact of efforts in new product development-manufacturing integration (NPDMI) on new product introduction (NPI) and product customization (PC) abilities and the moderating effects of product design complexity and importance of new product development order winners...... (NPIOW) on the above relationships. The results from the data on 136 Indian manufacturing plants show that NPDMI, product design complexity and NPIOW all have significant positive impact on NPI and PC abilities. Importance of NPIOW has a positive moderating effect on the relationship between NPDMI and PC...... ability change but product design complexity demonstrate no such effect on the above relationships....

  20. Family Therapy in Poland: Development and Current Perspectives.

    Science.gov (United States)

    Józefik, Barbara; de Barbaro, Bogdan; Iniewicz, Grzegorz; Namysłowska, Irena

    2013-06-01

    The authors of the present article describe the historical context of family therapy in Poland and current issues in the field. They highlight the fact that Polish therapists first began to develop the field after coming into contact with family therapy leaders from the United States and Western Europe. With the political breakthrough of 1989, there were new opportunities for multilateral cooperation, attendance at international conferences, and the exchange of experiences. Currently, the work of Polish family therapists, the place of family therapy among other forms of psychotherapy, and the related problems and challenges do not differ from other European nations.

  1. Key performance indicators: Global product development

    DEFF Research Database (Denmark)

    Taylor, Thomas Paul; Ahmed-Kristensen, Saeema

    2014-01-01

    investigates the use of key performance indicators as an approach for measuring the success of global product development projects. With the conclusions from a survey and workshop together with observations during a global development project, the need for an alternative approach to measurement than...

  2. Improving Marketing's Contribution to New Product Development

    NARCIS (Netherlands)

    Drechsler, Wenzel; Natter, Martin; Leeflang, Peter S. H.

    In many firms, the marketing department plays a minor role in new product development (NPD). However, recent research demonstrates that marketing capabilities more strongly influence firm performance than other areas such as research and development. This finding underscores the importance of

  3. Requirements for Clinical Trials with Gene Therapy and Transplant Products in Switzerland.

    Science.gov (United States)

    Marti, Andreas

    2015-01-01

    This chapter aims to describe and summarize the regulation of gene and cell therapy products in Switzerland and its legal basis. Product types are briefly described, as are Swiss-specific terminologies such as the term "transplant product," which means products manufactured from cells, tissues, or even whole organs. Although some parts of this chapter may show a guideline character, they are not legally binding, but represent the current thinking of Swissmedic, the Swiss Agency for Therapeutic Products. As so far the experience with marketing approval of gene therapy and cell therapy products in Switzerland is limited, this chapter focuses on the regulation of clinical trials conducted with these products. Quality, nonclinical, and clinical aspects are summarized separately for gene therapy products and transplant products.

  4. Developing communications requirements for Agile Product Realization

    Energy Technology Data Exchange (ETDEWEB)

    Forsythe, C.; Ashby, M.R.

    1994-03-01

    Sandia National Laboratories has undertaken the Agile Product Realization for Innovative electroMEchanical Devices (A-PRIMED) pilot project to develop and implement technologies for agile design and manufacturing of electrochemical components. Emphasis on information-driven processes, concurrent engineering and multi-functional team communications makes computer-supported cooperative work critical to achieving significantly faster product development cycles. This report describes analyses conducted in developing communications requirements and a communications plan that addresses the unique communications demands of an agile enterprise.

  5. ENVISION, developing Positron Emission Tomography for particle therapy

    CERN Multimedia

    2013-01-01

    Particle therapy is an advanced technique of cancer radiation therapy, using protons or other ions to target the cancerous mass. ENVISION aims at developing medical imaging tools to improve the dose delivery to the patient, to ensure a safer and more effective treatment. The animation illustrates the use of Positron Emission Tomography (PET) for monitoring the dose during treatment. Produced by: CERN KT/Life Sciences and ENVISION Project Management: Manuela Cirilli 3D animation: Jeroen Huijben, Nymus3d

  6. Development of the Productivity in European Aggregate Production

    Directory of Open Access Journals (Sweden)

    Y. Kasap

    2017-01-01

    Full Text Available Aggregate industry is one of the indispensable sectors of country economies due to the employment potential and the intense input-output relations with other sectors, especially with the construction sector. In this study, the productivity growth of the countries producing aggregates in Europe over the years 2012 to 2014 is investigated. Data were analyzed using the MPI (Malmquist Productivity Index, which can evaluate the multiple and different unit parameters simultaneously and examine the improvement of the decision making units over time. According to the results, the greatest development was obtained in Latvia and Turkey among the evaluated countries.

  7. An Emerging Theoretical Model of Music Therapy Student Development.

    Science.gov (United States)

    Dvorak, Abbey L; Hernandez-Ruiz, Eugenia; Jang, Sekyung; Kim, Borin; Joseph, Megan; Wells, Kori E

    2017-07-01

    Music therapy students negotiate a complex relationship with music and its use in clinical work throughout their education and training. This distinct, pervasive, and evolving relationship suggests a developmental process unique to music therapy. The purpose of this grounded theory study was to create a theoretical model of music therapy students' developmental process, beginning with a study within one large Midwestern university. Participants (N = 15) were music therapy students who completed one 60-minute intensive interview, followed by a 20-minute member check meeting. Recorded interviews were transcribed, analyzed, and coded using open and axial coding. The theoretical model that emerged was a six-step sequential developmental progression that included the following themes: (a) Personal Connection, (b) Turning Point, (c) Adjusting Relationship with Music, (d) Growth and Development, (e) Evolution, and (f) Empowerment. The first three steps are linear; development continues in a cyclical process among the last three steps. As the cycle continues, music therapy students continue to grow and develop their skills, leading to increased empowerment, and more specifically, increased self-efficacy and competence. Further exploration of the model is needed to inform educators' and other key stakeholders' understanding of student needs and concerns as they progress through music therapy degree programs.

  8. Criteria Assessment Model for Sustainable Product Development

    Science.gov (United States)

    Mohd Turan, Faiz; Johan, Kartina; Hisyamudin Muhd Nor, Nik

    2016-11-01

    The instability in today's market and the ever increasing and emerging demands for mass customized and hybrid products by customers, are driving companies and decision makers to seek for cost effective and time efficient improvements in their product development process. Design concept evaluation which is the end of conceptual design is one of the most critical decision points in product development. It relates to the final success of product development, because poor criteria assessment in design concept evaluation can rarely compensated at the later stages. This has led to real pressure for the adaptation of new developmental architecture and operational parameters to remain competitive in the market. In this paper, a new integrated design concept evaluation based on fuzzy-technique for order preference by similarity to ideal solution (Fuzzy-TOPSIS) is presented, and it also attempts to incorporate sustainability practices in assessing the criteria. Prior to Fuzzy-TOPSIS, a new scale of “Weighting criteria” for survey process is developed to quantify the evaluation criteria. This method will help engineers to improve the effectiveness and objectivity of the sustainable product development. Case example from industry is presented to demonstrate the efficacy of the proposed methodology. The result of the example shows that the new integrated method provides an alternative to existing methods of design concept evaluation.

  9. Life cycle management in product development

    DEFF Research Database (Denmark)

    Skelton, Kristen; Pattis, Anna

    2013-01-01

    The integration of Life Cycle Thinking (LCT) and Life Cycle Management (LCM) into business operations poses great challenges, as it requires a wider range of environmental responsibility often extending beyond a company's immediate control. Simultaneously, it offers many opportunities...... such as the reduction of a product's or industry’s environmental impacts, an increase in process efficiency or the interconnectedness within the organization itself or across a supply chain. Product development has been an area where application of LCM has been discussed most, since most product impacts are determined...... in the innovation and design phases. This comparative analysis explores the various approaches and challenges two companies are currently facing in their attempts to integrate LCT into their core product development processes....

  10. PLM system support for modular product development

    DEFF Research Database (Denmark)

    Bruun, Hans Peter Lomholt; Mortensen, Niels Henrik; Harlou, Ulf

    2015-01-01

    (PDM) and product lifecycle management (PLM) systems offer support by automating and managing some of the operational complexity of modular design activities. PLM system tools are used for handling a variety of product definitions, to manage workflow of development activities, and to measure relational......A modular design strategy both enables, but also demands, parallelism in design activities and collaboration between a diversity of disciplines in companies, which often involves supporting computer-based tools for enhancing interaction, design management, and communication. Product data management...... properties such as cost and performance. Companies often use a PLM tool for management of CAD files, documents, and drawings, but they do not take advantage of the full potential of the PLM system to support the development activities of modular product designs. The key result of this paper...

  11. Challenging the sustainability of micro products development

    DEFF Research Database (Denmark)

    De Grave, Arnaud; Olsen, Stig Irving

    2006-01-01

    regarding the impact of size for recycling or environment. Indeed micro production is often seen as environmental friendly thanks to the small amount of material used. Such a statement can be misleading. In this article EcoDesign or Design for Environment (DFE) and Life Cycle Assessment (LCA......Environmental aspects are one of the biggest concerns regarding the future of manufacturing and product development sustainability. Furthermore, micro products and micro technologies are often seen as the next big thing in terms of possible mass market trend and boom. Many questions are raised...... and the intermediate parts which can be in-process created. Possible future trends for micro products development scheme involving environmental concerns are given....

  12. Decentralised manufacturing of cell and gene therapy products: Learning from other healthcare sectors.

    Science.gov (United States)

    Harrison, Richard P; Ruck, Steven; Rafiq, Qasim A; Medcalf, Nicholas

    2017-12-24

    Decentralised or 'redistributed' manufacturing represents an attractive choice for production of some cell and gene therapies (CGTs), in particular personalised therapies. Decentralised manufacturing splits production into various locations or regions and in doing so, imposes organisational changes on the structure of a company. This confers a significant advantage by democratising supply, creating jobs without geographical restriction to the central hub and allowing a more flexible response to external pressures and demands. This comes with challenges that need to be addressed including, a reduction in oversight, decision making and control by central management which can be critical in maintaining quality in healthcare product manufacturing. The unwitting adoption of poor business strategies at an early stage in development has the potential to undermine the market success of otherwise promising products. To maximise the probability of realising the benefits that decentralised manufacturing of CGTs has to offer, it is important to examine alternative operational paradigms to learn from their successes and to avoid their failures. Whilst no other situation is quite the same as CGTs, some illustrative examples of established manufacturing paradigms are described. Each of these shares a unique attribute with CGTs which aids understanding of how decentralised manufacturing might be implemented for CGTs in a similar manner. In this paper we present a collection of paradigms that can be drawn on in formulating a roadmap to success for decentralised production of CGTs. Copyright © 2017. Published by Elsevier Inc.

  13. Research and development for ethylbenzene production

    Energy Technology Data Exchange (ETDEWEB)

    Xue, Mingwei; Sun, Hongmin; Shen, Zhenhao; Zhang, Bin; Yang, Weimin [SINOPEC Shanghai Research Institute of Petrochemical Technology (China); Huan, Mingyao

    2013-11-01

    Ethylbenzene (EB) is important raw material for the production of styrene. Now, EB is mainly produced by the alkylation of benzene with ethylene catalyzed by zeolite in vapour phase or liquid phase. Shanghai Research Institute of Petrochemical Technology (SRIPT) began to research the catalysts for the production of ethylbenezene in 1993. With near 20 years work, three series of catalysts for the alkylation of benzene with pure ethylene, dilute ethylene and ethanol are in commerical in China. This paper mainly introduced the research and development of SRIPT for the EB production. (orig.)

  14. Implementing Life Cycle Assessment in Product development

    DEFF Research Database (Denmark)

    Bhander, Gurbakhash Singh

    2003-01-01

    The overall aim of the paper is to provide an understanding of the environmental issues involved in the early stages of product development and the capacity of life cycle assessment techniques to address these issues. The paper aims to outline the problems for the designer in evaluating......, and of the opportunities for introducing environmental criteria in the design process through meeting the information requirements of the designer on the different life cycle stages, producing an in-depth understanding of the attitudes of practitioners among product developers to the subject area, and an understanding...... of possible future directions for product development. An Environmentally Conscious Design method is introduced and trade-offs are presented between design degrees of freedom and environmental solutions. Life cycle design frameworks and strategies are addressed. The paper collects experiences and ideas around...

  15. Using market information in product development

    DEFF Research Database (Denmark)

    Søndergaard, Helle Alsted; Harmsen, Hanne

    2007-01-01

    concepts. Originality/value - The proposed model gathers and simplifies the requirements for improved market-oriented product development of fast-moving consumer goods and can remind development teams of considering the situation before and after product experience as well as the different levels......Purpose - The need for better links to the market as well as improved internal sharing and use of market information has been stressed as central for market-oriented product development. This paper aims to suggest a conceptual model for the identification of relevant market information (based...... on the understanding of consumers' vertical and horizontal decision structure) combined with considerations on effective internal use of the information. Design/methodology/approach - The suggested model is applied in case studies in an action research project, and experiences with the application are discussed...

  16. Drivers of Changes in Product Development Rules

    DEFF Research Database (Denmark)

    Christiansen, John K.; Varnes, Claus J.

    2015-01-01

    Purpose: - The purpose of this research is to investigate the drivers that induce companies to change their rules for managing product development. Most companies use a form of rule-based management approach, but surprisingly little is known about what makes companies change these rules...... 10 years based on three rounds of interviews with 40 managers. Findings: - Previous research has assumed that the dynamics of product development rules are based on internal learning processes, and that increasingly competent management will stimulate the implementation of newer and more complex rule...... indicate that many factors influence the modification of rules, and that there is no simple linear progression from one generation to another. Organizational learning is one among several other factors that influences the dynamics of rules for managing product development. Further research is needed...

  17. Development of the cyclotron radioisotope production technology

    Energy Technology Data Exchange (ETDEWEB)

    Suh, Yong Sup; Chun, K.S.; Yang, S.D.; Lee, J.D.; Ahn, S.H.; Yun, Y.K.; Park, H.; Lee, J.S.; Chai, J.S.; Kim, U.S.; Hong, S.S.; Lee, M.Y.; Park, C.W.; Baik, S. K.; Kim, E. H.; Kim, T. K.; Kim, K. S.; Kim, J. H

    1999-04-01

    The purpose of this study is to contribute the advance of nuclear medicine and to the improvement of human health through the development of various accelerator radionuclides and mass production with automization of production. The results obtained from this study are following: 1) In order to introduce 30 MeV high current cyclotron, the specification of cyclotron has been made, the building site was selected and we drew the draw-up of cyclotron. The cyclotron installation contract was postponed until the financial resources could be secured. 2) For a development high purity 1-123 producing system, a Xe-124 target system, a temperature measurement system of the inner part of the target and a target window were fabricated. A Xe-124 gas target recovery system and a full production system of 1-123 was drew up. 3) For a development of a therapeutic nuclide At-211, a target for the production of At-211 via {sup 209}Bi(alpha, 2n) reaction was fabricated. Produced At-211 was separated by distillation method. 4) For development of beta-emitting nuclides, Ti-45, C-11, F{sub 2}-18, beam irradiation system suitable for each target were fabricated. 5) For automatic production of Ga-67, automated module and PLC program was made 6) For the quality control of radiopharmaceuticals, analytical method of thallium and copper by polarography was investigated and established.

  18. Art Therapy. Prevention Against the Development of Depression

    DEFF Research Database (Denmark)

    Skov, Vibeke

    2013-01-01

    The aim in this research study was to focus on art therapy as a method to explore the inner life as prevention against the development of depression and to address the possibility for art therapy to be used as an early intervention tool related to depression. A Jungian epistemology was used...... as a frame for the overall understanding of well-being together with a holistic approach, including the biological, psychological, social and spiritual domains in life. Art therapy processes in the clinical part of the study aimed to include all these levels as the activation of these are considered...... as a mixed-methods design, with the quantitative part imbedded in the qualitative part. Seven participants were chosen to participate in an art therapy group during a 6-month intervention with a total of 13 meetings. The inclusion criteria were identification of mild to moderate depression based on the test...

  19. Development and efficacy of music therapy techniques within palliative care.

    Science.gov (United States)

    Clements-Cortés, Amy

    2016-05-01

    Music therapy is increasingly becoming an intervention used in palliative care settings around the globe. While the specialty of palliative care music therapy is relatively young having emerged in the late 1980s, there is a strong and growing body of evidence demonstrating its efficacy in assisting a variety of issues common at end-of-life. There are multiple music therapy techniques that are implemented with clients in palliative care and they can be categorized in four broad areas: receptive, creative, recreative and combined. These techniques will be presented with respect to their development by clinicians as supported by the descriptive and research literature. Information is also provided on the use of music therapy in facilitating the grieving and bereavement process. Copyright © 2015 Elsevier Ltd. All rights reserved.

  20. Recent developments in drying of food products

    Science.gov (United States)

    Valarmathi, T. N.; Sekar, S.; Purushothaman, M.; Sekar, S. D.; Rama Sharath Reddy, Maddela; Reddy, Kancham Reddy Naveen Kumar

    2017-05-01

    Drying is a dehydration process to preserve agricultural products for long period usage. The most common and cheapest method is open sun drying in which the products are simply laid on ground, road, mats, roof, etc. But the open sun drying has some disadvantages like dependent on good weather, contamination by dust, birds and animals consume a considerable quantity, slow drying rate and damages due to strong winds and rain. To overcome these difficulties solar dryers are developed with closed environment for drying agricultural products effectively. To obtain good quality food with reduced energy consumption, selection of appropriate drying process and proper input parameters is essential. In recent years several researchers across the world have developed new drying systems for improving the product quality, increasing the drying rate, decreasing the energy consumption, etc. Some of the new systems are fluidized bed, vibrated fluidized bed, desiccant, microwave, vacuum, freeze, infrared, intermittent, electro hydrodynamic and hybrid dryers. In this review the most recent progress in the field of drying of agricultural food products such as new methods, new products and modeling and optimization techniques has been presented. Challenges and future directions are also highlighted. The review will be useful for new researchers entering into this ever needed and ever growing field of engineering.

  1. Development of medical application methods using radiation. Radionuclide therapy

    Energy Technology Data Exchange (ETDEWEB)

    Choi, Chang Woon; Lim, S. M.; Kim, E.H.; Woo, K. S.; Chung, W. S.; Lim, S. J.; Choi, T. H.; Hong, S. W.; Chung, H. Y.; No, W. C. [Korea Atomic Energy Research Institute. Korea Cancer Center Hospital, Seoul, (Korea, Republic of); Oh, B. H. [Seoul National University. Hospital, Seoul (Korea, Republic of); Hong, H. J. [Antibody Engineering Research Unit, Taejon (Korea, Republic of)

    1999-04-01

    In this project, we studied following subjects: 1. development of monoclonal antibodies and radiopharmaceuticals 2. clinical applications of radionuclide therapy 3. radioimmunoguided surgery 4. prevention of restenosis with intracoronary radiation. The results can be applied for the following objectives: (1) radionuclide therapy will be applied in clinical practice to treat the cancer patients or other diseases in multi-center trial. (2) The newly developed monoclonal antibodies and biomolecules can be used in biology, chemistry or other basic life science research. (3) The new methods for the analysis of therapeutic effects, such as dosimetry, and quantitative analysis methods of radioactivity, can be applied in basic research, such as radiation oncology and radiation biology.

  2. Research into the Development of Voice Assessment in Music Therapy

    DEFF Research Database (Denmark)

    Storm, Sanne

    This study was a research into the development of a voice assessment profile (VOIAS). Already a preliminary literature search showed that no such profile within music therapy existed, and only very sparse research within music therapy focusing on and involving the human voice. The development...... of VOIAS is based on vocal parameters extracted from the literature review and my clinical approach “Psychodynamic Voice Therapy”. The parameters’ relevance is based on clinical practice and the focus of population in this study, clients suffering from depression....

  3. Mechatronics design principles for biotechnology product development.

    Science.gov (United States)

    Mandenius, Carl-Fredrik; Björkman, Mats

    2010-05-01

    Traditionally, biotechnology design has focused on the manufacture of chemicals and biologics. Still, a majority of biotechnology products that appear on the market today is the result of mechanical-electric (mechatronic) construction. For these, the biological components play decisive roles in the design solution; the biological entities are either integral parts of the design, or are transformed by the mechatronic system. This article explains how the development and production engineering design principles used for typical mechanical products can be adapted to the demands of biotechnology products, and how electronics, mechanics and biology can be integrated more successfully. We discuss three emerging areas of biotechnology in which mechatronic design principles can apply: stem cell manufacture, artificial organs, and bioreactors. Copyright 2010 Elsevier Ltd. All rights reserved.

  4. Anti-inflammatory plant natural products for cancer therapy.

    Science.gov (United States)

    Aravindaram, Kandan; Yang, Ning-Sun

    2010-08-01

    Much of the current research in cancer therapeutics is aimed at developing drugs or vaccines to target key molecules for combating tumor cell growth, metastasis, proliferation, or changes in the associated stromal microenvironment. Studies on a wide spectrum of plant secondary metabolites extractable as natural products from fruits, vegetables, teas, spices, and traditional medicinal herbs show that these plant natural products can act as potent anti-inflammatory, antioxidant or anticancer agents. The recent advances in genomics and metabolomics have enabled biologists to better investigate the potential use of immunomodulatory natural products for treatment or control of various cancerous diseases. The cancer preventive or protective activities of the various immunomodulatory natural products lie in their effects on cellular defenses including detoxifying and antioxidant enzyme systems, and the induction of anti-inflammatory and antitumor or antimetastasis responses, often by targeting specific key transcription factors like nuclear factor kappa B (NF-kappaB), activator protein (AP-1), signal transducers and activators of transcription (STAT) and others. This review presents recent findings and hypotheses on the molecular mechanisms through which various inflammatory activities are linked to tumorigenic processes and the specific immunomodulatory natural products that may suppress inflammation and the associated tumor progression and metastasis both IN VITRO and IN VIVO. In addition to tumor cells PER SE, the various associated roles of myeloid-derived suppressor cells, stromal fibroblasts, myofibroblasts, and inflammatory immune cells, and the possible effects of phytomedicines on these cells in the tumor microenvironment will be discussed. Georg Thieme Verlag KG Stuttgart-New York.

  5. Recent Developments in Biological Hydrogen Production Processes

    Directory of Open Access Journals (Sweden)

    DEBABRATA DAS

    2008-07-01

    Full Text Available Biohydrogen production technology can utilize renewable energy sources like biomass for the generation of hydrogen, the cleanest form of energy for the use of mankind. However, major constraints to the commercialization of these processes include lower hydrogen yields and rates of hydrogen production. To overcome these bottlenecks intensive research work has already been carried out on the advancement of these processes such as the development of genetically modified microorganisms, the improvement of the bioreactor design, molecular engineering of the key enzyme hydrogenases, the development of two stage processes, etc. The present paper explores the recent advancements that have been made till date and also presents the state of the art in molecular strategies to improve the hydrogen production.

  6. Lean Product Development Performance Measurement Tool

    OpenAIRE

    Al-Ashaab, Ahmed; Petritsch, Christoph; Gourdin, Mathilde; Aliende, Usue Aliende; Andino, Alberto; Varro, Brigitta; Rigatti, Carlotta; Golob, Matic; Summers, Mark; El-Nounu, Abdulrahman; Kayani, Amir

    2013-01-01

    The need of applying lean thinking to product development is becoming a must for the organisations to success in the current industry. This paper presents a tool that helps to define the actual status of the organisations in relation to the lean principles. Extensive literature highlighted the need of developing a tool focused on assessing the implementation of lean principles themselves, rather than quantitate metrics. Based on the Balanced Scorecard, four perspectives, with corresponding se...

  7. New product development with dynamic decision support

    CSIR Research Space (South Africa)

    Venter, JP

    2007-08-01

    Full Text Available of this study is to apply decision support techniques (especially Bayesian networks) to the area of new product development management in order to address some of the shortcomings. The research approach is one of decision structuring and modeling. A three...

  8. Navigating sticky areas in transdermal product development.

    Science.gov (United States)

    Strasinger, Caroline; Raney, Sam G; Tran, Doanh C; Ghosh, Priyanka; Newman, Bryan; Bashaw, Edward D; Ghosh, Tapash; Shukla, Chinmay G

    2016-07-10

    The benefits of transdermal delivery over the oral route to combat such issues of low bioavailability and limited controlled release opportunities are well known and have been previously discussed by many in the field (Prausnitz et al. (2004) [1]; Hadgraft and Lane (2006) [2]). However, significant challenges faced by developers as a product moves from the purely theoretical to commercial production have hampered full capitalization of the dosage forms vast benefits. While different technical aspects of transdermal system development have been discussed at various industry meetings and scientific workshops, uncertainties have persisted regarding the pharmaceutical industry's conventionally accepted approach for the development and manufacturing of transdermal systems. This review provides an overview of the challenges frequently faced and the industry's best practices for assuring the quality and performance of transdermal delivery systems and topical patches (collectively, TDS). The topics discussed are broadly divided into the evaluation of product quality and the evaluation of product performance; with the overall goal of the discussion to improve, advance and accelerate commercial development in the area of this complex controlled release dosage form. Published by Elsevier B.V.

  9. Development of Cotton-Based Nonwovens Products

    Science.gov (United States)

    This article briefly describes the planned or projected developments of cotton-based nonwoven products, using state-of-the art technologies and equipment that now, after the devastating hurricane Katrina, have been made available for research at the Southern Regional Reserach Center. Although we sti...

  10. Encouraging help speeds up product development projects

    NARCIS (Netherlands)

    F.J. Sting (Fabian)

    2015-01-01

    markdownabstract__Abstract__ Ensuring new product development projects stay on track is challenging at the best of times. Part of the problem can lie with how project team members behave and communicate. However, a novel approach that triggers help for problems is successfully overcoming such

  11. Performance Measurement in Global Product Development

    DEFF Research Database (Denmark)

    Taylor, Thomas Paul; Ahmed-Kristensen, Saeema

    2013-01-01

    An organisation looking to form collaborations across borders is a consequence of an increasingly competitive world market. Recent studies highlighted key challenges and success factors organisation’s face when globalising stages of product development. To optimize performance along these factors...

  12. New product development with dynamic decision support

    CSIR Research Space (South Africa)

    Venter, Jacobus P

    2009-06-01

    Full Text Available . The objective of this study is to apply decision support techniques (especially Bayesian networks) to the area of new product development management in order to address some of the shortcomings. The research approach is one of decision structuring and modeling...

  13. Developing a Support Tool for Global Product Development Decisions

    DEFF Research Database (Denmark)

    Søndergaard, Erik Stefan; Ahmed-Kristensen, Saeema

    2016-01-01

    This paper investigates how global product development decisions are made through a multiple-case study in three Danish engineering. The paper identifies which information and methods are applied for making decisions and how decision-making can be supported based on previous experience. The paper...... presents results from 51 decisions made in the three companies, and based on the results of the studies a framework for a decision-support tool is outlined and discussed. The paper rounds off with an identification of future research opportunities in the area of global product development and decision-making....

  14. Customer/User Workshops in Product development

    DEFF Research Database (Denmark)

    Brandt, Eva; Binder, Thomas

    1997-01-01

    and discuss experiences with this kind of collaborative fora. We have tried to demonstrate that having an on-going dialogue with users/customers also during detailed design in not only a means to keep 'the voive of the customer alive'. We have found that the workshops have an important impact on securing......In a recent product development project, we have taken part in establishing and organising a series of workshops with a group of customers/users of a future product line through out the development project. The workshops is a kind of informal meetingplace for engineering, marketing, customers......, and users where different needs, preferences, and interests can be discussed. Bringing together stakeholders with different experiences and competencies can provide a highly innovative setting if we are succesful in establishing common understandings of the development task.In this paper we present...

  15. Collaborative product development and situated knowledge contexts

    DEFF Research Database (Denmark)

    Andersen, Poul Houman; Munksgaard, Kristin B.

    2009-01-01

    Purpose - The purpose of this paper is to develop a framework for understanding how problem formulation, information search and division of work in new product development (NPD) activities is shaped by mind sets vested in organizations with diverging positions in the value chain and correspondingly...... situated knowledge contexts. The authors aim to focus on how this influences the marketability of new product ideas. Design/methodology/approach - The empirical data are derived from exploratory observation studies of NPD meetings and interviews of involved managers and specialists in three business dyads...... concerns the atmosphere of the relationship, involving emotions and attitudes of the actors involved from foregone exchange situations. Practical implications - For managers of NPD activities, the relationship between the knowledge contexts involved, the concept development outcomes and the marketability...

  16. Virtual Physical Therapy Clinician: Development, Validation and Testing

    Science.gov (United States)

    Huhn, Karen

    2011-01-01

    Introduction: Clinical reasoning skills develop through repeated practice in realistic patient scenarios. Time constraints, declining availability of clinical education sites and patient safety are some of the factors that limit physical therapy educators' ability to expose students to realistic patient scenarios. Computerized simulations may be…

  17. Toward development of imesenchymal stem cells for immunomodulatory therapy

    NARCIS (Netherlands)

    S.F. De Witte (Samantha Fh); M. Franquesa (Marcella); C.C. Baan (Carla); M.J. Hoogduijn (Martin)

    2016-01-01

    textabstractMesenchymal stem cells (MSC) are under development as an immunomodulatory therapy. The anticipated immunomodulatory effects of MSC are broad, from direct inhibition of lymphocyte proliferation, induction of regulatory T and B cells, to resetting the immune system via a hit-and-run

  18. Sustainability Assessment Model in Product Development

    Science.gov (United States)

    Turan, Faiz Mohd; Johan, Kartina; Nor, Nik Hisyamudin Muhd; Omar, Badrul

    2017-08-01

    Faster and more efficient development of innovative and sustainable products has become the focus for manufacturing companies in order to remain competitive in today’s technologically driven world. Design concept evaluation which is the end of conceptual design is one of the most critical decision points. It relates to the final success of product development, because poor criteria assessment in design concept evaluation can rarely compensated at the later stages. Furthermore, consumers, investors, shareholders and even competitors are basing their decisions on what to buy or invest in, from whom, and also on what company report, and sustainability is one of a critical component. In this research, a new methodology of sustainability assessment in product development for Malaysian industry has been developed using integration of green project management, new scale of “Weighting criteria” and Rough-Grey Analysis. This method will help design engineers to improve the effectiveness and objectivity of the sustainable design concept evaluation, enable them to make better-informed decisions before finalising their choice and consequently create value to the company or industry. The new framework is expected to provide an alternative to existing methods.

  19. Glucocorticoid Induced Cerebellar Toxicity in the Developing Neonate: Implications for Glucocorticoid Therapy during Bronchopulmonary Dysplasia

    Directory of Open Access Journals (Sweden)

    Kevin K. Noguchi

    2014-01-01

    Full Text Available Prematurely born infants commonly suffer respiratory dysfunction due to the immature state of their lungs. As a result, clinicians often administer glucocorticoid (GC therapy to accelerate lung maturation and reduce inflammation. Unfortunately, several studies have found GC therapy can also produce neuromotor/cognitive deficits and selectively stunt the cerebellum. However, despite its continued use, relatively little is known about how exposure to this hormone might produce neurodevelopmental deficits. In this review, we use rodent and human research to provide evidence that GC therapy may disrupt cerebellar development through the rapid induction of apoptosis in the cerebellar external granule layer (EGL. The EGL is a transient proliferative region responsible for the production of over 90% of the neurons in the cerebellum. During normal development, endogenous GC stimulation is thought to selectively signal the elimination of the EGL once production of new neurons is complete. As a result, GC therapy may precociously eliminate the EGL before it can produce enough neurons for normal cerebellar function. It is hoped that this review may provide information for future clinical research in addition to translational guidance for the safer use of GC therapy.

  20. Hiring, Developing, and Organizing Individual Employees for New Product Development versus Product-related Service Innovation

    DEFF Research Database (Denmark)

    Knudsen, Mette Præst; Schleimer, Stephanie

    product-related service innovations, there are also important differences between these. In particular, whilst the educational level of employees has a significant and positive effect on new product development success, hiring highly educated individuals has a significant and negative effect on new...... the value of human resource hiring and developing practices for new product development success; organizations will find it more beneficial to invest predominantly in employees with the highest possible educational level, whilst for product-related service innovations; employees with more general skills...... outcomes. An analysis of 335 survey responses of the multi-topic and multi-country European Manufacturing Survey (EMS) results in a number of interesting findings. First and foremost, although there are commonalities in organizing employees in flexible team arrangements for new product development versus...

  1. Wilson’s disease: Prospective developments towards new therapies

    Science.gov (United States)

    Ranucci, Giusy; Polishchuck, Roman; Iorio, Raffaele

    2017-01-01

    Wilson’s disease (WD) is an autosomal recessive disorder of copper metabolism, caused by mutations in the ATP7B gene. A clear demand for novel WD treatment strategies has emerged. Although therapies using zinc salts and copper chelators can effectively cure WD, these drugs exhibit limitations in a substantial pool of WD patients who develop intolerance and/or severe side effects. Several lines of research have indicated intriguing potential for novel strategies and targets for development of new therapies. Here, we review these new approaches, which comprise correction of ATP7B mutants and discovery of new compounds that circumvent ATP7B-deficiency, as well as cell and gene therapies. We also discuss whether and when these new therapeutic strategies will be translated into clinical use, according to the key requirements for clinical trials that remain to be met. Finally, we discuss the hope for the current rapidly developing research on molecular mechanisms underlying WD pathogenesis and for the related potential therapeutic targets to provide a solid foundation for the next generation of WD therapies that may lead to an effective, tolerable and safe cure. PMID:28852304

  2. Supervision of Occupational Therapy Level II Fieldwork Students: Impact on and Predictors of Clinician Productivity.

    Science.gov (United States)

    Ozelie, Rebecca; Janow, Janet; Kreutz, Corinne; Mulry, Mary Kate; Penkala, Ashley

    2015-01-01

    This study aimed to determine whether a difference in productivity exists between clinicians supervising and not supervising a Level II occupational therapy student and whether factors including clinician years of experience, practice setting, and clinician productivity without a student could predict clinician productivity while supervising a student. We used paired-sample t tests to examine clinician productivity with and without a student in 109 clinician-student encounters and regression analysis to determine factors predictive of clinician productivity with a student. Results indicated no difference in clinician productivity with or without a student. Clinician years of experience, practice area, and productivity without a student were significant predictors of clinician productivity while supervising a student. Study results contradict the belief that supervising Level II fieldwork students lowers clinicians' productivity. Findings suggest that practice area and productivity without a student are important factors influencing the productivity of clinicians supervising a fieldwork student. Copyright © 2015 by the American Occupational Therapy Association, Inc.

  3. [Development of ultrasonic cancer therapy using ultrasound sensitive liposome].

    Science.gov (United States)

    Suzuki, Ryo; Oda, Yusuke; Utoguchi, Naoki; Maruyama, Kazuo

    2010-12-01

    Ultrasound (US) has been utilized as a useful tool for diagnosis and therapy. US mediated drug and gene delivery is paid to attention as a non-invasive system. The combination of US and microbubbles generated microjet stream by inducing disruption of bubbles and resulted in enhancing permeability of cell membrane. This phenomenon has been utilized as driving force for drug and gene delivery. Recently, we developed ultrasound sensitive liposome [Bubble liposome (BL)] containing perfluoropropane gas. US combined with BL could effectively transfer gene in vivo compared to conventional cationic liposomes. Using this method, we succeeded to obtain a therapeutic effect in cancer gene therapy with Interleukin-12 corded plasmid DNA. Therefore, it is expected that US combined with BL might be a useful non-viral vector system. From this result, the fusion of liposomal and ultrasound technologies would be important for establishment of advanced cancer therapy.

  4. Immunotherapy and lung cancer: current developments and novel targeted therapies.

    Science.gov (United States)

    Domingues, Duarte; Turner, Alice; Silva, Maria Dília; Marques, Dânia Sofia; Mellidez, Juan Carlos; Wannesson, Luciano; Mountzios, Giannis; de Mello, Ramon Andrade

    2014-01-01

    Non-small-cell lung cancer (NSCLC) is a highly prevalent and aggressive disease. In the metastatic setting, major advances include the incorporation of immunotherapy and targeted therapies into the clinician's therapeutic armamentarium. Standard chemotherapeutic regimens have long been reported to interfere with the immune response to the tumor; conversely, antitumor immunity may add to the effects of those therapies. The aim of immunotherapy is to specifically enhance the immune response directed to the tumor. Recently, many trials addressed the role of such therapies for metastatic NSCLC treatment: ipilimumab, tremelimumab, nivolumab and lambrolizumab are immunotherapeutic agents of main interest in this field. In addition, anti-tumor vaccines, such as MAGE-A3, Tecetomide, TG4010, CIMAvax, ganglioside vaccines, tumor cell vaccines and dendritic cell vaccines, emerged as potent inducers of immune response against the tumor. The current work aims to address the most recent developments regarding these innovative immunotherapies and their implementation in the treatment of metastatic NSCLC.

  5. Production development for a mature oil field

    Energy Technology Data Exchange (ETDEWEB)

    Demiral, B.; Gumrah, F.; Okandan, E. [Middle East Technical Univ., Ankara (Turkey)

    2001-06-01

    Petroleum reservoir engineers often analyze production data and forecast reserves through the decline curve analysis method which is a useful tool for extrapolating oil production in the future. The recovery of oil can be defined in terms of the oil relative permeability, the drainage volume and the pressure gradient. Problems occur in using decline curve analysis when there are changes to the relative permeability relationship or drainage occurs. This paper presented development strategies for the Mishovdag oil field in Azerbaijan. This sandstone reservoir provides 40 per cent of the total oil produced from the Sirvan oilfield region. A total of 516 wells have been drilled in the area since 1956, of which 198 are still in production. The reservoir properties were evaluated using core and well log data as well as the decline curve analysis. Two development scenarios were considered. The one which showed a production rate increase of 50 per cent within four years involved the stopping of water injection from the anticline and continuing it from other injection wells into the sands. 20 refs., 3 tabs., 9 figs.

  6. Development of Processed Products from Guapple

    Directory of Open Access Journals (Sweden)

    Teresita Acevedo

    1995-12-01

    Full Text Available The study aimed to develop processed products from guapple. Characterization of the guapple fruit was intially conducted before proceeding to formulation studies.The following characteristics of the guapple fruit were observed: color of outer skin - yellow green with Munsell notation of 10 Y7/6, color of inner flesh - off white with Munsell notation of 7.5Y 8/2; texture, 20.4-37.1 mm; average weight per piece, from 219 to 420 gms; ph, 3.7; titrable acidity (citric acid, 0.34%, and soluble solids, 2.6° Brix.The identified processed products from guapple were puree, pickles, and preserves. Standardized processes and formulations for each of these products were developed in semi-pilot scale. Removal of the skin for the guapple preserves and pickles was facilitated using 5% brine-l % CaCI2.Suitable packaging materials were also identified. Flexible films were used for guapple puree while glass jars and flexible films were found to be satisfactory both for guapple pickles and preserves.Physico-chemical, microbiological, and sensory evaluation were done after two months of storage. Based on these tests, the pasteurization process of 180° F for 20 minutes for puree and 10 minutes for preserves and pickles, was found to make the products commercially sterile.

  7. Natural product β-thujaplicin inhibits homologous recombination repair and sensitizes cancer cells to radiation therapy.

    Science.gov (United States)

    Zhang, Lihong; Peng, Yang; Uray, Ivan P; Shen, Jianfeng; Wang, Lulu; Peng, Xiangdong; Brown, Powel H; Tu, Wei; Peng, Guang

    2017-12-01

    Investigation of natural products is an attractive strategy to identify novel compounds for cancer prevention and treatment. Numerous studies have shown the efficacy and safety of natural products, and they have been widely used as alternative treatments for a wide range of illnesses, including cancers. However, it remains unknown whether natural products affect homologous recombination (HR)-mediated DNA repair and whether these compounds can be used as sensitizers with minimal toxicity to improve patients' responses to radiation therapy, a mainstay of treatment for many human cancers. In this study, in order to systematically identify natural products with an inhibitory effect on HR repair, we developed a high-throughput image-based HR repair screening assay and screened a chemical library containing natural products. Among the most interesting of the candidate compounds identified from the screen was β-thujaplicin, a bioactive compound isolated from the heart wood of plants in the Cupressaceae family, can significantly inhibit HR repair. We further demonstrated that β-thujaplicin inhibits HR repair by reducing the recruitment of a key HR repair protein, Rad51, to DNA double-strand breaks. More importantly, our results showed that β-thujaplicin can radiosensitize cancer cells. Additionally, β-thujaplicin sensitizes cancer cells to PARP inhibitor in different cancer cell lines. Collectively, our findings for the first time identify natural compound β-thujaplicin, which has a good biosafety profile, as a novel HR repair inhibitor with great potential to be translated into clinical applications as a sensitizer to DNA-damage-inducing treatment such as radiation and PARP inhibitor. In addition, our study provides proof of the principle that our robust high-throughput functional HR repair assay can be used for a large-scale screening system to identify novel natural products that regulate DNA repair and cellular responses to DNA damage-inducing treatments such as

  8. Model of the Product Development Lifecycle.

    Energy Technology Data Exchange (ETDEWEB)

    He, Sunny L. [Sandia National Lab. (SNL-NM), Albuquerque, NM (United States); Roe, Natalie H. [Sandia National Lab. (SNL-NM), Albuquerque, NM (United States); Wood, Evan [Sandia National Lab. (SNL-NM), Albuquerque, NM (United States); Nachtigal, Noel M. [Sandia National Lab. (SNL-NM), Albuquerque, NM (United States); Helms, Jovana [Sandia National Lab. (SNL-NM), Albuquerque, NM (United States)

    2015-10-01

    While the increased use of Commercial Off-The-Shelf information technology equipment has presented opportunities for improved cost effectiveness and flexibility, the corresponding loss of control over the product's development creates unique vulnerabilities and security concerns. Of particular interest is the possibility of a supply chain attack. A comprehensive model for the lifecycle of hardware and software products is proposed based on a survey of existing literature from academic, government, and industry sources. Seven major lifecycle stages are identified and defined: (1) Requirements, (2) Design, (3) Manufacturing for hardware and Development for software, (4) Testing, (5) Distribution, (6) Use and Maintenance, and (7) Disposal. The model is then applied to examine the risk of attacks at various stages of the lifecycle.

  9. Decisions on new product development under uncertainties

    Science.gov (United States)

    Huang, Yeu-Shiang; Liu, Li-Chen; Ho, Jyh-Wen

    2015-04-01

    In an intensively competitive market, developing a new product has become a valuable strategy for companies to establish their market positions and enhance their competitive advantages. Therefore, it is essential to effectively manage the process of new product development (NPD). However, since various problems may arise in NPD projects, managers should set up some milestones and subsequently construct evaluative mechanisms to assess their feasibility. This paper employed the approach of Bayesian decision analysis to deal with the two crucial uncertainties for NPD, which are the future market share and the responses of competitors. The proposed decision process can provide a systematic analytical procedure to determine whether an NPD project should be continued or not under the consideration of whether effective usage is being made of the organisational resources. Accordingly, the proposed decision model can assist the managers in effectively addressing the NPD issue under the competitive market.

  10. Top Management Involvement in New Product Development

    DEFF Research Database (Denmark)

    Felekoglu, Burcu; Maier, Anja; Moultrie, James

    2010-01-01

    Involvement of top managers in new product development (NPD) is a critical factor affecting NPD performance and frequently considered to be the participation of top management to certain activities in NPD or their NPD related behaviours. However, “Top management involvement in NPD” occupies...... a broader conceptual space than this participation. This paper reviews the literature on top management involvement in new product development (NPD) and discusses relevance of different theoretical perspectives from other disciplines such as management, organisational behaviour and communication to analyse...... antecedents, realisation and consequences of top management involvement in NPD. It is argued that top management has different involvement at different NPD levels: organisation level and project level. Resulting from this literature review, a tentative framework for top management involvement in NPD...

  11. Two decades of orphan product development.

    Science.gov (United States)

    Haffner, Marlene E; Whitley, Janet; Moses, Marie

    2002-10-01

    Over the past 20 years, incentives of the Orphan Drug Act (ODA), the largest single source of extramural clinical grants at the US Food and Drug Administration, have had a substantial impact on public health. ODA incentives have contributed to the development of many innovative biotechnology products, and as our understanding of the human genome evolves, it is anticipated that pharmacogenomics will result in the identification of more 'orphan diseases'.

  12. Natural products as potential cancer therapy enhancers: A preclinical update

    Directory of Open Access Journals (Sweden)

    Abed Agbarya

    2014-09-01

    Full Text Available Cancer is a multifactorial disease that arises as a consequence of alterations in many physiological processes. Recently, hallmarks of cancer were suggested that include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis, along with two emerging hallmarks including reprogramming energy metabolism and escaping immune destruction. Treating multifactorial diseases, such as cancer with agents targeting a single target, might provide partial treatment and, in many cases, disappointing cure rates. Epidemiological studies have consistently shown that the regular consumption of fruits and vegetables is strongly associated with a reduced risk of developing chronic diseases, such as cardiovascular diseases and cancer. Since ancient times, plants, herbs, and other natural products have been used as healing agents. Moreover, the majority of the medicinal substances available today have their origin in natural compounds. Traditionally, pharmaceuticals are used to cure diseases, and nutrition and herbs are used to prevent disease and to provide an optimal balance of macro- and micro-nutrients needed for good health. We explored the combination of natural products, dietary nutrition, and cancer chemotherapeutics for improving the efficacy of cancer chemotherapeutics and negating side effects.

  13. Environmental Priorities In Strategic Product Development

    DEFF Research Database (Denmark)

    Simon, M; Poole, S.; Sweatman, A.

    2000-01-01

    Reports progress of the Design for Environmental Decision Support (DEEDS) project, gives the project's aim as the development of appropriate tools and methods for eco-design for use in the electrical/electronics sector. Bases development of the tools and methods on the results of a survey of 19...... companies in the target sector. Reviews the available eco-design methodologies, e.g. life cycle assessment (LCA), quotes employee's of the surveyed companies regarding the companies' use of eco-design, and of environmental champions within product divisions and design teams. Presents a four-step eco...

  14. Natural products as starting points for future anti-malarial therapies: going back to our roots?

    Directory of Open Access Journals (Sweden)

    Wells Timothy NC

    2011-03-01

    Full Text Available Abstract Background The discovery and development of new anti-malarials are at a crossroads. Fixed dose artemisinin combination therapy is now being used to treat a hundred million children each year, with a cost as low as 30 cents per child, with cure rates of over 95%. However, as with all anti-infective strategies, this triumph brings with it the seeds of its own downfall, the emergence of resistance. It takes ten years to develop a new medicine. New classes of medicines to combat malaria, as a result of infection by Plasmodium falciparum and Plasmodium vivax are urgently needed. Results Natural product scaffolds have been the basis of the majority of current anti-malarial medicines. Molecules such as quinine, lapachol and artemisinin were originally isolated from herbal medicinal products. After improvement with medicinal chemistry and formulation technologies, and combination with other active ingredients, they now make up the current armamentarium of medicines. In recent years advances in screening technologies have allowed testing of millions of compounds from pharmaceutical diversity for anti-malarial activity in cellular assays. These initiatives have resulted in thousands of new sub-micromolar active compounds – starting points for new drug discovery programmes. Against this backdrop, the paucity of potent natural products identified has been disappointing. Now is a good time to reflect on the current approach to screening herbal medicinal products and suggest revisions. Nearly sixty years ago, the Chinese doctor Chen Guofu, suggested natural products should be approached by dao-xing-ni-shi or ‘acting in the reversed order’, starting with observational clinical studies. Natural products based on herbal remedies are in use in the community, and have the potential unique advantage that clinical observational data exist, or can be generated. The first step should be the confirmation and definition of the clinical activity of herbal

  15. Testing Software Development Project Productivity Model

    Science.gov (United States)

    Lipkin, Ilya

    Software development is an increasingly influential factor in today's business environment, and a major issue affecting software development is how an organization estimates projects. If the organization underestimates cost, schedule, and quality requirements, the end results will not meet customer needs. On the other hand, if the organization overestimates these criteria, resources that could have been used more profitably will be wasted. There is no accurate model or measure available that can guide an organization in a quest for software development, with existing estimation models often underestimating software development efforts as much as 500 to 600 percent. To address this issue, existing models usually are calibrated using local data with a small sample size, with resulting estimates not offering improved cost analysis. This study presents a conceptual model for accurately estimating software development, based on an extensive literature review and theoretical analysis based on Sociotechnical Systems (STS) theory. The conceptual model serves as a solution to bridge organizational and technological factors and is validated using an empirical dataset provided by the DoD. Practical implications of this study allow for practitioners to concentrate on specific constructs of interest that provide the best value for the least amount of time. This study outlines key contributing constructs that are unique for Software Size E-SLOC, Man-hours Spent, and Quality of the Product, those constructs having the largest contribution to project productivity. This study discusses customer characteristics and provides a framework for a simplified project analysis for source selection evaluation and audit task reviews for the customers and suppliers. Theoretical contributions of this study provide an initial theory-based hypothesized project productivity model that can be used as a generic overall model across several application domains such as IT, Command and Control

  16. Development of radioisotope production in the Philippines

    Energy Technology Data Exchange (ETDEWEB)

    Cabalfin, E.G. [Philippine Nuclear Research Institute, Quezon (Philippines)

    1998-10-01

    The Philippine Nuclear Research Institute (PNRI) started its activities on radioisotope production more than three decades ago, when the Philippine Research Reactor (PRR-1) started operating at its full rated power of 1 MW. Since then, several radionuclides in different chemical forms, were routinely produced and supplied for use in nuclear medicine, industry, agriculture, research and training, until the conversion of the PRR-1 to a 3 MW TRIGA type reactor. After the criticality test of the upgraded reactor, a leak was discovered in the pool liner. With the repair of the reactor still ongoing, routine radioisotope production activities have been reduced to dispensing of imported bulk {sup 131}I. In the Philippines, radioisotopes are widely used in nuclear medicine, with {sup 131}I and {sup 99m}Tc as the major radionuclides of interest. Thus the present radioisotope production program of PNRI is directed to meet this demand. With the technical assistance of the International Atomic Energy Agency (IAEA), PNRI is setting up a new {sup 131}I production facility. The in-cell equipment have been installed and tested using both inactive and active target, obtained from BATAN, Indonesia. In order to meet the need of producing {sup 99}Mo-{sup 99m}Tc generators, based on low specific activity reactor-produced {sup 99}Mo, research and development work on the preparation of {sup 99m}Tc gel generators is ongoing. (author)

  17. Challenges and future in vaccines, drug development, and immunomodulatory therapy.

    Science.gov (United States)

    Kling, Heather M; Nau, Gerard J; Ross, Ted M; Evans, Thomas G; Chakraborty, Krishnendu; Empey, Kerry M; Flynn, JoAnne L

    2014-08-01

    Pulmonary diseases and infections are among the top contributors to human morbidity and mortality worldwide, and despite the successful history of vaccines and antimicrobial therapeutics, infectious disease still presents a significant threat to human health. Effective vaccines are frequently unavailable in developing countries, and successful vaccines have yet to be developed for major global maladies, such as tuberculosis. Furthermore, antibiotic resistance poses a growing threat to human health. The "Challenges and Future in Vaccines, Drug Development, and Immunomodulatory Therapy" session of the 2013 Pittsburgh International Lung Conference highlighted several recent and current studies related to treatment and prevention of antibiotic-resistant bacterial infections, highly pathogenic influenza, respiratory syncytial virus, and tuberculosis. Research presented here focused on novel antimicrobial therapies, new vaccines that are either in development or currently in clinical trials, and the potential for immunomodulatory therapies. These studies are making important contributions to the areas of microbiology, virology, and immunology related to pulmonary diseases and infections and are paving the way for improvements in the efficacy of vaccines and antimicrobials.

  18. Sustainable development perspectives of poultry production

    DEFF Research Database (Denmark)

    Vaarst, Mette; Steenfeldt, Sanna; Horsted, Klaus

    2015-01-01

    The concept of ‘sustainability’ or ‘sustainable development’ is multi-dimensional, encompassing economic, environmental, social, and institutional governance aspects. The theoretical framework for this article on sustainability in poultry production is built on this multi-dimensional understanding...... of the concept, acknowledging that it is complex and contested. It is challenging to analyse or discuss the sustainability of one single sector within agriculture, because this sector is part of a global food system, and a systems approach is necessary. This article gives examples of elements which link to one...... throughout major parts of the world (economic aspects). There are numerous potential pathways for sustainable development of poultry production. Poultry are living, sentient animals that can be well integrated into many different types of urban and rural farming systems, where they benefit from...

  19. DNA Repair Mechanisms in Cancer Development and Therapy

    Directory of Open Access Journals (Sweden)

    Alessandro eTorgovnick

    2015-04-01

    Full Text Available DNA damage has been long recognized as causal factor for cancer development. When erroneous DNA repair leads to mutations or chromosomal aberrations affecting oncogenes and tumor suppressor genes, cells undergo malignant transformation resulting in cancerous growth. Genetic defects can predispose to cancer: Mutations in distinct DNA repair systems elevate the susceptibility to various cancer types. However, DNA damage not only comprises a root cause for cancer development but also continues to provide an important avenue for chemo- and radiotherapy. Since the beginning of cancer therapy, genotoxic agents have been applied that trigger DNA damage checkpoints that halt the growth and trigger the apoptotic demise of cancer cells. We provide an overview about the involvement of DNA repair systems in cancer prevention and the classes of genotoxins that are commonly used for the treatment of cancer. A better understanding of the roles and interactions of the highly complex DNA repair machineries will lead to important improvements in cancer therapy.

  20. Therapy Videotape Presentation for Eating Disorder Clients: Development and Evaluation

    OpenAIRE

    Quakenbush, Benita J.

    1998-01-01

    Eating disorder clients show low motivation, poor follow-through, and inordinate premature dropout rates in treatment. Earlier studies support the use of pretherapy training to help clients understand the tasks and challenges of therapy. However, a pretherapy intervention, such as showing prospective clients a video that outlines recovery issues and themes, had not yet been developed specifically for the prevalent, recalcitrant problem of eating disorders. Thus, of particular interest to clin...

  1. Development and Translation of Therapies for Spinal Muscular Atrophy

    Directory of Open Access Journals (Sweden)

    Hannah K. Shorrock

    2016-07-01

    Full Text Available Spinal muscular atrophy (SMA is an autosomal recessive neuromuscular disorder characterised by widespread loss of lower motor neurons from the spinal cord, leading to progressive weakness and muscle atrophy. SMA is largely caused by homozygous loss of the survival motor neuron (SMN 1 gene, resulting in reduced levels of full-length SMN protein. Although no approved treatment is currently available for SMA, several clinical trials investigating different approaches to increase SMN levels are showing promising early results. Trials investigating the use of therapies targeting muscle strength and neuroprotective pathways are also in progress, generating the possibility of delivering combination therapies utilising both SMN-dependent and SMN-independent targets. Due to an increased understanding of the cellular and molecular consequences of SMN depletion, a second wave of therapies targeted at pathways downstream of SMN are currently undergoing preclinical development. As these therapies move forward towards the clinic, new treatment options are likely to become available, raising the potential to generate an effective ‘cure’ for SMA.

  2. Development of Viral Vectors for Gene Therapy for Chronic Pain

    Directory of Open Access Journals (Sweden)

    Yu Huang

    2011-01-01

    Full Text Available Chronic pain is a major health concern that affects millions of people. There are no adequate long-term therapies for chronic pain sufferers, leading to significant cost for both society and the individual. The most commonly used therapy for chronic pain is the application of opioid analgesics and nonsteroidal anti-inflammatory drugs, but these drugs can lead to addiction and may cause side effects. Further studies of the mechanisms of chronic pain have opened the way for development of new treatment strategies, one of which is gene therapy. The key to gene therapy is selecting safe and highly efficient gene delivery systems that can deliver therapeutic genes to overexpress or suppress relevant targets in specific cell types. Here we review several promising viral vectors that could be applied in gene transfer for the treatment of chronic pain and further discuss the possible mechanisms of genes of interest that could be delivered with viral vectors for the treatment of chronic pain.

  3. Evolutionary game theory of growth factor production: implications for tumour heterogeneity and resistance to therapies

    National Research Council Canada - National Science Library

    Archetti, M

    2013-01-01

    .... I use evolutionary game theory to model collective interactions between cancer cells, to analyse the dynamics of the production of growth factors and the effect of therapies that reduce their amount...

  4. A Scandinavian Model of Innovative Product Development

    DEFF Research Database (Denmark)

    McAloone, Timothy Charles; Andreasen, Mogens Myrup; Boelskifte, Per

    2007-01-01

    competencies. We reflect on our efforts to produce a new type of design professionalism, pointing to new roles and identities for the professional-ism of synthesis and innovation. Finally, we round up by articulating what we see as the future pattern of product development, which should be sup-ported already......The educational systems in the small Scandinavian countries are open to experiments and new education programmes. This paper presents such an initiative from Denmark, showing new interpretations of industrial needs, research insights, educational ideas and identification of core innovative...

  5. Adp53 (Gendicine) 12 Years in Clinic - The First Approved Gene Therapy Product for Cancer.

    Science.gov (United States)

    Zhang, Wei-Wei; Li, Jianglong; Li, Dinggang; Liu, Jiliang; Li, Xiuqin; Li, Wei; Xu, Xiaolong; Zhang, Michael J; Chandler, Lois; Lin, Hong; Hu, Aiguo; Xu, Wei; Lam, Dominic Man-Kit

    2018-01-16

    Gendicine (Recombinant Human p53 Adenovirus, AdRSV-p53), developed by Shenzhen SiBiono GeneTech Company, was approved by CFDA in 2003. It has been used in clinical oncology for 12 years since it entered the market in 2004. As the first-in-class product for cancer gene therapy, Gendicine met its expectation and demonstrated with ample clinical data that it is safe and effective for treating cancer. SiBiono manufactured 41 batches in compliant with CFDA QC/QA requirements. Total 169,571 vials (1.0x1012 vector particles per vial) were used in more than 50,000 patients, among them about 5,000 were international form over 50 nations outside China. Comparing with the first-line standard therapies, intratumor injection of Gendicine combined with chemotherapy and radiotherapy resulted in response rate significantly higher than chemo or radiotherapy alone. The approved indication for Gendicine is Head & Neck Cancer, including NPC. However, Gendicine has been successfully applied for various types and at different disease stage cancers. Furthermore, Gendicine combination regimen has brought long-term benefits to the treated patients with 5-8 year progression-free survival significantly longer than standard therapy alone. Gendicine is a type of biological therapy and is minimally invasive via intratumor injection, intra-cavity or vascular infusion. No serious adverse event reported on Gendicine, except the vector-associated transient fever, which occurred in 50-60% patients treated. The fever, ranged 38-39.50C, took place within 24 hours after Gendicine administration and persisted a few hours. In this review, 30 clinical studies on Gendicine combination regimen with published data and 10 studies with long-term survival follow-up data are summarized and reported. Various types of cancer and a few special clinical cases treated with Gendicine are analyzed. Gendicine's manufacture accomplishments and clinical experience may cast some lights for the international gene therapy

  6. Progress and challenges in the development of a cell-based therapy for hemophilia A.

    Science.gov (United States)

    Fomin, M E; Togarrati, P P; Muench, M O

    2014-12-01

    Hemophilia A results from an insufficiency of factor VIII (FVIII). Although replacement therapy with plasma-derived or recombinant FVIII is a life-saving therapy for hemophilia A patients, such therapy is a life-long treatment rather than a cure for the disease. In this review, we discuss the possibilities, progress, and challenges that remain in the development of a cell-based cure for hemophilia A. The success of cell therapy depends on the type and availability of donor cells, the age of the host and method of transplantation, and the levels of engraftment and production of FVIII by the graft. Early therapy, possibly even prenatal transplantation, may yield the highest levels of engraftment by avoiding immunological rejection of the graft. Potential cell sources of FVIII include a specialized subset of endothelial cells known as liver sinusoidal endothelial cells (LSECs) present in the adult and fetal liver, or patient-specific endothelial cells derived from induced pluripotent stem cells that have undergone gene editing to produce FVIII. Achieving sufficient engraftment of transplanted LSECs is one of the obstacles to successful cell therapy for hemophilia A. We discuss recent results from transplants performed in animals that show production of functional and clinically relevant levels of FVIII obtained from donor LSECs. Hence, the possibility of treating hemophilia A can be envisioned through persistent production of FVIII from transplanted donor cells derived from a number of potential cell sources or through creation of donor endothelial cells from patient-specific induced pluripotent stem cells. © 2014 International Society on Thrombosis and Haemostasis.

  7. Competency development in antibody production in cancer cell biology

    Energy Technology Data Exchange (ETDEWEB)

    Park, M.S.

    1998-12-01

    This is the final report of a three-year, Laboratory Directed Research and Development (LDRD) project at Los Alamos National Laboratory (LANL). The main objective of this project was to develop a rapid recombinant antibody production technology. To achieve the objective, the authors employed (1) production of recombinant antigens that are important for cell cycle regulation and DNA repair, (2) immunization and specific selection of antibody-producing lymphocytes using the flow cytometry and magnetic bead capturing procedure, (3) construction of single chain antibody library, (4) development of recombinant vectors that target, express, and regulate the expression of intracellular antibodies, and (5) specific inhibition of tumor cell growth in tissue culture. The authors have accomplished (1) optimization of a selection procedure to isolate antigen-specific lymphocytes, (2) optimization of the construction of a single-chain antibody library, and (3) development of a new antibody expression vector for intracellular immunization. The future direction of this research is to continue to test the potential use of the intracellular immunization procedure as a tool to study functions of biological molecules and as an immuno-cancer therapy procedure to inhibit the growth of cancer cells.

  8. Development of a production meta Product State Model

    DEFF Research Database (Denmark)

    Larsen, Michael Holm; Sørensen, Christian; Langer, Gilad

    1999-01-01

    As products often deviate from their original design and specifications when being produced, adjustments of the product or process are required in order to meet specifications. A prerequisite for this adjustment, is appropriate and effectively collected shop floor data. The Product State Model (PSM...

  9. Cancer incidence and novel therapies developed in Japan

    Directory of Open Access Journals (Sweden)

    Masaru Iwasaki

    2012-01-01

    Full Text Available According to the ministry of Health, Labour and welfare of Japan, Cancer has been the leading cause of death in Japan since 1981. [1] As per the data in 2010, in Japan, one in every three deaths was due to cancer. [2] The Japanese Government has introduced so far, three terms of 10 years strategies for Cancer control since 1984 till date. The budget allocated for cancer control in 2009 was 52.5 billion yen in Japan. [3] Lung is the leading site for cancer in both males and females in Japan. In males, following the lung, stomach, liver, colon and pancreas are other leading sites while in the females, stomach, colon, pancreas and breast are the other leading sites.[1] In 2006, the cancer incidence was 694,000 and the male cancer incidence was 1.4 times as large as that of females. The peak age for cancer deaths in males is their fifties while in the females it is the sixties among Japanese. In addition to the conventional treatments such as surgery, radiotherapy and chemotherapy, some of other therapies in practice in Japan are the Hyperthermia [4] that uses high temperatures to kill or damage the cancer cells, the Ion Beam therapy using proton beams [5] to damage the DNA of the cells as cancer cells have high rate of cell divisions and lesser ability to repair DNA damage, the molecular targeted therapies that interfere with a specific molecular target involved in tumour growth and progression [6] and most importantly the autologous cell based Immunotherapies. Modern Cancer Immunotherapy started in the 1970s in Japan. The immunopotentiators using compounds from Bacteria, Beta Glucans from fungi were the first forms of modern Immunotherapy. Then was the era of direct injection of cytokines such as Interleukins, Interferons etc. The adverse effects associated with the injection of cytokines led to development of cell based Immunotherapies in the 1980s. [7] Immuno-cell therapies involve isolation of immune cells which are then processed and re

  10. Development of fission Mo-99 production technology

    Energy Technology Data Exchange (ETDEWEB)

    Park, Jin Ho; Choung, W. M.; Lee, K. I. and others

    2001-05-01

    This R and D project is planed to supply domestic demands of Mo-99 through fission route, and consequently this project will be expected to rise up utilization of HANARO and KAERI's capability for marketing extension into domestic and oversea radiopharmaceutical market. HEU and LEU target types are decided and designed for fission Mo-99 production in domestic. Experimental study of target fabrication technology was performed and developed processing equipments. And conceptual design of target loading/unloading in/from HANARO device are performed. Tracer test of Mo-99 separation and purification process was performed, test results reach to Mo-99 recovery yield above 80% and decontamination factor above 1600. Combined Mo-99 separation and purification process was decided for hot test scheduled from next year, and performance test was performed. Conceptual design for modification of existing hot cell for fission Mo-99 production facility was performed and will be used for detail design. Assumption for the comparison of LEU and HEU target in fission Mo-99 production process were suggested and compared of merits and demerits in view of fabrication technology and economy feasibility.

  11. Gene network analysis: from heart development to cardiac therapy.

    Science.gov (United States)

    Ferrazzi, Fulvia; Bellazzi, Riccardo; Engel, Felix B

    2015-03-01

    Networks offer a flexible framework to represent and analyse the complex interactions between components of cellular systems. In particular gene networks inferred from expression data can support the identification of novel hypotheses on regulatory processes. In this review we focus on the use of gene network analysis in the study of heart development. Understanding heart development will promote the elucidation of the aetiology of congenital heart disease and thus possibly improve diagnostics. Moreover, it will help to establish cardiac therapies. For example, understanding cardiac differentiation during development will help to guide stem cell differentiation required for cardiac tissue engineering or to enhance endogenous repair mechanisms. We introduce different methodological frameworks to infer networks from expression data such as Boolean and Bayesian networks. Then we present currently available temporal expression data in heart development and discuss the use of network-based approaches in published studies. Collectively, our literature-based analysis indicates that gene network analysis constitutes a promising opportunity to infer therapy-relevant regulatory processes in heart development. However, the use of network-based approaches has so far been limited by the small amount of samples in available datasets. Thus, we propose to acquire high-resolution temporal expression data to improve the mathematical descriptions of regulatory processes obtained with gene network inference methodologies. Especially probabilistic methods that accommodate the intrinsic variability of biological systems have the potential to contribute to a deeper understanding of heart development.

  12. Latest developments in ceramic fibre products

    Energy Technology Data Exchange (ETDEWEB)

    Christian, W.B. (Morganite Ceramic Fibres S.A., Herstal (Belgium))

    This paper will discuss the latest developments in ceramic fiber products and their utilization for new techniques with particular emphasis on energy conservation, time and maintenance saving in heat treatment installations throughout industry. Latest developments in ceramic fiber furnace linings will be highlighted by costs and thermal comparisons analyses between low thermal mass and 'dense' refractory materials. This will be an introduction to the most recent technique of energy conservation through the use of ceramic fibers in conjunction with existing refractory linings. This technique termed 'veneering' has for the last two years shown very interesting in the optimization of processes and economical use of electric and organic fuels.

  13. Strategic Alignment and New Product Development

    DEFF Research Database (Denmark)

    Acur, Nuran; Kandemir, Destan; Boer, Harry

    2012-01-01

    Strategic alignment is widely accepted as a prerequisite for a firm’s success, but insight into the role of alignment in, and its impact on, the new product evelopment (NPD) process and its performance is less well developed. Most publications on this topic either focus on one form of alignment...... of NPD performance indicators. Strategic planning and innovativeness appear to affect technological, market, and NPD-marketing alignment positively. Environmental munificence is negatively associated with NPD-marketing alignment, but has no effect on the two other forms of alignment. Technological change...... has a positive effect on technological alignment, a negative effect on NPD-marketing alignment, but no effect on market alignment. These findings suggest that internal capabilities are more likely to be associated with the development of strategic alignment than environmental factors are. Furthermore...

  14. Cross section measurements for production of positron emitters for PET imaging in carbon therapy

    Science.gov (United States)

    Salvador, S.; Colin, J.; Cussol, D.; Divay, C.; Fontbonne, J.-M.; Labalme, M.

    2017-04-01

    In light ion beam therapy, positron (β+) emitters are produced by the tissue nuclei through nuclear interactions with the beam ions. They can be used for the verification of the delivered dose using positron emission tomography by comparing the spatial distribution of the β+ emitters activity to a computer simulation taking into account the patient morphology and the treatment plan. However, the accuracy of the simulation greatly depends on the method used to generate the nuclear interactions producing these emitters. In the case of Monte Carlo (MC) simulations, the nuclear interaction models still lack the required accuracy due to insufficient experimental cross section data. This is particularly true for carbon therapy where literature data on fragmentation cross sections of a carbon beam with targets of medical interest are very scarce. Therefore, we performed at GANIL in July 2016 measurements on β+ emitter production cross sections with a carbon beam at 25, 50, and 95 MeV/nucleon on thin targets (C, N, O, and PMMA). We extracted the production cross section of C,1110, 13N, and O,1514 that are essential to constrain or develop MC nuclear fragmentation models.

  15. Production-perception relationships during speech development

    Science.gov (United States)

    Menard, Lucie; Schwartz, Jean-Luc; Boe, Louis-Jean; Aubin, Jerome

    2005-04-01

    It has been shown that nonuniform growth of the supraglottal cavities, motor control development, and perceptual refinement shape the vowel systems during speech development. In this talk, we propose to investigate the role of perceptual constraints as a guide to the speakers task from birth to adulthood. Simulations with an articulatory-to-acoustic model, acoustic analyses of natural vowels, and results of perceptual tests provide evidence that the production-perception relationships evolve with age. At the perceptual level, results show that (i) linear combination of spectral peaks are good predictors of vowel targets, and (ii) focalization, defined as an acoustic pattern with close neighboring formants [J.-L. Schwartz, L.-J. Boe, N. Vallee, and C. Abry, J. Phonetics 25, 255-286 (1997)], is part of the speech task. At the production level, we propose that (i) frequently produced vowels in the baby's early sound inventory can in part be explained by perceptual templates, (ii) the achievement of these perceptual templates may require adaptive articulatory strategies for the child, compared with the adults, to cope with morphological differences. Results are discussed in the light of a perception for action control theory. [Work supported by the Social Sciences and Humanities Research Council of Canada.

  16. A Framework for successful new product development

    Directory of Open Access Journals (Sweden)

    Nadia Bhuiyan

    2011-12-01

    Full Text Available Purpose: The purpose of this paper is to propose a framework of critical success factors, metrics, and tools and techniques for implementing metrics for each stage of the new product development (NPD process.Design/methodology/approach: To achieve this objective, a literature review was undertaken to investigate decades of studies on NPD success and how it can be achieved. These studies were scanned for common factors for firms that enjoyed success of new products on the market.Findings: The paper summarizes NPD success factors, suggests metrics that should be used to measure these factors, and proposes tools and techniques to make use of these metrics. This was done for each stage of the NPD process, and brought together in a framework that the authors propose should be followed for complex NPD projects.Research limitations/implications: Several different research directions could provide additional useful information both to firms finding critical success factors (CSF and measuring product development success as well as to academics performing research in this area. The main research opportunity exists in implementing or testing the proposed framework.Practical implications: The framework can be followed by managers of complex NPD projects to ensure success.Originality/value: While many studies have been conducted on critical success factors for NPD, these studies tend to be fragmented and focus on one or a few phases of the NPD process. To the authors’ knowledge, this is the first time a framework that synthesizes these studies into a single framework.

  17. Male pubertal development and the role of androgen therapy.

    Science.gov (United States)

    Richmond, Erick J; Rogol, Alan D

    2007-04-01

    In boys, the hormonal changes that accompany normal puberty are well defined, as are the physical signs of pubertal development and the kinetics of the growth spurt. Most androgens are derived from the testes, although adrenal androgens may also contribute; testosterone can also be aromatized to estrogen to exert important effects during puberty. Androgens, but especially their conversion to estrogens by aromatase, have a major role in the dramatic changes in linear growth, secondary sexual characteristics, and changes to bone, muscle and fat distribution that occur during puberty. Androgen therapy for delayed puberty should permit full normal pubertal development and thereby also address some of the associated psychosocial problems. Adolescent boys with conditions of permanent hypogonadism (hypogonadotropic or hypergonadotropic) or transient hypogonadotropic hypogonadism (constitutional delay of growth and puberty) can benefit from testosterone therapy. Long-term testosterone therapy should be given for hypothalamic or pituitary gonadotropin deficiency, or for primary hypogonadism such as for adolescents with Klinefelter syndrome, if endogenous testosterone levels drop or levels of luteinizing hormone rise. Intramuscular administration every few weeks is effective, but newer cutaneous forms, for example, gels or patches, also show promise in permitting adolescent males to reach adult body composition.

  18. ENVISION, developing motion monitoring techniques for particle therapy

    CERN Multimedia

    2013-01-01

    Particle therapy is an advanced technique of cancer radiation therapy, using protons or other ions to target the cancerous mass. ENVISION aims at developing medical imaging tools to improve the dose delivery to the patient, to ensure a safer and more effective treatment. The animation illustrates the challenge of treating a tumour as it moves due to patient breathing. The ENVISION project is co-funded by the European Commission under FP7 Grant Agreement N. 241851. ENVISION serves as a training platform for the Marie Curie Initial Training Programme ENTERVISION, funded by the European Commission under FP7 Grant Agreement N. 264552. Produced by: CERN KT/Life Sciences and ENVISION Project Management: Manuela Cirilli 3D animation: Jeroen Huijben, Nymus3d

  19. Recent developments in small molecule therapies for renal cell carcinoma.

    Science.gov (United States)

    Song, Minsoo

    2017-12-15

    Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults and is known to be the 10th most common type of cancer in the world. Most of the currently available RCC drugs are tyrosine kinase inhibitors (TKIs). However, combination therapies of TKIs and immune checkpoint inhibitors such as programmed cell death protein 1 (PD-1) and programmed cell death protein 1 ligand 1 (PD-L1) inhibitors are the focus of most of the final stage clinical trials. Meanwhile, other small molecule therapies for RCC that target indoleamine-2,3-dioxygenase (IDO1), glutaminase, C-X-C chemokine receptor 4 (CXCR4), and transglutaminase 2 (TG2) are emerging as the next generation of therapeutics. In this review, these three major streams for the development of small molecule drugs for RCC are described. Copyright © 2017 Elsevier Masson SAS. All rights reserved.

  20. Production cost structure in US outpatient physical therapy health care.

    Science.gov (United States)

    Lubiani, Gregory G; Okunade, Albert A

    2013-02-01

    This paper investigates the technology cost structure in US physical therapy care. We exploit formal economic theories and a rich national data of providers to tease out implications for operational cost efficiencies. The 2008-2009 dataset comprising over 19 000 bi-weekly, site-specific physical therapy center observations across 28 US states and Occupational Employment Statistics data (Bureau of Labor Statistics) includes measures of output, three labor types (clinical, support, and administrative), and facilities (capital). We discuss findings from the iterative seemingly unrelated regression estimation system model. The generalized translog cost estimates indicate a well-behaved underlying technology structure. We also find the following: (i) factor demands are downwardly sloped; (ii) pair-wise factor relationships largely reflect substitutions; (iii) factor demand for physical therapists is more inelastic compared with that for administrative staff; and (iv) diminishing scale economies exist at the 25%, 50%, and 75% output (patient visits) levels. Our findings advance the timely economic understanding of operations in an increasingly important segment of the medical care sector that has, up-to-now (because of data paucity), been missing from healthcare efficiency analysis. Our work further provides baseline estimates for comparing operational efficiencies in physical therapy care after implementations of the 2010 US healthcare reforms. Copyright © 2012 John Wiley & Sons, Ltd.

  1. Challenges in inhaled product development and opportunities for open innovation.

    Science.gov (United States)

    Forbes, Ben; Asgharian, Bahman; Dailey, Lea Ann; Ferguson, Douglas; Gerde, Per; Gumbleton, Mark; Gustavsson, Lena; Hardy, Colin; Hassall, David; Jones, Rhys; Lock, Ruth; Maas, Janet; McGovern, Tim; Pitcairn, Gary R; Somers, Graham; Wolff, Ron K

    2011-01-01

    Dosimetry, safety and the efficacy of drugs in the lungs are critical factors in the development of inhaled medicines. This article considers the challenges in each of these areas with reference to current industry practices for developing inhaled products, and suggests collaborative scientific approaches to address these challenges. The portfolio of molecules requiring delivery by inhalation has expanded rapidly to include novel drugs for lung disease, combination therapies, biopharmaceuticals and candidates for systemic delivery via the lung. For these drugs to be developed as inhaled medicines, a better understanding of their fate in the lungs and how this might be modified is required. Harmonized approaches based on 'best practice' are advocated for dosimetry and safety studies; this would provide coherent data to help product developers and regulatory agencies differentiate new inhaled drug products. To date, there are limited reports describing full temporal relationships between pharmacokinetic (PK) and pharmacodynamic (PD) measurements. A better understanding of pulmonary PK and PK/PD relationships would help mitigate the risk of not engaging successfully or persistently with the drug target as well as identifying the potential for drug accumulation in the lung or excessive systemic exposure. Recommendations are made for (i) better industry-academia-regulatory co-operation, (ii) sharing of pre-competitive data, and (iii) open innovation through collaborative research in key topics such as lung deposition, drug solubility and dissolution in lung fluid, adaptive responses in safety studies, biomarker development and validation, the role of transporters in pulmonary drug disposition, target localisation within the lung and the determinants of local efficacy following inhaled drug administration. Copyright © 2010 Elsevier B.V. All rights reserved.

  2. NITROSO RUBBER RESEARCH, DEVELOPMENT AND PRODUCTION.

    Science.gov (United States)

    COPOLYMERIZATION, VISCOSITY, VULCANIZATION, ANHYDRIDES, SUCCINATES, ANILINES , AROMATIC COMPOUNDS, NITRATES, BENZOIC ACIDS, NITRITES, NITROBENZENES ...FLUORINE COMPOUNDS, *HALOCARBON PLASTICS, *SYNTHETIC RUBBER, SYNTHESIS (CHEMISTRY), PRODUCTION, PRODUCTION, ORGANIC NITROGEN COMPOUNDS, ACETATES

  3. The meaning art therapy for the development of individual personality with visual impairment

    OpenAIRE

    WOHNIGOVÁ, Veronika

    2015-01-01

    The objective of this study is to identify the influence of art therapy on personality development of visually impaired individuals. Art therapy - an expressive therapy - is aimed at changing the behavior, thinking and emotions of a person with the use of art. Drawing is the basic diagnostic means in art therapy. The advantage of such form of therapy is that every individual is to some extent capable of expressing himself or herself through art. The goal of using art therapy with visually imp...

  4. Accelerator based production of auger-electron-emitting isotopes for radionuclide therapy

    Energy Technology Data Exchange (ETDEWEB)

    Thisgaard, H.

    2008-08-15

    In this research project the focus has been on the identification and production of new, unconventional Auger-electron-emitting isotopes for targeted radionuclide therapy of cancer. Based on 1st principles dosimetry calculations on the subcellular level, the Auger-emitter 119Sb has been identified as a potent candidate for therapy. The corresponding imaging analogue 117Sb has been shown from planar scintigraphy and single-photon emission computed tomography (SPECT) to be suitable for SPECT-based dosimetry of a future Sb-labeled radiopharmaceutical. The production method of these radioisotopes has been developed using a low-energy cyclotron via the nuclear reactions 119Sn(p,n)119Sb and 117Sn(p,n)117Sb including measurements of the excitation function for the former reaction. Moreover, a new high-yield radiochemical separation method has been developed to allow the subsequent separation of the produced 119Sb from the enriched 119Sn target material with high radionuclidic- and chemical purity. A method that also allows efficient recovery of the 119Sn for recycling. To demonstrate the ability of producing therapeutic quantities of 119Sb and other radioisotopes for therapy with a low-energy cyclotron, two new 'High Power' cyclotron targets were developed in this study. The target development was primarily based on theoretical thermal modeling calculations using finite-element-analysis software. With these targets, I have shown that it will be possible to produce several tens of GBq of therapeutics isotopes (e.g. 119Sb or 64Cu) using the PETtrace cyclotron commonly found at the larger PET-centers in the hospitals. Finally, research in a new method to measure the radiotoxicity of Auger-emitters invitro using cellular microinjection has been carried out. The purpose of this method is to be able to experimentally evaluate and compare the potency of the new and unconventional Auger-emitters (e.g. 119Sb). However, due to experimental complications, the development

  5. Management Control in New Product Development

    DEFF Research Database (Denmark)

    Jørgensen, Brian; Messner, Martin

    2009-01-01

    Several studies in management control have drawn upon the concepts of coercive and enabling forms of bureaucracy (Adler and Borys 1996) to discuss how the features of a control system may affect employees' attitudes toward control. This question is relevant because enabling forms of control allow...... organizations to better manage tensions between efficiency and flexibility, which is arguably a key issue in many organizations today. Our paper contributes to this stream of research by detailing how enabling control functions in the particular setting of new product development. To this end, we draw upon...... empirical material collected through an in-depth field study carried out in a manufacturing organization. We use data from interviews, participant observation, and internal documentation in this firm to demonstrate how the combination of different control mechanisms helps the organization balance efficiency...

  6. Effect of Continued Medical Therapy on Productivity Costs for Refractory Chronic Rhinosinusitis.

    Science.gov (United States)

    Rudmik, Luke; Soler, Zachary M; Smith, Timothy L; Mace, Jess C; Schlosser, Rodney J; DeConde, Adam S

    2015-11-01

    It is estimated that lost productivity related to chronic rhinosinusitis (CRS) costs society in excess of $13 billion per year in the United States. Given this tremendous cost to society, it is important to evaluate the effect of current interventions on improving this productivity loss. To define the change in productivity costs in patients with refractory CRS who select continued medical therapy. Observational cohort study. Thirty-eight patients with a guideline-based diagnosis of CRS whose initial appropriate medical therapy failed were enrolled from 4 tertiary-level rhinology clinics. The study was conducted from December 6, 2010, to April 23, 2013, and data analysis was performed from December 6, 2010, to June 1, 2015. Continued medical therapy for CRS. The human capital approach was applied to quantify productivity costs. Absenteeism, presenteeism, and lost leisure time were quantified to define annual lost productive time, which was measured at enrollment (baseline) and at a minimum of 6 months after treatment. Lost productive time was monetized using the annual daily wage rates obtained from the 2012 US National Census and the 2013 US Department of Labor statistics. Thirty-eight patients with refractory CRS who selected continued medical therapy had a mean (SD) baseline annual productivity cost of $3464 ($4900) per patient. After continued medical therapy for a mean of 12.8 (4.8) months, productivity costs were $2730 ($3720) (before vs after continued medical therapy productivity cost, P = .74). Mean annual absenteeism was reduced from 5 (12) days to 2 (8) days (P = .02). Mean annual presenteeism (17 [27] days reduced to 15 [23] days; P = .93) and mean annual household days lost (7 [7] days reduced to 6 [6] days; P = .51) were maintained at baseline levels. There were no significant differences in productivity outcomes based on endoscopy, the 22-item Sinonasal Outcome Test score, age, or polyp status (all P ≥ .11). Patients with

  7. Development of drug delivery systems for radionuclide therapy using a combination therapy

    Energy Technology Data Exchange (ETDEWEB)

    Kim, On Hee; Choi, Sun Ju [Korea Atomic Energy Research Institute, Taejon (Korea, Republic of)

    2005-07-01

    For the development of new controlled drug delivery systems, the application of combination therapy using angiogenesis inhibitor and tumor static agents has drawn great attention. This approach would be very beneficial for cancer treatment especially when a new drug deliver system utilizing biodegradable polymers is developed. Therefore, the present study for the combination therapy of angiogenesis inhibitor and chemotherapeutic agents was to carry out prior to the development of the novel drug delivery. In present study, the ability of inhibition on cell growth was investigated with treatment of anti-angiogenetic agent and anticancer agent. Thalidomide was used as an antivasculatory agents and Doxorubicine was treated as a chemotherapeutic agent. To demonstrate apoptotic process in in-vitro study, TUNEL assay was carried out. Also, the alteration of p53 level was examined by using western blotting. For the cell lines, NIH:OVCAR3, MKN45, SNU719, C6, L929, T98G, Hep3B and Calu6 were applied. Results showed that Thalidomide inhibited cell growth in tumor cell lines in a dose-dependent manner and Doxorubicin as well. A significant synergistic effect on the apoptotic was noticed in the combination treatment of Thalidomide and Doxorubicin compared to a single treatment of either drug. Therefore, it can be concluded that the mechanism of cytotoxicity was due to the enhancement of apoptosis in early cell death with combination treatment in tumor cell lines.

  8. Production and clinical development of nanoparticles for gene delivery

    Directory of Open Access Journals (Sweden)

    Jie Chen

    2016-01-01

    Full Text Available Gene therapy is a promising strategy for specific treatment of numerous gene-associated human diseases by intentionally altering the gene expression in pathological cells. A successful clinical application of gene-based therapy depends on an efficient gene delivery system. Many efforts have been attempted to improve the safety and efficiency of gene-based therapies. Nanoparticles have been proved to be the most promising vehicles for clinical gene therapy due to their tunable size, shape, surface, and biological behaviors. In this review, the clinical development of nanoparticles for gene delivery will be particularly highlighted. Several promising candidates, which are closest to clinical applications, will be briefly reviewed. Then, the recent developments of nanoparticles for clinical gene therapy will be identified and summarized. Finally, the development of nanoparticles for clinical gene delivery in future will be prospected.

  9. Trust in ICT-Based New Product Development - Guidelines for Virtual New Product Development Teams

    OpenAIRE

    Haas, Rainer; Meixner, Oliver; Poechtrager, Siegfried

    2006-01-01

    The traditional process of new product development is focusing on an intra-organizational workflow, which should - in its ideal form - be done by virtual interdisciplinary teams. Team members should be from several departments like manufacturing, research & development, sales and marketing. But innovation is happening more and more in networks of companies, clusters or so called network companies. The following article delivers a framework of guidelines for virtual team management in order to...

  10. 47 CFR 7.7 - Product design, development, and evaluation.

    Science.gov (United States)

    2010-10-01

    ...? § 7.7 Product design, development, and evaluation. (a) Manufacturers and service providers shall... usability as part of such a product design and development process. (b) In developing such a process... 47 Telecommunication 1 2010-10-01 2010-10-01 false Product design, development, and evaluation. 7...

  11. Business Cooperation and Regional Productive Development in ...

    International Development Research Centre (IDRC) Digital Library (Canada)

    The research will characterize each country's regional productive specialization and analyze business networks, focusing on successful economic performance and the determinants and effects of cooperation among businesses. In addition, the project will generate policy recommendations for enhancing productive ...

  12. Gene therapies development: slow progress and promising prospect

    OpenAIRE

    Hanna, Eve; R?muzat, C?cile; Auquier, Pascal; Toumi, Mondher

    2017-01-01

    ABSTRACT Background: In 1989, the concept of human gene therapies has emerged with the first approved human gene therapy trial of Rosenberg et al. Gene therapies are considered as promising therapies applicable to a broad range of diseases. Objective: The objective of this study was to review the descriptive data on gene therapy clinical trials conducted worldwide between 1989 and 2015, and to discuss potential success rates of these trials over time and anticipated market launch in the upcom...

  13. Modelling architectures in multi-product oriented technology development

    DEFF Research Database (Denmark)

    Guðlaugsson, Tómas Vignir

    and breakdown of product technologies based on a generic product technology architecture as organs and organ alternatives and links these through product concepts to application concepts and requirements.The Production Architecture modelling framework enables modelling a Production Architecture from three......This thesis investigates the use of architecture modelling in a technology development context.This context presents greater uncertainties than more mature new product development. Applications—the use of products based on the technology being developed—are not fully identified and the requirements...... to be fulfilled are not completely defined.The products to be based on the technology are yet to be developed as the foundation for their development will be developed during the technology development. Furthermore, the production of a new technology is not defined as both the technology and derivative products...

  14. Molecular target-guided tumor therapy with natural products derived from traditional Chinese medicine.

    Science.gov (United States)

    Efferth, Thomas; Fu, Yu-Jie; Zu, Yuan-Gang; Schwarz, Günter; Konkimalla, Venkata Sai Badireenath; Wink, Michael

    2007-01-01

    A tremendous interest exists in the Western world in Traditional Chinese Medicine (TCM) with rapidly increasing export rates of TCM products from China to Europe and USA. This led to a national decision of the Chinese government to implement a "Plan for the Modernization of Chinese Medicine". Concerning the use of Chinese medicinal herbs, two major directions can be distinguished. One field is phytochemistry and pharmacognosy. Secondary metabolites isolated from Chinese plants can be easily subjected to pharmacological, molecular biological, and pharmacogenomic analyses using methods of modern cell and molecular biology as exemplified for camptothecin from Camptotheca acuminata in the present review. The second field of interest is phytomedicine. Standardized international quality guidelines help to improve quality, safety and efficacy of Chinese medicinal herbs. Sustainability of natural products from TCM can be reached by breeding high-yield varieties or by biotechnological approaches. In the long term, natural products from TCM can contribute to the development of molecular target-guided therapies and individualized treatment strategies.

  15. Bilateral Ischemic Optic Neuropathy Developed under Interferon Therapy

    Directory of Open Access Journals (Sweden)

    Fatih Selcukbiricik

    2012-01-01

    Full Text Available Introduction. Interferon is a glycoprotein produced by assigned cells of immune system. It has been used in many different diseases. Although flu-like syndrome, myalgia, rash, hypotension, thrombocytopenia and peripheral neuropathy due to interferon use are encountered frequently, ocular side effects are rare, generally mild and transient. Case Report. 47-year-old female patient, presented with a mass lesion in right renal pelvis. Right radical nephrectomy was applied and the histopathological examination was consistent with papillary renal cell carcinoma. Interferon alpha treatment was started subcutaneously at the dose of 5 MIU/3 times in a week. Four weeks after the interferon therapy, suddenly bilateral visual loss developed. We discussed the diagnosis, followup, and treatment of the patient who developed irreversible ischemic optic neuropathy and had no previous known primary systemic disease to cause this condition. Conclusion. We suggest that patients should be screened for risk factors causing optic ischemic neuropathy, before interferon therapy. Although there was no adequate information in the literature for the followup, patients should be monitorized before, 1 month after, and 2 months after the treatment. And if there is no complication, we suggest that they should be followed up at 3-month intervals.

  16. Corporate Production Transfers to Developing Countries

    DEFF Research Database (Denmark)

    Bruun, Peter; Wulff, Henrik

    1997-01-01

    . From a technical point of view this paper analyses some experiences of Danish companies' production transfers to the south-east Asia region with a focus on technology, quality, organisational and management issues as well as location concerns. Keywords: Production transfer, international production......Production transfer is defined by the set of activities attached to send off, receipt and running-in a production system in a new environment. The activities concern handling of physical elements as well as non-material, knowledge based issues like documentation, education/training and management...

  17. Conditions and strategies for integrating ergonomics into product development

    DEFF Research Database (Denmark)

    Broberg, Ole

    1996-01-01

    Ergonomics considerations at the stage of product development in industry is a major strategy for prevention of work-related injuries and illnesses among employees at the time of manufacture of new products. This study elucidates some important conditions and possibilities for integrating...... such considerations during the product development process. Special attention is paid to the role of design and production engineers. Based on different understandings of the product development process four approaches to integration of ergonomics are outlined....

  18. Environmentally-friendly product development: methods and tools

    National Research Council Canada - National Science Library

    Abele, Eberhard; Anderl, R; Birkhofer, Herbert

    2005-01-01

    ... to assess a product's environmental effects. Fig. 1. Vision of Environment as a key target for product development vvi Preface Product related environmental issues are getting more and more political and public awareness. Development of environmentally friendly products has become an action item for both, politics and industry (UNFCCC 1997). Energy...

  19. [The development history and future perspective of molecularly targeted therapy].

    Science.gov (United States)

    Mizuki, Masao; Kanakura, Yuzuru

    2014-06-01

    The origin of molecularly targeted drugs dates back to 'magic bullet' theory proposed by Paul Ehrlich. The success of Abl tyrosine kinase inhibitor, imatinib for the treatment of chronic myeloid leukemia realized that small molecules inhibiting ATP binding can become specific inhibitors for the relevant kinases. Subsequently, a number of kinase inhibitors which targets various signal transduction molecules, are in the clinical field or under development. The clinical success of antibody therapeutics has been achieved by the genetic engineering which makes human-mouse chimeric, humanized or human antibody. To augment the therapeutic effects of antibody, radioisotope-conjugate antibody and antibody-drug conjugate have come to the clinical field. In the near future, we have to develop the combination therapy of molecularly targeted drugs and also inhibitors for epigenetic and transcriptional regulators.

  20. Definition and evaluation of product configurator development strategies

    DEFF Research Database (Denmark)

    Haug, Anders; Hvam, Lars; Mortensen, Niels Henrik

    2012-01-01

    Product configurators represent one of the most successful applications of artificial intelligence principles. Product configurators are a subtype of software-based expert systems with a focus on the creation of product specifications. The use of product configurators has resulted in many positive...... for the development of product configurators. The relevance of the defined strategies is supported by seven named case studies....

  1. Material interaction and art product in art therapy assessment in adult mental health

    NARCIS (Netherlands)

    Pénzes, I.J.N.J.; Hooren, S. van; Dokter, D.; Smeijsters, H.; Hutschemaekers, G.J.M.

    2016-01-01

    Background: Art materials have a central role in art therapy. The way a client interacts with art materials - material interaction - is an important source of information in art therapy assessment in adult mental health. The aim of this study was to develop the categories of material interaction and

  2. Dynamic simulation for effective workforce management in new product development

    National Research Council Canada - National Science Library

    M. Mutingi

    2012-01-01

    Effective planning and management of workforce for new product development (NPD) projects is a great challenge to many organisations, especially in the presence of engineering changes during the product development process...

  3. International product development - Challenges in knowledge sharing

    DEFF Research Database (Denmark)

    Sonne, Anne-Mette

    2008-01-01

    Knowledge and internationalization are two important concepts in the corporate world today. Knowledge is companies' most important resource, and internationalization is a factor which affects all areas of management - particularly product development. The development of successful products for th...

  4. EVALUATION OF PRODUCT DEVELOPMENT PROCESS USING EMVS

    Directory of Open Access Journals (Sweden)

    Iara Tonissi Moroni Cutovoi

    2014-12-01

    Full Text Available This paper evaluates a PDP model application in an auto parts company, leader in its segment. From the application of lean thinking in the supply chain and the EMVS performance analysis methodology for PDP, a check list is created to avoid waste in project management. In this paper, we show that EMVS can be positively impacted through active management of knowledge within a project. This paper suggests that the value-enabling portion of a project manager's role requires aligning knowledge across these three key domains regarding PDP Gates (Phases at company manufacturers of auto parts, Lean Thinking and Value Stream, and methodology for managing projects through performance-term rates and costs. The results show that the methodology has positive aspects, but its implementation takes time and has repercussions throughout the supply chain. Further this research try to explain the types of wastes and view of new products' development is enhanced and associates a manufacturing strategy focus on EMVS performance analysis and lean thinking, PDP and value stream mapping  showing the important of contribution this tools at reduction of waste.

  5. Oral rehydration therapy products - a plaque pH study under normal and dry mouth conditions.

    Science.gov (United States)

    Salehi, Sonja; Daneshian, Masoumeh; Forsberg, Birger C; Birkhed, Dowen

    2013-10-01

    The aim of this study was to investigate oral rehydration therapy (ORT) products and their effect on plaque pH under normal and dry mouth conditions. Three commercial oral rehydration therapy products, prepared according to the manufacturers' instruction, plus a 10% glucose solution, which served as control, were tested in 10 healthy subjects (mean age 25 years): (1) Electral (Arrow Pharmaceuticals), (2) Resorb Junior (Nestlé) and (3) Vätskeersättning (Semper). pH was measured in the maxillary premolar region in situ with the so-called microtouch method. The area under the pH curve was calculated. Their carbohydrate content was also analysed. The oral rehydration therapy products gave the same low pH values in plaque as the glucose solution. Dry mouth condition, obtained by injection of methylscopolamine nitrate in the labial sulcus, resulted in an overall more pronounced fall in pH and in a delay in the pH recovery compared with normal salivary conditions. The chemical analyses showed that all three test-products contained glucose and starch as the main carbohydrates. Rinsing with oral rehydration therapy products leads to a greater pH decrease in dental plaque during low compared with normal salivary conditions. As diarrhoea may result in dehydration and thereby in dry mouth, we believe that ORT products have a high cariogenic potential. © 2013 FDI World Dental Federation.

  6. Technological progress and challenges towards cGMP manufacturing of human pluripotent stem cells based therapeutic products for allogeneic and autologous cell therapies.

    Science.gov (United States)

    Abbasalizadeh, Saeed; Baharvand, Hossein

    2013-12-01

    Recent technological advances in the generation, characterization, and bioprocessing of human pluripotent stem cells (hPSCs) have created new hope for their use as a source for production of cell-based therapeutic products. To date, a few clinical trials that have used therapeutic cells derived from hESCs have been approved by the Food and Drug Administration (FDA), but numerous new hPSC-based cell therapy products are under various stages of development in cell therapy-specialized companies and their future market is estimated to be very promising. However, the multitude of critical challenges regarding different aspects of hPSC-based therapeutic product manufacturing and their therapies have made progress for the introduction of new products and clinical applications very slow. These challenges include scientific, technological, clinical, policy, and financial aspects. The technological aspects of manufacturing hPSC-based therapeutic products for allogeneic and autologous cell therapies according to good manufacturing practice (cGMP) quality requirements is one of the most important challenging and emerging topics in the development of new hPSCs for clinical use. In this review, we describe main critical challenges and highlight a series of technological advances in all aspects of hPSC-based therapeutic product manufacturing including clinical grade cell line development, large-scale banking, upstream processing, downstream processing, and quality assessment of final cell therapeutic products that have brought hPSCs closer to clinical application and commercial cGMP manufacturing. © 2013.

  7. Biotechnology and genetic engineering in the new drug development. Part II. Monoclonal antibodies, modern vaccines and gene therapy.

    Science.gov (United States)

    Stryjewska, Agnieszka; Kiepura, Katarzyna; Librowski, Tadeusz; Lochyński, Stanisław

    2013-01-01

    Monoclonal antibodies, modern vaccines and gene therapy have become a major field in modern biotechnology, especially in the area of human health and fascinating developments achieved in the past decades are impressive examples of an interdisciplinary interplay between medicine, biology and engineering. Among the classical products from cells one can find viral vaccines, monoclonal antibodies, and interferons, as well as recombinant therapeutic proteins. Gene therapy opens up challenging new areas. In this review, a definitions of these processes are given and fields of application and products, as well as the future prospects, are discussed.

  8. 36 CFR 1193.23 - Product design, development, and evaluation.

    Science.gov (United States)

    2010-07-01

    ... 36 Parks, Forests, and Public Property 3 2010-07-01 2010-07-01 false Product design, development... § 1193.23 Product design, development, and evaluation. (a) Manufacturers shall evaluate the accessibility... incorporate such evaluation throughout product design, development, and fabrication, as early and consistently...

  9. 21 CFR 601.21 - Products under development.

    Science.gov (United States)

    2010-04-01

    ... 21 Food and Drugs 7 2010-04-01 2010-04-01 false Products under development. 601.21 Section 601.21...) BIOLOGICS LICENSING Biologics Licensing § 601.21 Products under development. A biological product undergoing development, but not yet ready for a biologics license, may be shipped or otherwise delivered from one State...

  10. Managing R&D and New Product Development

    NARCIS (Netherlands)

    von Zedtwitz, Maximilian; Friesike, Sascha; Gassmann, Oliver; Dodgson, Mark; Gann, David M.; Phillips, Nelson

    2014-01-01

    This article examines the importance of R&D and new product development and explores their management. It describes three central aspects of managing R&D and new product development in firms: the product development funnel, R&D portfolio management, and R&D organization. Concepts such as the ‘fuzzy

  11. Therapy Development for Spinal Muscular Atrophy in SMN Independent Targets

    Directory of Open Access Journals (Sweden)

    Li-Kai Tsai

    2012-01-01

    Full Text Available Spinal muscular atrophy (SMA is an autosomal recessive neurodegenerative disorder, leading to progressive muscle weakness, atrophy, and sometimes premature death. SMA is caused by mutation or deletion of the survival motor neuron-1 (SMN1 gene. An effective treatment does not presently exist. Since the severity of the SMA phenotype is inversely correlated with expression levels of SMN, the SMN-encoded protein, SMN is the most important therapeutic target for development of an effective treatment for SMA. In recent years, numerous SMN independent targets and therapeutic strategies have been demonstrated to have potential roles in SMA treatment. For example, some neurotrophic, antiapoptotic, and myotrophic factors are able to promote survival of motor neurons or improve muscle strength shown in SMA mouse models or clinical trials. Plastin-3, cpg15, and a Rho-kinase inhibitor regulate axonal dynamics and might reduce the influences of SMN depletion in disarrangement of neuromuscular junction. Stem cell transplantation in SMA model mice resulted in improvement of motor behaviors and extension of survival, likely from trophic support. Although most therapies are still under investigation, these nonclassical treatments might provide an adjunctive method for future SMA therapy.

  12. Product carbon footprint developments and gaps

    DEFF Research Database (Denmark)

    Kronborg Jensen, Jesper

    2012-01-01

    Purpose - Over the last decade, multiple initiatives have been undertaken to learn how to capture the carbon footprint of a supply chain at a product level. The purpose of this paper is to focus on the process of standardization to secure consistency of product carbon footprinting (PCF...

  13. Production planning development and paradigm integration

    OpenAIRE

    Galina Ledneva; Viktor Jludov; Alexander Pesin; Viktor Salganik; Vladimir Shmakov

    2009-01-01

    The paper reviews principles of different concepts of enterprise management including a theory of constrains, a Balanced Scorecard, lean production, Six Sigma. The authors believe that creating some mix or integration of these paradigms can bring extraordinary effect for production management. As example the modified Balanced Scorecard based on constraints and its application on Magnitorsk metallurgical enterprise in Russia is described.

  14. Recent progress in development of radioisotope production

    Energy Technology Data Exchange (ETDEWEB)

    Yoon, Byung Mok [HANARO Center, Korea Atomic Energy Research Institute, Taejon (Korea, Republic of)

    1998-10-01

    The Korea multipurpose research reactor, HANARO(Hi-flux Advanced Neutron Application Reactor) is designed and constructed to obtain high density neutron flux (max. 5x10{sup 14} n/cm{sup 2}{center_dot}sec) with relatively low thermal output (30 MW) in order to utilize for various studies such as fuel and material test, radioisotope production, neutron activation analysis, neutron beam experiment, neutron transmutation doping, etc. HANARO has 32 vertical channels (3 in-core, 4 out-core, 25 reflector) and 7 horizontal channels. KAERI has constructed 4 concrete hot cells for production of Co-60, Ir-192, etc. and 6 lead hot cells for production of medical RIs(I-131, Mo-99, etc.). Other 11 lead hot cells will be completed by Feb. 1998 for production of Sm-153, Dy-165, Ho-166, etc. Clean room facilities were installed for production of radiopharmaceuticals. (author)

  15. The Current of Continuing Professional Development for Product Designers

    OpenAIRE

    山内, 勉; Yamauchi, Tsutomu

    2010-01-01

    Product Designers are required some skills and knowledge in the product development. Based on my professional career, I presumed three skills, they are, Technical skills, Conceptual skills and Human skills. In this study, I interviewed some Product Designers to make sure what skills are needed in the product development process. It emerged that Product Designers are expected to improve their Conceptual and Human skills besides Technical skills for playing a part at the upper and lower stage o...

  16. Proposal for product development model focused on ce certification methodology

    Directory of Open Access Journals (Sweden)

    Nathalia Marcia Goulart Pinheiro

    2015-09-01

    Full Text Available This paper presents a critical analysis comparing 21 product development models in order to identify whether these structures meet the demands Product Certification of the European Community (CE. Furthermore, it presents a product development model, comprising the steps in the models analyzed, including improvements in activities for referred product certification. The proposed improvements are justified by the growing quest for the internationalization of products and processes within companies.

  17. Good Manufacturing Practices (GMP) manufacturing of advanced therapy medicinal products: a novel tailored model for optimizing performance and estimating costs.

    Science.gov (United States)

    Abou-El-Enein, Mohamed; Römhild, Andy; Kaiser, Daniel; Beier, Carola; Bauer, Gerhard; Volk, Hans-Dieter; Reinke, Petra

    2013-03-01

    Advanced therapy medicinal products (ATMP) have gained considerable attention in academia due to their therapeutic potential. Good Manufacturing Practice (GMP) principles ensure the quality and sterility of manufacturing these products. We developed a model for estimating the manufacturing costs of cell therapy products and optimizing the performance of academic GMP-facilities. The "Clean-Room Technology Assessment Technique" (CTAT) was tested prospectively in the GMP facility of BCRT, Berlin, Germany, then retrospectively in the GMP facility of the University of California-Davis, California, USA. CTAT is a two-level model: level one identifies operational (core) processes and measures their fixed costs; level two identifies production (supporting) processes and measures their variable costs. The model comprises several tools to measure and optimize performance of these processes. Manufacturing costs were itemized using adjusted micro-costing system. CTAT identified GMP activities with strong correlation to the manufacturing process of cell-based products. Building best practice standards allowed for performance improvement and elimination of human errors. The model also demonstrated the unidirectional dependencies that may exist among the core GMP activities. When compared to traditional business models, the CTAT assessment resulted in a more accurate allocation of annual expenses. The estimated expenses were used to set a fee structure for both GMP facilities. A mathematical equation was also developed to provide the final product cost. CTAT can be a useful tool in estimating accurate costs for the ATMPs manufactured in an optimized GMP process. These estimates are useful when analyzing the cost-effectiveness of these novel interventions. Copyright © 2013 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.

  18. Seeking a better landscape for therapy development in neuromuscular disorders.

    Science.gov (United States)

    Larkindale, Jane; Porter, John D

    2018-01-01

    Although the neuromuscular field has seen accelerated approval of a drug for Duchenne muscular dystrophy (DMD) and full approval of one for spinal muscular atrophy, these experiences have shown that objective data and an adequate level of effect are essential for drug approval and reimbursement. The appropriateness and validity of biomarkers and clinically meaningful endpoints and an understanding of disease progression rates all played essential roles in the levels of evidence for these drugs. Such tools are best developed through integration of clinical data. The siloing of clinical data for rare neuromuscular diseases represents a considerable barrier to achieving better care and novel therapies for patients living with neuromuscular diseases. We discuss a data-sharing model implemented for DMD and urge cultural changes in the ways natural history and clinical trial data are collected and shared across all neuromuscular diseases in order to benefit the primary stakeholder, the patient. Muscle Nerve 57: 16-19, 2018. © 2017 Wiley Periodicals, Inc.

  19. Overcoming challenges to initiating cell therapy clinical trials in rapidly developing countries: India as a model.

    Science.gov (United States)

    Viswanathan, Sowmya; Rao, Mahendra; Keating, Armand; Srivastava, Alok

    2013-08-01

    Increasingly, a number of rapidly developing countries, including India, China, Brazil, and others, are becoming global hot spots for the development of regenerative medicine applications, including stem cell-based therapies. Identifying and overcoming regulatory and translational research challenges and promoting scientific and ethical clinical trials with cells will help curb the growth of stem cell tourism for unproven therapies. It will also enable academic investigators, local regulators, and national and international biotechnology and biopharmaceutical companies to accelerate stem cell-based clinical research that could lead to effective innovative treatments in these regions. Using India as a model system and obtaining input from regulators, clinicians, academics, and industry representatives across the stem cell field in India, we reviewed the role of key agencies and processes involved in this field. We have identified areas that need attention and here provide solutions from other established and functioning models in the world to streamline and unify the regulatory and ethics approval processes for cell-based therapies. We also make recommendations to check the growth and functioning of clinics offering unproven treatments. Addressing these issues will remove considerable hurdles to both local and international investigators, accelerate the pace of research and development, and create a quality environment for reliable products to emerge. By doing so, these countries would have taken one important step to move to the forefront of stem cell-based therapeutics.

  20. Efficacy Dependence of Photodynamic Therapy Mediated by Upconversion Nanoparticles: Subcellular Positioning and Irradiation Productivity.

    Science.gov (United States)

    Chen, Dexin; Tao, Ran; Tao, Ke; Chen, Biqiong; Choi, Seok Ki; Tian, Qing; Xu, Yawen; Zhou, Guangdong; Sun, Kang

    2017-04-01

    Singlet oxygen (1 O2 ), as an important kind of reactive oxygen species (ROS) and main therapeutic agent in photodynamic therapy (PDT), only have a half-life of 40 ns and an effective radius of 20 nm, which cause significant obstacles for improving PDT efficacy. In this work, novel upconversion nanoparticle (UCN)-based nanoplatforms are developed with a minimized distance between UCNs and a photosensitizer, protoporphyrin IX (PpIX), and a controllable payload of PpIX, to enhance and control ROS production. The ability of the nanoplatform to target different subcellular organelles such as cell membrane and mitochondria is demonstrated via surface modification of the nanoplatform with different targeting ligands. The results show that the mitochondria-targeting nanoplatforms result in significantly increased capability of both tumor cell killing and inhibition of tumor growth. Subcellular targeting of nanoparticles leads to the death of cancer cells in different manners. However, the efficiency of ROS generation almost have no influence on the tumor cell viability during the period of evaluation. These findings suggest that specific subcellular targeting of the nanoplatforms enhances the PDT efficacy more effectively than the increase of ROS production, and may shed light on future novel designs of effective and controllable PDT nanoplatforms. © 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

  1. Market Dynamics and Productivity in Developing Countries ...

    International Development Research Centre (IDRC) Digital Library (Canada)

    25 nov. 2009 ... To what degree are trade liberalization, productivity, and economic growth correlated? Can economic policies designed to encourage competition and curtail industry protection result in large-scale improvements, such as increased innovation and reduced unemployment?

  2. Education and Manpower development for Cleaner Production

    DEFF Research Database (Denmark)

    Jørgensen, Michael Søgaard

    1996-01-01

    An overview of the needs for education and training for dissemination and implementation of cleaner production. Expericne from training in companies and training of officials from public authorities and from integration into engineering, business and management and social science curricula...

  3. Measures to minimize cross-contamination risks in Advanced Therapy Medicinal Product manufacturing

    Directory of Open Access Journals (Sweden)

    Livia Roseti

    2014-12-01

    Full Text Available Current European regulations define in vitro expanded cells for clinical purposes as substantially manipulated and include them in the class of Advanced Therapy Medicinal Products to be manufactured in compliance with current Good Manufacturing Practice. These quality requirements are generally thought to be elaborate and costly. However, they ensure three main product characteristics: safety, consistency, and absence of cross-contamination. The term crosscontamination is used to indicate misidentification of one cell line or culture by another. The Good Manufacturing Practice Guidelines suggest some recommendations in order to prevent cross-contaminations and require a demonstration that the implemented actions are effective. Here we report some practical examples useful both to minimize crosscontamination risks in an Advanced Therapy Medicinal Products production process and to evaluate the efficacy of the adopted measures.

  4. Modelling and using product architectures in mechatronic product development

    DEFF Research Database (Denmark)

    Bruun, Hans Peter Lomholt; Mortensen, Niels Henrik

    , experiences by using the architecture representation in a mechatronic development project, and the scope of using the architecture model as a skeleton for a data structure in a PLM system. The fundamental idea for planning and modeling holistic architectures is that an improved understanding of the whole...

  5. Company competencies as a network: The role of product development

    DEFF Research Database (Denmark)

    Harmsen, Hanne; Grunert, Klaus G.; Bove, Karsten

    2000-01-01

    investigate these matters in a survey with top managers in 513 Danish production companies. Ten areas important for achieving company objectives are identified. These are product development, market intelligence, production management, strategy and vision, sales, market responsiveness, promotion, internal co......-operation, image, and finally supply management. Product development is rated a fairly important competence as it ranks four with sales, market responsiveness, and production management as numbers one to three. Yet a distressing negative impact on overall company success is found for product development...

  6. Product Innovation Development in the Companies of Creative Industries

    Directory of Open Access Journals (Sweden)

    Rolandas Strazdas

    2011-10-01

    Full Text Available Many authors distinguish product innovation as a key factor for long-term competitiveness. Dominant narrow perception of a product is leading towards incorrect product development process and the consequent result is a bad product. Narrow perception of a product is one of the main paralysing factors affecting the creator in the process of product development, which leads towards a low level of product innovation. As a result, a company is losing its uniqueness, originality, and is not of  interest neither for consumers nor the product developers themselves. This article deals with the product perception problems in the companies of creative industries. The main limiting factors for the perception of a product are analysed in the article as well as possibilities to expand the perception of a product. Five main product development methods: conservative, delegative, holistic, limited open, fully open are described in the article. The choice of the product development methods is especially important for the creative industries companies whose product development process is very intensive. 

  7. DEVELOPMENT OF WOOD-BASED PRODUCTS WORLDWIDE

    Directory of Open Access Journals (Sweden)

    Marius C. BARBU

    2015-12-01

    Full Text Available The tendency in recent decades for manufacturing plants of semi-finished products such as composite panels, has been to invest in order to achieve high production capacities (>2,000 m³/day for panels and >3,000 t/day for paper with one line. The trend of concentrating the primary processing capacities and manufacturing wood-based panels will continue for the next few years not only in Europe but in North and South America as well. The ten largest panel manufacturers had a combined manufacturing capacity that exceeded a third of the worldwide production capacity. The financial crisis that started in 2008 has caused the closure of a large number of factories especially in North America and Central Europe. Small- and medium-sized producers will only survive if they will continue to specialize in the manufacture of panel types and sizes (niche products that are “unprofitable” for mega-groups. The installed production capacity worldwide of all wood-based composite panels combined (includes PY, PB, MDF, OSB rose by more than 2.5 times between 1980 and 2005 (225 mil.m³, and continues to increase despite the crises reaching approx. 300 mil.m³ in 2013. The forecast for the coming years varies greatly from continent to continent. In North America and Central Europe, both a consolidation of the available production capacities and the closure of less efficient older lines are expected. The lowest point of the effect of the financial crisis on the building industry seems to have been overcome. The furniture production companies will continue to move from one continent and region to another.

  8. Sustainable Product Development Through a Life-Cycle Approach to Product and Service Creation (Keynote speech)

    DEFF Research Database (Denmark)

    McAloone, Timothy Charles

    . These two schools of environmental re-search practice are mirrored in the way in which industry approaches environmental problems. Since the definition in 1987 of Sustainable Development [2] efforts have been made to relate the goals and ideals of sustainabil-ity to the domain of product development, thus...... adding new dimensions, such as social and moral values, to the original agenda of environmental improvement. The redefinition of the role of the product developer, from environmentally conscious product de-veloper to sustainably aware product developer has led to new insights into the way in which...... products are developed and used ¿ and to where environmental effects occur in the lifetime of a product. The role of the product developer is thus more complex in relation to sustainability, as the focus for improvement of a product may not (and very often does not) lie in the physical artefactual...

  9. Natural products for cancer-targeted therapy: citrus flavonoids as potent chemopreventive agents.

    Science.gov (United States)

    Meiyanto, Edy; Hermawan, Adam; Anindyajati

    2012-01-01

    Targeted therapy has been a very promising strategy of drug development research. Many molecular mechanims of diseases have been known to be regulated by abundance of proteins, such as receptors and hormones. Chemoprevention for treatment and prevention of diseases are continuously developed. Pre-clinical and clinical studies in chemoprevention field yielded many valuable data in preventing the onset of disease and suppressing the progress of their growth, making chemoprevention a challenging and a very rational strategy in future researches. Natural products being rich of flavonoids are those fruits belong to the genus citrus. Ethanolic extract of Citrus reticulata and Citrus aurantiifolia peels showed anticarcinogenic, antiproliferative, co-chemotherapeutic and estrogenic effects. Several examples of citrus flavonoids that are potential as chemotherapeutic agents are tangeretin, nobiletin, hesperetin, hesperidin, naringenin, and naringin. Those flavonoids have been shown to possess inhibition activity on certain cancer cells' growth through various mechanisms. Moreover, citrus flavonoids also perform promising effect in combination with several chemotherapeutic agents against the growth of cancer cells. Some mechanisms involved in those activities are through cell cycle modulation, antiangiogenic effect, and apoptosis induction. Previous studies showed that tangeretin suppressed the growth of T47D breast cancer cells by inhibiting ERK phosphorylation. While in combination with tamoxifen, doxorubicin, and 5-FU, respectively, it was proven to be synergist on several cancer cells. Hesperidin and naringenin increased cytotoxicitity of doxorubicin on MCF-7 cells and HeLa cells. Besides, citrus flavonoids also performed estrogenic effect in vivo. One example is hesperidin having the ability to decrease the concentration of serum and hepatic lipid and reduce osteoporosis of ovariectomized rats. Those studies showed the great potential of citrus fruits as natural product

  10. What and how about customer-driven product development

    DEFF Research Database (Denmark)

    Sommer, Anita Friis; Steger-Jensen, Kenn

    2012-01-01

    Collaborative product development is of increasing interest as customer demands increases while product life cycles decrease. This study investigates how suppliers handle active customers including managing customer requests for new products and customer-driven product development. A large...... structured literature review of the top 20 supply chain management journals is conducted to explore existing literature. Research states the importance of active integration in product development, but does not provide answers to how suppliers can manage this in practice. A 2x2 matrix is developed describing...

  11. Accelerator based Production of Auger-Electron-emitting Isotopes for Radionuclide Therapy

    DEFF Research Database (Denmark)

    Thisgaard, Helge

    In this research project the focus has been on the identification and production of new, unconventional Augerelectron- emitting isotopes for targeted radionuclide therapy of cancer. Based on 1st principles dosimetry calculations on the subcellular level, the Augeremitter 119Sb has been identified...

  12. Development of a men's Preference for Testosterone Replacement Therapy (P-TRT instrument

    Directory of Open Access Journals (Sweden)

    Szeinbach SL

    2012-08-01

    Full Text Available Sheryl L Szeinbach,1 Enrique Seoane-Vazquez,2 Kent H Summers31Ohio State University, College of Pharmacy, Columbus, OH, USA; 2International Center for Pharmaceutical Economics and Policy, Massachusetts College of Pharmacy and Health Sciences, Boston, MA, 3Endo Health Solutions, Chadds Ford, PA, USABackground: This study used a standard research approach to create a final conceptual model and the Preference for the Testosterone Replacement Therapy (P-TRT instrument.Methods: A discussion guide was developed from a literature review and expert opinion to direct one-on-one interviews with participants who used testosterone replacement therapy and consented to participate in the study. Data from telephone interviews were transcribed for theme analysis using NVivo 9 qualitative analysis software, analyzed descriptively from a saturation grid, and used to evaluate men's P-TRT. Data from cognitive debriefing for five participants were used to evaluate the final conceptual model and validate the initial P-TRT instrument.Results: Item saturation and theme exhaustion was achieved by 58 male participants of mean age 55.0 ± 10.0 (22–69 years who had used testosterone replacement therapy for a mean of 175.0 ± 299.2 days. The conceptual model was developed from items and themes obtained from the participant interviews and saturation grid. Items comprising eight dimensions were used for instrument development, ie, ease of use, effect on libido, product characteristics, physiological impact, psychological impact, side effects, treatment experience, and preference. Results from the testosterone replacement therapy preference evaluation provide a detailed insight into why most men preferred a topical gel product over an injection or patch.Conclusion: Items and themes relating to use of testosterone replacement therapy were in concordance with the final conceptual model and 29-item P-TRT instrument. The standard research approach used in this study produced the

  13. The importance of clinical mistletoe cancer therapy and korean mistletoe pharmacopuncture preparation development and application possibility for oriental medicine

    Directory of Open Access Journals (Sweden)

    Ok-Byung Choi

    2009-03-01

    Full Text Available Objectives : Mistletoe extracts have been in use for around 85 years, predominantly in the area of cancer therapy. Today mistletoe preparations are among the most prescribed drugs in cancer medicine, thus constituting a standard biological therapy in the area of oncology. The purpose of this study is to analyze the practical implications of mistletoe cancer therapy, their clinical status, their preparation techniques and companies. Contents : Mistletoe therapy for cancer has been developed within the context of anthroposophical medicine. One major effect of mistletoe extract is that it stimulates the immune system and cancer defences. In Germany, a total of eight different mistletoe preparations are available, five developed by Anthroposophic Medicine and three evolved from research in phytotherapy. Therapy always consists of an introductory phase in order to test the patient′s tolerance, find the right dosage and choose the most suitable preparation. This paper covers the background of mistletoe medical plant materials, mistletoe therapy for cancer, the anthroposophical medicine and clinical research, the practical regulation of treatment, preparation of mistletoe drugs. Result & suggestion : Mistletoe extracts are a complementary teratment of cancer, widely used in intergrative cancer care. The study of the integration of korean mistletoe extracts to oriental cancer medicine, its development and feasibility in Korea are urgently needed. The products, substances, compositions of european mistletoe drugs are very similar to those of oriental medicine theory. Applying the mistletoe cancer therapy and its preparation techniques to oriental medicine, the herbal acupuncture preparation should be modernized and korean mistletoe products are to be developed. To this end, government and herbal acupuncture society need to interact each other for the development of oriental mistletoe cancer medicine.

  14. Telehealth: A Rapidly Developing Service Delivery Model For Occupational Therapy

    OpenAIRE

    Cason, Jana

    2014-01-01

    Over the past decade, the practice of occupational therapy has been increasingly influenced by technological advances in the use of information and communication technologies (ICT) and associated changes in health care policy. Emergent from this evolution is the application of telehealth to deliver occupational therapy services to clients who are in a different physical location than the provider. This article furnishes an overview of the evidence for telehealth use in occupational therapy, d...

  15. Protein Kinases as Drug Development Targets for Heart Disease Therapy

    Directory of Open Access Journals (Sweden)

    Alison L. Müller

    2010-07-01

    Full Text Available Protein kinases are intimately integrated in different signal transduction pathways for the regulation of cardiac function in both health and disease. Protein kinase A (PKA, Ca2+-calmodulin-dependent protein kinase (CaMK, protein kinase C (PKC, phosphoinositide 3-kinase (PI3K and mitogen-activated protein kinase (MAPK are not only involved in the control of subcellular activities for maintaining cardiac function, but also participate in the development of cardiac dysfunction in cardiac hypertrophy, diabetic cardiomyopathy, myocardial infarction, and heart failure. Although all these kinases serve as signal transducing proteins by phosphorylating different sites in cardiomyocytes, some of their effects are cardioprotective whereas others are detrimental. Such opposing effects of each signal transduction pathway seem to depend upon the duration and intensity of stimulus as well as the type of kinase isoform for each kinase. In view of the fact that most of these kinases are activated in heart disease and their inhibition has been shown to improve cardiac function, it is suggested that these kinases form excellent targets for drug development for therapy of heart disease.

  16. Invasive Fetal Therapy: Global Status and Local Development

    Directory of Open Access Journals (Sweden)

    Ming Chen

    2004-12-01

    Full Text Available There are few congenital anomalies that can be treated in utero, despite the rapid development of fetal medicine. The number of available antenatal treatments is growing with the advance of supplementary tools, especially ultrasound and endoscopy. Disorders involving accumulation of excessive fluid in the amniotic cavity (polyhydramnios, chest (hydrothorax, abdomen (ascites and urinary system (obstructive uropathy are regularly treated using aspiration or shunt drainage under ultrasound monitoring. Electrolyte solutions or concentrated blood component supplements are used to treat oligohydramnios (amnioinfusion and amniopatch and fetal anemia (fetal transfusion. Placental tumor (chorioangioma and fetal tumors (cystic hygroma and sacrococcygeal teratoma are also successfully treated by antenatal injection of medications. Fetoscopic procedures, especially obstetric endoscopy, are now used regularly in North America, Europe, Australasia and Japan after the validity was established in the treatment of twin-twin transfusion syndrome when compared with traditional amnioreduction. However, most procedures involving surgical fetoscopy or open fetal surgery remain experimental. Their validity and efficacy are not confirmed in a number of fetal diseases for which they were claimed to be effective. A brief review of the global status and history of invasive fetal therapy is given, and its status in Taiwan is also described. Future development in this field relies on greater understanding of the basic physiology and pathology of the diseases involved, as well as on the progress of sophisticated instrumentation.

  17. Autophagy as a target for cancer therapy: new developments

    Directory of Open Access Journals (Sweden)

    Carew JS

    2012-10-01

    Full Text Available Jennifer S Carew, Kevin R Kelly, Steffan T NawrockiThe Department of Medicine and Institute for Drug Development, Cancer Therapy and Research Center at The University of Texas Health Science Center, San Antonio, TX, USAAbstract: Autophagy is an evolutionarily conserved lysosomal degradation pathway that eliminates cytosolic proteins, macromolecules, organelles, and protein aggregates. Activation of autophagy may function as a tumor suppressor by degrading defective organelles and other cellular components. However, this pathway may also be exploited by cancer cells to generate nutrients and energy during periods of starvation, hypoxia, and stress induced by chemotherapy. Therefore, induction of autophagy has emerged as a drug resistance mechanism that promotes cancer cell survival via self-digestion. Numerous preclinical studies have demonstrated that inhibition of autophagy enhances the activity of a broad array of anticancer agents. Thus, targeting autophagy may be a global anticancer strategy that may improve the efficacy of many standard of care agents. These results have led to multiple clinical trials to evaluate autophagy inhibition in combination with conventional chemotherapy. In this review, we summarize the anticancer agents that have been reported to modulate autophagy and discuss new developments in autophagy inhibition as an anticancer strategy.Keywords: autophagy, chloroquine, lucanthone, cancer, apoptosis

  18. Market Dynamics and Productivity in Developing Countries ...

    International Development Research Centre (IDRC) Digital Library (Canada)

    2009-11-25

    Nov 25, 2009 ... The results suggest a number of policy recommendations designed to foster competition and contribute to innovation, productivity growth, and improved return on capital investments. The book not only reveals important correlations among policy and market factors in MENA , but suggests fruitful areas of ...

  19. Consumer-Oriented New Product Development

    NARCIS (Netherlands)

    Grunert, K.G.; Trijp, van J.C.M.

    2014-01-01

    Introduction For most companies, the introduction of successful new products is critical to the achievement of the short- and longterm corporate strategic goals of profitability, growth, and continuity. As an illustration, more than 25% of the current retail food sales in the US have been reported

  20. THE NECESSITY OF DEVELOPING BLUEBERRY PRODUCTION

    Directory of Open Access Journals (Sweden)

    Florentina BADIU

    2013-12-01

    Full Text Available This article presents the advantages of cultivating blueberries, both economically and from an alimentary and therapeutic point of view. By calculating profit per hectare for the most productive varieties of blueberry, it was shown that this culture is particularly profitable for young farmers. In fact, blueberries have significant therapeutic value, being used in food and pharmaceutical industry.

  1. Developments and constraints in fermentative hydrogen production

    NARCIS (Netherlands)

    Bartacek, J.; Zabranska, J.; Lens, P.N.L.

    2007-01-01

    Fermentative hydrogen production is a novel aspect of anaerobic digestion. The main advantage of hydrogen is that it is a clean and renewable energy source/carrier with high specific heat of combustion and no contribution to the Greenhouse effect, and can be used in many industrial applications.

  2. Foundation-industry relationships--a new business model joint-venture philanthropy in therapy development.

    Science.gov (United States)

    Bartek, Ronald J

    2014-01-01

    The business model for medical therapy development has changed drastically. Large companies that once conducted their own Research and Development (R&D) and funded all the preclinical studies, all phases of clinical development and marketing of the products are increasingly turning to others for more and more of the earlier work in hopes of being able to in-license a de-risked program well downstream, take it through the final phases of clinical development and into the marketplace. This new paradigm has required patient-advocacy foundations, especially in the rare-disease space, to become far more effective in building relationships with all the players along the therapy-development pathway -- academic scientists, government agencies, other foundations with overlapping interests, biotechs, small biopharmaceutical entities and even the larger industry companies. From the perspective of the patient-advocacy community, these increasingly essential public-private partnerships have taken on the nature of what could be called joint-venture philanthropy and involve a broad spectrum of collaborations and financial relationships between foundations and industry partners that are not without concerns about potential conflicts of interest.

  3. Adaptation through Collaboration: Developing Novel Platforms to Advance the Delivery of Advanced Therapies to Patients

    Directory of Open Access Journals (Sweden)

    Magdalini Papadaki

    2017-05-01

    Full Text Available For the nascent field of advanced therapies, collaboration will be a game-changer, turning scientific progress that was once unimaginable into transformative medical practice. Despite promise for lifelong management and even cure of disease, skepticism remains about the feasibility of their delivery to patients, fueling investment risks. With the potential for long-term effectiveness in need of frequent reassessment, current approaches to predict real-life drug performance bear little relevance, necessitating novel and iterative schemes to monitoring the benefit–risk profiles throughout the life span of advanced therapies. This work explains that reinventing an adoption route for Advanced Therapy Medicinal Products is as much about the scientific and clinical components, as it is about the organizational structures, requiring an unprecedented level of interactions between stakeholders not traditionally connected; from developers and regulators, to payers, patients, and funders. By reflecting on the successes and lessons learned from the growing space of global precompetitive consortia and public–private partnerships, as well as a number of emerging accelerated development pathways, this work aims to inform the foundations for a future roadmap that can smooth the path to approval, reimbursement, and access, while delivering value to all stakeholders. Echoing the growing demands to bring these transformative products to patients, it provides critical insights to enhance our capacity in three fundamental domains: deploying the operational flexibilities offered by the growing space of collaborations, utilizing emerging flexible and accelerated pathways to tackle challenges in quantifying long-term effectiveness, and building the necessary digital and clinical infrastructure for knowledge development.

  4. Food Retailers’ Objectives of Developing Private Label Products and their Perspectives to Private Label Products

    OpenAIRE

    Serkan Kilic

    2011-01-01

    In the intensive competitive environment, retailers incline to develop their own branded products (private label products) to make a differentiation over their rivals and to gain a market share. On the other side, retailers’ have some objectives in developing private label products. At this point, this study put forwards the differences between retailers’ some characteristics and objectives of developing private label products and investigates the tendencies and expectations towards private l...

  5. MODERN TRENDS IN DEVELOPMENT OF ORGANIC AGRICULTURAL PRODUCTION. GERMAN EXPERIENCE

    OpenAIRE

    Khasanova S. A.; Grashorn M.

    2015-01-01

    The organic agriculture is an important issue for sustainable development and food quality production. For this reason we analyzed the data on land use in organic production and the volume of the market for organic products in Europe and Russia. The motivation of farmers and the driving factors for the transition to organic farming methods in developed countries and the role of subsidies have been shown. The analysis of the state of organic production in Germany has been carried out. In 2013,...

  6. A Comparison of New Service versus New Product Development

    DEFF Research Database (Denmark)

    Schleimer, Stephanie Christine; Schulman, Arthur

    2011-01-01

    Collaboration among firms for innovation has received considerable attention. However, little is known about how firm-to-firm collaboration is configured in new service development (NSD) versus new product development (NPD). This study takes a multidimensional approach and measures firm...... in product development and performance than when a new service is developed. However, the intensity of mutual trust has a stronger, positive relationship with development performance when a new service is developed than when a new product is developed. Implications are discussed, and suggestions for future...

  7. Investigating product development strategy in beverage industry using factor analysis

    Directory of Open Access Journals (Sweden)

    Naser Azad

    2013-03-01

    Full Text Available Selecting a product development strategy that is associated with the company's current service or product innovation, based on customers’ needs and changing environment, plays an important role in increasing demand, increasing market share, increasing sales and profits. Therefore, it is important to extract effective variables associated with product development to improve performance measurement of firms. This paper investigates important factors influencing product development strategies using factor analysis. The proposed model of this paper investigates 36 factors and, using factor analysis, we extract six most influential factors including information sharing, intelligence information, exposure strategy, differentiation, research and development strategy and market survey. The first strategy, partnership, includes five sub-factor including product development partnership, partnership with foreign firms, customers’ perception from competitors’ products, Customer involvement in product development, inter-agency coordination, customer-oriented approach to innovation and transmission of product development change where inter-agency coordination has been considered the most important factor. Internal strengths are the most influential factors impacting the second strategy, intelligence information. The third factor, introducing strategy, introducing strategy, includes four sub criteria and consumer buying behavior is the most influencing factor. Differentiation is the next important factor with five components where knowledge and expertise in product innovation is the most important one. Research and development strategy with four sub-criteria where reducing product development cycle plays the most influential factor and finally, market survey strategy is the last important factor with three factors and finding new market plays the most important role.

  8. Drug development from marine natural products.

    Science.gov (United States)

    Molinski, Tadeusz F; Dalisay, Doralyn S; Lievens, Sarah L; Saludes, Jonel P

    2009-01-01

    Drug discovery from marine natural products has enjoyed a renaissance in the past few years. Ziconotide (Prialt; Elan Pharmaceuticals), a peptide originally discovered in a tropical cone snail, was the first marine-derived compound to be approved in the United States in December 2004 for the treatment of pain. Then, in October 2007, trabectedin (Yondelis; PharmaMar) became the first marine anticancer drug to be approved in the European Union. Here, we review the history of drug discovery from marine natural products, and by describing selected examples, we examine the factors that contribute to new discoveries and the difficulties associated with translating marine-derived compounds into clinical trials. Providing an outlook into the future, we also examine the advances that may further expand the promise of drugs from the sea.

  9. Psychoactive natural products: overview of recent developments

    Directory of Open Access Journals (Sweden)

    István Ujváry

    2014-03-01

    Full Text Available Natural psychoactive substances have fascinated the curious mind of shamans, artists, scholars and laymen since antiquity. During the twentieth century, the chemical composition of the most important psychoactive drugs, that is opium, cannabis, coca and "magic mushrooms", has been fully elucidated. The mode of action of the principal ingredients has also been deciphered at the molecular level. In the past two decades, the use of herbal drugs, such as kava, kratom and Salvia divinorum, began to spread beyond their traditional geographical and cultural boundaries. The aim of the present paper is to briefly summarize recent findings on the psychopharmacology of the most prominent psychoactive natural products. Current knowledge on a few lesser-known drugs, including bufotenine, glaucine, kava, betel, pituri, lettuce opium and kanna is also reviewed. In addition, selected cases of alleged natural (or semi-natural products are also mentioned.

  10. Development of a Lubricant Therapy to Prevent Development of Osteoarthritis after Acute Injury of Synovial Joints

    Science.gov (United States)

    2016-10-01

    arthritis could be used to inform the development of patient-specific therapies. REFERENCES:​ [1] Gelber AC +, ​Ann Intern Med​ 133:321, 2000. [2... Joints PRINCIPAL INVESTIGATOR: Robert L. Sah CONTRACTING ORGANIZATION: University of California La Jolla, CA 92093 REPORT DATE: October 2016...Osteoarthritis after Acute Injury of Synovial Joints 5b. GRANT NUMBER W81XWH-14-1-0562 5c. PROGRAM ELEMENT NUMBER 6. AUTHOR(S) Robert L. Sah 5d. PROJECT NUMBER

  11. Development of a booklet on insulin therapy for children with diabetes mellitus type 1.

    Science.gov (United States)

    Moura, Denizielle de Jesus Moreira; Moura, Nádya Dos Santos; Menezes, Luciana Catunda Gomes de; Barros, Ariane Alves; Guedes, Maria Vilani Cavalcante

    2017-01-01

    to describe the process of developing of an educational booklet on insulin therapy for children with diabetes mellitus type 1. methodological approach, in which the following steps were carried out: selecting of the content and type of technology to be developed (for this step, an integrative review, an analysis of the comments of blogs about Diabetes Mellitus type 1 and interviews with the children were performed), creation of images, formatting and layout composition. the work resulted in the production of the final version of the educational booklet, which was titled Aplicando a insulina: a aventura de Beto [Applying insulin: Beto's adventure]. The process of developing of the booklet was based on the active participation of the children and guided by the theoretical framework of Piagetian Constructivism. the resource is a facilitator for the improvement of the knowledge and practices of self care of children with Diabetes Mellitus type 1.

  12. Industrial Diversification, Financial Development and Productive Investments

    OpenAIRE

    Alfredo Schclarek

    2007-01-01

    This paper analyzes, from a theoretical perspective, the role of the financial system to promote growth and macroeconomic stability. It also endogenously explains the performance of the financial systems as a consequence of industrial (or sectoral) diversification. In the model, the productive sector carries out R&D activities and finances its activities through the financial system. While vertical innovation fosters economic growth, horizontal innovation creates new industrial sectors and th...

  13. Popular product development: strategy, innovation and decision making

    Directory of Open Access Journals (Sweden)

    Maria Cecília Sobral

    2007-09-01

    Full Text Available This work studies the decision process involved in the development of a popular product in Brazil for a multinational company. The method was case study. The product was launched in the market at the end of 2003, being the first popular product of the company in the world. Some interesting points of this study: a The importance of the new market (the bottom of income pyramid to the company; b The development of a product specifically addressed to the needs of this market with a totally customized solution; c The decision of a new product platform development.

  14. Preparing Undergraduate Students for Work in Virtual Product Development Teams

    Science.gov (United States)

    Zavbi, Rdoman; Tavcar, Joze

    2005-01-01

    The development of innovative and competitive products and mastery of IT&T technologies are crucial for a company's long-term success in the global market. The main flag bearers for development are product developers, but it is questionable whether the existing systems are appropriate for the education of such professionals. For example, one…

  15. The application of lean principles in product development

    DEFF Research Database (Denmark)

    Bjarnø, Ole-Christian

    2007-01-01

    Although Lean Manufacturing has been a megatrend for several years, its principles have not been broadly applied in product development processes. We have therefore found it useful to look into the theories of lean manufacturing and to discuss how and to what extent they could be applied...... in the product development processes, and this study is compared with industrial practices in several front running companies in Denmark. From this research a suggestion for a framework and a tool-box for lean product development is created and discussed from a HR management, an implementation, an operational...... and an effectiveness point of view. Keywords Lean Thinking, Effective product development, The Toyota Product Development System, Lean Product Development, Flow, Waste, Value...

  16. Challenges associated with knowledge sharing in international product development teams

    DEFF Research Database (Denmark)

    Sonne, Anne-Mette; Harmsen, Hanne

    Motivated by and accelerating the globalization process, product development is increasingly taking place in international firms with employees of various nationalities and aimed at international markets. This poses a number of new managerial challenges. This paper draws together literature...... on product development teams, knowledge sharing, and international product development management to form a conceptual framework of factors that influence knowledge sharing in international teams. Four in-depth case studies are used to explore and expand the understanding of the challenges associated...... with international product development teams. Results indicate that international product development might not be as international as would be expected and that even if many of the characteristics and problems associated with international product development in the literature are found, there are also a number...

  17. Product development for catering - how to integrate issues on nutrition, quality and environment in the products

    DEFF Research Database (Denmark)

    Jørgensen, Michael Søgaard

    1996-01-01

    Overview of the experience with integration of issues on nutrition, quality and environment from a development and technology assessment project about product development for the catering sector......Overview of the experience with integration of issues on nutrition, quality and environment from a development and technology assessment project about product development for the catering sector...

  18. The gender gap in peer-reviewed publications by physical therapy faculty members: a productivity puzzle.

    Science.gov (United States)

    Kaufman, Regina R; Chevan, Julia

    2011-01-01

    Studies of peer-reviewed article publication by faculty in higher education show men publish more than women. Part of the difference in publishing appears to be attributable directly to gender. Gender differences in publishing productivity have not been explored in physical therapy. The purpose of this study was to explore effects of gender on peer-reviewed publication productivity in physical therapy. This was a cross-sectional study using survey methods. A survey was administered to a random sample of 881 physical therapy faculty members; 459 responses were used for analysis. Men were more likely than women to be married, have children, hold a PhD degree, be tenured or on a tenure track, and hold the position of department chair. There was a significant difference in peer-reviewed publication rates between male and female respondents. Negative binomial regression models revealed that female gender was a negative predictor of peer-reviewed publication, accounting for between 0.51 and 0.58 fewer articles per year for women than for men over the course of a career. Reasons for the gender differences are not clear. Factors such as grant funding, laboratory resources, nature of collaborative relationships, values for different elements of the teaching/research/service triad, and ability to negotiate the academic culture were not captured by our model. The gender gap in peer-reviewed publishing productivity may have implications for individuals and the profession of physical therapy and should be subject to further exploration.

  19. A System Architecture Approach to Global Product Development

    OpenAIRE

    Tripathy, Anshuman; Eppinger, Steven D

    2007-01-01

    Recent advances in engineering collaboration tools and internet technology have enabled the distribution of product development tasks to offshore sites and global outsourcing partners while still maintaining a tightly connected process. Most firms in complex engineering industries are indeed experimenting with various ways to structure their product development processes on a global basis. In this research, we have explored global product development structures from the perspectives of proces...

  20. Green development within product families, Electronics goes green 2000+ conference

    DEFF Research Database (Denmark)

    Lenau, Torben Anker; Willum, Ole; Frees, Niels

    2001-01-01

    From 1991 to 1996 the EDIP-methodology (Environmental Design of Industrial Products) was developed. One experience from the EDIP-project is that environmental assessment of products must give simple and operational conclusions, which can be acknowledged in the product development and by other...... decision makers throughout the product life cycle. The EDIP-project has demonstrated that it is possible to identify "the ten most important environmental hot spots". The documentation achieved by the environmental assessment shows where the most serious environmental impacts in the product life cycle...... be very time consuming to perform an environmental Life Cycle Assessment (LCA), and it would be an advantage if a number of similar products - product families - could be handled in one and the same LCA as a whole. The project has presently developed a method for selecting and forming product families...

  1. Consumer orientation of product developers and their product perception compared to that of consumers

    NARCIS (Netherlands)

    Sijtsema, S.J.; Backus, G.B.C.; Linnemann, A.R.; Jongen, W.M.F.

    2004-01-01

    This research concludes that although product developers (58, response rate 35%) and consumers (344, response rate 57%) perceive health and its relation to product characteristics in the same way, the perception of product developers is more extreme. Furthermore, factor analysis reveals four

  2. Development of Targeted Molecular Therapy for Cancers Harboring BAP1 Mutations

    Science.gov (United States)

    2016-10-01

    AWARD NUMBER: W81XWH-15-1-0578 TITLE: Development of Targeted Molecular Therapy for Cancers Harboring BAP1 Mutations PRINCIPAL INVESTIGATOR: Dr...CONTRACT NUMBER Development of Targeted Molecular Therapy for Cancers Harboring BAP1 Mutations 5b. GRANT NUMBER W81XWH-15-1-0578 5c. PROGRAM... mutations could provide a powerful new strategy for treating these cancers. Unfortunately, there are several obstacles to developing such therapies

  3. Neural underpinnings for model-oriented therapy of aphasic word production.

    Science.gov (United States)

    Abel, Stefanie; Weiller, Cornelius; Huber, Walter; Willmes, Klaus

    2014-05-01

    Model-oriented therapies of aphasic word production have been shown to be effective, with item-specific therapy effects being larger than generalisation effects for untrained items. However, it remains unclear whether semantic versus phonological therapy lead to differential effects, depending on type of lexical impairment. Functional imaging studies revealed that mainly left-hemisphere, perisylvian brain areas were involved in successful therapy-induced recovery of aphasic word production. However, the neural underpinnings for model-oriented therapy effects have not received much attention yet. We aimed at identifying brain areas indicating (1) general therapy effects using a naming task measured by functional magnetic resonance imaging (fMRI) in 14 patients before and after a 4-week naming therapy, which comprised increasing semantic and phonological cueing-hierarchies. We also intended to reveal differential effects (2) of training versus generalisation, (3) of therapy methods, and (4) of type of impairment as assessed by the connectionist Dell model. Training effects were stronger than generalisation effects, even though both were significant. Furthermore, significant impairment-specific therapy effects were observed for patients with phonological disorders (P-patients). (1) Left inferior frontal gyrus, pars opercularis (IFGoper), was a positive predictor of therapy gains while the right caudate was a negative predictor. Moreover, less activation decrease due to therapy in left-hemisphere temporo-parietal language areas was positively correlated with therapy gains. (2) Naming of trained compared to untrained words yielded less activation decrease in left superior temporal gyrus (STG) and precuneus, bilateral thalamus, and right caudate due to therapy. (3) Differential therapy effects could be detected in the right superior parietal lobule for the semantic method, and in regions involving bilateral anterior and mid cingulate, right precuneus, and left middle

  4. The Circadian Clock in Cancer Development and Therapy

    Science.gov (United States)

    Fu, Loning; Kettner, Nicole M.

    2014-01-01

    Most aspects of mammalian function display circadian rhythms driven by an endogenous clock. The circadian clock is operated by genes and comprises a central clock in the brain that responds to environmental cues and controls subordinate clocks in peripheral tissues via circadian output pathways. The central and peripheral clocks coordinately generate rhythmic gene expression in a tissue-specific manner in vivo to couple diverse physiological and behavioral processes to periodic changes in the environment. However, as the world industrialized, activities that disrupt endogenous homeostasis with external circadian cues have increased. This change in lifestyle has been linked to increased risk of diseases in all aspects of human health, including cancer. Studies in humans and animal models have revealed that cancer development in vivo is closely associated with the loss of circadian homeostasis in energy balance, immune function and aging that are supported by cellular functions important for tumor suppression including cell proliferation, senescence, metabolism and DNA damage response. The clock controls these cellular functions both locally in cells of peripheral tissues and at the organismal level via extracellular signaling. Thus, the hierarchical mammalian circadian clock provides a unique system to study carcinogenesis as a deregulated physiological process in vivo. The asynchrony between host and malignant tissues in cell proliferation and metabolism also provides new and exciting options for novel anti-cancer therapies. PMID:23899600

  5. New developments of 11C post-accelerated beams for hadron therapy and imaging

    Science.gov (United States)

    Augusto, R. S.; Mendonca, T. M.; Wenander, F.; Penescu, L.; Orecchia, R.; Parodi, K.; Ferrari, A.; Stora, T.

    2016-06-01

    Hadron therapy was first proposed in 1946 and is by now widespread throughout the world, as witnessed with the design and construction of the CNAO, HIT, PROSCAN and MedAustron treatment centres, among others. The clinical interest in hadron therapy lies in the fact that it delivers precision treatment of tumours, exploiting the characteristic shape (the Bragg peak) of the energy deposition in the tissues for charged hadrons. In particular, carbon ion therapy is found to be biologically more effective, with respect to protons, on certain types of tumours. Following an approach tested at NIRS in Japan [1], carbon ion therapy treatments based on 12C could be combined or fully replaced with 11C PET radioactive ions post-accelerated to the same energy. This approach allows providing a beam for treatment and, at the same time, to collect information on the 3D distributions of the implanted ions by PET imaging. The production of 11C ion beams can be performed using two methods. A first one is based on the production using compact PET cyclotrons with 10-20 MeV protons via 14N(p,α)11C reactions following an approach developed at the Lawrence Berkeley National Laboratory [2]. A second route exploits spallation reactions 19F(p,X)11C and 23Na(p,X)11C on a molten fluoride salt target using the ISOL (isotope separation on-line) technique [3]. This approach can be seriously envisaged at CERN-ISOLDE following recent progresses made on 11C+ production [4] and proven post-acceleration of pure 10C3/6+ beams in the REX-ISOLDE linac [5]. Part of the required components is operational in radioactive ion beam facilities or commercial medical PET cyclotrons. The driver could be a 70 MeV, 1.2 mA proton commercial cyclotron, which would lead to 8.1 × 10711C6+ per spill. This intensity is appropriate using 11C ions alone for both imaging and treatment. Here we report on the ongoing feasibility studies of such approach, using the Monte Carlo particle transport code FLUKA [6,7] to simulate

  6. New developments of {sup 11}C post-accelerated beams for hadron therapy and imaging

    Energy Technology Data Exchange (ETDEWEB)

    Augusto, R.S., E-mail: r.s.augusto@cern.ch [European Organization for Nuclear Research – CERN, 1211 Geneva 23 (Switzerland); Ludwig Maximilians – University of Munich, Munich (Germany); Mendonca, T.M.; Wenander, F. [European Organization for Nuclear Research – CERN, 1211 Geneva 23 (Switzerland); Penescu, L. [MedAustron GmbH, Wiener Neustadt (Austria); Orecchia, R. [CNAO – Centro Nazionale di Adroterapia Oncologica per il trattamento dei tumori, Pavia (Italy); Parodi, K. [Ludwig Maximilians – University of Munich, Munich (Germany); Ferrari, A.; Stora, T. [European Organization for Nuclear Research – CERN, 1211 Geneva 23 (Switzerland)

    2016-06-01

    Hadron therapy was first proposed in 1946 and is by now widespread throughout the world, as witnessed with the design and construction of the CNAO, HIT, PROSCAN and MedAustron treatment centres, among others. The clinical interest in hadron therapy lies in the fact that it delivers precision treatment of tumours, exploiting the characteristic shape (the Bragg peak) of the energy deposition in the tissues for charged hadrons. In particular, carbon ion therapy is found to be biologically more effective, with respect to protons, on certain types of tumours. Following an approach tested at NIRS in Japan [1], carbon ion therapy treatments based on {sup 12}C could be combined or fully replaced with {sup 11}C PET radioactive ions post-accelerated to the same energy. This approach allows providing a beam for treatment and, at the same time, to collect information on the 3D distributions of the implanted ions by PET imaging. The production of {sup 11}C ion beams can be performed using two methods. A first one is based on the production using compact PET cyclotrons with 10–20 MeV protons via {sup 14}N(p,α){sup 11}C reactions following an approach developed at the Lawrence Berkeley National Laboratory [2]. A second route exploits spallation reactions {sup 19}F(p,X){sup 11}C and {sup 23}Na(p,X){sup 11}C on a molten fluoride salt target using the ISOL (isotope separation on-line) technique [3]. This approach can be seriously envisaged at CERN-ISOLDE following recent progresses made on {sup 11}C{sup +} production [4] and proven post-acceleration of pure {sup 10}C{sup 3/6+} beams in the REX-ISOLDE linac [5]. Part of the required components is operational in radioactive ion beam facilities or commercial medical PET cyclotrons. The driver could be a 70 MeV, 1.2 mA proton commercial cyclotron, which would lead to 8.1 × 10{sup 711}C{sup 6+} per spill. This intensity is appropriate using {sup 11}C ions alone for both imaging and treatment. Here we report on the ongoing feasibility

  7. Association of hepatic oxidative stress and iron dysregulation with HCC development after interferon therapy in chronic hepatitis C.

    Science.gov (United States)

    Nanba, Shintaro; Ikeda, Fusao; Baba, Nobuyuki; Takaguchi, Koichi; Senoh, Tomonori; Nagano, Takuya; Seki, Hiroyuki; Takeuchi, Yasuto; Moritou, Yuki; Yasunaka, Tetsuya; Ohnishi, Hideki; Miyake, Yasuhiro; Takaki, Akinobu; Nouso, Kazuhiro; Iwasaki, Yoshiaki; Yamamoto, Kazuhide

    2016-03-01

    Oxidative stress may play pathogenic roles in the mechanisms underlying chronic hepatitis C (CHC). The impact of excessive oxidative stress and iron dysregulation on the development of hepatocellular carcinoma (HCC) after interferon therapy has not been established. We investigated the impact of oxidative stress and iron deposition on HCC development after therapy with pegylated interferon (PegIFN)+ribavirin in CHC patients. Systemic and intracellular iron homeostasis was evaluated in liver tissues, peripheral blood mononuclear cells and sera. Of 203 patients enrolled, 13 developed HCC during the 5.6-year follow-up. High hepatic 8-hydroxy-2-deoxyguanosine (8-OHdG) levels were significantly associated with HCC development in multivariate analysis (p=0.0012) which was also significantly correlated with severity of hepatic iron deposition before therapy (poxidative stress before antiviral therapy is useful for the prediction of HCC development after interferon therapy. Low baseline levels of the intracellular iron regulators of FBXL5 in addition to a suppressed hepcidin level might be associated with severe hepatic iron deposition in CHC patients. UMIN 000001031. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

  8. Successes and problems in the development of medical radioisotope production in Russia

    Science.gov (United States)

    Zhuikov, B. L.

    2016-05-01

    There are many challenges that face radionuclide production and application for medical diagnostics and therapy in Russia. In this article, the development of novel production methods for medical radionuclides (82Sr, 82Sr/82Rb-generator, 117mSn, 225Ac, etc.) at the Institute for Nuclear Research, RAS is described, providing an example of how supporting basic nuclear facilities, backing fundamental research, granting scientists and medical specialists freedom in choosing a research area, and effective international collaboration involving developed countries combine to enable progress in the field.

  9. Medical Countermeasure Product Development - Alternatives Paper

    Science.gov (United States)

    2014-04-01

    of infrastructure and skilled labour (PFRA, industry or academia) to develop a MedCM in a health emergency. Advantages • Clear strategy when...immediate response to a national emergency as provided by this Alternative only makes sense when the Government has the information about capability... membership and business growth and diversification opportunities within established targets and ensure the long-term sustainable development of the

  10. A systematic apporach to service oriented product development

    DEFF Research Database (Denmark)

    Matzen, Detlef

    operations. This integration of manufacturing and service business holds a number of potential advantages, such as optimised operational performance and improved insights into use phase processes. To realise these potential advantages, products and service operations must fit to and support each other, which...... calls for an integrated approach to their development. The integrated development of solution concepts spanning products, service delivery systems and matching delivery business models is the theme of this thesis. A design based approach - service oriented product development - is proposed...... for the creation of these Product/Service-Systems (PSS). The contribution builds on the foundations of engineering design and product development research performed at the Section of Engineering Design and Product Development at The Technical University of Denmark, also dubbed the Copenhagen school. Service...

  11. Telehealth: a rapidly developing service delivery model for occupational therapy.

    Science.gov (United States)

    Cason, Jana

    2014-01-01

    Over the past decade, the practice of occupational therapy has been increasingly influenced by technological advances in the use of information and communication technologies (ICT) and associated changes in health care policy. Emergent from this evolution is the application of telehealth to deliver occupational therapy services to a client who is in a different physical location than the provider. This article furnishes an overview of the evidence for telehealth use in occupational therapy, discusses key policy considerations, and provides resources to guide practitioners in the ethical use of telehealth.

  12. Telehealth: A Rapidly Developing Service Delivery Model for Occupational Therapy

    Directory of Open Access Journals (Sweden)

    Jana Cason

    2014-09-01

    Full Text Available Over the past decade, the practice of occupational therapy has been increasingly influenced by technological advances in the use of information and communication technologies (ICT and associated changes in health care policy. Emergent from this evolution is the application of telehealth to deliver occupational therapy services to clients who are in a different physical location than the provider. This article furnishes an overview of the evidence for telehealth use in occupational therapy, discusses key policy considerations, and provides resources to guide practitioners in the ethical use of telehealth.

  13. Developing the organization's productivity strategy in various sectors of industry

    NARCIS (Netherlands)

    Oeij, P.R.A.; Looze, M.P. de; Have, K.T.; Rhijn, J.W. van; Kuijt-Evers, L.F.M.

    2011-01-01

    Purpose: The paper aims to present an approach to improve the organisation's productivity which is applicable in every industrial sector. The nucleus of the approach is to develop an optimal productivity strategy in an organization by the application of a uniform static model of productivity

  14. Successful new product development in the food packaging industry ...

    African Journals Online (AJOL)

    The relevance of product innovations and new product development for the competitive performance of firms and for the longterm economic growth is a known and recognized topic. In the context of the food industry, process and product innovations are usually the result of cross-discipline ideas, involving, for instance, ...

  15. SPECIFIC FEATURES OF DEVELOPMENT OF ORGANIC PRODUCTS MARKET IN UKRAINE

    Directory of Open Access Journals (Sweden)

    T. Kharchenko

    2013-08-01

    Full Text Available The article is dedicated to the development of new and improvement of existing theoretical and methodological basis of forming and developing the market of organic products, its correspondence to the present-day situation, determination of problems and ways of their solving, introduction in practical activity of Ukrainian enterprises. The main objective of the article is to determine the specific features of forming and developing organic products market in Ukraine, and the perspective directions of its development based on analysis and practice of functioning of such markets in the world. The environmentally sound products market in the world is being analyzed, some information on the countries with the most commodity turnover of organic products, structure of international market of organic products, volumes of sales of organic products in the European countries is provided. As a result of studying the modern trends of economic development the authors reach a conclusion on problems of standard introduction, investigate the European norms and requirements for organic products. The conducted research allows distinguishing the basic features of Ukrainian market of organic products: it quickly grows, which makes it especially appealing for the participants of market relations, however entry into this market requires considerable capital investments and is characterized by high risk; criteria for qualifying products as environmentally sound products are unstructured and unclear. The potential for growth of organic products market in Ukraine is examined.

  16. Production of the PET isotope (11)C in hadron therapy via neutron knockout.

    Science.gov (United States)

    Simpson, E C

    2016-12-01

    Positron emitting isotopes such as (11)C and (10)C can be used for vital dose verification in hadron therapy. These isotopes are produced when the high energy (12)C primary beam particles undergo nuclear reactions within the patient. We discuss a model for calculating cross sections for the production (11)C in (12)C+(12)C collisions, applicable at hadron therapy energies. Good agreement with the available cross section measurements is found for (12)C(-1n), though more detailed, systematic measurements would be very valuable. Nuclear structure plays a crucial role in the reactions of light nuclei, particularly when those reactions are peripheral and involve only a few nucleons. For such reactions, nuclear structure has a strong influence on the energy and angular distribution of the cross section, and is an important consideration for reliable dose verification using (11)C in hadron therapy. Copyright © 2016. Published by Elsevier Ltd.

  17. Product Development in Higher Education Marketing

    Science.gov (United States)

    Durkin, Mark; Howcroft, Barry; Fairless, Craig

    2016-01-01

    Purpose: During the last 20 years or so the changing environment in which universities operate has meant that commensurately more emphasis has been placed on marketing principles. In light of this emphasis, it is perhaps a little surprising that relatively little attention has been directed towards the processes by which universities develop their…

  18. Developing engineering processes through integrated modelling of product and process

    DEFF Research Database (Denmark)

    Nielsen, Jeppe Bjerrum; Hvam, Lars

    2012-01-01

    This article aims at developing an operational tool for integrated modelling of product assortments and engineering processes in companies making customer specific products. Integrating a product model in the design of engineering processes will provide a deeper understanding of the engineering...... activities as well as insight into how product features affect the engineering processes. The article suggests possible ways of integrating models of products with models of engineering processes. The models have been tested and further developed in an action research study carried out in collaboration...... with a major international engineering company....

  19. Design models in the development of mechatronic products

    DEFF Research Database (Denmark)

    Habib, Tufail; Brunø, Thomas Ditlev; Nielsen, Kjeld

    2012-01-01

    with the aid of models. The role of software not only as part of the product but also in the development process. These models contribute to product structuring and evaluation of design process by reducing the complexity and their use for product customization.......In view of widespread application of mechatronic systems and the competition to offer customized products at high quality and low cost, there has been considerable attention to introduce new methods and models in this regard. This paper explores design process of mechatronic product development...

  20. Cost planning in the stage of product development

    Directory of Open Access Journals (Sweden)

    Todić Vladimir V.

    2014-01-01

    Full Text Available The total product life cycle cost can be planned based on one of the methods of global cost estimation. Also, total product life cycle cost can be planned based on cost plans and estimates by phases of the product life cycle, such as the phases of development, production, use and termination of the life cycle. By identifying the specific activities related to the relevant phases of life cycle as corresponding cost drivers, it is possible to accurately determine the total cost of individual phases using suitable methods known in the literature. This paper presents planning possibility respectively cost assessment of product development phase.

  1. Development of a Nanotechnology Platform for Prostate Cancer Gene Therapy

    Science.gov (United States)

    2013-07-01

    characterized to be CAR¯/HER2¯. This means that they are not a good candidate for adenoviral gene therapy or Herceptin anti-HER2 immunotherapy...can potentially be used in the treatment of the patients that do not respond to adenoviral gene therapy or Herceptin immunotherapy. References...growth factor receptor 2 (HER2) making them non-responsive to treatment with anti-HER2 antibodies such as Herceptin . In addition, PC-3 cells don’t

  2. External knowledge search and use in new product development

    NARCIS (Netherlands)

    Peeters, T.J.G.

    2013-01-01

    With rapidly shifting technological frontiers, innovative organizations cannot rely solely on internally generated knowledge and technologies anymore. Therefore, externally developed knowledge and technologies are getting more and more important in the development of new products. Not surprisingly,

  3. Product Development and Commercialization of Diagnostic or Life Science Products for Scientists and Researchers.

    Science.gov (United States)

    Alonso, Meghan M

    2017-01-01

    Commercializing a diagnostic or life science product often encompasses different goals than that of research and grant funding. There are several necessary steps, and a strategy needs to be well defined in order to be successful. Product development requires input from and between various groups within a company and, for academia, outside entities. The product development stakeholder groups/entities are research, marketing, development, regulatory, manufacturing, clinical, safety/efficacy, and quality. After initial research and development, much of the work in product development can be outsourced or jointly created using public-private partnerships. This chapter serves as an overview of the product development process and provides a guide to best define a product strategy.

  4. Food production in developing countries - the role of plant biotechnology

    Directory of Open Access Journals (Sweden)

    D. I. Ferreira

    1995-07-01

    Full Text Available The world is facing major problems with regard to food production. Agricultural land suffers from various conditions which make it less efficient for crop production while the rapid population growth, especially in developing countries, raises concern for sustainable food production. The Green Revolution has failed to secure sustainable food production and it is hoped that biotechnology will facilitate the transition to more sustainable agriculture. Excellent progress has been made with both Cell Biology (tissue culture and Molecular Biology (genetic engineering.

  5. Constraints on developing organic poultry production OF0128T

    OpenAIRE

    Lampkin, Nicolas; Padel, Susanne; Fowler, Sue; Rajah, Kanes; McDougall, Iain; Langstaff, Lesley; O'Regan, Tony; Sharples, Trevor

    1997-01-01

    This study aimed to provide MAFF with an assessment of the potential for organic poultry production in England and Wales and, in particular, to identify likely constraints on the development of organic poultry production enterprises, including physical, financial and market factors. The study will e composed of 3 specific objectives outlines as follows, together with ways in which they might be achieved: 1. Definition of the physical production parameters for alternative poultry production t...

  6. Development of Alcoa aluminum foam products

    Energy Technology Data Exchange (ETDEWEB)

    Bryant, J.D.; Crowley, M.D.; Wang, W.; Wilhelmy, D.M.; Hunter, D.E. [Alcoa Technical Center, Alcoa Center, PA (United States)

    2007-07-01

    A new lightweight aluminum foam product was described. The foam was made through the controlled decomposition of carbonate powders within molten aluminum and was able to resist both coalescence and drainage. The fine-celled aluminum foam derived its physical and mechanical properties from the properties of the aluminum alloy matrix from which they were produced. The rheology of the molten aluminum was modified to provide a superior mesostructure. Stabilization was achieved by creating a solid-gas-liquid suspension initiated by the addition of carbonates into an aluminum alloy melt. A cascade of chemical reactions then occurred within the melt to create a foamable suspension. Carbon monoxide (CO) was generated to initiate an additional sequence of chemical reactions which resulted in the formation of solid particles within the liquid metal. CO reacted with liquid Al to form graphite. The graphite then reacted with Al to form aluminum carbide (Al{sub 4}C{sub 3}). The microstructural, mesostructural, and mechanical character of the foams produced under different processing conditions were examined. Details of experimental test procedures were also described. It was concluded that the specific crush energy absorption was as high as 20 kJ/kg. The foam exhibited a bending stiffness that was approximately 20 to 30 times higher than balsa and polymer foams. 14 refs., 2 tabs., 7 figs.

  7. Designing photosensitizers for photodynamic therapy: strategies, challenges and promising developments.

    Science.gov (United States)

    Garland, Martin J; Cassidy, Corona M; Woolfson, David; Donnelly, Ryan F

    2009-07-01

    Photodynamic therapy (PDT) and photodynamic antimicrobial chemotherapy (PACT) are techniques that combine the effects of visible light irradiation with subsequent biochemical events that arise from the presence of a photosensitizing drug (possessing no dark toxicity) to cause destruction of selected cells. Despite its still widespread clinical use, Photofrin(®) has several drawbacks that limit its general clinical use. Consequently, there has been extensive research into the design of improved alternative photosensitizers aimed at overcoming these drawbacks. While there are many review articles on the subject of PDT and PACT, these have focused on the photosensitizers that have been used clinically, with little emphasis placed on how the chemical aspects of the molecule can affect their efficacy as PDT agents. Indeed, many of the PDT/PACT agents used clinically may not even be the most appropriate within a given class. As such, this review aims to provide a better understanding of the factors that have been investigated, while aiming at improving the efficacy of a molecule intended to be used as a photosensitizer. Recent publications, spanning the last 5 years, concerning the design, synthesis and clinical usage of photosensitizers for application in PDT and PACT are reviewed, including 5-aminolevulinic acid, porphyrins, chlorins, bacteriochlorins, texaphyrins, phthalocyanines and porphycenes. It has been shown that there are many important considerations when designing a potential PDT/PACT agent, including the influence of added groups on the lipophilicity of the molecule, the positioning and nature of these added groups within the molecule, the presence of a central metal ion and the number of charges that the molecule possesses. The extensive ongoing research within the field has led to the identification of a number of potential lead molecules for application in PDT/PACT. The development of the second-generation photosensitizers, possessing shorter periods of

  8. 47 CFR 6.7 - Product design, development, and evaluation.

    Science.gov (United States)

    2010-10-01

    ... and services covered by this part and shall incorporate such evaluation throughout product design... identify barriers to accessibility and usability as part of such a product design and development process. (b) In developing such a process, manufacturers and service providers shall consider the following...

  9. 15 CFR 12.3 - Development of voluntary product standards.

    Science.gov (United States)

    2010-01-01

    ... 15 Commerce and Foreign Trade 1 2010-01-01 2010-01-01 false Development of voluntary product standards. 12.3 Section 12.3 Commerce and Foreign Trade Office of the Secretary of Commerce FAIR PACKAGING AND LABELING § 12.3 Development of voluntary product standards. (a) Invitation to participate in the...

  10. Improving product development practice: An action-research based approach

    DEFF Research Database (Denmark)

    Harmsen, Hanne

    In studies of new product development it has often been concluded that to a large extent new product suc-cess is tunder the influence of companies and long lists of direct norma-tive guide-lines have been formulated. Nevertheless descriptive studi that deve-lopment practice is still far from...

  11. Development and use of dynamic product-line architectures

    NARCIS (Netherlands)

    Andersson, J; Bosch, J

    Software product families are used to shorten time-to-market, improve quality and lower cost, by means of effective reuse. The paper presents the results of case study conducted at four Swedish companies that are involved in either the development of or development with a software product family.

  12. Managing supplier involvement in new product development: a portfolio approach

    NARCIS (Netherlands)

    Wynstra, Finn; ten Pierick, E.

    2000-01-01

    Supplier involvement in new product development projects has become an increasingly popular method for improving project effectiveness (product costs and quality) and project efficiency (development costs and time). One of the key issues in managing this involvement is determining which type of

  13. Economic Development and Food Demand Changes: Production and Management Implications

    OpenAIRE

    Rask, Norman; Rask, Kolleen

    2005-01-01

    Per capita food consumption and production changes during economic development are analyzed using a resource-based cereal equivalent measure. Diet up-grades to livestock products during economic development contribute to an increase in per capita food resource use by a factor of five or more. Food consumption changes are generally consistent across countries and are only marginally affected by a country’s food production resource base (land). Food consumption increases tend to exceed food pro...

  14. Designing a Family of Development-Intensive Products

    OpenAIRE

    Krishnan, V.; Zhu, W

    2006-01-01

    Faced with fragmented markets, saturated and demanding customers, and global competition, firms increasingly must design and offer a line of innovative, quality-differentiated products to target customers with differing willingness to pay (WTP). In this context, designing a special class of products that we term development-intensive products (DIPs)--for which the fixed costs of development far outweigh the unit-variable costs--presents some unique managerial challenges. Examples of such deve...

  15. Product development in IT and telecommunications information acquisition strategies

    OpenAIRE

    Lund, Arne-Christian; Mæland, Jøril

    2007-01-01

    Investment projects within information technology and telecommunication industries face high uncertainty with respect to future cash flows, especially due to technological innovations and changing markets. Competition among IT and telecommunications companies leads to rapid technological innovations, and companies develop new products amd product features in order to be competitive. We evaluate development of a product, to be launched when a higher telecommunications network opens at a pre-sp...

  16. Hospital Exemption for Advanced Therapy Medicinal Products: Issue in Application in the European Union Member States.

    Science.gov (United States)

    Ivaskiene, Tatjana; Mauricas, Mykolas; Ivaska, Justinas

    2017-01-01

    Regulation (EC) 1394/2007 of the European Parliament and the Council on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004 allowed the use of non - authorized advanced therapy medicinal products under the certain circumstances. This socalled hospital exemption rule needs to be applied in the each Member State of the European Union individually and for this purpose Member States should provide national procedures and control measures. The aim of this article is to clear up the criteria for hospital exemption listed in Regulation (EC) 1394/2007 and to contrast the difference in implementing hospital exemption rule into national legal regimes on examples of the United Kingdom, Lithuania and Poland.

  17. Success in Global New Product Development

    DEFF Research Database (Denmark)

    de Bretani, Ulrike; Kleinschmidt, Elko J.; Salomo, Søren

    2010-01-01

    and strategies by which firms can effectively tackle the challenges and opportunities associated with international NPD. Based on the resource-based view (RBV) and the entrepreneurial strategic posture (ESP) literature, the present study develops and tests a model that emphasizes the resources of the firm...... America and Europe, business-to-business, services and goods), a structural model testing for the hypothesized mediation effects was substantially supported. Specifically, having an organizational posture that, at once, values innovation plus globalization, as well as a senior management that is active...

  18. Development of production processes for Micromegas detectors

    CERN Document Server

    De Oliveira, R

    2008-01-01

    Depuis une dizaines d'années de nombreuses nouveautés sont apparues dans le domaine de la réalisation des détecteurs de radiation à gaz. La première partie de la présentation décrira en détail le principe de l'un d'entre eux: le détecteur "MICROMEGAS" Micro-Mesh-Gas détecteur (ionisation des gaz, effet d'avalanche dans des forts champs électriques, récupération des charges). La seconde partie sera réservée à l'explication des procédés de fabrication et en particulier celui utilisé pour la réalisation des chambres appelées "BULK Micromegas". Ces derniers développés par le CERN en collaboration avec le laboratoire de SACLAY, donnent la possibilité de réaliser des détecteurs très rapides avec des tailles envisagées de l'ordre d'un mètre carré. La première production (CERN TS-DEM) à une échelle semi industrielle pour le détecteur de l'expérience T2K au Japon sera présentée et les défauts des préséries décrits.

  19. Development of new targeted therapies for breast cancer.

    Science.gov (United States)

    Doyle, Danielle M; Miller, Kathy D

    2008-01-01

    Clinical application of truly targeted therapy relies on identification of a specific molecular feature (the target) that is biologically relevant, reproducibly measurable and definably correlated with clinical benefit. Ideally the target should be crucial to the tumor's malignant phenotype. The target must be easily measurable in readily obtained clinical samples. Interruption, interference or inhibition of the target should yield a clinical response in a significant proportion of patients whose tumors express the target but in few patients whose tumors do not express the target. As such, targeted therapy offers the twin hopes of maximizing efficacy while minimizing toxicity. A critical review of the hallmarks of malignancy provides a framework for considering potential targets and novel therapeutic interventions. The hallmarks of malignancy include uncontrolled proliferation, insensitivity to negative growth regulation, evasion of apoptosis, lack of senescence, invasion and metastasis, angiogenesis, and genomic elasticity. Existing therapies predominantly target proliferation either with cytotoxic agents, ionizing radiation or inhibition of estrogen receptor and HER2 growth factor signaling pathways. Further improvements in therapy must attack the other hallmarks of malignancy and will undoubtedly be accompanied by better means of individual patient selection for such therapies. Indeed, each of these hallmarks presents a therapeutic opportunity. To believe otherwise would be to assume that a feature is both biologically crucial yet therapeutically unimportant, an unlikely paradox.

  20. Current pathogenic Escherichia coli foodborne outbreak cases and therapy development.

    Science.gov (United States)

    Yang, Shih-Chun; Lin, Chih-Hung; Aljuffali, Ibrahim A; Fang, Jia-You

    2017-08-01

    Food contamination by pathogenic microorganisms has been a serious public health problem and a cause of huge economic losses worldwide. Foodborne pathogenic Escherichia coli (E. coli) contamination, such as that with E. coli O157 and O104, is very common, even in developed countries. Bacterial contamination may occur during any of the steps in the farm-to-table continuum from environmental, animal, or human sources and cause foodborne illness. To understand the causes of the foodborne outbreaks by E. coli and food-contamination prevention measures, we collected and investigated the past 10 years' worldwide reports of foodborne E. coli contamination cases. In the first half of this review article, we introduce the infection and symptoms of five major foodborne diarrheagenic E. coli pathotypes: enteropathogenic E. coli (EPEC), Shiga toxin-producing E. coli/enterohemorrhagic E. coli (STEC/EHEC), Shigella/enteroinvasive E. coli (EIEC), enteroaggregative E. coli (EAEC), and enterotoxigenic E. coli (ETEC). In the second half of this review article, we introduce the foodborne outbreak cases caused by E. coli in natural foods and food products. Finally, we discuss current developments that can be applied to control and prevent bacterial food contamination.

  1. Development of Multifunctional Nanoparticles for Cancer Therapy Applications

    Science.gov (United States)

    Huth, Christopher

    The focus of this thesis is the functionalization and tailoring of nanoparticle surfaces to perform specific objectives in a biological environment. The nanoparticles examined include carbon nanotubes (CNTs), superparamagnetic iron oxide nanoparticles and superparamagnetic iron oxide nanocomposites. The unique nanomaterials have been developed to address continued issues in cancer therapy, including cancer diagnosis and efficient drug delivery. CNT surfaces were modified by plasma polymerization, providing functional groups for conjugation. Luminescent amine labeled quantum dots were fixed to the surface of the CNTs to aid in cancer diagnosis by in vivo imaging. Mice, injected with the quantum dot functionalized carbon nanotubes, were imaged displaying the in vivo imaging capability. In addition, the drug loading and drug release capabilities were examined by incorporating the drug paclitaxel into PLGA-coated CNTs, which showed much higher cytotoxicity to PC-3MM2 human prostate carcinoma cells compared to CNTs without paclitaxel. Paclitaxel was loaded at 112.5 microg/mg of PLGA-coated CNTs. Iron oxide nanocomposites were functionalized with quantum dots for diagnosis applications. Because the nanocomposites contain iron oxide, the nanoparticle provides the opportunity for magnetic hyperthermia, creating a unique material for diagnosis and therapy. Mice, injected with the quantum dot functionalized iron oxide nanocomposites, were imaged displaying the in vivo imaging capability. The magnetic hyperthermic property of the quantum dot functionalized nanocomposites was observed with the attainment of temperatures above 50°C during exposure to an alternating magnetic field. Thermoresponsive nanoparticles were prepared by immobilizing a 2 - 3 nm thick phospholipid layer on the surface of superparamagnetic Fe3O 4 nanoparticles via high affinity avidin/biotin interactions. Morphological and physicochemical surface properties were assessed using TEM, confocal laser scanning

  2. THE RENEWABLE ENERGY PRODUCTION-ECONOMIC DEVELOPMENT NEXUS

    Directory of Open Access Journals (Sweden)

    Gorkemli Kazar

    2014-04-01

    Full Text Available As renewable energy requirements increases, its relation with development is controversial. In this study, by taking human development index for development level, the relationship between renewable electricity net generation values and development has been searched with panel analysis. Study covers two different time periods: 1980-2010 with 5 year data to analyze long term effects and 2005-2010 yearly data for short term effects. Unlike previous studies, energy generation has been taken into consideration for it is thought to be more related with economic development. It is found that in the long run economic development will be leading to renewable energy production, while in the short run there exists a bidirectional causal relationship between renewable energy production and economic development. In addition, the causal relationship between economic development and renewable energy production varies both in the long run and in the short run due to human development level of the countries.

  3. Parallel Development of Products and New Business Models

    DEFF Research Database (Denmark)

    Lund, Morten; Hansen, Poul H. Kyvsgård

    2014-01-01

    The perception of product development and the practical execution of product development in professional organizations have undergone dramatic changes in recent years. Many of these chances relate to introduction of broader and more cross-disciplinary views that involves new organizational functi...... and innovation management the 4th generation models are increasingly including the concept business models and business model innovation....... functions and new concepts. These chances can be captured in various generations of practice. This paper will discuss the recent development of 3rd generation product development process models and the emergence of a 4th generation. While the 3rd generation models included the concept of innovation...

  4. Decision Making Processes for Global Product Development - a Case Study

    DEFF Research Database (Denmark)

    Søndergaard, Erik Stefan; Ahmed-Kristensen, Saeema

    2015-01-01

    Global Product Development (GPD), outsourcing and offshoring of product development is a widespread phenomenon on today’s global economy, and consequently most engineering manufacturing companies will have to make decisions regarding how to organise their product development activities globally...... to investigate how decisions are made and which information decisions are based on. The study found that decision making is not always structured, and that prioritised decision making is more dominant than planned decision making. The findings set the stage for further analysis of decision making in GPD......, and for development of support tools decision support tools for manager, which are based on empirical evidence and experience....

  5. Production of Ac-225 for cancer therapy by photon-induced transmutation of Ra-226.

    Science.gov (United States)

    Melville, G; Meriarty, H; Metcalfe, P; Knittel, T; Allen, B J

    2007-09-01

    The increasing application of Ac-225 for cancer therapy indicates the potential need for its increased production and availability. The production of Ac-225 has been achieved using bremsstrahlung photons from an 18 MV medical linear accelerator (linac) to bombard a Ra-226 target. A linac dose of 2800 Gy produced about 64 microCi of Ra-225, which decays to Ac-225. This result, while consistent with the theoretical calculations, is far too low to be of practical use. A more powerful linac is required that runs at a higher current, longer pulse length and higher frequency for practical production. This process could also lead to the reduction of the nuclear waste product Ra-226.

  6. The Role of the EMTC for development and recognition of the music therapy profession

    DEFF Research Database (Denmark)

    Ridder, Hanne Mette Ochsner; Lerner, Adrienne; Suvini, Ferdinando

    2015-01-01

    , and therefore the training of students, continuing education and research. This leads to a further demand for recognition of music therapy as a profession and for regulation, registration and governmental recognition. Looking back over the past 60 years, we are able to define some common paths of development......The rapid development of music therapy in Europe is reflected in the increasing number of trained professionals, music therapy positions and research publications. A development of the discipline implies increased requirements regarding the skills and competences of music therapy clinicians...... in relation to the music therapy profession throughout the European countries. With this as a starting point, as well as our own engagement in the European Music Therapy Confederation (EMTC) for more than a decade, we will explore the innate complexity of the profession and formulate our views for the future...

  7. Developing engineering design core competences through analysis of industrial products

    DEFF Research Database (Denmark)

    Hansen, Claus Thorp; Lenau, Torben Anker

    2011-01-01

    Most product development work carried out in industrial practice is characterised by being incremental, i.e. the industrial company has had a product in production and on the market for some time, and now time has come to design a new and upgraded variant. This type of redesign project requires...... that the engineering designers have core design competences to carry through an analysis of the existing product encompassing both a user-oriented side and a technical side, as well as to synthesise solution proposals for the new and upgraded product. The authors of this paper see an educational challenge in staging...... a course module, in which students develop knowledge, understanding and skills, which will prepare them for being able to participate in and contribute to redesign projects in industrial practice. In the course module Product Analysis and Redesign that has run for 8 years we have developed and refined...

  8. The Effects of Development Team Skill on Software Product Quality

    Science.gov (United States)

    Beaver, Justin M.; Schiavone, Guy A.

    2006-01-01

    This paper provides an analysis of the effect of the skill/experience of the software development team on the quality of the final software product. A method for the assessment of software development team skill and experience is proposed, and was derived from a workforce management tool currently in use by the National Aeronautics and Space Administration. Using data from 26 smallscale software development projects, the team skill measures are correlated to 5 software product quality metrics from the ISO/IEC 9126 Software Engineering Product Quality standard. in the analysis of the results, development team skill is found to be a significant factor in the adequacy of the design and implementation. In addition, the results imply that inexperienced software developers are tasked with responsibilities ill-suited to their skill level, and thus have a significant adverse effect on the quality of the software product. Keywords: software quality, development skill, software metrics

  9. Risks in New Product Development: Developing a Risk Reference Framework

    NARCIS (Netherlands)

    Keizer, Jimme A.; Vos, Jan-Peter; Halman, Johannes I.M.

    2005-01-01

    This paper describes the development and applicability of a risk reference framework (RRF) for diagnosing risks in technological breakthrough projects. In contrast to existing risk identification strategies, the RRF centers on an integral perspective on risk (i.e. business, technological and

  10. Rural Tourism and Local Development: Typical Productions of Lazio

    OpenAIRE

    Francesco Maria Olivieri

    2014-01-01

    The local development is based on the integration of the tourism sector with the whole economy. The rural tourism seems to be a good occasion to analyse the local development: consumption of "tourist products" located in specific local contexts. Starting from the food and wine supply chain and the localization of typical productions, the aim of the present work will be analyse the relationship with local development, rural tourism sustainability and accommodation system, referring to Lazio. W...

  11. Improving occupational safety and health by integration into product development

    DEFF Research Database (Denmark)

    Broberg, Ole

    1996-01-01

    A cross-sectional case study was performed in a large company producing electro-mechanical products for industrial application. The objectives were: (i) to study the product development process and the role of key actors', (ii) to identify current practice on integrating occupational safety...... and studies of documents. A questionnaire regarding product development tasks and occupational safety and health were distributed to 30 design and production engineers. A total of 27 completed the questionnaire corresponding to a response rate of 90 per cent....

  12. Project and Innovation Management in New Product Development Processes

    DEFF Research Database (Denmark)

    Henriksen, Leif; Gayretli, Ahmet

    2010-01-01

    Although the process of innovation is one of the most important drivers behind the growth and prosperity of today’s global economy, it is one of the least understood. This paper aims to address specific problems in carrying out new product development processes. There are crucial issues related...... to product design processes like inefficient project management, increasing product complexity, conflict management, shortfall of existing methods and tools, and high failures in new product introduction. A new approach has been proposed for a system based platform, which consist of a product platform...

  13. Impact of Faculty Development on Physical Therapy Professors' Beliefs

    Science.gov (United States)

    Behar-Horenstein, Linda S.; Zafar, Mueen A.; Roberts, Kellie W.

    2012-01-01

    Physical therapy faculty share similarities with faculty across allied health fields, such as nursing, and other clinical disciplines that educate students in licensing and board certification programs. Most have clinical experience and discipline-based expertise, however they may not have had the benefit of continuous learning aimed at enhancing…

  14. The lean product design and development journey a practical view

    CERN Document Server

    Pessôa, Marcus Vinicius Pereira

    2017-01-01

    This book presents a series of high performance product design (PD) and development best practices that can create or improve product development organization. In contrast to other books that focus only on Toyota or other individual companies applying lean IPD, this book explains the lean philosophy more broadly and includes discussions of systems engineering, design for X (DFX), agile development, integrated product development, and project management. The “Lean Journey” proposed here takes a value-centric approach, where the lean principles are applied to PD to allow the tools and methods selected to emerge from observation of the individual characteristics of each enterprise. This means that understanding lean product development (LPD) is not about knowing which tools are available but knowing how to apply the philosophy. The book comes with an accompanying manual with problems and solutions available on Springer Extras.

  15. Product development alliances: factors influencing formation and success

    DEFF Research Database (Denmark)

    Olsen, Johanne Rønnow; Harmsen, Hanne; Friis, Alan

    2008-01-01

    Purpose - The objective of this paper is to develop a framework, based on existing literature, for factors influencing the formation and success of product development alliances, and relate this specifically to the food industry. Design/methodology/approach - Case study of a product development......, results indicate that success factors are rather universal across industries and types of alliances. Research limitations/implications - Further research should explore the findings further, both within the food industry context, as well as more broadly in terms of geography and industry. Practical...... implications - Managers obtain a tool for planning and refining their innovation strategy and actions regarding product development alliances. Originality/value - This research contributes to the presently limited literature on product development alliances, specifically in the food industry context....

  16. Action Research in User-Centered Product Development

    DEFF Research Database (Denmark)

    Brandt, Eva

    2004-01-01

    and responsibilities both inside and outside the company. This paper reports experiences from using action research to introduce new user-centred work practices in two commercial product development projects. The interventions varied. In the first project it was found rewarding to engage customers and users...... and reifying insights in design representations and using these to both support collaboration, and create continuity in the project. The paper ends with a discussion of scientific rigor in action research and what the new work practices imply for the development team.......Technological development and increased international competition have imposed a significant burden on the product development function of many companies. The growing complexity of products demands a larger product development team with people having various competencies. Simultaneously...

  17. A Product Development Decision Model for Cockpit Weather Information Systems

    Science.gov (United States)

    Sireli, Yesim; Kauffmann, Paul; Gupta, Surabhi; Kachroo, Pushkin

    2003-01-01

    There is a significant market demand for advanced cockpit weather information products. However, it is unclear how to identify the most promising technological options that provide the desired mix of consumer requirements by employing feasible technical systems at a price that achieves market success. This study develops a unique product development decision model that employs Quality Function Deployment (QFD) and Kano's model of consumer choice. This model is specifically designed for exploration and resolution of this and similar information technology related product development problems.

  18. A Product Development Decision Model for Cockpit Weather Information System

    Science.gov (United States)

    Sireli, Yesim; Kauffmann, Paul; Gupta, Surabhi; Kachroo, Pushkin; Johnson, Edward J., Jr. (Technical Monitor)

    2003-01-01

    There is a significant market demand for advanced cockpit weather information products. However, it is unclear how to identify the most promising technological options that provide the desired mix of consumer requirements by employing feasible technical systems at a price that achieves market success. This study develops a unique product development decision model that employs Quality Function Deployment (QFD) and Kano's model of consumer choice. This model is specifically designed for exploration and resolution of this and similar information technology related product development problems.

  19. New Product Development (NPD) Process - An Example of Industrial Sector

    Science.gov (United States)

    Kazimierska, Marianna; Grębosz-Krawczyk, Magdalena

    2017-12-01

    This aim of this article is to present the process of new product introduction on example of industrial sector in context of new product development (NPD) concept. In the article, the concept of new product development is discussed and the different stages of the process of new electric motor development are analysed taking into account its objectives, implemented procedures, functions and responsibilities division. In the article, information from secondary sources and the results of empirical research - conducted in an international manufacturing company - are used. The research results show the significance of project leader and regular cooperation with final client in the NPD process.

  20. Consumer behaviour and opportunities for new product development

    DEFF Research Database (Denmark)

    Grunert, Klaus G

    and Q-PORKCHAINS and a Danish project, all dealing with new product development in the meat sector, it is shown how the use of consumer insight techniques can a) support the identification of market opportunities, b) make sure that technologies applied are acceptable to consumers, c) aid the selection......Successful new product development requires input from the market throughout the produce development process, from identification of opportunities via screening of ideas, development of concepts, development of physical prototypes and launch. Drawing on work done in the EU FP6 projects PROSAFEBEEF...

  1. APPLICABILITY OF ACTIVITY BASED COSTING IN NEW PRODUCT DEVELOPMENT PROCESSES

    Directory of Open Access Journals (Sweden)

    Ewa Wanda MARUSZEWSKA

    2015-01-01

    Full Text Available The purpose of the article is to emphasis that activity based costing is a proper tool for engineers to enhance their deci-sion-making process while developing new product. The theoretical analysis shows that variety of factors shall be en-compassed into new product decision-making process and therefore engineers and management should pay great attention to proper cost allocation. The paper suggests the usage of Activity Based Costing methodology for new product development decision-making process. Author states that application ABC in the process of rational decision-making referring to new product development enables managers and engineers to prioritize possible solutions, and reallocate resources used in production process in order to meet wider organizational goals. It would also contribute in coopera-tion of managers and engineers for the sake of organizational goal.

  2. Modified Stage-Gate: A Product Development Process

    OpenAIRE

    Ebrahim, Nader Ale

    2014-01-01

    In today’s dynamic marketplace, manufacturing companies are under strong pressure to introduce new products for long-term survival with their competitors. Increased competition and reduced product life cycles put force upon companies to develop new products faster. In response to these pressing needs, there should be some new approach compatible in flexible circumstances. This presentation presents a solution based on the popular Stage-Gate system, which is closely linked with virtual team ap...

  3. A conceptual model of virtual product development process

    OpenAIRE

    Ale Ebrahim, Nader; Ahmed, Shamsuddin; Zahari TAHA

    2009-01-01

    In today’s dynamic marketplace, companies are under strong pressure to introduce new products for long-term survival with their competitors. Besides, every company cannot cope up progressively or immediately with the market requirements due to knowledge dynamics being experienced in competitive milieu. Increased competition and reduced product life cycles put force upon companies to develop new products faster. In response to this pressing need there should be some new approach compatible in ...

  4. Three Essays on Strategic Considerations for Product Development

    OpenAIRE

    Sawhill, James Winslow

    2010-01-01

    This dissertation is composed of three essays focused on strategic considerations for product development. In chapter I, I address the question of whether consumers equally weigh capital and operating costs when purchasing durable goods. This trade off is important to manufacturers as they determine how much of their product design and production costs should be dedicated to keeping operating costs low. I test this empirically using data from the automobile industry. Chapter II is also an...

  5. Development of Hybrid Product Breakdown Structure for NASA Ground Systems

    Science.gov (United States)

    Monaghan, Mark W.; Henry, Robert J.

    2013-01-01

    The Product Breakdown Structure is traditionally a method of identification of the products of a project in a tree structure. It is a tool used to assess, plan, document, and display the equipment requirements for a project. It is part of a product based planning technique, and attempts to break down all components of a project in as much detail as possible, so that nothing is overlooked. The PBS for ground systems at the Kennedy Space Center is being developed to encompass the traditional requirements including the alignment of facility, systems, and components to the organizational hierarchy. The Ground Operations Product Breakdown Structure is a hybrid in nature in that some aspects of a work breakdown structure will be incorporated and merged with the Architecture Concept of Operations, Master Subsystem List, customer interface, and assigned management responsibility. The Ground Operations Product Breakdown Structure needs to be able to identify the flexibility of support differing customers (internal and external) usage of ground support equipment within the Kennedy Space Center launch and processing complex. The development of the Product Breakdown Structure is an iterative activity Initially documenting the organization hierarchy structure and relationships. The Product Breakdown Structure identifies the linkage between the customer program requirements, allocation of system resources, development of design goals, and identification logistics products. As the Product Breakdown Structure progresses the incorporation of the results of requirement planning for the customer occurs identifying facility needs and systems. The mature Product Breakdown Structure is baselined with a hierarchical drawing, the Product Breakdown Structure database, and an associated document identifying the verification of the data through the life cycle of the program/product line. This paper will document, demonstrate, and identify key aspects of the life cycle of a Hybrid Product

  6. User Experience Evaluation Methods in Product Development (UXEM'09)

    Science.gov (United States)

    Roto, Virpi; Väänänen-Vainio-Mattila, Kaisa; Law, Effie; Vermeeren, Arnold

    High quality user experience (UX) has become a central competitive factor of product development in mature consumer markets [1]. Although the term UX originated from industry and is a widely used term also in academia, the tools for managing UX in product development are still inadequate. A prerequisite for designing delightful UX in an industrial setting is to understand both the requirements tied to the pragmatic level of functionality and interaction and the requirements pertaining to the hedonic level of personal human needs, which motivate product use [2]. Understanding these requirements helps managers set UX targets for product development. The next phase in a good user-centered design process is to iteratively design and evaluate prototypes [3]. Evaluation is critical for systematically improving UX. In many approaches to UX, evaluation basically needs to be postponed until the product is fully or at least almost fully functional. However, in an industrial setting, it is very expensive to find the UX failures only at this phase of product development. Thus, product development managers and developers have a strong need to conduct UX evaluation as early as possible, well before all the parts affecting the holistic experience are available. Different types of products require evaluation on different granularity and maturity levels of a prototype. For example, due to its multi-user characteristic, a community service or an enterprise resource planning system requires a broader scope of UX evaluation than a microwave oven or a word processor that is meant for a single user at a time. Before systematic UX evaluation can be taken into practice, practical, lightweight UX evaluation methods suitable for different types of products and different phases of product readiness are needed. A considerable amount of UX research is still about the conceptual frameworks and models for user experience [4]. Besides, applying existing usability evaluation methods (UEMs) without

  7. Pharma Success in Product Development—Does Biotechnology Change the Paradigm in Product Development and Attrition.

    Science.gov (United States)

    Evens, Ronald P

    2016-01-01

    The biotechnology segment of the overall biopharma industry has existed for only about 40–45 years, as a driver of new product development. This driving force was initiated with the FDA approval of recombinant human insulin in 1982, originating from the Genentech company. The pharma industry in the early years of 1970s and 1980s engaged with biotechnology companies only to a small extent with their in-licensing of a few recombinant molecules, led by Roche, Eli Lilly, and Johnson and Johnson. However, subsequently and dramatically over the last 25 years, biotechnology has become a primary driver of product and technology innovation and has become a cornerstone in new product development by all biopharma companies. This review demonstrates these evolutionary changes regarding approved products, product pipelines, novelty of the products, FDA approval rates, product sales, financial R&D investments in biotechnology, partnerships, mergers and acquisitions, and patent issues. We now have about 300 biotechnology products approved in USA covering 16 medical disciplines and about 250 indications, with the engagement of 25 pharma companies, along with their biotechnology company innovators and partners. The biotechnology pipeline involves over 1000 molecules in clinical trials, including over 300 molecules associated with the top 10 pharma companies. Product approval rates by the FDA for biotechnology products are over double the rate for drugs. Yes, the R&D paradigm has changed with biotechnology now as one of the major focuses for new product development with novel molecules by the whole biopharma industry.

  8. What Happens to Integrated Product Development Models with Product/Service-System Approaches?

    DEFF Research Database (Denmark)

    Tan, Adrian; McAloone, Timothy Charles; Andreasen, Mogens Myrup

    2006-01-01

    Integrated Product Development (IPD) has traditionally focused on the development activities relating to physical technological artefacts. With the advent of business approaches for manufacturing firms based on providing customers the utility of integrated products and services – a term dubbed...... ‘product/service-systems (PSS)’ – companies need to extend their activities to include new dimensions of development. Within the paradigm of mass production and consumption, traditional product-oriented business strategies regarded physical technological artefacts (products) as the mediators of customer......, maintenance and disposal to customers that are often oblivious to proper behaviour, as well as, 3) it allows little opportunity for customers to influence the design to best suit their individual needs and preferences. PSS approaches are business strategies where companies provide value to customers...

  9. Strategy Development through Interview Technique from Narrative Therapy

    DEFF Research Database (Denmark)

    Kryger, Anders

    2017-01-01

    workshop, facilitated with interview technique from narrative therapy, and later authorized by the business area director. The organizational intervention preceded the scholarly inquiry. Findings: Employees’ retrospective storytelling about working at the company enabled them to formulate a joint mission......Purpose: The purpose of this paper is to demonstrate the successful strategy formulation process of a new purchasing department at an international engineering group. Design/methodology/approach: The strategy formulation was co-created by the department manager and employees at a storytelling...... statement using words and expressions from their own stories. Prospective storytelling enabled them to formulate a joint medium- and long-term vision and a corresponding action plan. This paper proposes interview technique from narrative therapy as a new practice-oriented strategic management tool and calls...

  10. Nature-Inspired Design : Strategies for Sustainable Product Development

    NARCIS (Netherlands)

    De Pauw, I.C.

    2015-01-01

    Product designers can apply different strategies, methods, and tools for sustainable product development. Nature-Inspired Design Strategies (NIDS) offer designers a distinct class of strategies that use ‘nature’ as a guiding source of knowledge and inspiration for addressing sustainability.

  11. New Product Development: Can Technique Substitute for Technology?

    Science.gov (United States)

    Meyers, Barbara E.

    1984-01-01

    Overview of research techniques involved in gathering information on current products that can provide input into new product development highlights consumer purchase and use patterns. Comparison of mail questionnaires, telephone surveys, focus group sessions, and in-person interviews notes type of data, timing, relative costs, and advantages and…

  12. 17 Human Resource Development and the Productivity of the Civil ...

    African Journals Online (AJOL)

    FIRST LADY

    2011-01-18

    Jan 18, 2011 ... of civil employees and how it affects their present and future productive capacities. Survey design was ... required to perform tasks effectively and these has a direct and immediate impact on productivity. It was recommended that government should expose its .... efforts at self development. The result of the ...

  13. Managing cross-functional cooperation for new product development success

    NARCIS (Netherlands)

    Gemser, G.; Leenders, M.A.A.M.

    2011-01-01

    This article focuses on conditions that make cross-functional cooperation in new product development projects more or less productive. We investigate 40 NPD projects in the consumer electronics and pharmaceuticals industries in which R&D and marketing played key roles. We find that the contributions

  14. Development of electrostatic therapy in recent years; Saikin no seidenki ryoho

    Energy Technology Data Exchange (ETDEWEB)

    Suzuki, S. [Chuo Univ., Tokyo (Japan)

    1998-08-25

    Accompanying the differentiation and development of electric engineering and medicine, the therapy in the form of loading a body entirely with static electricity is developed to therapies with the portions to be treated as the objects, such as the introduction of ionized chemicals to the portion to be treated by a direct current; twitch stimulus of paralytic muscle by faradism; thermotherapy with high frequency; and the like. In this paper, the history, kinds and effects of electrostatic therapy are described. Electrostatic therapy instruments are mainly divided in to three kinds including alternating current type potential therapy instruments; direct current type potential therapy instruments and AC-DC multiple type potential therapy instruments. Since the greatest characteristics of the electrostatic therapy instrument is the simple usage, the direct current type potential therapy instrument which was first developed for medical department are transferred to general patients whereby the functions of the instrument are not used effectively and sufficiently. Further, the effects of these instruments can be understood from the phenomenal aspect while there are still many unclear points needing the examination form engineering field. 26 refs., 6 figs., 1 tab.

  15. Management of salivary gland malignancies: current and developing therapies

    Directory of Open Access Journals (Sweden)

    Mark Agulnik

    2011-12-01

    Full Text Available Salivary gland tumors are rare, clinically diverse neoplasms that represent less than 1% of all malignancies. In locoregional recurrent or metastatic disease, systemic therapy is the standard approach. While numerous small phase II studies have evaluated the activity of cytotoxic agents, either alone or in combination, the response rates are generally modest with objective response rates ranging from 15%–50%. Duration of response is cited in the range of 6–9 months. Given this, further evaluation of novel therapies is mandatory in these diseases. With the emergence of molecular targeted therapy, these tumors become optimal candidates for trials of investigational drugs and established drugs for new indications. Of note, given the often indolent nature of disease, only patients with progressive disease should be enrolled and treated on these clinical trials. Study designs must incorporate stringent inclusion criteria to enable accurate reporting of disease response and stabilization. With dedication and co-operation, patients with these rare neoplasms can be accrued to clinical trials and the establishment of new treatment guidelines will be forthcoming.

  16. Development of ethanol production from cooking oil glycerol waste ...

    African Journals Online (AJOL)

    Tuoyo Aghomotsegin

    2016-10-12

    Oct 12, 2016 ... Full Length Research Paper. Development of ethanol production from cooking oil glycerol waste by mutant Enterobacter aerogenes. Thalisa Yuwa-amornpitak* and Kannika Chookietwatana. Department of Biotechnology, Faculty of Technology, Mahasarakham University, Khamriang, Kantarawichai, Maha.

  17. Characteristics of Strategies in Product/Service-System Development

    DEFF Research Database (Denmark)

    Tan, Adrian; McAloone, Timothy Charles

    2006-01-01

    The underlying principle in Product/Service-Systems (PSS) strategy is to shift from business based on the value of the transfer of product ownership and responsibility, to business based on the value of utility of the product and services. This paper identifies characteristics of various strategies...... that may be applied in PSS development. PSS concepts created in projects by third year Design & Innovation students at the Technical University of Denmark (DTU) working with product-life oriented design approaches were reviewed, and the strategies developed were analysed. This identification and mapping...... of PSS strategy types gives us the opportunity to develop methods and approaches to PSS development, more tailored to specific business strategies....

  18. Sustainable development of production in Russia: an informative aspect

    Directory of Open Access Journals (Sweden)

    Vidyaev Igor G.

    2016-01-01

    Full Text Available This paper is devoted to the study of the problems of introduction of the concept of sustainable development of production at modern enterprises. The paper substantiates the necessity of application of this concept at enterprises, gives reasons hindering this process. In addition, the analysis of the notion of sustainable development of production, wherein this process is represented as development of production by means of rational and economical use of resources oriented to provision of a long-term competitive advantage, was conducted in the paper. Moreover, the paper presents the basic principles of successful introduction of the concept of sustainable development of production. By the example of Toyota Company the benefits, which can be derived by an enterprise from application of this concept, were shown.

  19. Global product development: an attempt at harmonising the research effort

    DEFF Research Database (Denmark)

    Hansen, Zaza Nadja Lee; Simplay, Steve

    More companies are increasingly globalising activities throughout the product development process, from R&D to manufacturing. This presents companies with both technical and organisational challenges. These are addressed in different theoretical areas, in particular within Engineering Design & De...

  20. Adding to Product Development Theory - A Language Perspective

    DEFF Research Database (Denmark)

    Hansen, Poul H. Kyvsgård; Berg, Pekka; Mabogunje, Ade

    2014-01-01

    The paper explores the effect that the languages associated with the applied methods have on product development processes. Product development does increasingly involve more diverse disciplines and expanded cross-disciplinary views. Most importantly, the new disciplines: Design Thinking, and......, Innovation Management have introduced new cross-disciplinary methods and approaches. Some of the most important cognitive processes involved in product development: perceiving, meaning making, conceptualizing, communicating, and learning have been reframed and expanded as new disciplines have been introduced...... of these new languages reveals that the traditional methods applied in product development are highly influenced and limited by the languages that are traditionally associated with the application of these methods. Though language plays an important part in these essential processes it is rarely addressed...

  1. Control and Diagnosis in Integrated Product Development - Observations during the Development of an AGV

    Science.gov (United States)

    Stetter, R.; Simundsson, A.

    2015-11-01

    This paper is concerned with the integration of control and diagnosis functionalities into the development of complete systems which include mechanical, electrical and electronic subsystems. For the development of such systems the strategies, methods and tools of integrated product development have attracted significant attention during the last decades. Today, it is generally observed that product development processes of complex systems can only be successful if the activities in the different domains are well connected and synchronised and if an ongoing communication is present - an ongoing communication spanning the technical domains and also including functions such as production planning, marketing/distribution, quality assurance, service and project planning. Obviously, numerous approaches to tackle this challenge are present in scientific literature and in industrial practice, as well. Today, the functionality and safety of most products is to a large degree dependent on control and diagnosis functionalities. Still, there is comparatively little research concentrating on the integration of the development of these functionalities into the overall product development processes. The main source of insight of the presented research is the product development process of an Automated Guided Vehicle (AGV) which is intended to be used on rough terrain. The paper starts with a background describing Integrated Product Development. The second section deals with the product development of the sample product. The third part summarizes some insights and formulates first hypotheses concerning control and diagnosis in Integrated Product Development.

  2. Lean Production Development in SMEs: A Case Study

    Directory of Open Access Journals (Sweden)

    Majava Jukka

    2017-06-01

    Full Text Available The competitiveness of small and medium sized enterprises (SMEs is vital for the European economy. Also, manufacturing is often the core competence of SMEs. Adopting lean philosophy is a viable and popular approach for developing production and enabling continuous improvement. Despite the increased interest in empirical lean research, the body of knowledge about lean manufacturing development in SMEs is currently insufficient. This paper describes a study of a lean development project in a Finnish-based manufacturing SME. A current state analysis and development proposals are presented. The project applies a framework that other SMEs can utilize in identifying their problem areas and creating development proposals for their production activities. The results of the study contribute to the existing body of knowledge in lean manufacturing. In addition, managers in SMEs can utilize the study results as a reference when designing production development projects.

  3. Modelling production system architectures in the early phases of product development

    DEFF Research Database (Denmark)

    Guðlaugsson, Tómas Vignir; Ravn, Poul Martin; Mortensen, Niels Henrik

    2016-01-01

    This article suggests a framework for modelling a production system architecture in the early phases of product development.The challenge in these phases is that the products to be produced are not completely defined and yet decisions need to be made early in the process on what investments...... are needed and appropriate to enable determination of obtainable product quality. In order to meet this challenge, it is suggested that a visual modelling framework be adopted that clarifies which product and production features are known at a specific time of the project and which features will be worked...... on – leading to an improved basis for prioritizing activities in the project. Requirements for the contents of the framework are presented, and literature on production and system models is reviewed. The production system architecture modelling framework is founded on methods and approaches in literature...

  4. Development of novel arginase inhibitors for therapy of endothelial dysfunction

    Directory of Open Access Journals (Sweden)

    Jochen eSteppan

    2013-09-01

    Full Text Available Endothelial dysfunction and resulting vascular pathology have been identified as an early hallmark of multiple diseases, including diabetes mellitus. One of the major contributors to endothelial dysfunction is a decrease in nitric oxide (NO bioavailability, impaired NO signaling and an increase in the amount of reactive oxygen species (ROS. In the endothelium NO is produced by eNOS (endothelial nitric oxide synthase, for which L-arginine is a substrate. Arginase, an enzyme critical in the urea cycle also metabolizes L-arginine, thereby directly competing with eNOS for their common substrate and constraining its bioavailability for eNOS, thereby compromising NO production. Arginase expression and activity is upregulated in many cardiovascular diseases including ischemia reperfusion injury, hypertension, atherosclerosis, and diabetes mellitus. More importantly, since the 1990s, specific arginase inhibitors such as N-hydroxy-guanidinium or N-hydroxy-nor-L-arginine, and boronic acid derivatives, such as, 2(S-amino-6-boronohexanoic acid, and S-(2-boronoethyl-L-cysteine (BEC, that can bridge the binuclear manganese cluster of arginase have been developed. These highly potent and specific inhibitors can now be used to probe arginase function and thereby modulate the redox milieu of the cell by changing the balance between NO and ROS. Inspired by this success, drug discovery programs have recently led to the identification of α-α-disubstituted amino acid based arginase inhibitors (such as (R-2-amino-6-borono-2-(2-(piperidin-1-ylethylhexanoic acid, that are currently under early investigation as therapeutics. Finally, some investigators concentrate on identification of plant derived compounds with arginase inhibitory capability, such as piceatannol-3'-O-β-D-glucopyranoside (PG. All of these synthesized or naturally derived small molecules may represent novel therapeutics for vascular disease particularly that associated with diabetes.

  5. Ground-breaking virtual research in product development

    DEFF Research Database (Denmark)

    Søndergaard, Helle Alsted; Jespersen, Kristina Risom; Buck, Nuka

    2008-01-01

    MAPP also focuses on virtual reality. In the research project RIPS - the Role of Information Processing in NPD Strategy - a simulation of a product development process was used as a data collection instrument.......MAPP also focuses on virtual reality. In the research project RIPS - the Role of Information Processing in NPD Strategy - a simulation of a product development process was used as a data collection instrument....

  6. Uncovering product development competence by applying the laddering technique

    DEFF Research Database (Denmark)

    Jensen, Bjarne; Harmsen, Hanne

    This paper addresses companies' lack of implementation of success factors in new product development. Drawing on theories in the competence perspective and an exploratory empirical study, the paper points to two major areas that have not been covered by previous studies on new product development...... success factors. The two areas are individual employees' knowledge, skills, and values and norms. It is suggested that increased understanding of these two areas hold potential in making identified success factors more accessible to companies....

  7. Customized products and cloud service information system development research

    Directory of Open Access Journals (Sweden)

    Hung Chien-Wen

    2017-01-01

    Full Text Available This study presents a cloud service customized product information system to enable businesses to provide customized product marketing on the Internet to meet consumer demand for customized products. The cloud service of the information system development strategic framework proposed in this study contains three elements: (1 e-commerce services, (2 promotion type modules, and (3 cloud services customized promotional products. In this study, a mining cloud information system to detect customer behavior is proposed. The association rules from relational database design are utilized to mine consumer behavior to generate cross-selling proposals for customer products and marketing for a retailing mall in Taiwan. The study is composed of several parts, as follows. A market segment and application of association rules in data exploration techniques (Association Rule Mining and sequence-like exploration (Sequential Pattern Mining, efficient analysis of customers, consumer behavior, identification of candidates for promotional products, and using cloud service delivery and evaluation of targets to evaluate candidates for promotional products for production. However, in addition to cloud service customized promotional products, the quantity of promotional products sales varies for different customers. We strive to achieve increased customer loyalty and profits through the use of active cloud service customized promotional products.

  8. Co-development of diagnostic vectors to support targeted therapies and theranostics: Essential tools in Personalized Cancer Therapy.

    Directory of Open Access Journals (Sweden)

    Nicholas C Nicolaides

    2014-06-01

    Full Text Available Novel technologies are being developed to improve patient therapy through the identification of targets and surrogate molecular signatures that can help direct appropriate treatment regimens for efficacy and drug safety. This is particularly the case in oncology whereby patient tumor and biofluids are routinely isolated and analyzed for genetic, immunohistochemical and/or soluble markers to determine if a predictive biomarker signature exists as a means for selecting optimal treatment. Improvements in diagnostics that can prescreen predictive response biomarker profiles will continue to optimize the ability to enhance patient therapy via molecularly defined disease-specific treatment. A goal for drug developers is to identify and implement new strategies that can rapidly enable the development of beneficial disease-specific therapies for broad, patient-specific targeting without the need of tedious predictive biomarker discovery and validation efforts, currently a bottleneck for development timelines. Here we discuss the use of co-developing diagnostic-targeting vectors to identify patients whose malignant tissue can specifically uptake a drug linked vector prior to treatment. Using this system, a patient can be predetermined in real time as to whether or not their tumor(s can uptake a drug-linked diagnostic vector, thus inferring the uptake of a similar vector linked to an anti-cancer agent. If tumor-specific uptake is observed, then the patient may be suitable for drug-linked vector therapy and have a higher likelihood of clinical benefit while patients with no tumor uptake should consider other therapeutic options. This approach offers complementary opportunities to rapidly develop broad tumor-specific agents for use in personalized medicine.

  9. Production Assistance for Cellular Therapies (PACT): four-year experience from the United States National Heart, Lung, and Blood Institute (NHLBI) contract research program in cell and tissue therapies.

    Science.gov (United States)

    Reed, William; Noga, Stephen J; Gee, Adrian P; Rooney, Cliona M; Wagner, John E; McCullough, Jeffrey; McKenna, David H; Whiteside, Theresa L; Donnenberg, Albert D; Baker, Acacia K; Lindblad, Robert W; Wagner, Elizabeth L; Mondoro, Traci Heath

    2009-04-01

    In 2002, the US National Heart, Lung, and Blood Institute (NHLBI) conducted a workshop to determine needs of the cell therapy community. A consensus emerged that improved access to cGMP facilities, regulatory assistance, and training would foster the advancement of cellular therapy. A 2003 NHLBI request for proposals resulted in four contracts being awarded to three cell-manufacturing facilities (Baylor College of Medicine, University of Minnesota, and University of Pittsburgh) and one administrative center (The EMMES Corporation). As a result, Production Assistance for Cellular Therapies (PACT) was formed. As of October 1, 2008, PACT has received 65 preliminary applications of which 45 have been approved for product manufacture. A variety of cell therapies are represented including T-regulatory cells, natural killer cells, adipose-derived stem cells, cardiac progenitor cells for cardiac disease, hematopoietic progenitor cells (HPCs) for central nervous system applications, cytotoxic T lymphocytes, and dendritic cells. A total of 169 products have been administered under 12 applications and 2 reagents were manufactured and delivered. Fourteen peer-reviewed publications and 15 abstracts have resulted from the PACT project to date. A cell therapy textbook is nearly complete. PACT technical projects have addressed assay development, rapid endotoxin testing, shipping of cell products, and CD34+ HPC isolation from low-volume marrow. Educational Web seminars and on-site training through workshops have been conducted. PACT is an active and successful cell therapy manufacturing resource in the United States, addressing research and training while forging relationships among academia, industry, and participating institutions.

  10. The Development of Core Competencies for the Practice of Marriage and Family Therapy

    Science.gov (United States)

    Nelson, Thorana S.; Chenail, Ronald J.; Alexander, James F.; Crane, D. Russell; Johnson, Susan M.; Schwallie, Linda

    2007-01-01

    In response to a series of national policy reports regarding what has been termed the "quality chasm" in health and mental health care in the United States, in January 2003, the American Association for Marriage and Family Therapy convened a task force to develop core competencies (CC) for the practice of marriage and family therapy (MFT). The…

  11. Development of a Quantitative Tool to Assess the Content of Physical Therapy for Infants

    NARCIS (Netherlands)

    Blauw-Hospers, Cornill H.; Dirks, Tineke; Hulshof, Lily J.; Hadders-Algra, Mijna

    2010-01-01

    Purpose: The study aim was to describe and quantify physical therapy interventions for infants at high risk for developmental disorders. Methods: An observation protocol was developed based on knowledge about infant physical therapy and analysis of directly observable physiotherapeutic (PT) actions.

  12. Development of an Intravenous Therapy Module for Second Year Registered Nursing Students.

    Science.gov (United States)

    Balint, Marilyn

    A study aimed at developing an intravenous therapy module for second-year registered nursing students is described in this practicum report. The report's five chapters define the underlying problem and purpose of the study; discuss the history of intravenous therapy and the significance of the module to the host institution; review the relevant…

  13. A checklist to assess patient education in physical therapy practice: development and reliability.

    NARCIS (Netherlands)

    Sluijs, E.M.

    1991-01-01

    Patient education in physical therapy is gaining attention because it can contribute to patient compliance and prevention. This article describes the development of an assessment tool for investigating patient education in physical therapy. A checklist of 65 educational activity items was

  14. Development of curative therapies for Ewing sarcomas by interdisciplinary cooperative groups in Europe

    NARCIS (Netherlands)

    Bölling, T.; Braun-Munzinger, G.; Burdach, S.; Calaminus, G.; Craft, A.; Delattre, O.; Deley, M.-C. L.; Dirksen, U.; Dockhorn-Dworniczak, B.; Dunst, J.; Engel, S.; Faldum, A.; Fröhlich, B.; Gadner, H.; Göbel, U.; Gosheger, G.; Hardes, J.; Hawkins, D. S.; Hjorth, L.; Hoffmann, C.; Kovar, H.; Kruseova, J.; Ladenstein, R.; Leuschner, I.; Lewis, I. J.; Oberlin, O.; Paulussen, M.; Potratz, J.; Ranft, A.; Rössig, C.; Rübe, C.; Sauer, R.; Schober, O.; Schuck, A.; Timmermann, B.; Tirode, F.; van den Berg, H.; van Valen, F.; Vieth, V.; Willich, N.; Winkelmann, W.; Whelan, J.; Womer, R. B.

    2015-01-01

    Curative therapies for Ewing sarcoma have been developed within cooperative groups. Consecutive clinical trials have systematically assessed the impact and timing of local therapy and the activity of cytotoxic drugs and their combinations. They have led to an increase of long-term disease-free

  15. Emerging potential of natural products for targeting mucins for therapy against inflammation and cancer.

    Science.gov (United States)

    Macha, Muzafar A; Krishn, Shiv Ram; Jahan, Rahat; Banerjee, Kasturi; Batra, Surinder K; Jain, Maneesh

    2015-03-01

    Deregulated mucin expression is a hallmark of several inflammatory and malignant pathologies. Emerging evidence suggests that, apart from biomarkers, these deregulated mucins are functional contributors to the pathogenesis in inflammation and cancer. Both overexpression and downregulation of mucins in various organ systems is associated with pathobiology of inflammation and cancer. Restoration of mucin homeostasis has become an important goal for therapy and management of such disorders has fueled the quest for selective mucomodulators. With improved understanding of mucin regulation and mechanistic insights into their pathobiological roles, there is optimism to find selective non-toxic agents capable of modulating mucin expression and function. Recently, natural compounds derived from dietary sources have drawn attention due to their anti-inflammatory and anti-oxidant properties and low toxicity. Considerable efforts have been directed towards evaluating dietary natural products as chemopreventive and therapeutic agents; identification, characterization and synthesis of their active compounds; and improving their delivery and bioavailability. We describe the current understanding of mucin regulation, rationale for targeting mucins with natural products and discuss some natural products that modulate mucin expression and functions. We further discuss the approaches and parameters that should guide future research to identify and evaluate selective natural mucomodulators for therapy. Copyright © 2015 Elsevier Ltd. All rights reserved.

  16. Preclinical development of the green tea catechin, epigallocatechin gallate, as an HIV-1 therapy.

    Science.gov (United States)

    Nance, Christina L; Siwak, Edward B; Shearer, William T

    2009-02-01

    Previously, we presented evidence that at physiologic concentrations the green tea catechin, epigallocatechin gallate (EGCG), inhibited attachment of HIV-1 glycoprotein 120 to the CD4 molecule on T cells, but the downstream effects of EGCG on HIV-1 infectivity were not determined. To evaluate the inhibition of HIV-1 infectivity by EGCG and begin preclinical development of EGCG as a possible therapy. PBMCs, CD4(+) T cells, and macrophages were isolated from blood of HIV-1-uninfected donors. HIV-1 infectivity was assessed by an HIV-1 p24 ELISA. Cell survival was assessed by cell viability by Trypan blue exclusion assay, cell growth by thymidine incorporation, and apoptosis by flow-cytometric analysis of annexin-V binding. Epigallocatechin gallate inhibited HIV-1 infectivity on human CD4(+) T cells and macrophages in a dose-dependent manner. At a physiologic concentration of 6 mumol/L, EGCG significantly inhibited HIV-1 p24 antigen production across a broad spectrum of both HIV-1 clinical isolates and laboratory-adapted subtypes (B [P < .001], C, D, and G [P < .01]). The specificity of the EGCG-induced inhibition was substantiated by the failure of EGCG derivatives lacking galloyl and/or pyrogallol side groups to alter HIV-1 p24 levels. EGCG-induced inhibition of HV-1 infectivity was not a result of cytotoxicity, cell growth inhibition, or apoptosis. We conclude that by preventing the attachment of HIV-1-glycoprotein 120 to the CD4 molecule, EGCG inhibits HIV-1 infectivity. Because this inhibition can be achieved at physiologic concentrations, the natural anti-HIV agent EGCG is a candidate as an alternative therapy in HIV-1 therapy.

  17. The development of regional markets of eggs production in Russia

    Directory of Open Access Journals (Sweden)

    Natal'ya Anatol'evna Alekseeva

    2011-12-01

    Full Text Available The current state of regional markets development and the production of eggs and egg products for a long period — from 1990 to 2009 — is reviewed in this paper. The main research method is the method of statistical groupings. The variable amount of egg production was chosen as the grouping characteristic, since this figure fits well into research goals and has the property of the prevalence in the aggregate / total. To analyze the trends of the Russian regional markets involved into egg production, official statistics on consumer prices was used as well as producer prices, the volume of egg production per capita based on food import and export products. This allowed to group regions for comparison with average values of indicators carried out by different criteria, and to draw conclusions about trends in the development of regional markets. The most relevant factors influencing the development of egg production, among which the factor of vertical integration of production was especially noticed: building own plants and feed mills, joining the land in order to ensure the needs for higher quality raw materials and other activities were identified.

  18. New Products and Technologies, Based on Calculations Developed Areas

    Directory of Open Access Journals (Sweden)

    Gheorghe Vertan

    2013-09-01

    Full Text Available Following statistics, currently prosperous and have high GDP / capita, only countries that have and fructify intensively large natural resources and/or produce and export products massive based on patented inventions accordingly. Without great natural wealth and the lowest GDP / capita in the EU, Romania will prosper only with such products. Starting from the top experience in the country, some patented, can develop new and competitive technologies and patentable and exportable products, based on exact calculations of developed areas, such as that double shells welded assemblies and plating of ships' propellers and blade pump and hydraulic turbines.

  19. Barriers in green lean six sigma product development process

    DEFF Research Database (Denmark)

    Kumar, Sanjay; Luthra, Sunil; Govindan, Kannan

    2016-01-01

    In today’s competitive globalised business environment, production cost cutting is a primary issue before operation managers. As a research area, green lean six sigma (GLS) is proposed to have strategic importance in product development towards cutting costs, contributing to optimisation......, and achieving sustainability. This research requirement has been realised to draw benefits out of three recent and involved approaches (green, lean and six sigma). In this research, an attempt has been made to address barriers in GLS product development (GLSPD) from an extensive literature review and from...

  20. The sustainable utilization of human resources in global product development

    DEFF Research Database (Denmark)

    Hansen, Zaza Nadja Lee; Rasmussen, Lauge Baungaard; Hansen, Mette Sanne

    2010-01-01

    This empirical paper investigates the challenges global product development faces in regard to a sustainable utilization of resources through case studies and interviews in six Danish multinational corporations. Findings revealed 3 key challenges, which relates to increased rework in product...... development and production, overlapping work and a lack of utilization of knowledge and information at the supplier or subsidiary. The authors suggest the use of strategic simulation in order to gain greater transparency in the global network and thus utilize resources better. Strategic simulation...

  1. New Product Development in Traditional Industries: Decision-Making Revised

    Directory of Open Access Journals (Sweden)

    Jon Mikel Zabala-Iturriagagoitia

    2012-02-01

    Full Text Available This paper investigates whether decisions considered as common in new product development literature are also valid in a region characterized by traditional industries. The research is grounded on innovative companies in the Valencian Region (Spain. Using the statistical tool of factor analysis, we test if the groups of decisions identified by the literature can be confirmed in our empirical sample. Therewith, we aim to link the theoretical and empirical fields in the context of new product development and product innovation management.

  2. Using Boundary Management for More Effective Product Development

    Directory of Open Access Journals (Sweden)

    John Thomson

    2013-10-01

    Full Text Available Twenty years ago, most companies developed their own products in a single location and brought them to market themselves. Today, original equipment manufacturers (OEMs are enlisting partners on a global scale as subsystem designers and producers in order to create and deliver new products into the market more rapidly and more frequently. This is especially true for large, complex products from the aerospace, telecommunications, electronics, and software industries. To assure the delivery of information across organizational boundaries, new coordination mechanisms need to be adopted (boundary management. In this article, best practices are described on how OEMs and partners self-organize and use agile, cooperative techniques to maintain daily communication among numerous internal and partner engineers to better coordinate product design and system integration. This article focuses on examples from the aerospace industry; however; these tactics can be applied in any organization to innovate at faster rates, to make delivery times more predictable, and to realize shorter product development timelines.

  3. Improving the quality of pork and pork products for the consumer : development of innovative, integrated, and sustainable food production chains of high quality pork products matching consumer demands

    NARCIS (Netherlands)

    Heimann, B.; Christensen, M.; Rosendal Rasmussen, S.; Bonneau, M.; Grunert, K.G.; Arnau, J.; Trienekens, J.H.; Oksbjerg, N.; Greef, de K.H.; Petersen, B.

    2012-01-01

    Improving the quality of pork and pork products for the consumer: development of innovative, integrated, and sustainable food production chains of high quality pork products matching consumer demands.

  4. Guideline for the development of products for visually impaired

    Directory of Open Access Journals (Sweden)

    Ana Carolina Richter do Nascimento

    2013-03-01

    Full Text Available The concern about the needs of disabled people has grown, worldwide and in Brazil. The government seeks to address this issue. Visually impaired people represent 48,1% of the disabled person group in Brazil. Brazilian products that are used by visually impaired people are not developed specifically for this group and this fact is a big gap. Predominantly, product development approaches do not study methodologies to design products for people that can not see. Therefore, the objective of this paper is the development and application of a guideline for the development of products for visually impaired people. The proposed model is the result of literature review and product analysis. The Guideline is structured in groups and subgroups, helping the designer to find the correct recommendation. Each recommendation has a description and example. An illustrative application shows how the guideline works. An experimental application illustrates that the proposed guideline is: i consistent with the recommended products for the visually impaired people; ii applicable for experienced and novice designers; iii applicable for the “Conceptual Design” phase; iv tool for improve the quality of product conception and for reducing the design lead time.

  5. Production of orally applicable new drug or drug combinations from natural origin capsaicinoids for human medical therapy.

    Science.gov (United States)

    Mózsik, Gyula; Past, Tibor; Dömötör, András; Kuzma, Mónika; Perjési, Pál

    2010-01-01

    It is well known that the capsaicin stimulates (in small doses) or impairs (in high doses) the capsaicin-sensitive afferent nerves and the final effects of capsaicin depend on its applied doses. The effects of capsaicin were analyzed on the gastrointestinal mucosal protection and injury in animal experiments and in human beings (from 1980 up to now). From 2005 to 2008 an interdisciplinary group (21 researchers) participated in the production of orally applicable drug or drug combinations from capsaicin for human medical therapy of patients suffering from cardiovascular, degenerative joint and locomotor diseases, who received in their treatments non-steroidal anti-inflammatory compounds (NSAIDs). Our studies were based on the results of the NSAIDs-induced gastrointestinal side effects could be detected by application of small doses of capsaicin. Because natural (plant origin) capsaicin is chemically does not represent a uniform entity and used in the international research, consequently the authors met a lot of unpredictable scientific problems during the time of production of new capsaicin containing (alone or in combinations) drug before receiving official permissions from the different national and international authorities to start the classical human clinical pharmacological studies. This paper summarizes the different steps from the basic physiological and pharmacological notes (in animals), plant cultivation, chemistry of substance(s), animal (general and germinative) acute and chronic toxicology, human actions, basic clinical pharmacology of natural capsaicin (capsaicinoids) to introduce and to develop a new drug (or drug combinations) in the human medical therapy.

  6. Lean Startup and Lean Canvas Using for Innovative Product Development

    Directory of Open Access Journals (Sweden)

    Alena Buchalcevová

    2016-06-01

    Full Text Available Recently, new approaches to product development have emerged that focus on idea generation techniques and customer itself. One of them is the Lean Startup method that is described in this article along with the Lean Canvas method. The main goal of the article is to demonstrate the application of both methods to an innovative product development focused on providing interactive trips for families with children. The development of the product during individual phases is described and application of the Lean Startup and Lean Canvas principles is demonstrated. Finally, benefits of both methods contributing to the product success are discussed. Similar case studies start emerging worldwide, however in the Czech context are quite rare.

  7. THE TOTAL SOLUTION FOR DEVELOPING NEW PRODUCTS OF FOOTWEAR INDUSTRY

    Directory of Open Access Journals (Sweden)

    DRIŞCU Mariana

    2014-05-01

    Full Text Available This paper presents new solutions for shoemakers, for developing new products and new markets of footwear industry using the basic function of the system CRISPIN Dynamics CAD SUITE. These are the key issues - this is why CRISPIN Dynamics CAD SUITE has developed a range of quality software products to give the shoemaker a major advantage in shoe-making. This application offer functions for creating realistic looking designs of footwear products and for flattening the styles for development in 2D. There are also facilities to re-centre front and back guide lines, change foot (no need to re-digitize and set the correct heel height and roll. It is also possible to create guidelines to match with the last and extend the last for a boot design. The last type can also be changed to a type that allows the entire last surface to be used for a design. The system brings cutting-edge CAD/CAM technology to footwear designers providing benefits through all stages of their product development process. Major benefits include the ability to visualize a design for appraisal and the transfer of the design into CRISPIN 2D pattern development products. This allows increased productivity, shorter lead times, accurate interpretation of 3D designs in 2D and a reduction in the number of samples needed before approval of the design.

  8. Developments in the treatment of hemophilia B: focus on emerging gene therapy

    Directory of Open Access Journals (Sweden)

    Cancio MI

    2013-10-01

    Full Text Available Maria I Cancio,1 Ulrike M Reiss,2 Amit C Nathwani,3 Andrew M Davidoff,4 John T Gray2 1Department of Hematology-Oncology, 2Department of Hematology, St Jude Children’s Research Hospital, Memphis, TN, USA; 3Department of Haematology, University College London Cancer Institute, London, UK; 4Department of Surgery, St Jude Children’s Research Hospital, Memphis, TN, USA Abstract: Hemophilia B is a genetic disorder that is characterized by a deficiency of clotting factor IX (FIX and excessive bleeding. Advanced understanding of the pathophysiology of the disease has led to the development of improved treatment strategies that aim to minimize the acute and long-term complications of the disease. Patients with hemophilia B are ideal candidates for gene therapy, mostly because a small increase in protein production can lead to significantly decreased bleeding diathesis. Although human clotting FIX was cloned and sequenced over 30 years ago, progress toward achieving real success in human clinical trials has been slow, with long-term, therapeutically relevant gene expression only achieved in one trial published in 2011. The history of this extensive research effort has revealed the importance of the interactions between gene therapy vectors and multiple arms of the host immune system at multiple stages of the transduction process. Different viral vector systems each have unique properties that influence their ability to deliver genes to different tissues, and the data generated in several clinical trials testing different vectors for hemophilia have guided our understanding toward development of optimal configurations for treating hemophilia B. The recent clinical success implementing a novel adeno-associated virus vector demonstrated sufficient FIX expression in patients to convert a severe hemophilia phenotype to mild, an achievement which has the potential to profoundly alter the impact of this disease on human society. Continued research should

  9. Method for Developing Descriptions of Hard-to-Price Products: Results of the Telecommunications Product Study

    Energy Technology Data Exchange (ETDEWEB)

    Conrad, F.; Tonn, B.

    1999-05-01

    This report presents the results of a study to test a new method for developing descriptions of hard-to-price products. The Bureau of Labor Statistics (BLS) is responsible for collecting data to estimate price indices such as the Consumers Price Index (BLS) is responsible for collecting data to estimate price indices such as the Consumers Price Index (CPI). BLS accomplishes this task by sending field staff to places of business to price actual products. The field staff are given product checklists to help them determine whether products found today are comparable to products priced the previous month. Prices for non-comparable products are not included in the current month's price index calculations. A serious problem facing BLS is developing product checklists for dynamic product areas, new industries, and the service sector. It is difficult to keep checklists up-to-date and quite often simply to develop checklists for service industry products. Some people estimates that upwards of 50 % of US economic activity is not accounted for in the CPI

  10. Development of small-scale peat production; Pienturvetuotannon kehittaeminen

    Energy Technology Data Exchange (ETDEWEB)

    Erkkilae, A.; Kallio, E. [VTT Energy, Jyvaeskylae (Finland)

    1997-12-01

    The aim of the project is to develop production conditions, methods and technology of small-scale peat production to such a level that the productivity is improved and competitivity maintained. The aim in 1996 was to survey the present status of small-scale peat production, and research and development needs and to prepare a development plan for small-scale peat production for a continued project in 1997 and for the longer term. A questionnaire was sent to producers by mail, and its results were completed by phone interviews. Response was obtained from 164 producers, i.e. from about 75 - 85 % of small-scale peat producers. The quantity of energy peat produced by these amounted to 3.3 TWh and that of other peat to 265 000 m{sup 3}. The total production of energy peat (large- scale producers Vapo Oy and Turveruukki Oy included) amounted to 25.0 TWh in 1996 in Finland, of which 91 % (22.8 TWh) was milled peat and 9 % (2.2 TWh) of sod peat. The total production of peat other than energy peat amounted to 1.4 million m{sup 3}. The proportion of small-scale peat production was 13 % of energy peat, 11 % of milled peat and 38 % of sod peat. The proportion of small-scale producers was 18 % of other peat production. The results deviate clearly from those obtained in a study of small-scale production in the 1980s. The amount of small-scale production is clearly larger than generally assessed. Small-scale production focuses more on milled peat than on sod peat. The work will be continued in 1997. Based on development needs appeared in the questionnaire, the aim is to reduce environmental impacts and runoff effluents from small- scale production, to increase the efficiency of peat deliveries and to reduce peat production costs by improving the service value of machines by increasing co-operative use. (orig.)

  11. The moderating effect of product complexity on new product development and supply chain management integration

    NARCIS (Netherlands)

    Caniato, F.; Größler, A.

    2015-01-01

    The purpose of this study is to investigate whether product complexity moderates the impact of integration programs in both new product development (NPD) and supply chain (SC) management on operational performance. Results are based on statistical analyses of data collected from an international

  12. The market valuation of outsourcing new product development

    NARCIS (Netherlands)

    Raassens, N.; Wuyts, S.H.K.; Geyskens, I.

    2012-01-01

    Firms are increasingly outsourcing new product development (NPD), yet little is known about the financial performance implications of this decision. An empirical test shows that there is considerable variation in the performance implications of NPD outsourcing. The authors develop a contingency

  13. Capturing Design Process Information in Complex Product Development

    NARCIS (Netherlands)

    Woestenenk, Krijn; Bonnema, Gerrit Maarten; Alvarez Cabrera, Andres A.; Tomiyama, Tetsuo

    2011-01-01

    From interviewing developers and analyzing examples from industry, the authors have concluded that communication issues during the design process are a key factor of the complexity of product development. These communication issues stem from a lack of insight in the workflow between designers and

  14. Research in gilt development to improve lifetime productivity of sows

    Science.gov (United States)

    Proper development and selection of gilts is essential to the productivity and longevity of the sow herd. A gilt must remain in the sow herd for 2 to 3 parities before she produces enough piglets to pay for the cost of her development. Average age at culling in U.S. swine herds is approximately 3....

  15. System Development of Estimated Figures of Volume Production Plan

    Science.gov (United States)

    Brazhnikov, Maksim A.; Khorina, Irina V.; Minina, Yulia I.; Kolyasnikova, Lyudmila V.; Streltsov, Aleksey V.

    2016-01-01

    The relevance of this problem is primarily determined by a necessity of improving production efficiency in conditions of innovative development of the economy and implementation of Import Substitution Program. The purpose of the article is development of set of criteria and procedures for the comparative assessment of alternative volume production…

  16. Product assurance policies and procedures for flight dynamics software development

    Science.gov (United States)

    Perry, Sandra; Jordan, Leon; Decker, William; Page, Gerald; Mcgarry, Frank E.; Valett, Jon

    1987-01-01

    The product assurance policies and procedures necessary to support flight dynamics software development projects for Goddard Space Flight Center are presented. The quality assurance and configuration management methods and tools for each phase of the software development life cycles are described, from requirements analysis through acceptance testing; maintenance and operation are not addressed.

  17. New Product Development, R&D, and Culture

    DEFF Research Database (Denmark)

    Brem, Alexander; Kürzdörfer, Tamara

    2016-01-01

    Recent developments in the global economy indicate that new product development (NPD) activities are not limited to any single country; rather, they have spread across nations and cultures. This study aims to increase the understanding of NPD through an intercultural analysis by comparing innovat......-spanning corporate cultures, but there are differences between the countries with regard to idea generation and management....

  18. Collaborative Knowledge Production Model in the Field of Organizational Development

    Science.gov (United States)

    Ramstad, Elise

    2008-01-01

    The paper proposes a framework for collaborative knowledge production in order to enhance the amount and quality of knowledge in the field of organizational development (OD). We distinguish three types of actors that offer development services for work organizations: academic R&D units, training and educational institutes and management…

  19. Global production networks and linkages: a new development perspective

    OpenAIRE

    Shamsavari, Ali

    2005-01-01

    This paper attempts to bring together advances in literature on industrial economics and marketing, development economics, complexity (evolutionary theory), international business and geography of global production in order to illustrate an emerging paradigm of development which I call linkage promotion (LP).

  20. FORMATION AND DEVELOPMENT OF INSTITUTIONS OF EFFICIENCY PRODUCTION INFRASTRUCTURE

    Directory of Open Access Journals (Sweden)

    Anzor H. Jankaziev

    2015-01-01

    Full Text Available The article presents the methodological andmethodical bases of research and development institutes forming effi ciency production infrastructure. Focuses on the organizationalside of the issue as the comparative characteristics. It is proposed allocation of integraland differential approach to assessing the investment attractiveness of the industrial infrastructure of the enterprise. Consideredsectoral, regional, national and internationallevels of development of industrial infrastructure.

  1. An Empirical Study on the Factors Affecting Software Development Productivity

    Directory of Open Access Journals (Sweden)

    Luigi Lavazza

    2018-02-01

    Full Text Available Background: Software development productivity is widely investigated in the Software Engineering literature. However, continuously updated evidence on productivity is constantly needed, due to the rapid evolution of software development techniques and methods, and also the regular improvement in the use of the existing ones. Objectives: The main goal of this paper is to investigate which factors affect productivity. It was also investigated whether economies or diseconomies of scale exist and whether they may be influenced by productivity factors. Method: An empirical investigation was carried out using a dataset available at the software project repository ISBSG. The major focus was on factors that may affect productivity from a functional point of view. The the conducted analysis was compared with the productivity data provided by Capers Jones in 1996 and 2013 and with an investigation on open-source software by Delorey et al. Results: This empirical study led to the discovery of interesting models that show how the different factors do (or do not affect productivity. It was also found out that some factors appear to allow for economies of scale, while others appear to cause diseconomies of scale. Conclusions: This paper provides some more evidence about how four factors, i.e., programming languages, business areas, architectural types, and the usage of CASE tools, influence productivity and highlights some interesting divergences in comparison with the results reported by Capers Jones and Delorey et al.

  2. Development of wind power production in arctic climate

    Energy Technology Data Exchange (ETDEWEB)

    Peltola, E.; Kaas, J.; Aarnio, E. [Kemijoki Oy (Finland)

    1998-10-01

    The project Development of wind power production in arctic climate is a direct continuation of Arctic wind energy research project, which started in 1989. The main topics in 1996-97 have been production development and commercialising the blade heating systems, development of operation and maintenance practices of arctic wind power plants, preparations for new wind farms and various network connection and energy system studies. Practical operations have taken place in Pyhaetunturi test power plant and in Paljasselkae and Lammashovi power plants, which are in commercial operation

  3. Perceived external uncertainty, new product development, and the timeliness of international product launch: A commentary essay

    National Research Council Canada - National Science Library

    Ludwig Bstieler

    2012-01-01

    .... The central premise of the study is that this external uncertainty requires innovating companies to match their product development approaches to the uncertain context in order to achieve on-time launch...

  4. Research and development productivity map: visualization of industry status.

    Science.gov (United States)

    Shimura, H; Masuda, S; Kimura, H

    2014-04-01

    Decline in research and development (R&D) productivity and changes in the business environment have led to pharmaceutical company management to strive to improve R&D productivity. This decline is widely considered to be a major cause of industry consolidation and has received increased scholarly attention. This study aims to construct an R&D productivity map to visualize the industry's R&D productivity and to identify similarity in corporate actions with a view to investigate whether there is a relationship between deterioration in R&D productivity and industry consolidation. Research and development productivity is decomposed into two subprocesses to measure productivity: R&D efficiency and R&D effectiveness, and scores were calculated using a two-stage data envelopment analysis (DEA). The map is then constructed by projecting outputs. To identify any relationship between DEA scores and merger and acquisition transactions, a multiple regression model is employed. Data on 21 global pharmaceutical companies, statistical results indicated that companies with lower R&D efficiency scores were more likely to engage in consolidation. Three US companies that were least successful in terms of R&D effectiveness, as measured by our indicators, were either acquired or changed their business model. The R&D productivity map is a useful means for visualizing productivity among companies. By grouping companies into four groups, behavioural commonalities can be observed. The R&D productivity map should be useful for monitor the industry's productivity and help to improve it. © 2014 John Wiley & Sons Ltd.

  5. Development of system technology for radiation cancer therapy with the dexterous auto lesions tracking

    Energy Technology Data Exchange (ETDEWEB)

    Kim, Seungho; Jeong, Kyungmin; Jung, Seungho; Lee, Namho; and others

    2013-01-15

    The project objectives are to establish the fundamental core technologies for precise auto lesions tracking radiation cancer therapy and developing related system technology as well. Radiation cancer therapy apparatus should be domestically produced to reduce medical expenses, hence advanced technologies are suggested and developed to make cost down medical expenses and save expenditure for importing 10 million dollars/set from overseas. To achieve these targets, we have carried out reviewing of domestic and foreign technology trend. Based on review of state-of-the-art technology, radiation sensory system is studied. 3m high precise image processing technique and intelligent therapy planning software are developed. Also precedent study on the redundant robot for dexterous motion control system has been performed for developing of radiation cancel therapy robot system.

  6. New development in CAR-T cell therapy

    Directory of Open Access Journals (Sweden)

    Zhenguang Wang

    2017-02-01

    Full Text Available Abstract Chimeric antigen receptor (CAR-engineered T cells (CAR-T cells have yielded unprecedented efficacy in B cell malignancies, most remarkably in anti-CD19 CAR-T cells for B cell acute lymphoblastic leukemia (B-ALL with up to a 90% complete remission rate. However, tumor antigen escape has emerged as a main challenge for the long-term disease control of this promising immunotherapy in B cell malignancies. In addition, this success has encountered significant hurdles in translation to solid tumors, and the safety of the on-target/off-tumor recognition of normal tissues is one of the main reasons. In this mini-review, we characterize some of the mechanisms for antigen loss relapse and new strategies to address this issue. In addition, we discuss some novel CAR designs that are being considered to enhance the safety of CAR-T cell therapy in solid tumors.

  7. A proposal for a classification of product-related dependencies in development of mechatronic products

    DEFF Research Database (Denmark)

    Torry-Smith, Jonas; Mortensen, Niels Henrik; Achiche, Sofiane

    2014-01-01

    to the classification of product-related dependencies. Traditionally these dependencies have been described as appearing between the following product attributes: function, properties and structure. By analysing three mechatronic projects from industry we identified and classified 13 types of product......-related dependencies. Each product-related dependency is described and illustrated using the practical examples from the industrial projects. The value of the classification is evaluated by applying it to an industrial development setting not used for the analysis. The evaluation shows that delays in the project...

  8. Anticoagulation therapy a risk factor for the development of chronic subdural hematoma

    DEFF Research Database (Denmark)

    Aspegren, Oskar P.; Åstrand, Ramona; Lundgren, Maria I.

    2013-01-01

    Chronic subdural hematoma (CSDH) is a common disease among the elderly and with increasing incidence we have chosen to focus on associations between development and recurrence of CSDH and anticoagulation and/or antiplatelet agent therapy.......Chronic subdural hematoma (CSDH) is a common disease among the elderly and with increasing incidence we have chosen to focus on associations between development and recurrence of CSDH and anticoagulation and/or antiplatelet agent therapy....

  9. BOBATH THERAPY IN CORRECTION OF PSYCHOMOTOR DEVELOPMENT OF CHILDREN WITH ORGANIC INJURIES CNS

    OpenAIRE

    Bukhovets, B. O.; Romanchuk, A. P.

    2014-01-01

    The article represents therapy of Bobath such as one of the most effective author method which use in correction psychomotor development of children with disorders of musculoskeletal system. Bobath method is not new in the correction of movement disorders since last century and still supplementing and improving. In this work highlight topic of the effective use Bobath therapy in correction of psychomotor development in children age 3 – 6 years with organic involvement CNS. the experiment w...

  10. First-line treatment: a critical appraisal of cognitive behavioral therapy developments and alternatives.

    Science.gov (United States)

    Arch, Joanna J; Craske, Michelle G

    2009-09-01

    In this article, the authors assess the successes, remaining challenges, and new developments in cognitive behavioral therapy (CBT) for anxiety disorders. They define CBT, examine treatment components, review treatment efficacy, and discuss the challenges of attrition, long-term follow-up, co-occurring/comorbid disorders, limited treatment comparisons, treatment mediators, and broader implementation. In addition, they present recent developments in cognitive behavioral therapy for anxiety disorders, including linking exposure therapy to basic science, mindfulness and acceptance-based treatments, and unified or transdiagnostic treatment protocols.

  11. The Design and Development of Enhanced Thermal Desorption Products

    Directory of Open Access Journals (Sweden)

    R. Humble

    2005-01-01

    Full Text Available This research study is based on a knowledge-transfer collaboration between The National Centre for Product Design and Development Research (PDR and Markes International Ltd. The aim of the two-year collaboration has been to implement design tools and techniques for the development of enhanced thermal desorption products. Thermal desorption is a highly-specialised technique for the analysis of trace-level volatile organic compounds. This technique allows minute quantities of these compounds to be measured; however, there is an increasing demand from customers for greater sensitivity over a wider range of applications, which means new design methodologies need to be evaluated. The thermal desorption process combines a number of disparate chemical, thermal and mechanical disciplines, and the major design constraints arise from the need to cycle the sample through extremes in temperature. Following the implementation of a comprehensive product design specification, detailed design solutions have been developed using the latest 3D CAD techniques. The impact of the advanced design techniques is assessed in terms of improved product performance and reduced development times, and the wider implications of new product development within small companies are highlighted.  

  12. Pharmaceutical product development: A quality by design approach.

    Science.gov (United States)

    Pramod, Kannissery; Tahir, M Abu; Charoo, Naseem A; Ansari, Shahid H; Ali, Javed

    2016-01-01

    The application of quality by design (QbD) in pharmaceutical product development is now a thrust area for the regulatory authorities and the pharmaceutical industry. International Conference on Harmonization and United States Food and Drug Administration (USFDA) emphasized the principles and applications of QbD in pharmaceutical development in their guidance for the industry. QbD attributes are addressed in question-based review, developed by USFDA for chemistry, manufacturing, and controls section of abbreviated new drug applications. QbD principles, when implemented, lead to a successful product development, subsequent prompt regulatory approval, reduce exhaustive validation burden, and significantly reduce post-approval changes. The key elements of QbD viz., target product quality profile, critical quality attributes, risk assessments, design space, control strategy, product lifecycle management, and continual improvement are discussed to understand the performance of dosage forms within design space. Design of experiments, risk assessment tools, and process analytical technology are also discussed for their role in QbD. This review underlines the importance of QbD in inculcating science-based approach in pharmaceutical product development.

  13. QA4ECV: Developing Metrological Traceability Through ECV Products

    Science.gov (United States)

    Nightingale, Joanne; Scanlon, Tracy; Farquhar, Clive

    2015-04-01

    Meteorological traceability is the relation of the result to a reference (for example SI) through an unbroken chain of documented calibrations or comparisons. Each link in the chain contributes to the uncertainty associated with the derived value. The QA4ECV project (which has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under QA4ECV grant agreement no. 607405) aims to demonstrate traceability through the processing steps associated with the production and validation of 6 Essential Climate Variable (ECV) products (3 land and 3 atmosphere). This involves the development of ECV algorithm and product validation diagrams and demonstrable uncertainty estimation processes through each step of these chains. A traceability and uncertainty propagation tool (TUPT), which graphically demonstrates the propagation of uncertainties through an algorithm and product validation chain will be developed to support a pioneering and robust quality assurance framework for ECV climate data records.

  14. A classification of strategies for the development of product configurators

    DEFF Research Database (Denmark)

    Haug, Anders; Hvam, Lars; Mortensen, Niels Henrik

    2009-01-01

    Product configurators are a subtype of software-based expert systems with a focus on the creation of product specifications. Product configurators are increasingly being applied by engineering-oriented companies, which has resulted in many positive effects, such as reduced lead times, fewer errors......, shorter learning periods for new employees, etc. Unfortunately, also many configuration projects fail because the task of developing the configurator turns out to be much more difficult and time-consuming than anticipated. In order to minimize the chance of project failure, it is crucial to apply...... the right strategy. However, the literature does not discuss different strategic alternatives in a detailed manner, but only provides generalised recommendations of single strategies. To deal with this issue, this paper defines three main and four additional strategies for the development of product...

  15. Natural Resources and Productivity: Can Banking Development Mitigate the Curse?

    Directory of Open Access Journals (Sweden)

    Ramez Abubakr Badeeb

    2017-04-01

    Full Text Available This paper contributes to the literature concerning the natural resource curse by exploring the role of banking development in reducing the resource curse in a natural resource-based country, Yemen. Using time series data over the period 1980–2012, we find that natural resource dependence is negatively related to productivity, and this relationship depends on the level of banking development. Increasing this level reduces the negative consequences of the natural resource curse. Therefore, policymakers should proactively encourage credit to enable the banking sector to play a more efficient intermediary role in mobilizing domestic savings and channeling them to productive investments. This will help to accumulate permanent productive wealth to enhance any diversification effort and compensate for the decline in natural resource production.

  16. Developing an Emergency Physician Productivity Index Using Descriptive Health Analytics.

    Science.gov (United States)

    Khalifa, Mohamed

    2015-01-01

    Emergency department (ED) crowding became a major barrier to receiving timely emergency care. At King Faisal Specialist Hospital and Research Center, Saudi Arabia, we identified variables and factors affecting crowding and performance to develop indicators to help evaluation and improvement. Measuring efficiency of work and activity of throughput processes; it was important to develop an ED physician productivity index. Data on all ED patients' encounters over the last six months of 2014 were retrieved and descriptive health analytics methods were used. Three variables were identified for their influence on productivity and performance; Number of Treated Patients per Physician, Patient Acuity Level and Treatment Time. The study suggested a formula to calculate the productivity index of each physician through dividing the Number of Treated Patients by Patient Acuity Level squared and Treatment Time to identify physicians with low productivity index and investigate causes and factors.

  17. Virtual Collaborative Simulation Environment for Integrated Product and Process Development

    Science.gov (United States)

    Gulli, Michael A.

    1997-01-01

    Deneb Robotics is a leader in the development of commercially available, leading edge three- dimensional simulation software tools for virtual prototyping,, simulation-based design, manufacturing process simulation, and factory floor simulation and training applications. Deneb has developed and commercially released a preliminary Virtual Collaborative Engineering (VCE) capability for Integrated Product and Process Development (IPPD). This capability allows distributed, real-time visualization and evaluation of design concepts, manufacturing processes, and total factory and enterprises in one seamless simulation environment.

  18. Development of real-time GNSS ZTD products

    Science.gov (United States)

    Dousa, Jan; Vaclavovic, Pavel; Gyori, Gabriel; Kostelecky, Jan

    2013-04-01

    Geodetic Observatory Pecný (GOP) has been routinely estimating near real-time zenith total delay (ZTD) parameters from GPS permanent stations since 2001. Currently, the GOP ZTDs are assimilated in several meteorological institutions. During last years new other tropospheric products were developed at GOP: 1) global hourly ZTD product, 2) multi-GNSS (GPS+GLONASS) regional ZTD product and 3) real-time ZTD product. All operationally running hourly updated ZTD solutions (stand-alone GPS, multi-GNSS and global) are based on the processing of batch data in a differential mode and using Bernese GNSS software and IGS ultra-rapid orbits. New real-time ZTD solution is implemented with completely different strategy - the Precise Point Positioning (PPP) and filtering technique - using real-time data streams and products and applying new developed software in GOP. Firstly, the presentation gives a brief introduction into the in-house software library (G-Nut) development and into the specific end-user application Tefnut, which was implemented for PPP-based tropospheric estimates in post-processing, near real-time and real-time modes. Tefnut is ready for its first release, which will be available through www.pecny.cz. Secondly, ZTDs based on new software and strategy were evaluated with respect to the precise products from EUREF and IGS using a benchmark campaing over 40 days. Statistical evaluation included both post-processing and real-time (simulated) mode. Finally, an operational real-time performance of new product is demonstrated, which is aimed for the now-casting and severe weather monitoring applications. Statistical ZTD results (standard deviations of 5-8 mm) proved that PPP using IGS real-time orbit and clock products are already well suitable to fulfill the requirements of now-casting applications. Ongoing work is assessing an optimal balance between the timelines and the product quality.

  19. DEVELOPMENT OF METRICS FOR PROTOCOLS AND OTHER TECHNICAL PRODUCTS

    Directory of Open Access Journals (Sweden)

    Daniela Francescato Veiga

    Full Text Available Objective: To develop a proposal for metrics for protocols and other technical products to be applied in assessing the Postgraduate Programs of Medicine III - Capes. Methods: The 2013 area documents of all the 48 Capes areas were read. From the analysis of the criteria used by the areas at the 2013's Triennal Assessment, a proposal for metrics for protocols and other technical products was developed to be applied in assessing the Postgraduate Programs of Medicine III. This proposal was based on the criteria of Biological Sciences I and Interdisciplinary areas. Results: Only seven areas have described a scoring system for technical products. The products considered and the scoring varied widely. Due to the wide range of different technical products which could be considered relevant, and that would not be punctuated if they were not previously specified, it was developed, for the Medicine III, a proposal for metrics in which five specific criteria to be analyzed: Demand, Relevance/Impact, Scope, Complexity and Adherence to the Program. Based on these criteria, each product can receive 10 to 100 points. Conclusion: This proposal can be applied to the item Intellectual Production of the evaluation form, in subsection "Technical production, patents and other relevant production". The program will be scored as Very Good when it reaches mean ≥150 points/permanent professor/quadrennium; Good, mean between 100 and 149 points; Regular, mean between 60 and 99 points; Weak mean between 30 and 59 points; Insufficient, up to 29 points/permanent professor/quadrennium.

  20. Risk factors for developing hyponatremia in thyroid cancer patients undergoing radioactive iodine therapy.

    Directory of Open Access Journals (Sweden)

    Jung Eun Lee

    Full Text Available Due to the alarming increase in the incidence of thyroid cancer worldwide, more patients are receiving postoperative radioactive iodine (RAI therapy and these patients are given a low-iodine diet along with levothyroxine withdrawal to induce a hypothyroid state to maximize the uptake of RAI by thyroid tissues. Recently, the reported cases of patients suffering from life-threatening severe hyponatremia following postoperative RAI therapy have increased. This study aimed to systematically assess risk factors for developing hyponatremia following RAI therapy in post-thyroidectomy patients.We reviewed the medical records of all thyroid cancer patients who underwent thyroidectomy and postoperative RAI therapy from July 2009 to February 2012. Demographic and biochemical parameters including serum sodium and thyroid function tests were assessed along with medication history.A total of 2229 patients (47.0±11.0 years, female 76.3% were enrolled in the analysis. Three hundred seven patients (13.8% of all patients developed hyponatremia; 44 patients (2.0% developed moderate to severe hyponatremia (serum Na+≤130 mEq/L and another 263 (11.8% patients showed mild hyponatremia (130 mEq/Ltherapy were significantly associated with hyponatremia in patients undergoing RAI therapy after total thyroidectomy. Multivariate analysis showed that old age, female sex, use of thiazide diuretics, and hyponatremia at the initiation of RAI therapy were independent risk factors for the development of hyponatremia.Our data suggest that age greater than 60 years, female sex, use of thiazide, and hyponatremia at the initiation of RAI therapy are important

  1. Psychologists experience of cognitive behaviour therapy in a developing country: a qualitative study from Pakistan

    Directory of Open Access Journals (Sweden)

    Ayub Muhammad

    2010-01-01

    Full Text Available Abstract Background Psychological therapies especially Cognitive Behaviour Therapy (CBT are used widely in the West to help patients with psychiatric problems. Cognitive Behaviour Therapy has an established evidence base for the treatment of different emotional disorders. In spite of these developments in the developed world, patients in most developing countries hardly benefit from non pharmacological interventions. Although a significant number of psychologists are trained in Pakistan each year, psychological interventions play only a minor role in treatment plans in Pakistan. We conducted interviews with psychologists in Pakistan, to explore their experiences and their views on "providing CBT in Pakistan". These interviews were conducted as part of a project whose focus was to try to develop culturally-sensitive CBT in Pakistan. Methods In depth semi structured interviews were conducted with 5 psychologists working in psychiatry departments in Lahore, Pakistan. Results All the psychologists reported that psychotherapies, including CBT, need adjustments for use in Pakistan, although they were not able to elicit on these in details. Four major themes were discovered, hurdles in therapy, therapy related issues, involvement of the family and modification in therapy. The biggest hurdles in therapy were described to be service and resource issues. Conclusions For CBT to be acceptable, accessible and effective in Non Western cultures numerous adjustments need to be made, taking into consideration; factors related to service structure and delivery, patient's knowledge and beliefs about health and the therapy itself. Interviews with the psychologists in these countries can give us insights which can guide development of therapy and manuals to support its delivery.

  2. The intractability of non-word production difficulties in jargon aphasia: Insights from therapy

    Directory of Open Access Journals (Sweden)

    Arpita Bose

    2015-04-01

    Full Text Available Severe word production difficulties remain one of the most challenging clinical symptoms to treat in individuals with jargon aphasia (JA. Although research has found a beneficial effect of phonological therapy in JA (e.g., FF in Bose 2013; GF in Robson et al., 1998, a lack of improvement in naming performance following this approach has also been reported (e.g., P9 in Leonard et al., 2008. Clinically, it is important to determine why some individuals with JA improve following phonological therapy when others do not. This research investigates the effect of phonological therapy on naming performance in JA and explores possible reasons for improvement or lack thereof (e.g., input/ output processing skills, ability to use and maintain cues. Methods Participant: AM, an 86 year old, English-speaking male, was 16 years post-stroke and presented with persistent, severe neologistic jargon, characterized by very high proportions of non-words and perseverations. Part 1: Effects of phonological cuing (initial phoneme vs. semantic cuing (semantically-related item on naming performance were tested on items from the Philadelphia Naming Test (Roach et al., 1996 to determine the most suitable course of therapy. Part 2: Using a single-subject multiple baseline design, Phonological Component Analysis (Leonard et al., 2008 was administered for three sets of words. In addition to analysis of therapy performance, naming accuracy was compared across three lists in three instances of a word being treated (i.e., 1st attempt without any phonological cues, 2nd attempt immediately after the phonological cues, and 3rd attempt after review of the phonological cues. Results and Discussion Part 1: Results showed a significant increase in naming accuracy following phonological cuing [χ2 (1 = 5.782, p = .01], whereas semantic cuing did not [χ2 (1 =.386, ns], thus motivating the implementation of a phonological therapy. Part 2: There was a significant difference in accuracy

  3. Defining a strategy of integration of packaging development into product development

    OpenAIRE

    Motte, Damien; Bjärnemo, Robert; Jönson, Gunilla

    2007-01-01

    1 INTRODUCTION In a global and highly competitive economy, companies have now adopted an increasingly integrated ap-proach to product development. However, packaging logistics has been left out from this integration trend. The reasons are multiple: first packaging is not considered to be an integral part of the product, so it is not part of the product “culture” of the company. In most companies, packaging is considered only at the production phase or as a logistic matter. Secondly, and as...

  4. Sustainable Industrial Product Systems. Integration of Life Cycle Assessment in Product development and Optimization of Product Systems

    Energy Technology Data Exchange (ETDEWEB)

    Hanssen, Ole Joergen

    1997-12-31

    This thesis contributes to the development and testing of environmental life cycle assessment (LCA) in product development and management in industry. It is based on systems theory and systems engineering. It develops a method for sustainable product development that has been successfully tested in the Nordic project called NEP. The LCA method is also a basis for an optimization model, where life cycle economy and environmental impacts from product systems are optimized with a non-linear model. A more complete mathematical model for LCA, based on the functional requirements on a product system, is also developed. The statistical properties of emission factors are studied using a data set from the Swedish Kraft Mill industry. It is shown that emission factors may be assumed constants in the LCA model, but with rather large variations within a population of Kraft mills. It is shown that there are a few environmental impacts which are important for most types of products under Scandinavian conditions, especially global warming potential, acidification, human toxicity and fossil energy depletion. There are significant differences between the contribution to these impacts from different life cycle stages, where raw material processing and use of products are generally more important than the other stages. Test cases indicate that there are no large conflicts between improvements in environmental impacts and customer requirements. Environmental improvements seem to increase purchase cost of products in some cases, but the life cycle cost of the products seem in most cases to be reduced. It is concluded that there are opportunities for 30-50% improvements in product system, based on relatively simple modifications of the systems. 246 refs., 63 figs., 19 tabs.

  5. Matching food service products to consumer demands through product development alliances and modularisation

    DEFF Research Database (Denmark)

    Olsen, Johanne Rønnow

    2009-01-01

    in the composition of meal solutions and, therefore cannot control all processing steps and interactions with other meal components. In this project, it is proposed that cooperation between food producers on product development (product development alliances) in relation to meal solutions can improve the quality......An increasing number of meals are being consumed outside the home, and a new, interesting market for food producers are therefore emerging. However, meeting consumers’ demands, among others for quality, can represent a challenge, especially because producers are typically not involved....... In the case of meal solutions, this is a complex task, because there are several food producers involved, who are responsible for different parts of the product, and who all have their own priorities in relation to quality and product development. However, the consumer bases his quality evaluation primarily...

  6. POPULAR MARKETS: FROM FUTURE STUDIES TO THE DEVELOPMENT OF PRODUCTS

    Directory of Open Access Journals (Sweden)

    Antonio Thiago Benedete da Silva

    2009-10-01

    Full Text Available Strategies for running companies in low-income markets have been in the spotlight in both the academic and the corporate environments.However, the first discussions about the relevance of such markets arose during the 1980s, when scenario-prospecting studies showed that popular markets would provide many opportunities around the year 2000.Indeed, at present, the base of the pyramid has many unaddressed needs that offer business possibilities for those companies that are willing to review their strategies. In this context, product development becomes increasingly important, since products targeting consumers of the C, D and E classes may need different features from those of goods manufactured for the A and B classes.The aim of this study is to revisit past popular market forecasts and to identify development trends for goods that target low- income consumers.Our results indicate that Wright and Johnson’s (1984 studies predicted that Brazil would maintain both qualitative and quantitative progress in its socioeconomic development over the next two decades and that the development of popular products is undergoing a buoyant phase.Several functional perspectives were used to develop an understanding of the phenomenon, especially marketing, engineering and manufacturing.Key words: Future studies. Popular markets. Product development.

  7. Implementation of Life Cycle Assessment in Product Development

    DEFF Research Database (Denmark)

    McAloone, Timothy Charles; Hauschild, M.

    2003-01-01

    The overall aim of the paper is to provide an understanding of the environmental issues involved in the early stages of product development and the capacity of life cycle assessment techniques to address these issues. The paper aims to outline the problems for the designer in evaluating......, and of the opportunities for introducing environmental criteria in the design process through meeting the information requirements of the designer on the different life cycle stages, producing an in-depth understanding of the attitudes of practitioners among product developers to the subject area, and an understanding...... of possible future directions for product development. An Environmentally Conscious Design method is introduced and trade-offs are presented between design degrees of freedom and environmental solutions. Life cycle design frameworks and strategies are addressed. The paper collects experiences and ideas around...

  8. Development of Local Chicken Production Based on Local Feed Ingredients

    Directory of Open Access Journals (Sweden)

    Cecep Hidayat

    2012-06-01

    Full Text Available Development of local chicken production based on local feed ingredient is in line with the vision of Indonesian goverment to fulfill meat and egg national requirement based on local resources. There are two big problem which become stumblingblock in developing local chicken production. The first problem is the difficulty to get day old chick of local chicken. This problem can be solved by integrating breeder institutions belong to goverment with research institution and with local chicken producer association. The second problem is the low performance of local chicken. To improve local chicken performance, it can be done by improving the breed, feed and management. Several research results show that good performance of local chicken were obtained by inclusion of local feed ingredients in the ration. Therefore, development of local chicken production based an local feed resources can be applied.

  9. Nanotherapeutics--product development along the "nanomaterial" discussion.

    Science.gov (United States)

    Wacker, Matthias G

    2014-03-01

    Nanomaterials have become part of formulation development in the pharmaceutical industry and offer exciting opportunities in the area of targeted drug delivery. But they may also exert unexpected toxicities and potentially pose a threat to human health and the environment. Since the Scientific Committee on Emerging and Newly Identified Health Risks recommended a definition of "nanomaterials" for implementation into the existing and upcoming regulatory framework in the European Union, a discussion about safety requirements of new nanoscale products has emerged. At the same time, the Food and Drug Administration of the United States still observes recent developments in this area. Although the impact on the pharmaceutical product chain is still uncertain, guidelines on risk assessment in food products and cosmetics are available and offer a preview of future developments in the regimens of pharmaceuticals. © 2014 Wiley Periodicals, Inc. and the American Pharmacists Association.

  10. Microbeam radiation therapy. Physical and biological aspects of a new cancer therapy and development of a treatment planning system

    Energy Technology Data Exchange (ETDEWEB)

    Bartzsch, Stefan

    2014-11-05

    Microbeam Radiation Therapy (MRT) is a novel treatment strategy against cancer. Highly brilliant synchrotron radiation is collimated to parallel, a few micrometre wide, planar beams and used to irradiate malignant tissues with high doses. The applied peak doses are considerably higher than in conventional radiotherapy, but valley doses between the beams remain underneath the established tissue tolerance. Previous research has shown that these beam geometries spare normal tissue, while being effective in tumour ablation. In this work physical and biological aspects of the therapy were investigated. A therapy planning system was developed for the first clinical treatments at the European Synchrotron Radiation Facility in Grenoble (France) and a dosimetry method based on radiochromic films was created to validate planned doses with measurements on a micrometre scale. Finally, experiments were carried out on a cellular level in order to correlate the physically planned doses with the biological damage caused in the tissue. The differences between Monte Carlo dose and dosimetry are less than 10% in the valley and 5% in the peak regions. Developed alternative faster dose calculation methods deviate from the computational intensive MC simulations by less than 15% and are able to determine the dose within a few minutes. The experiments in cell biology revealed an significant influence of intercellular signalling on the survival of cells close to radiation boundaries. These observations may not only be important for MRT but also for conventional radiotherapy.

  11. Integration of International Service Learning in Developing Countries within Occupational Therapy Education: Process and Implications.

    Science.gov (United States)

    Cipriani, Joseph

    2017-01-01

    International service learning (ISL) is included in an increasing number of courses at post-secondary levels of education, including programs which educate future occupational therapy practitioners. There is a limited amount of literature and research concerning best practices for course-based occupational therapy education featuring ISL experiences, in particular within developing countries. The purpose of this paper is to (a) to review key literature on ISL, (b) explicate key elements which can help design course-based ISL experiences; and (c) suggest areas for further research and development of course-based ISL. The seven elements of focus that provide a base to guide occupational therapy educators who create ISL courses with an immersion component in a country with a developing economy are discussed, as well as future challenges and possibilities when providing occupational therapy services to a global society.

  12. FORMATION AND FURTHER DEVELOPMENT OF MODERN PROMOTION OF PHARMACEUTICAL PRODUCTS

    Directory of Open Access Journals (Sweden)

    Юрий Владимирович Тарасов

    2014-02-01

    Full Text Available The articles addresses key notions and elements of marketing of pharmaceutical companies. Key stages and particularities of formation of pharmaceutical marketing are considered. It is proved that in general pharmaceutical market is developing under general marketing rules, however while developing strategy of promotion of pharmaceutical products specific features of the industry must be taken into consideration. The authors describes specific features of modern pharmaceutical market, which must be considered while developing policy of promotion of pharmaceutical products.The analysis is made of modern state of Russian pharmaceutical industry, its place in world pharmaceutical market. It is found that development of pharmaceutical market is directly influenced by the reform of pharmaceutical industry initiated by the Government of our country in 2008. Characteristic of current stage of market development is more strict conditions in marketing sphere and promotion of drugs. DOI: http://dx.doi.org/10.12731/2218-7405-2013-12-2

  13. Incorporating Natural Products, Pharmaceutical Drugs, Self-Care and Digital/Mobile Health Technologies into Molecular-Behavioral Combination Therapies for Chronic Diseases.

    Science.gov (United States)

    Bulaj, Grzegorz; Ahern, Margaret M; Kuhn, Alexis; Judkins, Zachary S; Bowen, Randy C; Chen, Yizhe

    2016-01-01

    Merging pharmaceutical and digital (mobile health, mHealth) ingredients to create new therapies for chronic diseases offers unique opportunities for natural products such as omega-3 polyunsaturated fatty acids (n-3 PUFA), curcumin, resveratrol, theanine, or α-lipoic acid. These compounds, when combined with pharmaceutical drugs, show improved efficacy and safety in preclinical and clinical studies of epilepsy, neuropathic pain, osteoarthritis, depression, schizophrenia, diabetes and cancer. Their additional clinical benefits include reducing levels of TNFα and other inflammatory cytokines. We describe how pleiotropic natural products can be developed as bioactive incentives within the network pharmacology together with pharmaceutical drugs and self-care interventions. Since approximately 50% of chronically-ill patients do not take pharmaceutical drugs as prescribed, psychobehavioral incentives may appeal to patients at risk for medication non-adherence. For epilepsy, the incentive-based network therapy comprises anticonvulsant drugs, antiseizure natural products (n-3 PUFA, curcumin or/and resveratrol) coupled with disease-specific behavioral interventions delivered by mobile medical apps. The add-on combination of antiseizure natural products and mHealth supports patient empowerment and intrinsic motivation by having a choice in self-care behaviors. The incentivized therapies offer opportunities: (1) to improve clinical efficacy and safety of existing drugs, (2) to catalyze patient-centered, disease self-management and behavior-changing habits, also improving health-related quality-of-life after reaching remission, and (3) merging copyrighted mHealth software with natural products, thus establishing an intellectual property protection of medical treatments comprising the natural products existing in public domain and currently promoted as dietary supplements. Taken together, clinical research on synergies between existing drugs and pleiotropic natural products

  14. Chronic spontaneous urticaria: latest developments in aetiology, diagnosis and therapy

    Science.gov (United States)

    Vestergaard, Christian; Deleuran, Mette

    2015-01-01

    Chronic urticaria is a debilitating disease characterized by itching and hives with or without angioedema lasting for more than 6 weeks. The disease carries a significant emotional and economic burden for the patient and often results in an odyssey between doctors of different specialities. Patients suffering from chronic urticaria are considered more difficult to satisfy, treat and to have a bigger emotional burden than the average patient in dermatology, paediatric and general practice settings. A joint initiative under the Dermatology section of the European Academy of Allergy and Clinical immunology (EAACI), the Global Allergy and Asthma European Network (GA2LEN), the European Dermatology Forum (EDF) and the World Allergy Organization (WAO) has resulted in recently published guidelines for the diagnosis, classification and treatment of chronic urticarial: these guidelines are clinically useful and have a high success rate when followed in daily clinical practice. The treatment of choice for chronic urticaria is still nonsedating antihistamines although other treatments are available, with omalizumab (humanized IgG anti IgE antibodies) as the newest therapy. The pathogenesis of urticaria is poorly understood but autoimmunity is considered as one of the major underlying causes for this disease, although other theories exist. PMID:26568807

  15. Bronchial carcinoma: recent developments in diagnosis and therapy

    Energy Technology Data Exchange (ETDEWEB)

    Hahn, H.L.; Longin, F.

    1980-12-03

    Basic methods of diagnosis for bronchial carcinoma are X-ray examinations, flexible bronchoscopy to obtain cytological and histological preparations, simple cytology of the sputum and percutaneous needle biopsy of peripheral tumours with fluoroscopic control. The best results are obtained with surgical measures in stages 1 and 2. In case of general inoperability, also radiation may destroy the tumour in these stages. However, if tumours are only irradiated in stage 3 because of local inoperability as is most often the case, relief will be given but the survival time will not be prolonged considerably. Small-cell carcinomas are never operated on as tumours of this type of histology will generally have metastases at the time of discovery. A combined therapy of polychemotherapy and irradiation will prolong life in these cases but will not lead to healing. All in all, there is only a 10% chance of survival with bronchial carcinoma. Chances may be higher if specific risk groups are screened and new techniques of diagnosis are applied: Use of tumour labels and thermo- and radiosensitive probes in bronchoscopy, establishment of label profiles in the serum, use of new techniques like CT, ultrasonic methods, xerotomography, and scintiscanning with new radionuclides. Immunotherapy with BCG lengthens the interval between operation and recurrence of the tumour. Interferon treatment is now being tested.

  16. Development of a Virtual Maintenance System for Complex Mechanical Product

    Directory of Open Access Journals (Sweden)

    Xin-hua Liu

    2013-01-01

    Full Text Available In order to improve the maintenance training effect of complex mechanical product, a virtual maintenance system was developed. The system framework was proposed, and the main functional modules were elaborated. A multilevel information representation model for complex mechanical product was put forward, and the flowchart of model transformation technology was designed. Moreover, a collision detection method based on hierarchical bounding volume was proposed, and the maintainability analysis and evaluation solution based on maintenance knowledge was presented. Finally, a prototype system was developed, and the proposed system was provedto be efficient through an example of hydraulic winch.

  17. Applying lean thinking to risk management in product development

    DEFF Research Database (Denmark)

    Willumsen, Pelle Lundquist; Oehmen, Josef; Rossi, Monica

    2017-01-01

    This paper re-conceptualizes risk management (RM) in product development (PD) through a lean thinking perspective. Arguably, risk management in PD projects became a victim of its own success. It is often implemented as a highly formalized, compliance driven activity, ending up disconnected from...... delay or cost overrun. This paper explores the relationship between product development and risk management and proposes to make RM an integrated value adding part of PD. Through a literature review we identify the potential of re-conceptualizing RM through lean thinking. We then conceptualize...

  18. Increasing loyalty to breastfeeding: investigating a product development strategy.

    Science.gov (United States)

    Parkinson, Joy; Russell-Bennett, Rebekah; Previte, Josephine

    2012-01-01

    This article demonstrates how social marketing insights were used to influence women's loyalty to breastfeeding. The article reports on a social marketing campaign undertaken by the Australian Breastfeeding Association and a government health department, which used a product development strategy in order to increase breastfeeding loyalty. Seeking new approaches to support breastfeeding behaviors is critical and timely, because while initiation rates of breastfeeding are high in developed countries such as the United Kingdom, Australia, Canada, and the United States, duration rates are significantly lower. Results indicate that a product- focused strategy influences pregnant women's loyalty to exclusively breastfeeding.

  19. Development of potent inhibitors of pyocyanin production in Pseudomonas aeruginosa.

    Science.gov (United States)

    Miller, Laura C; O'Loughlin, Colleen T; Zhang, Zinan; Siryaporn, Albert; Silpe, Justin E; Bassler, Bonnie L; Semmelhack, Martin F

    2015-02-12

    The development of new approaches for the treatment of antimicrobial-resistant infections is an urgent public health priority. The Pseudomonas aeruginosa pathogen, in particular, is a leading source of infection in hospital settings, with few available treatment options. In the context of an effort to develop antivirulence strategies to combat bacterial infection, we identified a series of highly effective small molecules that inhibit the production of pyocyanin, a redox-active virulence factor produced by P. aeruginosa. Interestingly, these new antagonists appear to suppress P. aeruginosa virulence factor production through a pathway that is independent of LasR and RhlR.

  20. Development of Antiatherosclerotic Drugs on the basis of Natural Products Using Cell Model Approach

    Directory of Open Access Journals (Sweden)

    Alexander N. Orekhov

    2015-01-01

    Full Text Available Atherosclerosis including its subclinical form is one of the key medical and social problems. At present, there is no therapy available for widespread use against subclinical atherosclerosis. The use of synthetic drugs for the prevention of arteriosclerosis in its early stages is not sufficient because of the limited indications for severe side effects and high cost of treatment. Obviously, effective antiatherosclerotic drugs based on natural products would be a preferred alternative. Simple cell-based models for testing different natural products have been developed and the ability of natural products to prevent intracellular lipid accumulation in primary cell culture was evaluated. This approach utilizing cell models allowed to test effects of such direct antiatherosclerotic therapy, analyzing the effects mimicking those which can occur “at the level” of arterial wall via the inhibition of intracellular lipid deposition. The data from the carried out clinical trials support a point of view that the identification of antiatherosclerotic activity of natural products might offer a great opportunity for the prevention and treatment of atherosclerotic disease, reducing cardiovascular morbidity and mortality.

  1. Development of a Creative Arts Therapies Center for People with Developmental Disabilities

    Science.gov (United States)

    Lister, Suzanne; Tanguay, Denise; Snow, Stephen; D'Amico, Miranda

    2009-01-01

    The Centre for the Arts in Human Development in Montreal has provided art, drama, music, and dance/movement therapies to adults with developmental disabilities for over 10 years with the goals of developing and enhancing self-esteem, social skills, and communication abilities. This report describes the development and purpose of the center,…

  2. Ethylene production throughout growth and development of plants

    Science.gov (United States)

    Wheeler, Raymond M.; Peterson, Barbara V.; Stutte, Gary W.

    2004-01-01

    Ethylene production by 10 or 20 m2 stands of wheat, soybean, lettuce, potato, and tomato was monitored throughout growth and development in an atmospherically closed plant chamber. Chamber ethylene levels varied among species and rose during periods of canopy expansion and rapid growth for all species. Following this, ethylene levels either declined during seed fill and maturation for wheat and soybean, or remained relatively constant for potato and tomato (during flowering and early fruit development). Lettuce plants were harvested during rapid growth and peak ethylene production. Chamber ethylene levels increased rapidly during tomato ripening, reaching concentrations about 10 times that measured during vegetative growth. The highest ethylene production rates during vegetative growth ranged from 1.6 to 2.5 nmol m-2 d-1 during rapid growth of lettuce and wheat stands, or about 0.3 to 0.5 nmol g-1 fresh weight per hour. Estimates of stand ethylene production during tomato ripening showed that rates reached 43 nmol m-2 d-1 in one study and 93 nmol m-2 d-1 in a second study with higher lighting, or about 50x that of the rate during vegetative growth of tomato. In a related test with potato, the photoperiod was extended from 12 to 24 hours (continuous light) at 58 days after planting (to increase tuber yield), but this change in the environment caused a sharp increase in ethylene production from the basal rate of 0.4 to 6.2 nmol m-2 d-1. Following this, the photoperiod was changed back to 12 h at 61 days and ethylene levels decreased. The results suggest three separate categories of ethylene production were observed with whole stands of plants: 1) production during rapid vegetative growth, 2) production during climacteric fruit ripening, and 3) production from environmental stress.

  3. Sustainable product development through a life-cycle approach to product and service creation

    DEFF Research Database (Denmark)

    McAloone, Timothy Charles; Tan, Adrian Ronald

    2005-01-01

    of examples where environmentally-based product-life ‘takeovers’ have been with environmentally-founded goals in mind. Thus the practice of Product-Service-System (PSS) development is born. This paper describes PSS development, an approach to new business definition and development that gives a number of new...... practice and as a research discipline, and we still lack overview in order to be able to understand how to design a PSS. For example, who should sit in the project team for the creation of PSS concepts? No longer merely a team of engineers… A PSS requires an orchestration of a complex network...

  4. Quantitative and Systems Pharmacology. 1. In Silico Prediction of Drug-Target Interactions of Natural Products Enables New Targeted Cancer Therapy.

    Science.gov (United States)

    Fang, Jiansong; Wu, Zengrui; Cai, Chuipu; Wang, Qi; Tang, Yun; Cheng, Feixiong

    2017-11-27

    Natural products with diverse chemical scaffolds have been recognized as an invaluable source of compounds in drug discovery and development. However, systematic identification of drug targets for natural products at the human proteome level via various experimental assays is highly expensive and time-consuming. In this study, we proposed a systems pharmacology infrastructure to predict new drug targets and anticancer indications of natural products. Specifically, we reconstructed a global drug-target network with 7,314 interactions connecting 751 targets and 2,388 natural products and built predictive network models via a balanced substructure-drug-target network-based inference approach. A high area under receiver operating characteristic curve of 0.96 was yielded for predicting new targets of natural products during cross-validation. The newly predicted targets of natural products (e.g., resveratrol, genistein, and kaempferol) with high scores were validated by various literature studies. We further built the statistical network models for identification of new anticancer indications of natural products through integration of both experimentally validated and computationally predicted drug-target interactions of natural products with known cancer proteins. We showed that the significantly predicted anticancer indications of multiple natural products (e.g., naringenin, disulfiram, and metformin) with new mechanism-of-action were validated by various published experimental evidence. In summary, this study offers powerful computational systems pharmacology approaches and tools for the development of novel targeted cancer therapies by exploiting the polypharmacology of natural products.

  5. Possibilities to develop low-fat products: a review

    Directory of Open Access Journals (Sweden)

    Tufeanu Roxana

    2016-06-01

    Full Text Available Research has proved a relationship between high fat consumption and rise in obesity, atherosclerosis, coronary heart diseases and high blood pressure. Therefore is recommended the moderate consumption of fat, such that the total fat does not exceed 30% of total energy intake. Our body needs fats because are providers of calories, essential fatty acids, fat-soluble vitamins and also they are necessary ingredients of the foods. The development of products with low-fat content can be considerate a challenge because the lipids offers aroma, texture, appearance, flavour and mouth feel, qualities that customers want in food products. A fat reduction can be achieved by using different fat replacers to ensure the functionality of the replaced fat. Functional components of fat replacers can have a significant role in promotion of wellbeing, in treating and preventing diseases. Thus, fat replacers should be recognized as safe and healthy, which have sensorial and functional properties. This paper reviews the fat replacers used to obtain foods as meat-based or dairy products. Some ways to obtain healthier meat products by reducing saturated fats content consist in the utilization of unsaturated vegetable oils, vegetable products, fibre. The utilization of fibre in products such bolognas, sausages or hamburgers, can improve the texture profile, binding properties and the characteristics regarding the cooking process. A fat reduction in dairy products can be achieved by replacing it with starches, polysaccharides, gums or fibres from cereal, vegetables and fruits. In acidified milk products, fibres have benefits as: low syneresis, sensory characteristics accepted by consumers, improvement of texture and rheological properties. In cheeses production, the fat reduction can be realised by replacing it with carbohydrate or protein-based replacers in order to obtain a final product with proper characteristics.

  6. White Rose development plan amendment production volume increase

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2006-09-15

    In January 2001, Husky Oil Operations Limited (Husky), in joint-venture with Petro-Canada, submitted a Benefits Plan for the White Rose Development to the Canada- Newfoundland and Labrador Offshore Petroleum Board (C-NLOPB). This revised document provided the case for requesting an increase in the facility maximum daily production rate and the average annual production rate for the White Rose field from 100,000 barrels per day (bpd) as stated in the approved White Rose Development Plan to 140,000 bpd. In order to determine the potential for increasing oil production through the Floating Production, Storage and Offloading (FPSO) vessel, two things were considered, namely the proper reservoir management of the White Rose field to ensure optimum resource recovery, and the capacity of the FPSO topsides processing system and supporting utilities to accommodate increased production. This document presented a detailed review of all the implications of increased production on the South White Rose Reservoir. In addition, the results from FPSO performance testing were reviewed, including a study of options for de-bottlenecking the process plant on the topsides and capacity testing of selected process streams and support systems. Vibration analysis was conducted before and during performance testing in July 2006 and a small number of areas addressed. The document also addressed flow metering, resource management, certifying authority review, safety plan revisions, environmental effects, as well as benefits to Canada and Newfoundland. 21 tabs., 60 refs.

  7. The prevention of the anemia development during malignant diseases therapy

    OpenAIRE

    Priesolová, Denisa

    2010-01-01

    The introduction of this work explains the importance of aknowledging the process of diagnostics and a treatment of the cases with an anemia during malignant diseases. The predictive factors of the anemia development and the general condition negative effects are presented. The chapter two brings the definition of an anemia, how to evaluate the blood count and the biochemical examination, tells the compensational mechanisms of the organism and describes the clinical features of the developed ...

  8. Production of retrovirus vector for gene therapy; Idenshi chiryo no tameno retoro uirusu bekuta no seisan

    Energy Technology Data Exchange (ETDEWEB)

    Yamaji, H. [Kobe Univ., Kobe (Japan)

    2000-12-05

    At present, retrovirus vector is used widely in clinical field in gene transducing methods. While vector cell secretes retrovirus vector being impossible self-replication into culture solution, production of vector in long term is possible by reason of not dying by gemmation of virus. At present, production of retrovirus vector is executed by monostratal culture of vector producing cell in lab-scale. In another hand, the development of efficient mass-production technology is expected for needs of mass volume for one patient and enlargement for adaptation disease. (translated by NEDO)

  9. Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among Texas Medicaid recipients.

    Science.gov (United States)

    Cheong, Chelim; Barner, Jamie C; Lawson, Kenneth A; Johnsrud, Michael T

    2008-10-01

    Little is known about the potential for improved adherence with and cost savings of fixed-dose combination therapy (FDCT) products compared with analogous dual therapy for type 2 diabetes mellitus. The objectives of this study were as follows: (1) to describe patient adherence to various oral antidiabetic regimens (ie, dual therapy and FDCT); (2) to determine whether there is a difference in medication adherence between FDCT users and analogous dual-therapy users; and (3) to assess whether there is a difference in reimbursement amounts between an FDCT product and its individual components. This study was a retrospective cohort analysis using the Texas Medicaid prescription claims database. The study subjects included those who used antidiabetic FDCT or dual therapy from August 1, 2000, to July 31, 2004. The identification period of study subjects was between August 1, 2000, and July 31, 2004, including 12 months before and after the index date, so that the overall time frame was from August 1, 1999, through July 31, 2005. Prescription claims were analyzed over a 12-month preindex and 12-month postindex period. Adherence was measured using medication possession ratio (MPR), and regimen costs per tablet were assessed utilizing the index prescription. Overall, 7570 FDCT users and 14,762 dual-therapy users were identified. Regarding the postindex period, FDCT users had 1.8% higher MPR compared with dual-therapy users (78.6% vs 77.2%). Patients who switched from monotherapy to FDCT had a 1.5% decrease in adherence (from 79.7% to 78.5%), whereas those who switched from monotherapy to dual therapy had a 10.0% decrease in adherence (from 83.0% to 74.7%). Those who switched from dual therapy to FDCT had a 12.4% increase in adherence (from 72.7% to 81.7%). Multivariate logistic regression analyses revealed that among preindex monotherapy users, FDCT users were significantly more likely to have higher adherence than dual-therapy users (odds ratio [OR] = 1.867; 95% CI, 1

  10. Affective design identification on the development of batik convection product

    Science.gov (United States)

    Prastawa, H.; Purwaningsih, R.

    2017-11-01

    The affective design is increasingly applied to product development in order to meet the desires and preferences of customers. Batik is a traditional Indonesian culture containing historical and cultural values. The development of batik design is one of the efforts to strengthen the identity and superiority of Indonesia’s creative industries as well as to preserve batik as the cultural heritage of the nation. Batik product designs offered by the manufacturers do not necessarily correspond with the wishes of consumers, especially the affective values involved. Therefore it is necessary to identify consumer perceptions of convection- based batik product in the form of clothing and fabrics, especially the affective value as the consideration for the designer or manufacturer to develop design alternatives to batik convection products. This research aims to obtain information on consumer affective value, to identify the affective value perception differences among X and Y Generation and to classify affective value in the corresponding cluster of the batik products convection. This study uses Kansei engineering to determine the perception of affective design in the form of Kansei word. Cluster Analysis was used to form clusters that classify affective value of the same class. The results showed that there were 16 pairs of Kansei word which was worth as an affective consumer desire, the 3 indicators that had significant differences among X and Y Generation and 4 clusters with different characteristics.

  11. Re-examination of regulatory opinions in Europe: possible contribution for the approval of the first gene therapy product Glybera

    Directory of Open Access Journals (Sweden)

    Natsumi Watanabe

    2015-01-01

    Full Text Available The first commercially approved human gene therapy in the Western world is Glybera (alipogene tiparvovec, which is an adenoassociated viral vector encoding the lipoprotein lipase gene. Glybera was recommended for marketing authorization by the European Medicines Agency in 2012. The European Medicines Agency had only ever reviewed three marketing authorization applications for gene therapy medicinal products. Unlike in the case of Glybera, the applications of the first two products, Cerepro and Contusugene Ladenovec Gendux/Advexin, both of which were for cancer diseases, were withdrawn. In this report, we studied the European public assessment reports of the three gene therapy products. During the assessment process, Glybera was re-examined and reviewed for a fourth time. We therefore researched the re-examination procedure of the European Union regulatory process. Approximately 25% of the new medicinal products initially given negative opinions from the Committee for Medicinal Products for Human Use were ultimately approved after re-examination from 2009 to 2013. The indications of most medicines were changed during the re-examination procedure, and the products were later approved with a mode of approval. These results suggested that the re-examination system in the European Union contributed to the approval of both several new drugs and the first gene therapy product.

  12. Evaluation of current trends and recent development in insulin therapy for management of diabetes mellitus.

    Science.gov (United States)

    Nawaz, Muhammad Sarfraz; Shah, Kifayat Ullah; Khan, Tahir Mehmood; Rehman, Asim Ur; Rashid, Haroon Ur; Mahmood, Sajid; Khan, Shahzeb; Farrukh, Muhammad Junaid

    2017-12-01

    Diabetes mellitus is a major health problem in developing countries. There are various insulin therapies to manage diabetes mellitus. This systematic review evaluates various insulin therapies for management of diabetes mellitus worldwide. This review also focuses on recent developments being explored for better management of diabetes mellitus. We reviewed a number of published articles from 2002 to 2016 to find out the appropriate management of diabetes mellitus. The paramount parameters of the selected studies include the insulin type & its dose, type of diabetes, duration and comparison of different insulin protocols. In addition, various newly developed approaches for insulin delivery with potential output have also been evaluated. A great variability was observed in managing diabetes mellitus through insulin therapy and the important controlling factors found for this therapy include; dose titration, duration of insulin use, type of insulin used and combination therapy of different insulin. A range of research articles on current trends and recent advances in insulin has been summarized, which led us to the conclusion that multiple daily insulin injections or continuous subcutaneous insulin infusion (insulin pump) is the best method to manage diabetes mellitus. In future perspectives, development of the oral and inhalant insulin would be a tremendous breakthrough in Insulin therapy. Copyright © 2017 Diabetes India. Published by Elsevier Ltd. All rights reserved.

  13. DEVELOPING A YEAST CELL FACTORY FOR THE PRODUCTION OF TERPENOIDS

    Directory of Open Access Journals (Sweden)

    Sotirios C. Kampranis

    2012-10-01

    Full Text Available Technological developments over the past century have made microbes the work-horses of large scale industrial production processes. Current efforts focus on the metabolic engineering of microbial strains to produce high levels of desirable end-products. The arsenal of the contemporary metabolic engineer contains tools that allow either targeted rational interventions or global screens that combine classical approaches with –omics technologies. Production of terpenoids in S. cerevisiae presents a characteristic example of contemporary biotechnology that integrates all the variety of novel approaches used in metabolic engineering. Terpenoids have attracted significant interest as pharmaceuticals, flavour and fragrance additives, and, more recently, biofuels. The ongoing metabolic engineering efforts, combined with the continuously increasing number of terpene biosynthetic enzymes discovered will enable the economical and environmentally friendly production of a wide range of compounds.

  14. Developing a yeast cell factory for the production of terpenoids

    Directory of Open Access Journals (Sweden)

    Sotirios C Kampranis

    2012-10-01

    Full Text Available Technological developments over the past century have made microbes the work-horses of large scale industrial production processes. Current efforts focus on the metabolic engineering of microbial strains to produce high levels of desirable end-products. The arsenal of the contemporary metabolic engineer contains tools that allow either targeted rational interventions or global screens that combine classical approaches with –omics technologies. Production of terpenoids in S. cerevisiae presents a characteristic example of contemporary biotechnology that integrates all the variety of novel approaches used in metabolic engineering. Terpenoids have attracted significant interest as pharmaceuticals, flavour and fragrance additives, and, more recently, biofuels. The ongoing metabolic engineering efforts, combined with the continuously increasing number of terpene biosynthetic enzymes discovered will enable the economical and environmentally friendly production of a wide range of compounds.

  15. Development and design for Mo production facility in JMTR

    Energy Technology Data Exchange (ETDEWEB)

    Iimura, Koichi; Hosokawa, Jinsaku; Izumo, Hironobu; Hori, Naohiko; Nakagawa, Tetsuya; Kanno, Masaru; Kawamura, Hiroshi [Japan Atomic Energy Agency, Ibaraki Ken (Japan)

    2008-11-15

    At Oarai Research and Development Center, Japan Atomic Energy Agency (JAEA) being advanced is the plan of refurbishing Japan Materials Testing Reactor (JMTR) to start the operation in FY 2011. As one of effective use of the JMTR, JAEA has a plan to product {sup 99}Mo, a parent nuclide of {sup 99m}Tc. {sup 99m}Tc is most commonly used as a radiopharmaceutical in the field of nuclear medicine. Currently the supplying of {sup 99}Mo depends only on imports from foreign countries, therefore JAEA is aiming at domestic production of a part of {sup 99}Mo in cooperation with industrial users. As JAEA's activities, mentioned are the process, the selection and fabric of the irradiation facilities for {sup 99}Mo production, the technical study of commercializing equipment after irradiation, and the cost evaluation for {sup 99}Mo production.

  16. The conditions of pellet production development in Poland

    Directory of Open Access Journals (Sweden)

    Elżbieta Mikołajczak

    2010-01-01

    Full Text Available Global trends of increase in prices of conventional energy sources, compatibility with trends for environment protection and the necessity to fulfill EU obligations result in price growth of sawmill by-products – raw material for the production of eco-fuels. Such circumstances create a huge chance for the improvement of efficiency of very often operating on the verge of profitability owners of those by-products – that is plants converting wood, which apart from selling those by-products to chipboard producers, pulp and paper industry or energy sector, should consider the possibility of refining them in the place where they have been created. Converting sawmill by-products into pellet significantly increases their value. However, the decision to launch such conversion involves high costs and entails substantial investments, therefore requiring recognition of the factors having an impact on the success of such venture: prices of sawmill by-products – raw material for pellet production, development prospects of domestic pellet market at the time of growing prices of conventional fuels, as well as the legal regulations imposing on the investors pro-ecological character of activities and analysis of the situation on the European pellet market, taking into consideration its quality demands and possible prices.

  17. Assistive products and the Sustainable Development Goals (SDGs).

    Science.gov (United States)

    Tebbutt, Emma; Brodmann, Rebecca; Borg, Johan; MacLachlan, Malcolm; Khasnabis, Chapal; Horvath, Robert

    2016-11-29

    The Sustainable Development Goals (SDGs) have placed great emphasis on the need for much greater social inclusion, and on making deliberate efforts to reach marginalized groups. People with disabilities are often marginalized through their lack of access to a range of services and opportunities. Assistive products can help people overcome impairments and barriers enabling them to be active, participating and productive members of society. Assistive products are vital for people with disabilities, frailty and chronic illnesses; and for those with mental health problems, and gradual cognitive and physical decline characteristic of aging populations. This paper illustrates how the achievement of each of the 17 SDGs can be facilitated by the use of assistive products. Without promoting the availability of assistive products the SDGs cannot be achieved equitably. We highlight how assistive products can be considered as both a mediator and a moderator of SDG achievement. We also briefly describe how the Global Cooperation on Assistive Technology (GATE) is working to promote greater access to assistive products on a global scale.

  18. Traditional products: Base for the sustainable development of Serbian animal origin products

    Directory of Open Access Journals (Sweden)

    Stevanović Jasna Lj.

    2016-01-01

    Full Text Available Research results on the diversity of traditional products of animal origin from certain areas of the Republic of Serbia, provides an opportunity to become part of the sustainable quality development, which would be based on their promotion and protection of local resources. Traditional products of animal origin are different and inseparable from the local identity, typical for nation and its food culture. Through confidence-building, and protection from oblivion, the value of domestic products, had preserved trough centuries-old tradition. Nowadays, each domestic product has its own recognisable taste, representing climate of the Republic of Serbia, from which it comes. Universally accepted model of rural institutional structure does not exist. Instead it accommodates and develops in accordance to needs, possibilities and area specific characteristics. By the efficient protection rural models becomes an investment incentives and contribute to general economic and industrial prosperity of the society.

  19. Potential Development Essential Oil Production of Central Java, Indonesia

    Science.gov (United States)

    Alighiri, D.; Eden, W. T.; Supardi, K. I.; Masturi; Purwinarko, A.

    2017-04-01

    Indonesia is the source of raw essential oil in the world. Essential oils are used in various types of industries such as food and beverage, flavour, fragrance, perfumery, pharmaceuticals, and cosmetics. However, the development of Indonesian essential oil industry has not been encouraging for the production of essential oils, further it is unable to meet global demand. Besides that, the quality of volatile oil resulted cannot meet the international market standards. Based on the facts, the potential of Indonesian essential oils needs to be developed to provide added value, through increased production, improved quality and product diversification. One part of Indonesia having abundant of raw essential oil source is Central Java. Central Java has the quite large potential production of essential oils. Some essential oils produced from refining industry owned by the government, private and community sectors include cananga oils (Boyolali district), clove oils (Semarang district), patchouli oils (Brebes district, Pemalang district, and Klaten district). The main problem in the development of plants industries that producing essential oil in Central Java is low crops production, farming properties, quality of essential oils are diverse, providing poor-quality products and volatile oil price fluctuations. Marketing constraints of Central Java essential oils are quite complex supply chain. In general, marketing constraints of essential oils due to three factors, namely the low quality due to type of essential oil business that generally shaped small businesses with different capital and technology, domestic marketing is still a buyer-market (price determined by the buyer) because of weak bargaining position processors businessman, and prices fluctuate (domestic and foreign) due to uncontrolled domestic production and inter-country competition among manufacturers.

  20. Processing of biowaste for sustainable products in developing countries

    DEFF Research Database (Denmark)

    Dantoft, Shruti Harnal; Hansen, Anders Cai Holm; Jensen, Peter Ruhdal

    2014-01-01

    The modern global society faces great challenges in supply of energy, feed, food, and other products in a sustainable way. One way to mitigate the negative effects of providing these local eco-services is to convert biomass – instead of petroleum or natural gas – into a variety of food, feed......, biomaterials, energy and fertilizer, maximizing the value of the biomass and minimizing the waste. This integrated approach corresponds to the biorefinery concept and is gaining attention in many parts of the world (Kam & Kam 2004). Energy, food and feed production is the driver for development in this area...... biowaste into a new resource for sustainable products. Our group is involved in developing strains and microbial fermentation processes for these bioconversions....

  1. Developing food products in accordance with customer demands

    DEFF Research Database (Denmark)

    Juhl, Hans Jørn; Kristensen, Kai; Poulsen, Carsten Stig

    1994-01-01

    Development of food products is considered as a design problem. Through development of a theoretical model QFD is applied to integrate market information on customer satisfaction with information from a sensory analysis. The aim is to translate th information from these two datasets into design...... quality and systematized in the most efficient manner. In the empirical part of the paper we analyze data on customer requirements in a LISRE setting in order to improve the understanding of the market....

  2. Development of Laser Application Technology for Stable Isotope Production

    Energy Technology Data Exchange (ETDEWEB)

    Jeong, Do Young; Ko, Kwang Hoon; Kwon, Duck Hee [Korea Atomic Energy Research Institute, Daejeon (Korea, Republic of)] (and others)

    2007-04-15

    Tl-203 is used as a source material to produce Tl-201 radioisotope which is produced in a cyclotron by irradiating the enriched Tl-203 target. Tl-201 is a radiopharmaceutical for SPECT (single photon emission computerized tomography) to diagnose heart diseases and tumors. This Project aim to develop laser application technology to product stable isotopes such as Tl-203, Yb-168, and Yb-176. For this, photoion extraction device, atomic beam generator, dye lasers, and high power IR lasers are developed.

  3. Market Driving to Develop Rabbit Meat Products in Indonesia

    Directory of Open Access Journals (Sweden)

    Atien Priyanti

    2012-09-01

    Full Text Available Rabbit meat is a nutritional food containing high protein and low cholesterol, fat and sodium. Current research in rabbit production is aimed for developing production strategies to increase the nutritional and economic values of rabbit meat products as functional food. Nowadays, producing rabbit is a popular farming activity in many parts of Indonesia as a small and medium scale operation for food security and cash income. Rabbit farming is to produce meat, skin and hides, fur, organic fertilizers and pet or fancy animals. Consumption of rabbit meat is considered very low, due partly to low meat supply and inavailability of marketing. In some tourist areas, such as Lembang (West Java, Tawangmangu (Central Java, Sarangan and Batu (East Java rabbit meat is a specific food. Attempt to create and drive rabbit markets will simultaneously increase meat production to fulfill the demand and meet economic scale of farming. Hence, this will give significant impact to the farmers’ welfare. Availability of good quality meat, dissemination and diversification of meat products, production efficiency toward competitive price along with its proper marketing strategy will drive consumers’ preferences to consume more rabbit meat. Market driving needs to be created in order to promote rabbit meat products by establishing food outlets. This program has been developed by a farmers group in Magelang, Central Java. During the period of 2006 – 2007 the food outlets had increased to 5 outlets, and in 2012 become 9 outlets. This market driving will also have an impact on changing orientation of rabbit farming from traditional to a small and medium economic scale that will influence the production efficiency.

  4. Concurrent Engineering Approaches within Product Development Processes for Managing Production Start-up phase

    OpenAIRE

    Ebrahimi M., Sajjad

    2011-01-01

    Nowadays in a turbulent market, developing and launching a new product is one of most competitive strategies implemented by many large and small enterprises. In fact, launching a new product depends upon the performance of four critical functions: design, manufacturing, distribution and marketing. Their performances would increase or decrease the total time-to-market and consequently time-to-money. Time-to-market would be improved if the manufacturing system can diminish time-to-volume/qualit...

  5. Approaching a reliable process simulation for the virtual product development

    NARCIS (Netherlands)

    Kose, K.; Rietman, Bert; Tikhomirov, D.; Bessert, N.

    2005-01-01

    In this paper an outline for a strategy to include manufacturing effects in subsequent simulations for the virtual product development from an industrial point of view is given. Especially the conditions for a successful mapping of geometry and results between different applications are discussed.

  6. Educational Development and Production of Accountants in Nigeria ...

    African Journals Online (AJOL)

    Toshiba

    academic accountants in Nigeria from meeting the demands of the growing Nigerian economy. Accordingly, the efforts of the two. Nigerian professional accounting regulatory bodies and tertiary educational institutions that share the responsibility for the development and production of accountants in Nigeria were examined.

  7. The contemporary art of cost management methods during product development

    NARCIS (Netherlands)

    Wouters, M.; Morales, S.; Epstein, M.J.; Lee, J.Y.

    2014-01-01

    Purpose To provide an overview of research published in the management accounting literature on methods for cost management in new product development, such as a target costing, life cycle costing, component commonality, and modular design. Methodology/approach The structured literature search

  8. Rural Tourism and Local Development: Typical Productions of Lazio

    Directory of Open Access Journals (Sweden)

    Francesco Maria Olivieri

    2014-12-01

    Full Text Available The local development is based on the integration of the tourism sector with the whole economy. The rural tourism seems to be a good occasion to analyse the local development: consumption of "tourist products" located in specific local contexts. Starting from the food and wine supply chain and the localization of typical productions, the aim of the present work will be analyse the relationship with local development, rural tourism sustainability and accommodation system, referring to Lazio. Which are the findings to create tourism local system based on the relationship with touristic and food and wine supply chain? Italian tourism is based on accommodation system, so the whole consideration of the Italian cultural tourism: tourism made in Italy. The touristic added value to specific local context takes advantage from the synergy with food and wine supply chain: made in Italy of typical productions. Agritourism could be better accommodation typology to rural tourism and to exclusivity of consumption typical productions. The reciprocity among food and wine supply chain and tourism provides new insights on the key topics related to tourism development and to the organization of geographical space as well and considering its important contribution nowadays to the economic competitiveness.

  9. Senior management support in the new product development process

    NARCIS (Netherlands)

    Gomes, J.F.; Gomes, Jorge; de Weerd-Nederhof, Petronella C.; Pearson, Alan; Fisscher, O.A.M.

    2001-01-01

    This paper studies the relationship between senior management support to new product development activities by means of a quantitative and qualitative analysis of questionnaire and interview data collected in the United Kingdom and the Netherlands. The quantitative analysis showed that there is a

  10. Open Source Development of Tangible Products - from a business perspective

    DEFF Research Database (Denmark)

    Fjeldsted, Asta S.; Adalsteinsdottir, Gudrun; Howard, Thomas J.

    This article’s objective is to set up some foundational theory and practices for Open Source Development (OSD) of tangible products, a novel and emerging approach derived from the well-known open source software movement. As a contribution to the first steps of research in this discipline a clear...

  11. Linking Social and Productive Development Policies for Inclusive ...

    International Development Research Centre (IDRC) Digital Library (Canada)

    Linking Social and Productive Development Policies for Inclusive Growth: A Program of Research and Capacity Building. Peru is one of the fastest growing economies in Latin America, but Peruvians continue to face large disparities in incomes, opportunities, and access to public services. While poverty has declined ...

  12. On the teaching of product development and innovation

    DEFF Research Database (Denmark)

    Andreasen, Mogens Myrup; McAloone, Timothy Charles; Hansen, Claus Thorp

    2000-01-01

    Danish industrialists point out, that the importance of product development and innovation in industry is strongly growing, but the focus upon the way we are working is weakening. Therefore there is concern about the necessary number of students and their abilities in the design area. Current...

  13. On the development of software product-family components

    NARCIS (Netherlands)

    Bosch, J; Nord, RL

    2004-01-01

    Several approaches to the development of shared artefacts in software product families exist. Each has advantages and disadvantages, but there is no clear framework for selecting among these alternatives. As a consequence, mismatches between the optimal approach and the one currently used by an

  14. Developing Product Lines with 3rd-party components

    NARCIS (Netherlands)

    De Jonge, M.

    2007-01-01

    The trends toward product line development and toward adopting more 3rd-party software are hard to combine. The reason is that productlines demand fine control over the software (e.g., for diversity management), while 3rd-party software (almost by definition) provides only little or no control. A

  15. Educational Development and Production of Accountants in Nigeria ...

    African Journals Online (AJOL)

    Toshiba

    Abstract. This paper, through the review of relevant literature, examined the factors that had hindered the educational development and production of sufficient numbers of desirable quality of professional and academic accountants in Nigeria from meeting the demands of the growing Nigerian economy. Accordingly, the ...

  16. Development of Management Methodology for Engineering Production Quality

    Science.gov (United States)

    Gorlenko, O.; Miroshnikov, V.; Borbatc, N.

    2016-04-01

    The authors of the paper propose four directions of the methodology developing the quality management of engineering products that implement the requirements of new international standard ISO 9001:2015: the analysis of arrangement context taking into account stakeholders, the use of risk management, management of in-house knowledge, assessment of the enterprise activity according to the criteria of effectiveness

  17. Soil science, population growth and food production: some historical developments

    NARCIS (Netherlands)

    Hartemink, A.E.

    2007-01-01

    The world¿s population has doubled since 1960. Currently, the developing world accounts for about 95% of the population growth with Africa as the world¿s fastest growing continent. The growing population has many implications but most of all it requires an increase in agricultural production to meet

  18. New insights into consumer-led food product development

    NARCIS (Netherlands)

    Costa, A.I.A.; Jongen, W.M.F.

    2006-01-01

    This paper builds upon a review of relevant marketing, consumer science and innovation management literature to introduce the concept of consumer-led new product development and describe its main implementation stages. The potential shortcomings of this concept's application in European food

  19. Educational Development and Production of Accountants in Nigeria ...

    African Journals Online (AJOL)

    This paper, through the review of relevant literature, examined the factors that had hindered the educational development and production of sufficient numbers of desirable quality of professional and academic accountants in Nigeria from meeting the demands of the growing Nigerian economy. Accordingly, the efforts of the ...

  20. Impact of Charcoal Production on the Sustainable Development of ...

    African Journals Online (AJOL)

    Impact of Charcoal Production on the Sustainable Development of Asa Local Government Area, Kwara State, Nigeria. ... Furthermore, the society should be enlightened through media, visual display and jingles on the impacts of environmental degradation on human health and biodiversity. Key words: Degradation, Climate ...

  1. Local Development of a Production Process for Replacement ...

    African Journals Online (AJOL)

    This paper describes the local development of a production process for a cylinder head of a single cylinder diesel engine. The design drawings were used to design the ... and ports before machining and actual engine tests. The performance of the cylinder head during the on load and no load tests were considered normal.

  2. Market research companies and new product development tools

    NARCIS (Netherlands)

    Nijssen, Edwin J.; Frambach, Ruud T.

    1998-01-01

    This research investigates (1) the share of new product development (NPD) research services in market research (MR) companies' turnover, (2) MR companies' awareness and use of NPD tools and the modifications made to these NPD tools, and (3) MR company managers' perceptions of the influence of client

  3. Market research companies and new product development tools

    NARCIS (Netherlands)

    Nijssen, E.J.; Frambach, R.T.

    1998-01-01

    This research investigates (1) the share of new product development (NPD) research services in market research (MR) companies’ turnover, (2) MR companies’ awareness and use of NPD tools and the modifications made to these NPD tools, and (3) MR company managers’ perceptions of the influence of client

  4. Development of Intelligent Spray Systems for Nursery Crop Production

    Science.gov (United States)

    Two intelligent sprayer prototypes were developed to increase pesticide application efficiency in nursery production. The first prototype was a hydraulic vertical boom system using ultrasonic sensors to detect tree size and volume for liner-sized trees and the second prototype was an air-assisted sp...

  5. Social networks for innovation and new product development

    NARCIS (Netherlands)

    Leenders, R.T.A.J.; Dolfsma, W.

    2016-01-01

    In this article we first provide a brief introduction into social network analysis, focusing on the measures and approaches that are used in the empirical contributions in this special issue. Second, we discuss the role of social networks in new product development. Social networks are inherently

  6. Information paths within the new product development process

    DEFF Research Database (Denmark)

    Jespersen, Kristina Risom

    2007-01-01

    The present study explores the information acquisition within the new product development process (NPD). The effect of the front-end and environmental turbulence on the inter-stage connectedness of information within the NPD process is examined. An agent-based simulation is applied as the data...

  7. "Rap Universal": Using Multimodal Media Production to Develop ICT Literacies

    Science.gov (United States)

    Turner, K. C. Nat

    2011-01-01

    Through a multimodal media production literacy intervention in an extended-day program, culturally and linguistically diverse youth developed valuable information and communication technology literacies, including: (1) Specific how-to skills useful in future academic, professional, social, and civic contexts; (2) Abilities to critically interpret…

  8. Applying the means-end chain concept to product development

    DEFF Research Database (Denmark)

    Søndergaard, Helle Alsted

    This paper proposes that the means-end chain (MEC) approach can influence the use of market information and inter-functional communication in new product development (NPD). The central question is whether market information represented by means-end chain data can be a vehicle for inter-functional...

  9. Production of reactive oxygen species after photodynamic therapy by porphyrin sensitizers.

    Science.gov (United States)

    Kolarova, H; Nevrelova, P; Tomankova, K; Kolar, P; Bajgar, R; Mosinger, J

    2008-06-01

    The objectives of this study was to investigate the production of reactive oxygen species (ROS) after photodynamic therapy (PDT) in vitro. We examined second generation sensitizers, porphyrines (TPPS4, ZnTPPS4 and PdTPPS4) and compared their effectivity on ROS generation in G361 cell line. Used porphyrines are very efficient water-soluble aromatic dyes with potential to use in photomedicine and have a high propensity to accumulate in the membranes of intracellular organelles like lysosomes and mitochondria. Interaction between the triplet excited state of the sensitizer and molecular oxygen leads to produce singlet oxygen and other ROS to induce cell death. Production of ROS was verificated by molecular probe CM-H2DCFDA and viability of cells was determined by MTT assay. Our results demonstrated that ZnTPPS4 induces the highest ROS production in cell line compared to TPPS4 and PdTPPS4 at each used concentration and light dose. These results consist with a fact that photodynamic effect depends on sensitizer type, its concentration and light dose.

  10. Speech production gains following constraint-induced movement therapy in children with hemiparesis.

    Science.gov (United States)

    Allison, Kristen M; Reidy, Teressa Garcia; Boyle, Mary; Naber, Erin; Carney, Joan; Pidcock, Frank S

    2017-01-01

    The purpose of this study was to investigate changes in speech skills of children who have hemiparesis and speech impairment after participation in a constraint-induced movement therapy (CIMT) program. While case studies have reported collateral speech gains following CIMT, the effect of CIMT on speech production has not previously been directly investigated to the knowledge of these investigators. Eighteen children with hemiparesis and co-occurring speech impairment participated in a 21-day clinical CIMT program. The Goldman-Fristoe Test of Articulation-2 (GFTA-2) was used to assess children's articulation of speech sounds before and after the intervention. Changes in percent of consonants correct (PCC) on the GFTA-2 were used as a measure of change in speech production. Children made significant gains in PCC following CIMT. Gains were similar in children with left and right-sided hemiparesis, and across age groups. This study reports significant collateral gains in speech production following CIMT and suggests benefits of CIMT may also spread to speech motor domains.

  11. Singlet oxygen in antimicrobial photodynamic therapy: photosensitizer-dependent production and decay in E. coli.

    Science.gov (United States)

    Ragàs, Xavier; He, Xin; Agut, Montserrat; Roxo-Rosa, Mónica; Gonsalves, António Rocha; Serra, Arménio C; Nonell, Santi

    2013-02-28

    Several families of photosensitizers are currently being scrutinized for antimicrobial photodynamic therapy applications. Differences in physical and photochemical properties can lead to different localization patterns as well as differences in singlet oxygen production and decay when the photosensitizers are taken up by bacterial cells. We have examined the production and fate of singlet oxygen in Escherichia coli upon photosensitization with three structurally-different cationic photosensitizers, namely New Methylene Blue N (NMB), a member of the phenothiazine family, ACS268, a hydrophobic porphyrin with a single cationic alkyl chain, and zinc(II)-tetramethyltetrapyridinoporphyrazinium salt, a phthalocyanine-like photosensitizer with four positive charges on the macrocycle core. The kinetics of singlet oxygen production and decay indicate different localization for the three photosensitizers, whereby NMB appears to localize in an aqueous-like microenvironment, whereas ACS268 localizes in an oxygen-shielded site, highly reactive towards singlet oxygen. The tetracationic zinc(II) tetrapyridinoporphyrazine is extensively aggregated in the bacteria and fails to produce any detectable singlet oxygen.

  12. Singlet Oxygen in Antimicrobial Photodynamic Therapy: Photosensitizer-Dependent Production and Decay in E. coli

    Directory of Open Access Journals (Sweden)

    Arménio C. Serra

    2013-02-01

    Full Text Available Several families of photosensitizers are currently being scrutinized for antimicrobial photodynamic therapy applications. Differences in physical and photochemical properties can lead to different localization patterns as well as differences in singlet oxygen production and decay when the photosensitizers are taken up by bacterial cells. We have examined the production and fate of singlet oxygen in Escherichia coli upon photosensitization with three structurally-different cationic photosensitizers, namely New Methylene Blue N (NMB, a member of the phenothiazine family, ACS268, a hydrophobic porphyrin with a single cationic alkyl chain, and zinc(II-tetramethyltetrapyridinoporphyrazinium salt, a phthalocyanine-like photosensitizer with four positive charges on the macrocycle core. The kinetics of singlet oxygen production and decay indicate different localization for the three photosensitizers, whereby NMB appears to localize in an aqueous-like microenvironment, whereas ACS268 localizes in an oxygen-shielded site, highly reactive towards singlet oxygen. The tetracationic zinc(II tetrapyridinoporphyrazine is extensively aggregated in the bacteria and fails to produce any detectable singlet oxygen.

  13. Links between livestock production, the environment and sustainable development.

    Science.gov (United States)

    Pradbre, J-P

    2014-12-01

    This study examines the prospects for strong growth in the supply and demand for animal products worldwide, especially in developing countries, where 80% of the world's population lives. Based on scientific publications, statistics and field observations, it reviews greenhouse gas emission levels from livestock, the ability of ruminant livestock systems to sequester carbon and the capacity of the livestock industry to meet the challenge of sustainable development and to share its benefits while minimising impacts to climate change. Special attention is paid to the situation of the 800 million livestock farmers in the world living at the extreme end of poverty. The study underlines the importance of improving livestock productivity and the interdependence of the economic, environmental and social components of sustainable development. It highlights how, in the least developed countries and most lower-middle-income countries, the pressure exerted by animal diseases hampers efforts to improve livestock productivity. Poor livestock farmers have not sufficiently benefited from development policies and need support to adopt technological advances to meet the challenges of sustainable development and poverty reduction.

  14. Taking a long look at Art: Reflections on the context of production and consumption of art in Art Therapy

    OpenAIRE

    Gilroy, Andrea

    2014-01-01

    This paper draws on experiences of looking at art to consider the influence of social context on the production and consumption of art in art therapy. I draw on art historical discourses to explore the experience and relate this to looking at art in art therapy. I suggest that professional socialisation profoundly influences how art therapists look and think about what they see. I propose that attention to our tacit knowledge about art, extending art therapy’s practices of looking to include ...

  15. Quality of local authority occupational therapy services: developing an instrument to measure the user's perspective.

    OpenAIRE

    Calnan, S.; Sixma, H.J.; Calnan, M W; Groenewegen, P P

    2000-01-01

    The aims of this paper are threefold: (1) to describe the development of an instrument measuring quality of care from the specific perspective of the users of local authority occupational therapy services; (2) to present the results from a survey of users' views about the quality of services offered by a county-wide local authority occupational therapy service compared with other health and social care services; and (3) to examine the potential of the instrument to form part of a more general...

  16. Targeting the Cholinergic System to Develop a Novel Therapy for Huntington's Disease.

    Science.gov (United States)

    D'Souza, Gary X; Waldvogel, Henry J

    2016-12-15

    In this review, we outline the role of the cholinergic system in Huntington's disease, and briefly describe the dysfunction of cholinergic transmission, cholinergic neurons, cholinergic receptors and cholinergic survival factors observed in post-mortem human brains and animal models of Huntington's disease. We postulate how the dysfunctional cholinergic system can be targeted to develop novel therapies for Huntington's disease, and discuss the beneficial effects of cholinergic therapies in pre-clinical and clinical studies.

  17. Improving the Safety of Cell Therapy Products by Suicide Gene Transfer

    Directory of Open Access Journals (Sweden)

    Antonio eDi Stasi

    2014-11-01

    Full Text Available Adoptive T-cell therapy can involve donor lymphocyte infusion (DLI after allogeneic hematopoietic stem cell transplantation, the administration of tumor infiltrating lymphocyte (TILs expanded ex-vivo, or more recently the use of T cell receptor (TCR or chimeric antigen receptor (CAR redirected T cells. However cellular therapies can pose significant risks, including graft-versus-host-disease and other on and off-target effects, and therefore strategies need to be implemented to permanently reverse any sign of toxicity. A suicide gene is a genetically encoded molecule that allows selective destruction of adoptively transferred cells. Suicide gene addition to cellular therapeutic products can lead to selective ablation of gene-modified cells, preventing collateral damage to contiguous cells and/or tissues. The ‘ideal’ suicide gene would ensure the safety of gene modified cellular applications by granting irreversible elimination of ‘all’ and ‘only’ the cells responsible for the unwanted toxicity. This review presents the suicide gene safety systems reported to date, with a focus on the state-of-the-art and potential applications regarding two of the most extensively validated suicide genes, including the clinical setting: herpes-simplex-thymidine-kinase (HSV-TK and inducible-caspase-9 (iCasp9.

  18. Improving the safety of cell therapy products by suicide gene transfer.

    Science.gov (United States)

    Jones, Benjamin S; Lamb, Lawrence S; Goldman, Frederick; Di Stasi, Antonio

    2014-01-01

    Adoptive T-cell therapy can involve donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation, the administration of tumor infiltrating lymphocyte expanded ex-vivo, or more recently the use of T cell receptor or chimeric antigen receptor redirected T cells. However, cellular therapies can pose significant risks, including graft-vs.-host-disease and other on and off-target effects, and therefore strategies need to be implemented to permanently reverse any sign of toxicity. A suicide gene is a genetically encoded molecule that allows selective destruction of adoptively transferred cells. Suicide gene addition to cellular therapeutic products can lead to selective ablation of gene-modified cells, preventing collateral damage to contiguous cells and/or tissues. The "ideal" suicide gene would ensure the safety of gene modified cellular applications by granting irreversible elimination of "all" and "only" the cells responsible for the unwanted toxicity. This review presents the suicide gene safety systems reported to date, with a focus on the state-of-the-art and potential applications regarding two of the most extensively validated suicide genes, including the clinical setting: herpes-simplex-thymidine-kinase and inducible-caspase-9.

  19. Deuteron induced Tb-155 production, a theranostic isotope for SPECT imaging and auger therapy.

    Science.gov (United States)

    Duchemin, C; Guertin, A; Haddad, F; Michel, N; Métivier, V

    2016-12-01

    Several terbium isotopes are suited for diagnosis or therapy in nuclear medicine. Tb-155 is of interest for SPECT imaging and/or Auger therapy. High radionuclide purity is mandatory for many applications in medicine. The quantification of the activity of the produced contaminants is therefore as important as that of the radionuclide of interest. The experiments performed at the ARRONAX cyclotron (Nantes, France), using the deuteron beam delivered up to 34MeV, provide an additional measurement of the excitation function of the Gd-nat(d,x)Tb-155 reaction and of the produced terbium and gadolinium contaminants. In this study, we investigate the achievable yield for each radionuclide produced in natural gadolinium as a function of the deuteron energy. Other reactions are discussed in order to define the production route that could provide Tb-155 with a high yield and a high radionuclide purity. This article aims to improve data for the Gd-nat(d,x) reaction and to optimize the irradiation conditions required to produce Tb-155. Copyright © 2016 Elsevier Ltd. All rights reserved.

  20. Production of recombinant streptokinase from Streptococcus pyogenes isolate and its potential for thrombolytic therapy.

    Science.gov (United States)

    Assiri, Abdullah S; El-Gamal, Basiouny A; Hafez, Elsayed E; Haidara, Mohamed A

    2014-12-01

    To produce an effective recombinant streptokinase (rSK) from pathogenic Streptococcus pyogenes isolate in yeast, and evaluate its potential for thrombolytic therapy. This study was conducted from November 2012 to December 2013 at King Khalid University, Abha, Kingdom of Saudi Arabia (KSA). Throat swabs collected from 45 pharyngitis patients in Asser Central Hospital, Abha, KSA were used to isolate Streptococcus pyogenes. The bacterial DNA was used for amplification of the streptokinase gene (1200 bp). The gene was cloned and in vitro transcribed in an eukaryotic expression vector that was transformed into yeast Pichia pastoris SMD1168, and the rSK protein was purified and tested for its thrombolytic activity. The Streptococcus pyogenes strain was isolated and its DNA nucleotide sequence revealed similarity to other Streptococcus pyogenes in the Gene bank. Sequencing of the amplified gene based on DNA nucleotide sequence revealed a SK gene closely related to other SK genes in the Gene bank. However, based on deduced amino acids sequence, the gene formed a separate cluster different from clusters formed by other examined genes, suggesting a new bacterial isolate and accordingly a new gene. The purified protein showed 82% clot lysis compared to a commercial SK (81%) at an enzyme concentration of 2000 U/ml. The present yeast rSK showed similar thrombolytic activity in vitro as that of a commercial SK, suggesting its potential for thrombolytic therapy and large scale production